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Abstract 
 
Current methods of forensic DNA analysis are mainly used for identification 
purposes and require a reference sample for comparison to an evidence DNA profile. 
The short tandem repeats (STR) is presently the major highly discriminating method for 
forensic DNA analysis; however, it does not provide useful investigative information, 
with an exception of sex. The ability to provide information on visual appearance of a 
person has great investigative potential in various types of criminal and mass disaster 
investigations. In the last few years this rationale has given rise to a new discipline of 
Forensic Molecular Phenotyping. To date, most work in this area has concentrated on 
pigmentation traits (eye, skin and hair colour), as well as on bio-geographic ancestry. 
Several forensic assays were developed, which were able to predict some of the eye and 
hair shades, as well as several ancestries. However, the genetics of the most intriguing 
part of the human appearance – the face, has not been explored extensively.  
This project aimed to identify single nucleotide polymorphisms (SNPs) influencing 
craniofacial morphology and subsequently incorporate a set of significantly associated 
markers in forensic molecular Identikit for prediction of facial appearance. The work to 
achieve this goal included an implementation of a candidate gene approach along with 
collecting almost 600 DNA samples, accompanied with 3 dimensional (3D) facial 
images. Specifically, more than 1,200 genetic markers located in genes, potentially 
involved in craniofacial embryonic development were genotyped using a Massively 
Parallel Sequencing (MPS) platform, while the 3D images were analysed for 92 various 
craniofacial measurements and ratios.   
In order to validate the statistical methods used for genetic association analysis, a set of 
markers, previously associated with pigmentation and ancestry were incorporated in the 
sequencing panel. Additional markers, such as autosomal STRs, INDELS and identity-
informative SNPs were included in the final genotyping panel as well. The final custom 
amplicon set included 1,700 amplicons, covering approximately 6,500 markers with 
various minor allele frequency, which were genotyped in 587 DNA samples. 
 
 
 
The statistical analysis was performed under stringent conditions and identified multiple 
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associations between craniofacial traits and candidate genetic markers. Over 160 SNPs 
in 63 genes and intergenic regions were strongly associated with either 3D craniofacial 
measurements or principal components, representing facial shapes (areas). Most of these 
genes were previously associated with either embryonic development or craniofacial 
syndromes, although for a few of them, this link was not described before. The 
association analysis of the pigmentation traits revealed multiple associations with both 
known pigmentation genes and novel genes, not yet linked to pigmentation. The 
analysis of four main population groups showed strong association with numerous 
markers, mostly associated with pigmentation, as well as novel ancestry-informative 
SNPs. Ancestry and pigmentation association results were in consensus with published 
data and provided verification of statistical methods used for analysis of the craniofacial 
traits. 
The association results provided strong evidence that novel polymorphisms are involved 
in the normal variation of craniofacial morphology. Subsequently, these results enabled 
creation of statistical models for potential prediction of craniofacial traits along with 
pigmentation and ancestry.    
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Population genetics and statistics terms 
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SNP: A single nucleotide polymorphism in the DNA sequence. 
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adjacent to each other.   
Tag SNP: A markers chosen from a large set of available SNPs, based on favourable 
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1.1. General Introduction 
The current use of human DNA for forensic identification relies on comparison 
of a Short Tandem Repeat (STR) profile, from a crime scene with a known reference 
from a suspect or victim. If the suspect is not available, a DNA profile can be compared 
to a DNA database. However, in cases where no suspect has been identified and a 
criminal DNA database comparison has not revealed a match, the conventional STR 
profile from a crime scene item remains a ‘black box’, unable to provide information 
that may serve as an investigative lead (with the exception of sex). Similarly, in a mass 
disaster or missing person cases, a DNA profile obtained from an unknown person has 
to be compared with a reference sample from personal belongings or known relatives of 
the missing person. In some cases, a craniofacial reconstruction is performed, providing 
additional information on the unknown person. However, this tool is not always 
available and when available, not always accurate.  
The ability to determine the biogeographic ancestry and visual appearance of an 
individual from unidentified skeletal remains or a biological specimen at a crime scene 
can provide important probative information to law enforcement investigators. This 
approach has recently become known in forensics as Forensic Molecular Phenotyping 
(FMP) [2, 3]. Additional information on external visible traits (EVTs), such as 
pigmentation, height, ancestry, and facial appearance may help to reduce the number of 
potential suspects and facilitate police efforts to find the perpetrator of a crime. In 
Disaster Victim Identification (DVI) cases, including unidentified skeletal remains, this 
information can also be helpful in reconstructing the visual appearance of an unknown 
individual. 
Another benefit of using this reverse facial recognition approach is that human 
eyewitnesses have been shown to be inaccurate or simply mistaken [4-7]. Thus, a 
scientific approach, supported by statistics, would be a preferable option in some cases. 
Accurate prediction of EVCs from a DNA sample may help to verify eyewitness 
testimony or provide additional information in the absence of such. 
While some physical characteristics are significantly affected by the environment, 
others are largely determined by the genome. These include the major physical 
descriptors of a person: eye, hair and skin colour, as well as height and facial features. 
These traits are known to be polygenic and are likely to be determined by a number of 
Single Nucleotide Polymorphisms (SNPs) that act in specific combinations to produce 
unique human phenotypes [8]. An extensive amount of work has been done in the last 
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few years on finding the genetic basis of pigmentation traits (eye, skin and hair colour) 
and detection of ancestry informative markers, which has led to the development of 
assays, capable of predicting these traits [9-14]. Detecting a set of polymorphisms in 
candidate genes responsible for the variance in craniofacial morphology will lead to the 
development of a robust, phenotypically informative forensic assay. This science-based 
“molecular identikit” will be less prone to the potential bias of an eyewitness and 
provide a valuable supplemental tool for solving crimes. In DVI cases, this information 
will help with traditional anthropological facial reconstruction by providing additional 
information on the soft facial tissue, which currently is reconstructed based on a best 
guess (as there is no accurate correlation between cranial bones shape and soft tissue 
organs). Finding the genetic basis for normal variety in craniofacial morphology will 
also extend our knowledge on understanding of the craniofacial embryonic development. 
In order to be able to predict human facial appearance from DNA, it is essential to 
understand the basic elements of the craniofacial anthropometry and genetics 
background, collect a range of accurate craniofacial measurements from a large group 
of individuals and genotype a set of candidate genetic markers, which may be 
subsequently associated with specific anthropometric measurements.   
 
 
 
1.2. Anthropometry of the head and face 
 
1.2.1. Craniofacial diversity in different human populations 
A primary visual characteristic of humans is the anatomy of their facial shape 
and features. Most individuals are able to recognise the specific differences in facial 
appearance between various people. In the process of facial recognition, people do not 
rely solely on facial morphology, but also use additional information available, such as 
skin, eye and hair colour. While perceiving a face, people often try to distinguish a 
person’s ethnicity as well. In this process, some facial features together with facial 
pigmentation would become the primary factors in categorising someone’s ethnicity and 
facial recognition. These factors form a complex image, which is recorded in the 
memory and used when needed [15]. However, the information perceived by human 
brain is not always adequately remembered. Some details may be forgotten or 
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remembered wrongly. In the forensic context, this may lead to apocryphal information 
provided by eyewitnesses and point the investigation in the wrong direction [4, 5, 7, 16]. 
As a result, retrieving scientifically reliable information about the ethnic origin and 
physical appearance of a person may verify eyewitness description and help with crime 
investigation. 
Physical anthropologists have long been aware of variation in facial measurements 
among different ethnic groups [17, 18]. However, originally most studies of this topic 
were non-systematic and represented only by visual observations, which lacked a 
standardised scientific basis until the early 18
th
 century [17-19]. Starting from 
approximately 30 years ago, these measurements have been systematically studied in 
various ethnic groups, which had not previously been compared [20-22].  
In addition to ethnic variation, there is an obvious sexual dimorphism in the craniofacial 
morphology. In general, males have larger facial features than females, although the 
reason for this dimorphism is not clear [17, 20, 21]. The most likely explanation is that 
the facial morphology is correlated with sexual dimorphism in body size and oxygen 
consumption. In fact, a recent study demonstrated that the larger noses in males 
significantly correlate with greater body mass and are needed to increase the oxygen 
intake and consumption [23]. 
The size and the shape of facial features are known to be under evolutionary pressure 
and some of them may even predict human behaviour or medical conditions. In addition 
to the most obvious influence of overall facial attractiveness on the mating choice and 
other social interactions, particular facial features may have significant psychological 
impact on humans’ social behaviour. Intuitively, this may include the shape and size of 
the chin (cleft or “strong”), straight or concave nose and thin or thick lips. Haselhuhn et. 
al. found that men with wider faces (specifically with greater width-to-height ratio) are 
perceived by others as more likely to lie, being aggressive and make other people act 
selfishly [24]. Another study showed that brown-eyes men are perceived as more 
dominant than blue-eyes men in the European population data set [25]. Interestingly, 
males with brown eyes have statistically significant broader and massive chins, broader 
mouths, larger noses, and eyes that are closer together with larger eyebrows. Other 
studies found association between head and face form (specifically increased cephalic 
index and decreased facial index) and brachycephaly with increased risk of obstructive 
sleep apnea or apnea hypopnea index respectively in the Caucasian population [26, 27].  
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Predicting several aspects of human behaviour, known to be in correlation with 
craniofacial features and derived from a DNA sample may provide additional useful 
information for crime investigation, although the genetics behind this link is still unclear. 
Since many human craniofacial anthropometric characteristics display a normal 
distribution (within a single healthy population), mean values appear to be useful in 
describing these characteristics [17, 18]. Figures 1 and 2 show average facial images of 
men and women of various nationalities, which were produced by merging 
approximately 50 images for each ethnicity, as a part of the “Face of Tomorrow” project 
(www.faceoftomorrow.com). Comparing the size and shape of facial features between 
the images, may provide useful information on the specific differences between these 
nationalities. While the differences in facial appearance between various ethnicities are 
easily recognisable, they only represent average features, which need to be “translated” 
into accurate anthropometric measurements to provide a useful tool in forensic 
investigation. 
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Figure 1. Average female face in different nationalities. 
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Figure 2. Average male face in different nationalities. 
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1.2.2. Anthropometric measurements of the head and face 
The following section briefly describes basic craniofacial landmarks on the skull 
and the soft facial tissue as well as various measurements derived from them. All 
specific measurements relevant to this work are described in details in the Chapter 2. 
 
1.2.2.1. Cranial (hard tissue) landmarks and measurements 
The cranium is a support matrix for the facial soft tissue, although its morphology is 
not a direct indication of the overlying facial structures. The bone is covered by a soft 
tissue layer, making it difficult to find most of the cranial landmarks on a living subject.  
There are a number of fundamental cranial landmarks, providing descriptive 
information about the cranium such as: Bregma (b), Euryon (eu), Gnathion (gn), Gonion 
(go), Nasion (n), Opisthocranion (op), Vertex (v) and Zygion (zy), as detailed in Figures 
3-5. These landmarks form the basis for numerous linear and angular measurements as 
well as over 160 indices (ratios between these measurements), which provide 
information on facial proportions, established largely by Farkas [17, 18]. There are 
more than 150 facial proportions described in the literature [18]. Not surprisingly, some 
proportions are significantly different between ethnicities and play an important role in 
describing facial aesthetics. Knowing aesthetical proportions in the relevant population 
is very useful in a case of surgical craniofacial intervention [18, 20-22, 28].     
Identification of some of the craniofacial landmarks can be challenging, especially 
landmarks whose location depends on the position of the head or are described only 
generally (such as the highest or the most distant point of the head) or are placed on 
bony prominences underlying the skin (like most soft tissue landmarks). This situation 
may lead to inter or intra examiner inconsistency in measurements.  
Figures 3 - 5 illustrate major cranial landmarks used in craniofacial anthropometry. A 
more comprehensive definition for each landmark is detailed in the List of Terms and 
Abbreviation and Materials and Methods Chapter. Most of these landmarks are 
identified by using a spreading calliper (as a maximum distance between two landmarks) 
or by palpating.   
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Figure 3. Frontal, lateral and bottom view of skull with cranial landmarks. Sourced from 
http://www.theapricity.com/snpa/index2.htm. 
  
 
Figure 4. Frontal and lateral view of a skull with major cranial distances. Sourced from 
http://www.theapricity.com/snpa/index2.htm. 
 
Figure 5. Major craniofacial landmarks. Sourced from http://www.theapricity.com/snpa/index2.htm. 
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Measuring the distance between various landmarks provides a set of craniofacial 
measurements. The most informative and widely used cranial measurements are:  
 Maximum head length (g-op) 
 Maximum head height (v-gn) 
 Maximum head width (eu-eu)  
 
The location of landmarks, used to calculate these measurements is illustrated in the 
following picture (Figure 6) 
 
 
 
Figure 6. Craniofacial surface landmarks of the head and face in frontal and lateral positions. Figure modified 
from Farkas L.,  Anthropometry of the Head and Face (1994) [17]. 
 
 
Two of these measurements are used to calculate the Cephalic index (C.I.), which is 
considered the most informative craniofacial index. C.I. is defined as: (Maximum head 
breadth (eu-eu) / Maximum head length (g-op))* 100. 
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The C.I. provides categorical information about head shape and size. According to the 
Frankfort Craniometric Agreement of 1882 [19], C.I. variation can be categorised as 
following: 
C.I. 55.0 - 59.9 = ultradolichocephalic (extremely long-/narrow-headed) 
C.I. 60.0 - 64.9 = hyperdolichocephalic (very long-/narrow-headed) 
C.I.  65 - 74.9  = dolichocephalic (long-/narrow-headed) 
C.I. 75.0 - 79.9 = mesocephalic (intermediate in head form) 
C.I. 80.0 - 84.9 = brachycephalic (round-/short-/broad-headed) 
C.I. 85.0 - 89.9 = hyperbrachycephalic (very round-/short-/broad-headed) 
C.I. 90.0 - 94.9 = ultrabrachycephalic (extremely round-/short-/broad-headed)  
The French system [17, 18] however, recognises less categories, omitting marginal 
values:  
C.I.          - 75.00 = dolichocephalic 
C.I. 75.01 - 77.77 = subdolichocephalic 
C.I. 77.78 - 80.00 = mesocephalic 
C.I. 80.01 - 83.33 = subbrachycephalic 
C.I. 83.34 -          = brachycephalic 
Each head type (according to specific CI value), provide additional information on the 
specific facial morphological traits [1, 17, 29]. A long and narrow dolichocephalic head 
would most likely demonstrate a protrusive nasomaxillary component to allow more 
efficient air flow. The nasomaxillary component would be also lowered relative to the 
mandible, resulting in posterior location of the latter. On the contrary, a wide and short 
brachycephalic head would most likely demonstrate a short, wide and more posterior 
located nasomaxillary component, allowing sufficient air flow. The mandible in this 
case would be located more anterior, protruding from the face. Some head types are 
more common in the specific population groups than other. Such as dolichocephalic 
heads are more common in the North African, North European and Middle Eastern 
populations, while the Asian population is more associated with the brachycephalic 
heads.  
Historically, the European population has been the most extensively studied by 
anthropologists, with the number of anthropometric studies comparing other population 
groups being quite limited [22, 28, 30]. In recent years, several studies have compared 
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additional population groups, such as African and Asian populations [17, 30-34]. These 
studies demonstrated that based on the C.I. measurements, the Chinese for example, 
generally have a short head, Europeans generally have a medial head and Africans have 
a relatively elongated head. Specifically, the greatest difference between these three 
populations is found in the head height and width. The head in the African population is 
the largest in length and smallest in width. In the Chinese population, the head is the 
largest in width and smallest in length. The head in the Caucasian population is 
generally wider than African, but narrower than in the Chinese population.  
Specifically, the mean values of the C.I. may range from the upper limits of 
dolichocephaly in the Anglo-Saxon, Scandinavian and African populations, through 
mesocephaly in the Slavic and Central European populations to hyperbrachycephality in 
the central Asian populations. In spite of the wide range of C.I. variation, the “normal” 
values range in the world – wide population is relatively limited and usually represented 
as between approximately 73-75 and 88-89 [28]. Despite the statistically significant 
difference in C.I. and other craniofacial measurements between various population 
groups, these measurements are not highly descriptive and prone to potential error in 
measurements. As a result, they cannot be efficiently used for descriptive population 
differentiation, especially in the modern cosmopolitan society with a high degree of 
admixture. This problem can be potentially solved by applying a set of DNA markers, 
which show strong association with specific anthropometric measurements and bio-
geographic ancestry.  
 
1.2.2.2. Facial (soft tissue) landmarks and measurements 
 Traditional anthropometry treats the face as a two-dimensional object. Most 
facial measurements cover the vertical plane (facial length), some cover the horizontal 
plane (facial breadth) and only a few cover the facial depth. The facial depth 
measurements are the most difficult to capture. However, the use of a 3-Dimentional 
scanner can provide extensive information of a facial surface and potential 
measurements (as detailed in Section 1.2.3)  
Some of the soft facial tissue landmarks represent the same landmarks, which can be 
found on the cranium (e.g. glabella, zygion and gonion), while others can be allocated 
only on a living subject. Figure 7 illustrate classical facial landmarks based on Farkas 
et.al [17].  
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a)                                         b)          c)  
 
Figure 7. Craniofacial landmarks of the soft tissue on a- frontal, b – lateral, c- base aspects. Sourced from Farkas 
et.al. [17]. 
 
 
 
In the traditional anthropometry, the direct assignment of the craniofacial landmarks is 
an integral part of the measurements. There is a need for location of the craniofacial 
landmarks by palpating, followed by manual measurement of the linear and angular 
distances between these landmarks using a calliper. In the 2D or 3D facial images 
however, the location of landmarks and relevant measurements performed indirectly. A 
difference between these approaches may introduce errors in the digital approach as 
well as significant challenges if a comparison between the measurements obtained by 
different methods is required. 
Figures 8 and 9 illustrate basic linear measurements of the head and face. A detailed list 
of the craniofacial landmarks used in this study is presented in the Chapter 2. 
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Facial measurements of the vertical plane: 
 
Physiognomic facial height (tr-gn) 
Forehead height (tr-n) 
Nose height (n-sn) 
Morphological face height (n-gn) (total face 
height) 
Lower face height (sn-gn) 
 Ear length (sa-sba) 
 
 
 
Facial measurements of the horizontal plane: 
 
Binocular width (ex-ex) 
Maximum facial breadth (zy-zy)  
Nose width (al-al)  
Mouth width (ch-ch) 
Mandible width (go-go) 
 
 
 
 
Figure 8. Perpendicular measurements of the 
face. Sourced from Farkas et.al. [1]. 
Figure 9. Horizontal measurements 
of the face. Sourced from Farkas 
et.al. [1]. 
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Linear measurements, illustrated in Figures 8 and 9 can be used for calculating several 
indexes. Among others, the facial index (F.I.) is an important basic facial measurement, 
also known as total facial index, which is calculated as follows: morphological face 
height (n-gn) / maximum facial breadth (zy-zy)* 100. 
According to Farkas [18], facial index measurements can be divided into four main 
groups, which used to categorize human faces:  
F.I.        - 79.9 = hypereuryprosopic (very short-/broad-faced) 
F.I. 80.0 - 89.9 = euryprosopic (short-/broad-faced) 
F.I. 90.0 - 94.9 = leptoprosopic (long-/narrow-faced) 
F.I. 95.0 -        = hyperleptoprosopic (very long-/narrow-faced)  
The nose is one of the most prominent facial features. Nose width and height show 
significant variation between various ethnicities. The ratio between nose width and 
height is represented by Nasal Index (N.I.), which is calculated as follows: nose width 
(al-al)*100 / nose height (n-sn). 
According to the Frankfort Agreement [19] N.I. can be categorized into four main 
groups: 
N.I.        - 47.0  = leptorrhine (narrow-nosed) 
N.I. 47.1 - 51.0 = mesorrhine (having a nose of moderathe width) 
N.I. 51.1 - 58.0 = platyrrhine (wide-nosed) 
N.I. 58.1 -         = hyperplatyrrhine (very wide-nosed) 
A comparison between the mean values of various population groups show that the 
Chinese population (for example), generally has a more euryprosopic face with a 
platyrrhine nose, while the European population has a more leptoprosopic face with a 
mesorrhine or leptorrhine nose and the African population tend to have a more 
euryprosopic face and a platyrrhine to hyperplatyrrhine nose [21, 22, 28]. Specifically, 
European noses tend to be longer and narrower than African and set more highly on the 
face. Europeans usually have narrow faces, higher cheekbones, wider cranium and more 
prominent foreheads than Africans. In addition, jaws in the African population protrude 
more from the face than do European jaws. Africans also have wider orbits and wider 
inter-orbital spaces than Europeans. Asians typically have wide and flat faces, wider 
spaced eyes and flat supranasal regions. In general, Europeans have smaller faces than 
most non-European populations, in spite of being taller and heavier than many non-
European populations. 
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1.2.3. Methods of facial landmarks analysis 
There are two types of craniofacial anthropometrical measurements: direct and 
indirect. Direct anthropometric measurements involve using traditional measuring 
equipment such as sliding and spreading callipers and measuring tape. The advantage of 
direct measurements is that this process is objective, reliable and inexpensive. The 
examiner has full access to all the bony landmarks, reducing potential errors in incorrect 
location of these landmarks in indirect methods. The main limitation of direct 
measurements is that the examination may take approximately an hour or even longer, 
making it ineffective for large sample size and working with children. 
The indirect approach involves using 2D or 3D images for performing craniofacial 
measurements. Since the publication of the first English-language manuscript on 
anthropometry by Ales Hrdliĉka in 1920 [35], which introduced a set of 14 cranial and 
facial measurements, the methods for accurate measurements of the craniofacial 
features have undergone significant changes. From using manual and time consuming 
devices such as a calliper and measuring tape, to more sophisticated, accurate and faster 
methods, such as 3-Dimentional image-capturing methods, represented by Computer 
Tomography (CT), Magnetic Resonance Imaging (MRI) and more recently by a 3-
Dimentional (3-D) laser scanning [36-43]. 
The advantage of the indirect measurement is that it takes significantly less time than 
the direct approach (few minutes) and offers better resolution (such as CT and MRI), 
providing an opportunity to collect more samples and also use this technique in the 
medical field [37, 44]. Using regular photographs (2D images) for collecting indirect 
measurements is also possible. This method is fast, cheap and easy. However, 3D image 
capturing technologies provide a more accurate image than 2D photos, with a computer 
file output, that can be processed further by automatically calculating craniofacial 
measurements. In addition, 2D photographs do not reflect the natural anatomy of the 
face and as a result do not provide information on the facial surface, omitting useful 
information. The CT scan offers a relatively high image quality, but involves exposure 
to low levels of radiation. This technology is also expensive and not easily accessible. 
MRI provides a very high resolution soft tissue representation without exposing patients 
to radiation, but it is even more costly than CT, is not easily accessible and is also time 
consuming. 3D laser-scanning on the contrary, is a completely health-safe, fast, easy 
and cost – effective procedure, offering high-resolution facial images. 3D laser 
digitizers have been validated in several studies, showing very high precision and have 
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been demonstrated to accurately capture even minor facial appearance differences in 
twins [38, 41, 45-47]. 
As an alternative to the traditional direct measurements, the use of digital equipment 
allows extraction of the Euclidean coordinates (x, y and z) for each landmark and 
subsequent calculation of various distances in an automatic and fast manner, without the 
need to perform each measurement separately.  
Based on the Euclidean geometry rules, the distance between two coordinates in the 3D 
space can be calculated using the following formula: 
Linear distance = √(     )  (     )  (     )  
Given that the distance between points 1 and 2 is “a”, between points 2 and 3 is “b” and 
between points 1 and 3 is “c”, the angle between points 1, 2 and 3 can be calculated by 
using this formula: 
 
Angular distance = 
     (        )
 (   )
 
These formulae can be programmed in to user-friendly software, such as an Excel 
spreadsheet, and used for relatively easy and fast extraction of various craniofacial 
measurements based on landmarks coordinates. 
However, digital technologies have a few limitations. The main limitation of the 3D (as 
well as 2D) image-capturing techniques is the image processing, which includes facial 
landmark location and extraction. Performing this procedure manually is tedious and 
time-consuming. Automatic facial image processing has been explored in several 
studies, but is still under development and standardization [36, 37, 44, 47-49]. It 
involves application of special algorithms, which recognize specific anatomical features 
and craniofacial landmarks. This approach usually involves using a set of images that 
have been processed manually for location of these landmarks, which are used by a 
computer program to automatically recognise the same landmarks on a new image 
based on the similarity. However, current algorithms used for this purpose are still not 
able to accurately recognize facial landmarks on various faces. Given that each face is 
different from another, this approach does not always produce an accurate outcome. As 
a result, most landmarks generated using this approach have to be re-examined 
manually, which may significantly decrease the advantage of this method versus manual 
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landmark allocation. In addition, most of the algorithms used for this purpose are “in-
house” developments and have not been extensively validated or are easily available for 
use. The majority of these algorithms are available as “command-line” software, 
requiring additional programming skills knowledge. 
 
1.2.4. Craniofacial reconstruction 
Facial reconstruction, which uses anthropometric measurements from skull 
remains to estimate the facial appearance of a person is an important tool in forensic 
investigation. Facial reconstruction is based on the fact that the bony cranium represents 
the supporting basis for soft facial tissue [50]. However, there is no precise correlation 
between the cranium and the soft tissue. The reconstruction of the nose, mouth and ears 
are particularly difficult, as these soft tissues are not supported by a bony frame and the 
cartilage under these facial features is often not present in skeletal remains [51, 52]. In 
addition, other phenotypic features such as pigmentation and hair texture cannot be 
reconstituted from anthropometric measurements and are usually a best guess by the 
anthropologist, based on inferred ancestry. As a result, most current facial 
reconstruction methods focus on generating an average face, which may or may not 
resemble the original one [52-54]. With the recent development of more accessible 3-D 
image – capturing technology this process has become more accurate, although it is still 
far from being standardised [46, 51, 55, 56].  
In some forensic cases the skull is not available for analysis. In such cases, the DNA 
analysis is essential. While DNA typing of skeletal remains is routinely used for 
identification or paternity purposes, the recent advances in human pigmentation genetics, 
offer an opportunity to predict of eye, skin and hair colour from skeletal remains [9]. A 
better understanding of the craniofacial genetics and in particular, knowing the genetic 
factors behind the size and shape of the specific craniofacial features, would allow 
potential prediction of these traits and more accurate craniofacial reconstruction from a 
skull or even a little piece of biological (even non-skeletal) evidence.  
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1.3. Craniofacial development and embryogenetics 
This section briefly outlines the major stages of the craniofacial embryonic 
development in Homo sapiens, the genes which regulate this complex process and 
discusses craniofacial malformations that may occur as a result of genetic mutation in 
these genes.  
Human craniofacial development is a complex multistep process, involving numerous 
signalling cascades of factors that control neural crest development, followed by a 
number of epithelial-mesenchymal interactions that control outgrowth, patterning and 
skeletal differentiation. The mechanisms involved in this process include various gene 
expression and protein translation patterns, which regulate cell migration and 
positioning. These events are precisely timed and are under hormonal and metabolic 
control. Most facial features of the developing human embryo are recognizable from as 
early as 5 weeks post conception (Figure 10). The resulting face is different from person 
to person, even in the case of monozygotic twins, whose faces (the soft tissue) acquire 
differences with the age – most likely, as a result of the epigenetic influence on 
phenotype. This influence may be a function of various factors, including differences in 
nutrition (influencing hormones and growth factors) as well as social interaction (e.g. 
various muscles involved in facial mimics) [57-60].  
 
Figure 10. Human embryo at 5 weeks showing early stages of facial feature formation. Eyes, nose and mouth are 
easily recognizable. Courtesy of Lennart Nilsson [61].   
A comprehensive overview of different stages of foetal development made by in vivo 
video animations is available from Lennart Nilsson’s web site: 
http://web.tt.se/lennart_nilsson_video/index_m.html. 
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The vertebrate head is a composite structure whose formation begins early in 
development, as the brain begins to form (Figure 11). 
 
 
 
Figure 11. Transverse section through 20-day-old embryo depicting neural folds and neural crest formation. 
Sourced from Sperber et.al.[62] . 
 
 
Central to the development of the head is the concept of segmentation, evident in 
development of the hindbrain and branchial arch systems. Together with migrating 
neural crest cells, these systems give rise to most of the head and neck compartments 
(Figure 12). 
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Figure 12. Neural crest induction and migration in the developing embryo. (A) The neural plate consists of a 
unified layer of ectoderm, beneath which lies the endoderm. The neural folds arise as the ectoderm begins to fold 
upwards. Interactions between signalling molecules cause the medial portion of ectoderm to begin to assume a 
neural character (green) while lateral portions of ectoderm begin to take on a non-neural character (blue). The 
prechordal plate mesendoderm (pcp) and the buccopharyngeal membrane (bpm) are indicated. (B) As the neural 
folds begin to fuse, the neural tube takes shape, giving rise to distinct tissue layers of neuroectoderm (green) and 
surface ectoderm (blue). Neural crest cells start to delaminate from the border region between the neuroectoderm 
and surface ectoderm. (C) Once the neural tube has closed, neural crest cells lie interposed between the facial 
(surface) ectoderm (fe) and the neuroectoderm (ne). (D–F) As the central nervous system begins to form from the 
neural tube, the neural crest starts to migrate anteriorly from rhombomeres (r1–r3) into different areas of the face, 
and into the pharyngeal arches. Abbreviations: C, caudal; is, isthmus; mes, mesencephalon; mn, mandible; PA, 
pharyngeal arch; pe, pharyngeal endoderm; rp, Rathke’s pouch; R, rostral; tel ne, telencephalic neuroectoderm. 
Based on Tapadia et.al. and Helms et. al. [63, 64]. 
 
The neural crest is a pluripotent cell population that plays a critical role in the 
development of the vertebrate head. This ectomesenchymal tissue arises from the crests 
of the neural fold during the gastrulation process of the embryonic disk (Figure 11). 
Unlike most parts of the body, the facial mesenchyme (whole viscerocranium and part 
of the neurocranium) is formed principally from the neural crest and not the mesoderm 
of the embryonic third germ layer [63, 64]. The cranial part begins its development as 
early as the middle of the third week post coitum. By the fourth week, neural crest cells 
migrate extensively throughout the embryo in four overlapping domains: cephalic, trunk, 
sacral and cardiac. Subsequently, the cephalic neural crest cells migrate from the 
posterior midbrain and hindbrain region into the branchial arch system. The 
ectomesenchymal neural crest cells then interact with epithelial and mesodermal cell 
populations present within the arches, leading to the formation of craniofacial bones, 
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cartilage and connective tissues. The dermatocranium (roof of the skull), is however 
formed not from cartilage, but from direct ossification of the deep layers of the dermis. 
Cells, which migrate within the cranial paraxial mesoderm form somitomeres, which 
subsequently develop into the muscles of the face and jaws. Other neural crest cell 
populations provide mesenchyme for angiogenesis to produce blood vessels, in addition 
to others, which will develop later to melanocytes for skin and eye pigmentation.  
The initial orofacial development is induced by two organizing centres. The first is 
called prosencephalic centre and is derived from prechordal mesoderm. It induces the 
development of eyes, inner ear and upper third of the face. The second is called 
rhombencephalic centre, and induces the middle and lower thirds of the face (Figures 13 
and 14). Simultaneously with these processes develops the forebrain, which induces 
multiple signalling areas in the ectoderm. These areas control the differential cell 
proliferation of the nasal area in the upper face region. Subsequently, these signalling 
cascades induce the ectomesenchyme to develop five prominences, such as paired 
maxillary and mandibular and single frontonasal, which give rise to the specific facial 
features.  
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Figure 13. Primary germ layers and their derivatives. Sourced from Sperber et.al., [62]. 
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Figure 14. Primary germ layers and their derivatives. Sourced from Sperber et.al., [62]. 
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The developing head is a community of all of these cell populations (Figure 14). 
Disruption to any one of these pathways, interfering with a normal craniofacial three-
dimensional developmental process, may lead to a variety of craniofacial syndromes 
including disruption of brain morphogenesis, usually accompanied by facial 
malformations. 
Interestingly, there are a number of known malformations of the limbs, which are 
expressed together with various craniofacial abnormalities [65-68]. This is most likely 
due to the overlap in signalling pathways involving limb and head development. 
Therefore, genes that are involved in limb development may also influence normal 
variation in craniofacial features.  
 
1.3.1. Craniofacial embryogenetics 
The cranial and facial tissues are comprised of a large number of complex structures 
whose development is controlled by a wide number of genes, expressed in a specific 
pattern during embryonic maturation (Figure 6). These genes represent different gene 
classes (many of which can be differentiated into further subcategories) and include: 
 Homeobox domain genes such as: distal-less homeobox (DLX), hedgehog 
(HH), wingless (WNT) and aristaless-like homeobox (ALX ) gene families;  
 Signalling and growth factors and their receptors such as: fibroblast growth 
factor and its receptor (FGF and FGFR), epidermal growth factor and its 
receptor (EGF and EGFR), transforming growth factor β (TGFβ), endothelin 1 
(ET1), Bone morphogenetic protein (Bmp) antagonists (e.g. Chordin and 
Noggin) and Jagged; 
 Transcription factors such as: ALX, BARX, BMP, FGF, DLX, GSC, LHX, 
MHOX, MSX, PAX, PITX, TP63, gene families;  
 Matrix proteins such as: Collagen, ANKH, FGD1; 
These genes can be also classified by their expression in various stages of embryonic 
development of particular facial tissues (Figure 15). For example, the genes ALX4, 
BMP2,4,7; BSP, COL1, DLX5, FGF1-3, FGFR1-3, FOXC1, ID1, MSX1, MSX2, PTC, 
RUNX2, TWIST, TGFβ1-2 and SHH are involved in cranial sutures development; 
ALK5, BMP, FGF, Lrp6, SHH, TGFβ1, WNT are involved in nasal pit, upper lip and 
upper jaw formation and DLX and PAX6 are involved in eye formation. 
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The majority of these genes have been identified in animal models, expressing various 
types of craniofacial malformations. Although many of mutations in these genes can 
lead to facial anomalies, currently there is little information available regarding specific 
polymorphisms, which can be identified as potentially indicative of normal variation in 
craniofacial shape and other facial characteristics. 
 
 
 
Figure 15. Keyed drawing of gene expression patterns of developing embryonic face of approximately 7 weeks 
post conception age. Sourced from Sperber et.al., [62]. 
 
 
1.4. Possible approaches for finding genes and markers associated with normal 
variation in the craniofacial appearance 
The identification of the markers responsible for normal craniofacial appearance 
can be achieved by taking two main approaches: 
1. Genome Wide Association Study (GWAS).  
This approach usually involves genotyping millions of SNPs in thousands of individuals 
and analysing the data for potential associations between the trait of interest and genetic 
markers [69]. This approach has successfully identified genes and mutations involved in 
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many complex disease and traits [70, 71]. In spite of being a very powerful approach, 
the requirement for such a large sample size and the need to type millions of genetic 
markers, as well as the high cost, renders the approach not feasible for this research 
project. 
2. Candidate gene approach. 
This method does not require as large a sample size as GWAS approach, due to a more 
focused genotyping of a limited number of markers.  It can be performed using one or 
all of the following pathways: 
o Identification of genes previously shown to be involved in normal human 
facial appearance and subsequently selecting markers, which may have an 
effect on the phenotype (as detailed in section 1.4.1). 
o Genotyping markers in genes, shown to be involved in craniofacial disorders 
in human and model organisms. Genes that result in disease phenotype may 
also affect normal variation of that phenotype, similar to genes involved in 
Albinism and normal pigmentation [72] . 
o Genotyping markers showing high population differentiation (high Fst 
values) and particularly in or near genes, potentially involved in craniofacial 
embryogenesis. Based on visual differences in craniofacial appearance 
between various populations, it may be hypothesized that markers with high 
Fst values, which are located in genes expressed in various stages of 
craniofacial embryonic development, would be involved in determination of 
the normal craniofacial appearance. 
Based on the cost and time limitations of this project, a candidate gene approach was 
chosen as the most appropriate method for finding the SNPs involved in the craniofacial 
appearance. 
 
 
1.5. Genetics of the normal craniofacial development in human 
Until recently, molecular cascades that control human craniofacial development, 
and particularly of specific facial features, have been poorly understood. In fact, prior to 
2010 there were only three studies that described associations between specific 
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craniofacial measurements and SNPs in only few genes such as GHR, FGFR1 and 
ENPP1 genes [73], [74], [75]. In 2012, a further two studies identified an association 
between several markers and specific craniofacial anthropometric measurements [76, 
77]. A GWAS undertaken in the same year found that PAX3 gene, previously 
associated with Waardenburg Syndrome, influences the growth of nasal tissue and 
specifically the ‘nasion’ position. SNP rs7559271 allele of PAX3 gene was found to be 
associated with an increase of 0.39 mm in nasion-mid endocanthion distance [78]. The 
second study identified associations between various facial measurements and SNPs, 
such as between rs4648379 in PRDM16 and alare-pronasale distance; between 
rs974448 in PAX3 and eyeball - nasion distance; between rs17447439 in TP63 and left 
and right eyeballs distance; between rs6555969 in C5orf50 and zygion – nasion and 
eyeball – nasion distances; and between rs805722 in COL17A1 genes and eyeballs and 
nasion distance [77].  
The limited number of studies on the normal human craniofacial appearance illustrates 
the demand for a complimentary approach in searching for the craniofacial candidate 
genes and markers.  
 
 
1.5.1. Craniofacial syndromes with known genetic mutations in human 
and model organisms 
The cranium is composed of two major groups of bones: those that surround the 
brain called neurocranium (composed of desmocranium and chondrocranium) and those 
that surround the oral cavity, pharynx and respiratory passages known as 
viscerocranium. Neurocranium gives rise to the bones of the cranial vault, known as 
calvaria. At birth, the cranial vault surrounding the brain consists of seven calvaria 
bones with adjoining bones separated by fibrous joints (growth centres) called calvarial 
sutures (Figure 16). Interestingly, the bones of the jaws and facial skeleton 
(viscerocranium) are evolutionary younger than chondrocranium and more susceptible 
for developmental defects [79]. While serious malformations in these structures may 
lead to different facial abnormalities, polymorphisms in genes responsible for the 
development of the cranial vault and specifically neurocranium, might influence normal 
cranial shape [80, 81]. 
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Figure 16. Anatomical features of the human skull at birth .The blue line indicates an approximate border 
between the neurocranium and viscerocranium. Sourced and edited from Wilkie et.al., [79]. 
 
There are at least 250 syndromes, that display various craniofacial abnormalities such as 
anencephaly, holoprosencephaly, exencephaly, as well as skeletal and facial defects, 
such as cleft lip/palate, (discussed in more detail in Section 1.4.3). The facial defects 
may be restricted to specific regions of the head, although are often linked to cardiac 
and aortic arch defects or developmental limb defects, reflecting the common origin of 
these structures.  
One of the most common craniofacial defects is craniosynostosis, caused by premature 
fusion of calvaria bones. Craniosynostosis can occur sporadically and termed non-
syndromic or be inherited (usually as a dominant trait) and termed syndromic [82, 83]. 
Syndromic craniosynostosis usually involves additional abnormalities of the skull, as 
well as normal phenotypes such as long or beaked nose, protrusive or retrusive jaws, 
wide eyes and large brow ridges. As a result, a research on syndromic craniosynostosis 
disorders may provide additional insights on the normal craniofacial morphology [74]. 
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Examples of such conditions include DiGeorge syndrome (1 in 4,000 births), Treacher-
Collins syndrome (1 in 10,000 births), Saethre-Chotzen syndrome (1 in 25,000 births), 
Pfeiffer syndrome (1 in 100,000 births) and Rieger syndrome (1 in 200,000 births), all 
of which are inherited in an autosomal dominant manner [84-96]. Malformations of the 
limbs and/or the skull have been associated with mutations in several human and model 
organism genes, such as sonic hedgehog (SHH), fibroblast growth factor (FGF) receptor 
family and transcription factors like TWIST [62, 79]. 
A number of other genetic syndromes are known to affect facial connective tissue and 
specifically the cartilage. These disorders are generally known as Collagenopathy type 
II and XI and caused by mutations in COL2A1 gene (type II collagen) or in COL11A1, 
and COL11A2 genes (type IX collagen). Various mutations in collagen genes may 
result in a number of conditions, such as Hypochondrogenesis, Achondrogenesis type 2, 
Stickler syndrome, Kniest dysplasia, Weissenbacher–Zweymüller syndrome, 
Otospondylomegaepiphyseal dysplasia and Spondyloepimetaphyseal dysplasia [97-100].  
In addition to “classic” craniofacial disorders, there are many syndromes that are not 
formally designated as craniofacial, but among other major symptoms, show distinct 
dysmorphic facial features which are often used to diagnose these disorders. This group 
includes conditions with various chromosomal aberrations such as Down syndrome, 
Fragile X Syndrome and Turner Syndrome [101-108] as well as specific mental 
conditions, such as schizophrenia [109-111]. For example, people suffering from Down 
syndrome demonstrate brachycephaly, smaller and flatter cranial base, almond-shaped 
eyes, epicantic folds, reduced orbital height and width, small nasal bones, mandibular 
prognathism and ear dysmorphology. Facial features of the Fragile X Syndrome are 
characterised by long and narrow face, prominent forehead and large ears. Females 
patients with Turner syndrome demonstrate distinct facial features, such as downward 
slanting eyes, prominent earlobes and very broad necks. Patients suffering from 
schizophrenia demonstrate narrowing and reduction of the mid to lower face and 
frontonasal prominences, including reduced width and posterior displacement of the 
mouth, lips, and chin, increased width of the upper face, mandible, and skull base, with 
lateral displacement of the cheeks, eyes, and orbits and greater downward displacement 
of the tip of the nose. Interestingly, the association of 22q chromosomal region with 
schizophrenia by Scutt et.al. [109], which was subsequently confirmed and extended by 
Xu et.al. [112], may in fact be an influence of nearby craniofacial genes/SNPs, rather 
than genes involved in schizophrenia itself, although this hypothesis was not considered 
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by the researchers. This is rather strange, as 22q11 deletion is primarily associated with 
Di George syndrome, which among other features characterized by elongated facial 
features often with flat cheekbones, a long ‘strong’ nose with a relatively broad and 
prominent nasal bridge, small nostrils and a small jaw. In fact, approximately 25% of 
adults with 22q11 deletion have schizophrenia [113]. 
 
The great number of craniofacial disorders may provide an indication of the number of 
genes involved in craniofacial embryogenesis and may partially explain molecular 
interactions between various factors involved in this process (Figure 17).  
 
 
Figure 17. Molecular interactions between several known factors involved in cranial sutures development and 
malformations, which might develop as a result of various mutations in corresponding genes. Sourced from 
Wilkie et. al. [79]. 
 
 
 
 
Table 1 briefly summarises information on human syndromes, with their respective 
craniofacial malformations and genes involved. The genes identified in these syndromes 
were used to search for candidate SNPs in this study, based on the criteria detailed in 
Section 1.7. 
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Table 1. Genetic syndromes with various craniofacial abnormalities. 
Syndrome Symptoms Prevalence Genetic origin 
Aarskog syndrome 
(OMIM:100050) 
Distinct facial features, such as: rounded face, 
underdeveloped mid-portion of the face (maxilla), 
small nose with nostrils tipped forward 
(anteverted), wide-set eyes, crease below the 
lower lip (hypertelorism) 
Rare Mutations in FGDY1 
gene on X chromosome 
[114] 
Alagille syndrome  
(OMIM: 118450) 
Distinct facial features, such as broad forehead, 
pointed mandible and bulbous tip of the nose and 
in the fingers 
1 in 70,000 Mutations in JAG1 gene 
[115] 
Alfi's Syndrome  
(OMIM: 158170) 
Mental retardation, trigonocephaly, mongoloid 
eyes, wide flat nasal bridge, anteverted nostrils, 
long upper lip, cleft lip/palate, short neck, long 
digits mostly secondary to long middle phalanges 
1 in 5 million Monosomy 9p or 
9p22.2-3 deletion [116] 
Apert Syndrome  
(OMIM: 101200) 
 
Various manifestations of craniosynostosis with 
cleft lip/palate. 
Between 1 in 
65,000 to 
200,000 
Mutations in FGFR2 
gene [117] 
Beckwith-
Wiedemann 
Syndrome  
(OMIM: 130650) 
Characteristic facial appearance and indentations 
of the ears, a large tongue which may cause 
breathing, feeding or speech difficulties, one side 
of the body grows more than the other 
Rare Mutation or deletion of 
genes H19, KCNQ1OT1 
or CDKN1C in 11p15.5 
chromosomal region 
[118-120] 
Cohen Syndrome  
(OMIM: 216550) 
Abnormalities of the head, characteristic facial 
features including high-arched or wave-shaped 
eyelids, a short philtrum, thick hair, and low 
hairline 
Rare Mutations in COH1 
gene [121] 
Cri-du-chat 
Syndrome (OMIM: 
123450). Other 
name: 5p deletion 
syndrome 
 
Abnormal larynx and epiglottis which causes a 
distinct sounding cry. The name literally means 
“cry of the cat.” Other symptoms include mental 
retardation, small head (microcephaly). 
Characteristic facial features at birth include a 
large nasal bridge, round face, wide-spaced eyes, 
low-set ears, and a down-turned mouth. As the 
child gets older the facial features change and a 
long, narrow face is more commonly observed 
1 in 50,000 
live births 
Mutations in two 
candidate genes: 
Semaphorine F 
(SEMA5A) and delta 
catenin (CTNND2), 
potentially involved in 
cerebral development 
[122] 
Crouzon Syndrome  
(OMIM: 123500) 
 
Craniosynostosis disorder causing secondary 
alterations of the facial bones and facial structure. 
Common features include hypertelorism, parrot-
1 in 60,000 Mutations in FGFR2 
gene [96, 123] 
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beaked nose, short upper lip, hypoplastic maxilla, 
and a relative mandibular prognathism 
Down Syndrome  
(OMIM: 190685). 
Other name: 
Trisomy 21 
People with Down Syndrome have similar facial 
features including a flattened facial profile, 
upward slanting eyes, small over-folded ears, flat 
nose and small mouth with a protruding tongue. 
They can also have low muscle tone, a shorter 
than typical neck, a single crease across the palm 
of the hand, heart defects, and varying levels of 
intellectual disability 
1 in 600-1000 
live births. 
Trisomy 21 is 
the most 
common 
trisomy seen 
in live born 
individuals 
Extra copy of 
chromosome 21 in each 
cell. Each person with 
Down syndrome may 
have slightly different 
symptoms due to 
variations in 
chromosomal 
abnormalities (e.g. 
Partial or full copy of 
chromosome 21). 
Several candidate genes 
have been identified in 
Down syndrome critical 
region, such as DSCR1, 
DSCR2, DSCR3 and 
DSCR4 [124] and SHH 
[125] 
Edward Syndrome. 
Other name: 
Trisomy 18  
Small head (microcephaly), small jaw/mouth 
(micrognathia), low-set malformed ears, cleft 
lip/cleft palate, upturned nose, narrow eyelid 
folds, widely spaced eyes, clenched fists with 
overlapping fingers, mental retardation, growth 
deficiency and other skeletal and organ anomalies 
1 in 3000-
8000 live 
births. 80% of 
people with 
this condition 
are female 
Extra chromosome 18 in 
each cell. Trisomy 18 is 
the second most 
common trisomy seen in 
live born individuals 
Floating-Harbor 
Syndrome (OMIM: 
136140) 
Short stature, a triangular shaped face with broad 
bulbous nose, long eyelashes, deep-set eyes and a 
wide mouth with thin lips 
Rare Mutations in SRCAP 
located in 16p11.2 
chromosomal region 
[126]. Rubinstein-Taybi 
syndrome (OMIM: 
180849) shows 
phenotypic overlap with 
Floating-Harbor 
syndrome and is caused 
by mutation in the 
CREBBP gene, for 
which SRCAP is a 
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coactivator 
Fragile X 
Syndrome 
(OMIM:300624) 
 
Range of learning disorders, distinctive facial 
appearance with large ears and a long face, 
prominent jaws, speech and language problems 
 A mutation in the FMR1 
gene located on the X 
chromosome [127, 128]. 
Within this gene, there 
is a region containing 
the sequence “CGG”, 
which is repeated 
multiple times. 
Normally the sequence 
is repeated no more than 
55 times in the gene. 
However, Fragile X 
Syndrome occurs when 
a person has more than 
200 “CGG” repeats in 
the FMR1 gene. 
A person who has more 
than 55 repeats, but less 
than 200, is considered a 
“pre-mutation carrier.” 
These individuals do not 
have Fragile X 
Syndrome themselves 
but are at risk of having 
children affected with 
the disorder since the 
number of repeats could 
expand in the next 
generation 
Langer-Giedion 
Syndrome 
(OMIM:190350 ( 
 
Short stature, small head, distinctive facial 
features including deep-set eyes, a bulbous nose, 
long narrow upper lip and missing teeth 
Rare Deletion of 8q23.2 to 
q24.1 chromosomal 
region. Candidate gene 
in this region: 
EXT1[129] 
Noonan Syndrome 
(OMIM:163950) 
Variable phenotype, which may change with age, 
many characteristics of which overlap those of the 
Turner syndrome. Short stature and mild mental 
1 in 1,000 to 
2,500 live 
births 
Mutation in the PTPN11 
gene on chromosome 
12q24.1[130, 131] 
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retardation are the main features of this syndrome. 
Characteristic facial features including short 
webbed neck and low-set posteriorly rotated ears 
Pallister Killian 
Syndrome (OMIM: 
601803) 
Coarse face with a high forehead, sparse hair on 
the scalp, an abnormally wide space between the 
eyes, a fold of the skin over the inner corner of the 
eyes and a flat nasal bridge with a highly arched 
palate 
Rare Mosaicism for 
tetrasomy of 
chromosome 12p [132] 
Patau Syndrome 
Other name: 
Trisomy 13 
Common features include: heart defects, small 
heads (microcephaly), cleft lip and/or palate, 
small eyes that are close together, extra fingers 
(polydactyly) and various skeletal abnormalities 
1 in 10,000 Trisomy of chromosome 
13 [133] 
Pfeiffer Syndrome  
(OMIM: 101600). 
Other name: 
Craniofacial-
Skeletal-
Dermatologic 
Dysplasia type 1, 2 
and 3. 
Craniosynostosis, midface deficiency, cloverleaf 
skull, broad thumbs, broad great toes 
1 in 100,000 Mutations in FGFR1, 
FGFR2 and FGFR3 [95, 
134] 
Saethre-Chotzen 
Syndrome 
(OMIM:101400). 
Other name: 
Acrocephalosyndac
tyly type III 
Acrocephaly, asymmetry of the skull, low set 
hairline, wide and tall forehead, thin, long pointed 
nose, small low-set ears, cleft palate 
1 in 25,000 to 
50,000 
Mutations in FGFR2 
and TWIST1 [90-93] 
Smith-Magenis 
Syndrome (OMIM: 
182290) 
 
Abnormalities of the craniofacial area such as 
brachycephaly, midface hypoplasia, small ears, 
broad nose and cleft palate. Overlapping features 
with Potocki-Lupski syndrome 
Rare Mutations in RAI1 gene 
[135, 136] 
Treacher Collins 
Syndrome 
(OMIM:154500) 
 
Various craniofacial abnormalities such as 
antimongoloid slant of the eyes, coloboma of the 
lid, micrognathia, microtia and other deformity of 
the ears, hypoplastic zygomatic arches and 
macrostomia 
1 in 25,000 to 
50,000 
Mutations in TCOF1 
gene [137-140] 
Turner Syndrome 
(Monosomy X) 
People with Turner Syndrome are females and 
typically have short stature, a webbed neck, heart 
defects, swelling of the hands and feet, and 
1 out of 2,500 
girls 
Females with only one 
X chromosome [108]. 
Potential involvement of 
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characteristic facial features SHOX gene [141] 
Velo-Cardio-Facial 
Syndrome (OMIM: 
192430) 
 
Highly variable phenotype with cleft palate, heart 
abnormalities, typical faces and over 180 other 
clinical findings 
1 out of 4000 
live births 
Point mutations in 
TBX1 [87, 89, 142] 
Waardenburg 
Syndrome (OMIM: 
193500) 
Characterized by pigmentary abnormalities of the 
hair, skin, eyes and facial structures, including 
broad nasal bridge 
Rare Mutations in PAX3 gene 
[143]. 
1.5.1.1. Orofacial clefting as a link to the normal facial variation 
Next to craniosynostosis, orofacial clefting (OFC) is one of the most common 
facial birth defects seen in approximately 1 in 600 births. OFC covers a wide range of 
facial abnormalities, which can be divided into 3 main groups: 
 Cleft lip only (CL) 
 Cleft palate only (CP) 
 Cleft lip with palate (CL/P) 
The main mechanism for the OFC is believed to be a failure of palatal fusion during 
embryonic development of the frontonasal prominence [144-146], as shown in Figure 
18.  
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Figure 18. Development of the lip and palate. A) The developing frontonasal prominence, paired maxillary 
processes and paired mandibular processes surround the primitive oral cavity by the fourth week of embryonic 
development. B) By the fifth week, the nasal pits have formed, which leads to the formation of the paired medial 
and lateral nasal processes. C) The medial nasal processes have merged with the maxillary processes to form the 
upper lip and primary palate by the end of the sixth week. The lateral nasal processes form the nasal alae. Similarly, 
the mandibular processes fuse to form the lower jaw. D)  During the sixth week of embryogenesis, the secondary 
palate develops as bilateral outgrowths from the maxillary processes, which grow vertically down the side of the 
tongue. E) Subsequently, the palatal shelves elevate to a horizontal position above the tongue, contact one another 
and commence fusion. F) Fusion of the palatal shelves ultimately divides the oronasal space into separate oral and 
nasal cavities. Sourced from M. Dixon et. al. [145]. 
 
 
 
The clefts can be unilateral and bilateral, as shown on Figure 19. OFC can occur as part 
of a complex craniofacial syndrome or as a non-syndromic facial defect (NSCL/P), with 
the latter being more common. 
While most research has focused on the syndromic form of OFC, a few recent studies 
have explored NSCL/P in various populations and identified several mutations in 
candidate genes that may cause this disorder [145, 147-154]. Several studies have 
shown between 40% - 60% concordance for NSCL/P in monozygotic (MZ) twins and 
between 5% - 10% in dizygotic twins (DZ), suggesting environmental as well as genetic 
influences [155, 156]. Interestingly, the highest prevalence of NSCL/P was observed in 
the Asian population, followed by Caucasians and Africans [155]. Based on the 
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anthropometric measurements, Asian faces are known to be the widest among the three 
populations. This fact may reflect the higher NSCL/P prevalence in this population as a 
matter of failure of correct timing of palatal fusion. A meta-analysis performed on 
several studies, using cephalometric measurements of unaffected parents of NSCL/P 
showed a significant increase in several values, including wider interorbital, nasal cavity 
and upper facial dimensions; narrower cranial vaults; longer cranial bases; longer and 
more protrusive mandibles; shorter upper faces and longer lower faces and mostly 
significantly – an increase in facial and nasal cavity width, compared to the control 
group [157]. 
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Figure 19. Types of clefts. A) Illustrative drawings of types of cleft lip and/or palate (CLP)114. a) and e) show 
unilateraland bilateral clefts of the soft palate; b), c) and d) show degrees of unilateral cleft lip and palate; f), g) and 
h) show degrees of bilateral cleft lip and palate. Clefts are indicated in purple. B) A collection of images of different 
types of clefts, some with associated anomalies such as lip pits. Descriptions are given above the images. CL, cleft lip; 
CP, cleft palate; CPO, cleft palate only. Sourced from M. Dixon et. al. and M. Muenke [145, 158].   
 
 
It can therefore be hypothesised that family-based studies of NSCL/P may help to reveal 
genes that influence normal facial width variation [43, 157, 159]. A recent study indeed 
found an association between nose width and SNP rs1258763 near the GREM1 gene 
(cysteine knot superfamily 1) and between bizygomatic distance and SNP rs987525 near 
the CCDC26 gene (retinoic acid modulator) [160]. 
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Table 2 summarises the candidate genes and respective mutations found to be involved 
in NSCL/P and such genes were used as candidates in this research project.  
Table 2. Summary of genes and known mutations with a role in NSCL/P, which were used as candidate genes for 
this project. 
Gene ID Top SNP (if known) Function  (if known) 
ABCA4 rs560426 
Abundant in the retina; expressed at lower levels in the brain. Mutations 
implicated in disorders of the retinal system. 
ARHGAP11A rs1258763 - 
ARHGAP29 
(PARG1)  Level of expression might be affected by folic acid. 
BMP4  
Induces cartilage and bone formation. Also act in mesoderm induction, 
tooth development and limb formation. 
C17orf67 
 
- 
CCDC26 rs987525 - 
CRISPLD2 
 
- 
DGKE 
 
Highly selective for arachidonate-containing species of diacylglycerol 
(DAG). May terminate signals transmitted through arachidonoyl-DAG or 
may contribute to the synthesis of phospholipids with defined fatty acid 
composition. 
FGF8 
 
Plays an important role in the regulation of embryonic development, cell 
proliferation, cell differentiation and cell migration. Required for normal 
brain, eye, ear and limb development during embryogenesis. 
FGFR2  
Promotes cell proliferation in keratinocytes and immature osteoblasts, but 
promotes apoptosis in differentiated osteoblasts. 
FMN1 
 
Controls the rate of actin nucleation, thus influencing cell mortality. 
Fmn1-knockout mice exhibit oligodactylism and show reduced activity of 
the BMP4 signaling pathway. 
FOXE1  
This gene functions as a thyroid transcription factor which likely plays a 
crucial role in thyroid morphogenesis. 
GREM1 
 
Member of the BMP antagonist family. Involved in fibroblast growth 
factor (FGF) signaling of limb bud outgrowth. Acts in cooperation with 
nog in axial skeleton development. 
GSTT1 
 
Glutathione S-transferase (GST) theta 1 is a member of a superfamily of 
proteins that catalyze the conjugation of reduced glutathione to a variety 
of electrophilic and hydrophobic compounds. 
IRF6 rs642961 
Probable DNA-binding transcriptional activator. Key determinant of the 
keratinocyte proliferation-differentiation switch, involved in appropriate 
epidermal development. Causative for Van der Woude syndrome. 
KCNK18 
 
Outward rectifying potassium channel. Produces rapidly activating 
outward rectifier K(+) currents. May function as background potassium 
channel that sets the resting membrane potential. 
KIAA1598 rs7078160 
Involved in generation of the asymmetric signals required for neuronal 
polarization and axon outgrowth. 
MAFB rs13041247 
Highly expressed in the epithelia of palatal shelves and in the medial 
edge during the process of palatal fusion in rodents. 
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MSX1 
 
Act as transcriptional repressor during embryogenesis through 
interactions with components of the core transcription complex and other 
homeoproteins. 
MTHFR 
 
Catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-
methyltetrahydrofolate, a co-substrate for homocysteine remethylation to 
methionine. 
MYH9  
Function as cellular myosin that appears to play a role in cytokinesis, cell 
shape, and specialized functions such as secretion and capping. 
NOG rs227731 
Antagonist of members of the TGF-β superfamily (e.g. BMP4), which are 
involved in mammalian palatogenesis and missense/nonsense variants are 
associated with cleft microforms in humans. 
None rs9574565 Located in the intergenic region 13q31. 
NTN1  
Putative function in axon guidance and cell migration during 
development. 
PAX7 rs742071 Involved in early specification of neural crest stem cells. 
PDGFC 
 
Platelet-derived growth factor that plays an essential role in the regulation 
of embryonic development, cell proliferation, cell migration, survival and 
chemotaxis. 
PIK3R5 
 
Phosphatidylinositol 3-kinases (PI3Ks) phosphorylate the inositol ring of 
phosphatidylinositol at the 3-prime position and play important roles in 
cell growth, proliferation, differentiation, motility, survival and 
intracellular trafficking. 
PIK3R6 rs9788972 
Phosphoinositide 3-kinase gamma is a lipid kinase that produces the lipid 
second messenger phosphatidylinositol 3,4,5-trisphosphate. Seems to be 
involved in angiogenesis. 
PVRL1 
 
Encodes a calcium(2+)-independent cell-cell adhesion protein that plays a 
role in the organization of adherens junctions and tight junctions in 
epithelial and endothelial cells. 
SCG5 
 
Acts as a molecular chaperone for PCSK2/PC2, preventing its premature 
activation in the regulated secretory pathway. Plays a role in regulating 
pituitary hormone secretion. 
SUMO1  
Ubiquitin-like protein that can be covalently attached to proteins as a 
monomer or a lysine-linked polymer. 
TGFA 
 
Encodes a growth factor that is a ligand for the epidermal growth factor 
receptor, which activates a signaling pathway for cell proliferation, 
differentiation and development. 
TGFB3  
Encodes a member of the TGF-beta family of proteins, which is involved 
in embryogenesis and cell differentiation. 
THADA 
 
- 
VAX1 
 
Transcription factor that may function in dorsoventral specification of the 
forebrain. Required for axon guidance and major tract formation in the 
developing forebrain. 
ZFP36L2 rs7590268 
Probable regulatory protein involved in regulating the response to growth 
factors. 
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1.5.2. Animal models in craniofacial disorders research 
Animal models have been extensively used to generate craniofacial syndrome 
models. This has led to the identification of genetic factors that cause these conditions 
in humans and allowed a better understanding of the embryonic craniofacial 
development. These animal models include mouse, bird and fish species, dog breeds 
and primates [161].  
 
1.5.3. Mice and fish models 
Targeting of specific genes in mice has generated more than 90 loss-of-function 
mutants that have various craniofacial malformations [62, 162-164]. Interestingly, some 
of these mutants demonstrate variation in facial morphology that can be considered 
normal, rather than abnormal, for example short or long nose, prominent or depressed 
face and different shapes of ears (illustrated in Figure 20). These and other mouse 
models are available from Jackson mouse laboratory [164]. 
 
 
Figure 20. Examples of mouse mutants showing various craniofacial defects. Reproduced from Jackson 
Laboratory web site (http://www.informatics.jax.org/). 
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Despite the successful identification of craniofacial genes in animal models, the 
generation of knockout alleles does not always provide a clear picture of the function of 
a particular gene in craniofacial development. There are two main reasons for this. 
Firstly, the disruption of a natural function might be lethal if a gene plays a critical role 
in earlier developmental stages. Genes included in this category encode various 
transcription factors, mostly belonging to homeobox-containing genes and represent a 
major portion of genes believed to be involved in craniofacial embryogenesis. Secondly, 
the expression pattern of the targeted knockout gene may not be fully visible due to 
genetic redundancy. These synergistic interactions might be detected by producing 
double-homozygous mutants [165]. Secondly, the phenotypic effects on a system of 
interest might be masked by a major effect on another system that developed earlier. For 
example, a role for a particular gene involved in skull vault formation will not be 
detected if its loss also affects neural-tube formation.  
Research on craniofacial mutants in fish and particularly in zebra fish (Danio rerio) 
[166-171] and cichlid species [172, 173] has also revealed a number of genes involved 
in various stages of craniofacial embryogenesis. Relatively easy mutagenesis and fast 
generation turnover in fish provided numerous craniofacial skeleton mutants with genes 
orthologous to other vertebrates, including humans. Many of the affected genes 
identified in fish replicated those identified in mouse, while some were novel candidates. 
The genes, identified in both animal models (listed according to the associated 
craniofacial malformations) include: 
 Neural tube defects, involving Pax3, Twist, Gli3, Dlx5, Tcfap2a and Cart1 genes 
[90-93, 167, 168, 174-179]. 
 Neural crest defects, involving Dlx, Msx, Pax, Prrx gene families, as well as Gsc 
and Hoxa2 genes [165, 180-191]. 
 Cranial truncations, involving Shh, Pcsk6, Sil, Lhx1, Hesx1, Otx2 genes [149, 
168, 171, 192-201]. 
 Defects of sensory organs, involving Pax2, Pax6, Chx10, Chrd, Rax and Bmp7 
genes [168, 188, 189, 202-204]. 
 Abnormalities of skeletal differentiation, involving Runx2, Col2a1, Col11a1, 
Crt11 and Hspg2 genes [98, 100, 167, 205-208]. 
 Clefts of the secondary palate, involving Jag2, Tgfb3 and Lhx8 genes [209-212]. 
A recent study discovered that craniofacial morphology in mice is regulated by distant – 
acting transcriptional enhancers [213]. Hundreds of such enhancer sequences were 
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identified, while targeted knockout of three of them resulted in slight alteration of the 
cranial shape in mice. The authors hypothesise that sequence and/or copy number 
variation in these regions may contribute to the variance in craniofacial appearance in 
human populations. 
In addition to the mouse and zebra fish, other animal models have been studied to 
explore additional factors involved in craniofacial development in these organisms and 
potentially in humans.  
 
 
1.5.4. Dog breeds 
Dogs have been domesticated for more than 30,000 years [214, 215] and maybe 
as early as about 135,000 years ago [214, 215]. On the other hand, a recent study have 
found that dogs and wolves diverged only 11,000–16,000 years ago from a common 
ancestor in a process involving extensive admixture [216]. In any respect, centuries of 
selective breeding has resulted in approximately 400 different breeds, according to 
International Kennel Association (Fédération Cynologique Internationale), making dogs 
probably the most diverse domesticated animal. During this process, dogs’ cranial 
morphologies and their brains, have been significantly affected [217-220]. This makes 
the dog a useful model organism to explore craniofacial variation and its potential 
implications in humans. Several studies have explored the difference between various 
dog breeds, especially between the brachycephalous or “shortened head” breeds, such as 
bulldog, pug, boxer and the dolichocephalous or ”elongated head”, such as greyhound, 
saluki, collie breeds [137, 139, 218, 221-224].  
While most research has focused on the genetics of the skull morphology, rather than 
the soft tissue, a few studies have revealed genes associated with additional phenotypic 
traits [225, 226]: 
 The MITF gene, associated with white spotting in bull terriers and boxers;  
 a 133kb duplication of the chromosomal region containing 5 genes: FGF3, 
FGF4, FGF19, ORAOV1 and CCDN1, associated with the “ridge” trait in 
ridgeback dogs; 
 The HAS2 gene, associated with excessive skin wrinkling in shar-pei dogs; 
The genes that have been found to be involved in influencing the craniofacial diversity 
in dogs and considered candidate genes for this project include: RUNX2, TCOF1, 
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BMP3, MSX2, THSB2 and SMOC2. A more comprehensive list of candidate 
craniofacial genes summarized from available studies in different animal models is 
detailed in Supplemental Table S1. 
 
 
 
1.5.5. Avian species 
Additional valuable information for determining genes involved in craniofacial 
development was contributed by Brugmann et. al. [209], who studied transcription 
factor (TF) gene expression patterns in cranial neural crest cells in the developing beaks 
of ducks, quails and chicken. This work demonstrated a species-specific transcription 
factor expression profile of 232 genes in neural crest cells that precedes morphological 
differences between the species. The most dramatic changes between species were 
found in the Wnt signalling pathway, with a 20-fold up-regulation of Dkk2, Fzd1 and 
Wnt1 in the duck compared with the other two species. Twenty-two genes of the 
differentially expressed genes, including Fgfr2, Jagged2, Msx2, Satb2 and Tgfb3, have 
previously been shown to be involved in a variety of mammalian craniofacial defects. 
Seventy-two of the differentially expressed genes represented new loci, potentially 
involved in human craniofacial disorders, making them candidate genes affecting 
normal craniofacial appearance (Table 3). 
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Table 3. Example of 72 genes differentially expressed between developing beak of the chicken, quail and duck. 
Based Brigmann et.al., (2010). 
Syndrome name Differentially expressed genes in region 
Van Der Woude syndrome  GJB5, MYCBP, PTCH2 
Rosselli-Gulienetti syndrome OCT11 
Smith-Magenis syndrome, Potocki-Lupski syndrome,  
Van Der Woude syndrome, Cleft palate 
ALDH3A2, SREBF1 
Hypercalciuria ASCL1, MORF4 
Coloboma BC052625, CDK5, PAXIP1L 
Chromosome 2p16.1-P15 Deletion syndrome BTF3L2 
Seckel syndrome  CDKN3, TRIM9 
Hemifacial Microsomia CRIP1, JAG2, TRIP11 
Orofacial Cleft  ARC, DKK2, FGF2, FLJ12517, LOC152485, MADH1, 
MGC15631, NKX6A, NR3C2, RAI15, RELB, PITX2, 
PRDM5, RREB1, TGFB2  
Craniofacioskeletal syndrome FGF13 
Chromosome 1q43-Q44 deletion syndrome FLJ12517 
Microphthalmia, Armfield X-Linked mental retardation syndrome FMR2 
Craniometaphyseal Dysplasia FOXO3A, SCML4 
Ectrodactyly, Ectodermal Dysplasia, Cleft Lip/Palate syndrome 1 FZD1 
Chromosome 2q32-Q33 Deletion syndrome FZD5, FZD7, NAB1, SATB2 
Seckel Syndrome 2 GATA6 
Pierre Robin syndrome GPRC5C 
Chromosome 3q29 Microdeletion syndrome HES1 
Orofacial Cleft, Adrenoleukodystrophy, Zellweger syndrome HES5 
Miller-Dieker Lissencephaly syndrome HIC1 
Moebius syndrome HMG1 
Cdags syndrome HRIHFB2122, LOC90322, MFNG, PPARA, SOX10, TCF20 
Split-Hand/Foot malformation  HSPC063, TLX1, NFE2L2 
Chromosome 1p36 Deletion syndrome ID3 
Hypothalamic Hamartoma IGFBP3 
Prader-Willi syndrome KLF13 
Cat Eye Syndrome, Digeorge syndrome, Opitz Gibb syndrome,  LZTR1, PCQAP 
Tarp syndrome MLLT7 
Craniosynostosis, Adelaide Type, Wolf-Hirschhorn syndrome NKX1-1, WHSC1 
Holoprosencephaly  PAX9, PFKL, PTTG1IP, TNRC15 
Axenfeld-Rieger syndrome type 2 RGC32 
Digeorge Syndrome/Velocardiofacial syndrome  TAF3 
Zellweger Syndrome THBS3 
Syndactyly Type I WNT6 
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1.5.6. Primates 
Primates are the closest human relatives, although information about the 
genetics of their craniofacial development is limited. A study on the craniofacial 
structure of baboons examined 43 anthropometric measurements on each of the 830 
skulls and revealed 14 significant quantitative trait loci (QTLs) for 12 craniofacial traits 
[227]. A subsequent study on 981 human cephalograms, identified additional QTLs for 
10 cranial measurements [228]. The candidate genes in QTLs included BMP6, WNT1, 
WNT10B, WNT5A, which have previously been shown to be involved in craniofacial 
embryogenesis in other model organisms.  
Supplemental Tables S1 and S2 provide a comprehensive list of candidate genes, which 
were used in this project.   
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1.6. Genomic factors that may influence craniofacial phenotype variation  
In addition to SNPs, other sequence variations and epigenetic factors may 
potentially affect facial appearance. Epigenetic differences can regulate transcription 
and subsequent gene expression by DNA methylation, histone modifications and 
chromatin packaging, without affecting the DNA sequence directly. On the other hand, 
SNPs in regulatory elements (such as enhancers) may also trans-regulate various factors, 
which affect gene expression [213]. This type of regulation may be responsible for 
phenotypic differences between monozygotic twins, which become more visible with 
age [38, 57, 58, 60, 156, 229]. While these epigenetic modifications may also play a 
role in determining craniofacial morphology, this research project focuses on single 
nucleotide polymorphisms.  
 
 
1.6.1. DNA methylation pattern 
DNA methylation is known to down regulate or silence genes. In vertebrates it is 
catalysed by the enzyme DNA methyltransferase, resulting in conversion of cytosine to 
5-methylcytosine and typically occurs at CpG sites. The human DNA has about 80-90% 
of CpG sites methylated, except for CpG islands, which are regions of DNA comprising 
approximately 65% unmethylated CG residues. CpG islands are found in the promoters 
of approximately 56% of mammalian genes, including all ubiquitously expressed genes. 
Thus the methylation pattern has an important role in regulation of the transcription 
activity and gene expression. DNA methylation is essential for normal development and 
is associated with a number of key processes including genomic imprinting, X-
chromosome inactivation, suppression of repetitive elements and carcinogenesis. It has 
been hypothesized that epigenetic differences of this kind may affect the difference in 
phenotypic appearance of monozygotic twins [58]. This type of genetic polymorphisms 
may also play a role in affecting craniofacial morphology.  
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1.6.2. Histones modifications 
Histone acetylation 
There are several types of histone modifications, but the most extensively 
studied is acetylation. Histone acetylation is associated with chromatin’s “open state” 
and resulting transcription activation [230]. Acetylation, performed by a number of 
histone acetyltransferases, neutralizes a positive charge on histones via the negative 
charge of the amine group on the histone tail, thus decreasing the affinity between the 
DNA and specific histone or the whole nucleosome (formed by eight histone sub-units 
and 147 bases of DNA). This event makes DNA more accessible to various 
transcription factors, regulating gene expression. This type of nucleosome remodelling 
may have a more global “house-keeping” effect at the cellular level and is not always 
inherited [231].  
 
Histone methylation 
This type of histone modification occurs by addition of methyl groups to 
arginine and lysine amino acids in histone proteins. Histone methylation can alter 
transcription by both repression and activation. In addition, methylation of a specific 
lysine residue on the histone tail can make it a target for continuous acetylation and 
deacetylation [232]. 
A recent study suggests that heterochromatin silencing by histone methylation may 
involve RNA interference and may be heritable [233]. Another recent study proposes, 
that a particular type of histone demethylase regulates zebrafish brain and craniofacial 
development [169]. These findings support a model in which PHF8 demethylase 
regulates zebrafish neuronal cell survival and jaw development in part by directly 
regulating the expression of the homeodomain transcription factor MSX1/MSXB [180]. 
Based on these and other sources, PHF8 and MSX1 were chosen as putative candidate 
genes for this research project. 
 
A recent histone-code hypothesis speculates that modified histones play a more active 
role, recruiting other proteins via specific recognition of protein domains, rather than 
just altering the interaction with a DNA molecule [234, 235]. The histone code believed 
to be extremely complex, as each of the four histone pairs, forming a nucleosome can be 
modified at multiple sites through multiples types of modifications, providing various 
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levels of transcriptional regulation. For example, given that histone H3 which contains 
19 lysines, known to be methylated by up to four methyl groups, can potentially form 
up to 4
19
 different lysine patterns. This number should be multiplied by additional 
possible modifications in three arginine methylation sites, nine acetylation sites and at 
least eight phosphorylation sites in each of the 44 million H3 histones in the human 
genome [236]. This additional level of regulation may potentially be involved in many 
cellular processes, including “fine tuning” of the craniofacial phenotype. 
 
 
 
1.6.3. Copy number variations (CNV) 
CNVs are alterations of genomic DNA that correspond to relatively large 
regions of the genome that have been deleted or amplified in the genome. CNVs can be 
caused by genomic rearrangements such as deletions, duplications, inversions, and 
translocations. This variation accounts for approximately 12% of human genomic DNA 
and may range from a few kilobases to several megabases in size. It is estimated that 
approximately 0.4% of the genomes of unrelated people typically differ with respect to 
copy number [237, 238]. De novo CNVs have also been observed between identical 
twins, who were believed until recently to have identical genomes [57, 229]. CNVs are 
less likely to be involved in determining a normal phenotypes, as such large aberrations 
in the genetic code can significantly alter various protein functions and as a result lead 
to disease.  
 
1.6.4. Non-coding RNA interference (RNAi) 
RNA interference is the process by which RNA molecule interferes with the 
accumulation of homologous transcripts (mRNA) from genes of the same origin [239]. 
This sub-class of non-coding RNA (usually 20-25 bases in length) together with other 
micro-RNAs, may represent a still-hidden layer of signals that regulate various levels of 
gene expression in physiology and development, transcriptional activity, epigenetic 
memory through chromatin remodelling, RNA splicing, editing and turnover [240-243]. 
Each of these networks, separately or together, may play a significant role in normal and 
abnormal genetic variation of human complex characteristics. 
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1.6.5. Single nucleotide polymorphisms (SNPs) 
Single nucleotide polymorphisms represent one of the most common type of 
variation in the human genome. SNP markers are typically bi-allelic base substitutions, 
insertions or deletions that occur approximately every 1 in 100-300 bases along the 3 
billion bases of human genome, according to the latest statistics from the NCBI dbSNP 
database [244]. The HapMap project, one of the largest efforts to identify human 
variation, has already genotyped approximately 3.2 million tag SNPs, representing 25-
35% of common SNPs, in several populations [245]. Tag SNPs are markers in high 
linkage disequilibrium, which represent a large number of SNPs (haplogroup) that tend 
to be inherited together. Genotyping of a relatively small number of tag SNPs is more 
cost-effective and may provide information on other markers, located within the same 
haploblocks.  
Another project, called “1000 genomes”, has to date genotyped 15 million single 
nucleotide polymorphisms, 1 million short insertions and deletions, and 20,000 
structural variants in 2,500 samples from 27 populations [246].  
In spite of the relatively limited forensic use of SNPs at present, these biomarkers have 
shown potential to be particularly useful for typing limited and highly degraded forensic 
samples [3, 247] and predicting pigmentation traits and ancestry [9, 13, 14, 248-252].  
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1.7. Types of craniofacial candidate SNPs and their selecting criteria 
In general, SNPs may be located in coding and/or non-coding regions of genes or in the 
intergenic regions. Thus, SNPs may be divided into several categories, according to 
their location and potential function (Figure 21):  
 
 
 
 
Figure 21. Schematic representation of SNPs classification. 
 
 
 
Based on the categorisation shown in Figure 21 and given that particular facial features 
are more prevalent in specific populations, it can be hypothesised that markers 
belonging to the following categories could have an impact on the proposed craniofacial 
candidate genes function: 
Non-coding 
region 
3'-UTR region 
Exonic splicing 
enhancers 
5'-UTR region 
Transcription 
regulation region 
TF binding sites 
Coding region 
Synonymous SNPs 
Non-synonymous 
SNPs 
Missense 
Nonsense 
Frameshift 
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 Ancestry informative markers (AIMs) - high population differentiation markers with 
Fst >0.5 
Genetic differentiation between two populations occurs when they diverge and 
become significantly isolated to limit gene flow between them. Population 
differentiation is sensitive to a variety of evolutionary events and can be measured 
by both Fst and LD-based tests, such as LRH, iHS and XP-EHH [253-256]. 
However, ancient selective events can mainly be detected with Fst-based tests [257]. 
In humans, the starting point of population differentiation is believed to coincide 
with the exodus from Africa, some 50,000 to 75,000 years ago [255, 258, 259]. 
Thus the Fst value can reveal the effects of natural selection for the last 75,000 years. 
Another advantage of using the Fst value to detect population diversity is that, 
unlike other tests, Fst is SNP specific, allowing targeting of specific genetic variants 
under selection [260]. A recent study has shown that a positive as well as negative 
selection has guaranteed the regional adaptation of human populations by increasing 
population differentiation primarily at nonsynonymous and 5’-UTR variants [257]. 
Based on the HapMap Phase II data, Barreiro et.al. identified a list of 582 genes 
showing signs of positive selection (Fst>0.65) and containing at least one 
polymorphism. Another study of 26,530 SNPs identified 174 candidate genes with 
SNPs that were a target of positive selection and as a result show high Fst values 
[261]. Several complementary studies have been published recently, providing a 
valuable resource for identification of AIMs in candidate genes for craniofacial 
morphology [256, 258, 262-268]. It was hypothesized that high Fst markers should 
provide a primary targeted SNPs subclass for the current project.  
An example of such two SNPs, showing different distribution in the world –wide 
population is illustrated in Figure 22. Hypothetically, a ‘T’ allele in SNP 
rs12595883 could be associated with a long face or more prominent nose (more 
common in the European population), while an ancestral ‘C’ allele is associated 
with a short face or depressed nose. Similarly, an ancestral allele ‘A’ in SNP 
rs12598094 could be associated with the decrease in facial width (eu-eu distance), 
while the ‘C’ allele is associated with the increase in this distance (more common in 
the Asian population, as shown in this figure). This is just a simplified illustration, 
as the variation in the same facial trait in different populations could be affected by 
different SNPs. 
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Figure 22. Example of two SNPs from dbSNP database with various population distribution. Sourced from NCBI 
website (http://www.ncbi.nlm.nih.gov/projects/SNP/). 
 
 
 
 Non-synonymous SNPs (nsSNPs) in coding regions  
The polymorphisms located in the coding regions can be of two types: 
synonymous and non-synonymous. The latter can impact the translation process 
by either missense, nonsense or frameshift mutations. According to a recent 
study on the basis of phase II HapMap data, there are approximately 15,259 
nsSNPs out of 2,841,354 SNPs tested in the human genome [257]. Any of these 
polymorphisms may result in a change to the polypeptide sequence, thus 
possibly influencing the protein folding and function and affecting the 
phenotypic expression of the gene. Such a significant change may have a 
subsequent dramatic effect on the gene expression, leading to various disease 
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conditions (supplemental Tables 1S and 2S) or simply normal variation in 
craniofacial phenotype.  
Due to the redundancy of the genetic code, synonymous SNPs typically do not 
alter protein structure and function. However, recent studies show that these 
mutations, previously believed to be “silent”, may affect mRNA stability and 
alter protein function and as a result lead to disease [269-273]. Nevertheless, this 
research has focused mainly on nsSNPs, as having the major impact on potential 
phenotype. 
 
 
 SNPs in splice sites 
Recent studies show that up to 94% of human genes are regulated by alternative 
splicing, providing a major mechanism for transcript diversity [274]. Alternative 
splicing is a complex process, regulated by a variety of cis and trans  acting 
factors, many of which recognise donor and acceptor splicing sites [275]. 
Mutations in splice sites can directly affect exon configuration by disrupting the 
splicing process. Therefore, SNPs located in splice sites can have a more 
pronounced effect on protein structure than non-synonymous SNPs. 
 
 
 SNPs in regulatory regions 
DNA transcription represents one of the key steps in transforming the genetic 
code into phenotype and is regulated through various sequence elements, such a 
promoters, enhancers and silencers [276]. 
Although our understanding of human transcriptional regulatory sequences is 
still limited, it is obvious that polymorphic variation in these regions may alter 
the level of protein expression and, as a result, play a significant role in 
phenotype diversity in general and craniofacial appearance in particular. This 
hypothesis has been successfully supported by a recent study in mice [213]. 
 
 
 Tag SNPs 
There are at least 12 million SNPs in the human genome [245, 246, 277]. 
Genotyping all these markers would be time consuming and costly. It is known 
that SNPs which are located in close proximity, tend to be inherited together. 
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Thus, genotyping such a set of strongly associated SNPs (a haplotype) can 
provide cost-effective information about genetic variation in a particular region 
of interest.  
The tag SNPs are chosen based on the haplotype frequencies in different 
populations. The HapMap project has identified about 3.2 million tag SNPs, 
which should provide almost as much information as the 10 million SNPs in the 
human genome. The use of tag SNPs should significantly reduce the number of 
SNPs needed for genotyping in this project. Those SNPs will be derived from 
markers from any of the categories described above.  
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1.8. Current state of the forensic DNA analysis and potential applications of 
this project  
 
1.8.1. Forensic application of the short tandem repeats (STRs) and 
mitochondrial DNA  
Most forensic laboratories use autosomal short tandem repeats (STRs) as the primary 
technology for routine identification purposes. Short tandem repeats represent a sub-
class of microsatellites, containing between 2-5 bp repeats. The forensic DNA 
community uses tetra-nucleotide repeats, as they can be amplified with less artefacts 
than bi- or tri-nucleotide repeats. PCR amplification of STR markers usually results in 
amplicons ranging from 100 bp to 500 bp and more recently of shorter amplicons 
(Mini-STRs), which may vary between 51 bp to 211bp [278, 279]. This technology is 
fast, robust, sensitive and uses a widely adopted capillary electrophoresis platform as a 
genotyping method. Most commercial STR kits provide multiplex reactions of at least 
10-20 markers, which can amplify as little as 0.3-0.5 ng of DNA.  
Y chromosome STR typing and in some instances, mitochondrial sequencing of the 
HV1 and HV2 regions are also used. The use of these methods include a resolution of 
female-male mixtures with a very low portion of male fraction (e.g. DNA under 
fingernails) and historical paternity issues (e.g. Thomas Jefferson slave child) by Y-STR 
typing [280], as well as successfully dealing with very degraded DNA evidence (e.g. 
mass disasters) [281] or maternal ancestry cases (e.g. Romanov family remains 
identification) by mitochondrial sequencing [282]. 
 
 
1.8.2. Forensically relevant SNP classes 
There are two main routes for forensic use of SNPs, namely identification 
(including lineage-informative) and intelligence (ancestry and phenotype informative). 
The following section outlines briefly each SNP category. 
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Identity testing SNPs  
Markers in this category are chosen according to the relatively high average 
heterozygosities of >0.4 and low Fst values of <0.06. The combination of approximately 
50 of such SNPs is highly discriminatory and the probability of any two unrelated 
individuals having identical DNA profile is extremely low [283-285].   
SNP-based identification assays have been developed for forensic purposes on 
numerous platforms [284, 286-289]. Efficient multiplex reactions for the amplification 
and typing portions of an assay can be optimized for the small sized amplicons, 
allowing more genetic data to be gleaned from an already limited sample. The selection 
of the typing platform is typically driven by the number of samples to be typed, as well 
as the number of SNPs to be interrogated. Although these assays are quite powerful in 
individualizing an evidentiary sample, they do not yield any information regarding 
phenotype appearance (such as pigmentation or facial features information) to narrow 
the search for suspects [284, 289]. 
 
 
Lineage informative SNPs  
Lineage informative SNPs are sets of tightly linked SNPs that function as haplotype 
markers to identify missing persons or mass disaster victims through kinship analyses. 
These markers have a low mutation rate, are inherited as a haploblock and are therefore 
better than STRs for analysis of kinship cases, especially if the evidence and reference 
samples are separated by several generations, as in the Romanov Royal family 
identification case and president Thomas Jefferson’s slave child [280, 282].  
Additionally, autosomal SNP haploblocks, which are inherited together and provide a 
higher discrimination power than individual SNPs inside this block, can also be used [3, 
290].  
 
Ancestry Informative SNPs (AIMs)  
AIMs are used in order to establish a reliable probability of an individual’s 
biogeographical ancestry. SNPs in this category are distributed with different 
frequencies in the world populations and therefore have low heterozygosity and high Fst 
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values [249, 291], similar to phenotype informative markers discussed below. 
Genotyping these markers may reveal ancestry information of the person and indirectly 
infer some phenotypic characteristics of investigative value [267]. An additional 
application of AIM markers might be detection of risk factors for various diseases and 
developing efficient treatment in the field of personalized medicine [265, 268]. These 
markers are discussed in more detail in Chapter 4. 
 
 
Phenotype informative SNPs  
This category of forensic DNA markers enables prediction of the physical appearance of 
an individual and in some aspects is overlapping with AIMs. These markers aim to 
detect particular phenotypic characteristics such as skin, hair or eye colour from a DNA 
sample for investigative purposes. Some of these traits can be also predicted indirectly 
knowing the bio-geographic ancestry of a person (although not with the same accuracy). 
In the past few years, many studies focused on the detection of polymorphisms in 
pigmentation genes, have been published [5, 248, 292, 293] and a few forensic assays 
have been developed, for detecting hair [5, 294, 295] and iris colour [292, 293] or both 
together with ancestry [12, 292, 296, 297].  
The genetic basis of additional phenotypic characteristics, such as height, weight and 
age is still poorly understood. However, the number of articles on the genetics of these 
complex traits is growing, providing hope for developing forensic assays for predicting 
these features in the not too distant future [298-300].  
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1.8.3. Advantages and limitations of identity-informative SNPs over STRs 
in forensic DNA analysis 
SNPs have several advantages over STRs: 
 SNPs are the most common form of variation at the DNA level, representing 
approximately 85% of all DNA variation [2, 3, 301, 302]. 
 SNPs are more stable over time. Their mutation rates in general are much lower 
(down to 10
-8
) than those of STRs (most frequently 10
-3
), making some of these 
markers appropriate for kinship or biogeographical analysis  [278, 303]. 
 Compared to the current semi-automation with STRs, genotyping technologies 
for SNPs are amenable for full automation with efficient high throughput and 
cost-effectiveness [285, 289, 304, 305].  
 Due to much smaller amplicons, genotyping of severely degraded DNA would 
have greater success with SNPs as compared to STRs [283, 306, 307].  
 SNPs may provide information on externally visible characteristics of the source 
of the DNA sample, not available through STR markers.  
 
Possible limitations of identity SNPs in forensic DNA analysis include: 
 Due to bi-allelic nature of most SNPs, their statistical power of discrimination is 
lower than of STR commercial kits. As a result, more markers are needed for a 
high discriminating power. 
 The analysis of mixed DNA profiles and mixture interpretation is more 
complicated with SNPs, due to difficulty to resolve different contributors alleles. 
 All current forensic DNA databases are based on STR data and include millions 
of profiles, making it problematic to replace them with SNPs. 
SNPs are unlikely to replace STRs as a primary method of forensic DNA identification 
[278, 303]. However, they may serve as a complementary tool in attempts to identify 
highly degraded human remains and a valuable tool in prediction of phenotypic and 
ethnic characteristics for investigative leads. The ultimate goal is to integrate the various 
categories of SNPs in one forensic assay, which would eventually provide information 
on identity, ancestry, pigmentation, appearance and other externally visible traits of the 
person, who is the source of the DNA sample.  
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1.9. Bioinformatical web-based resources for SNP search 
In the last decade substantial progress in genomic studies, especially in Genome 
Wide Association Studies (GWAS), has resulted in the availability of a growing number 
of bioinformatics resources for candidate marker selection and evaluation. These 
resources provide mostly free access to a range of data on gene functions and 
interactions, SNP locations, population data and statistical information. Given the size 
of the human genome, the number of polymorphisms and possible genomic and protein 
interactions, the amount of information offered by these resources is overwhelming. 
However, many of these tools are not systematized and not updated on an ongoing basis, 
which creates difficulties in candidate genes and SNPs selection process. 
One of the first successful attempts to systematize currently available resources for 
candidate markers selection was the “GeneEpi toolbox” [308]. This resource offers 
various workflows and resources for SNPs selection and subsequent evaluation (Figure 
23). 
 
 
Figure 23. GeneEpi toolbox schematic representation. 
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The major resource for searching SNP-related information is the dbSNP database. This 
database represents an international central repository for single base nucleotide 
substitutions, short deletions and insertion polymorphisms [244]. It represents a part of 
a greater database, offering a large amount of information on gene interactions, protein 
functions, taxonomy and disease-related genetic information (Figure 24). Additional 
web resources that were used in this project are detailed in the Chapter 2. 
 
 
Figure 24. Model of Entrez databases, showing interactions among them. The dbSNP database consists of over 12 
million SNPs (different species) up to January 2011. 
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1.10. Targeted massively parallel sequencing as a novel forensic 
genotyping platform 
There are many different SNP genotyping technologies which can be classified by 
the type of molecular mechanism employed: primer extension, allele specific 
hybridization, sequencing, oligonucleotide ligation and invasive cleavage, reviewed by 
Sobrino et. al. [304]. The major SNP detection methods include fluorescence, 
luminescence, mass spectrometry and more recently pH change detection [309-311].  
While the majority of forensic DNA laboratories use PCR, followed by capillary 
electrophoresis (CE) for the separation of STRs fragments [2, 3], alternative DNA 
typing methods utilize Massively Parallel Sequencing (MPS), also known as Next 
Generation Sequencing (MPS). MPS is a relatively new method, which uses various 
platforms and chemistries to perform DNA sequencing in an unprecedentedly fast 
manner [312]. Current forensic DNA analysis targets only tens of STR markers, while 
MPS methods can simultaneously type thousands of markers from the same sample, 
including STRs, SNPs, INDELs and mitochondrial DNA polymorphisms in a single 
multiplex reaction. As MPS becomes more established in basic research, it is also being 
investigated as an alternative method to capillary electrophoresis for forensic DNA 
analysis [313-315]. This approach would allow recovery of maximum useful genomic 
information from a limited DNA sample, without the need for additional amplification 
reactions. Most MPS methods enable processing of multiple samples through barcoding, 
providing increased output compared to CE methods. MPS platforms allow 
simultaneous analysis of millions of individual DNA reads, which would allow better 
resolution of complex mixtures [316]. An additional advantage of sequencing is the 
ability to detect intra-STR polymorphisms, which cannot be detected by CE, as it is a 
length-based detection method. This can maximize the amount of information revealed 
from a DNA sample, providing better resolution of genomic data [317]. It is possible 
that in the next few years, commercial forensic DNA assays will offer a “one for all 
assay”, able to generate not only the STR and SNP-based identity-informative data, but 
also type ancestry–informative, lineage–informative and phenotype – informative 
markers. The current major disadvantages of the MPS technology are the high cost and 
relatively complicated and time-consuming data analysis. These pitfalls however, are 
likely to be solved with the continuous progress in this technology.  
One of the relatively recent MPS technologies is the Ion Torrent
TM
 platform, 
manufactured by Life Technologies
TM.
. This methodology is based on the detection of 
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hydrogen ions, which are released during DNA synthesis by incorporation of 
complementary dNTP molecules (A, G, T or C). In this type of sequencing, DNA 
polymerization occurs directly on an electronic chip, which incorporates more than six 
million micro wells embodying a template and a sensor. During the sequencing, each 
ion that is released in the solution, causes a change in the electric signal (a change in 
pH), which is detected by a semiconductor sensor (a highly sensitive pH meter) and 
transferred to the computer for real-time data analysis. The main advantage of this 
technology is that signal detection does not involve labelled nucleotides, optics or any 
conversion process, but occurs directly through electronics. The Ion Torrent platform 
provides a relatively rapid sequencing time and low cost, compared to alternative MPS 
platforms. These advantages played a major role in choosing this platform for this 
research project. The main limitations of this system include the relatively short reads 
(up to 400 bp) and high error rate in sequencing of homopolymer  DNA repeats [318, 
319]. 
One of the examples of an Ion Torrent-based targeted MPS assay, which has the 
potential to be used in forensic DNA typing is the Ampliseq
TM
 assay, which provides 
several SNP panels for targeted DNA sequencing and detection of specific mutations 
(e.g. Cancer panel). This approach offers remarkable multiplexing capabilities, 
simultaneously amplifying thousands of custom markers from a relatively low amount 
of DNA template (10 ng versus approximately 250 ng needed for other platforms) in 
relatively short period of time. 
There are several consecutive steps in the custom Ampliseq protocol (illustrated in 
Figure 25). These steps include:  
 Primer design. 
Designing and building a custom panel of targeted markers, which is submitted to 
Life Technologies
TM
 for primer design. The current primer pipeline success rate is 
subject to multiple problems with primer design in specific genomic locations (e.g. 
homopolymer repeats). The panel may include thousands of markers, amplified in 
one or two pools.  
 
 Library construction.  
This step consists of amplification, primer digestion, barcode ligation and 
purification steps. It is performed using 10ng of DNA template with the possibility 
of processing multiples samples, using up to 96 specific barcodes. The final 
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sequencing library produced by generating DNA fragments flanked by the Ion 
Torrent sequencing adapters. This step is time and labour consuming, if performed 
on multiple samples. 
 
 Template preparation. 
This step involves clonal amplification of the library fragments on Ion Sphere 
particles by emulsion PCR and is performed using an automated instrument – One 
Touch
TM
.
 
 Subsequently, the Ion Sphere particles coated with template are deposited 
on a chip and sequenced using the Personal Genome Machine (PGM).  
 
 Data analysis. 
Data generated through the sequencing run are simultaneously transferred and 
analysed on the Ion Torrent server. The initial analysis includes signal processing 
and base calling, producing DNA sequences associated with individual reads. 
Following alignment of the sequenced data against reference sequence, the sequence 
can be subsequently transferred to third-party software (e.g. Ion Reporter
TM
) for 
annotation of specific variants.  
 
 
 
Figure 25. A general illustration of the custom Ampliseq protocol. 
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Although the actual sequencing step takes only a few hours to perform (on the 
IonTorrent platform), the library preparation and the data analysis steps are currently the 
major limiting factors of this process and may take days to weeks. Sequencing of 
hundreds and possibly thousands of markers from numerous samples would generate a 
large amount of data, which needs to be analysed in a user-friendly and time-efficient 
way. Additionally, the accuracy of sequencing can be severely affected by a number of 
factors, such as DNA quantity and quality, efficiency of library and template 
preparation as well as sequence alignment algorithms. Current bioinformatical 
platforms provide only a partial solution for these problems, still insufficient for 
forensic market needs, which requires standardized protocols and very high accuracy of 
genotyping from a variety of challenging samples. Nevertheless, given that MPS and 
related bioinformatics is a very dynamic field, it should be expected that solutions for 
these problems would emerge in the near future. 
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1.11. Project aims 
The main hypothesis of this research project is that SNPs in candidate genes may 
influence normal craniofacial variation in humans. The major aim of this research is to 
identify a set of SNPs potentially involved in normal human craniofacial variation, 
determine which of these markers are associated with craniofacial variation and 
subsequently test the power of these SNPs to predict visual appearance of a person. A 
secondary aim is to incorporate additional, previously identified markers, such as 
identity, lineage, ancestry and pigmentation – informative SNPs and test their prediction 
power on blind samples. This comprehensive assay would provide maximum 
information on the source of the DNA sample from a crime scene, helping with facial 
reconstruction in missing person and mass disaster cases as well as enriching our 
knowledge of the craniofacial embryogenetics. 
The specific aims of this project are summarized below: 
AIM 1:  To review the literature and relevant web resources in order to create a list of 
candidate genes and SNPs, potentially involved in normal craniofacial appearance. To 
generate a shortlist of SNPs, targeted for subsequent genotyping by sequencing. 
AIM 2: To collect a database of 300-500 DNA samples, along with 3D facial images 
and relevant phenotypic information. To analyse the 3D images for a set of craniofacial 
landmarks and various facial measurements.  
AIM 3: To validate and optimize the various methods used in this project, such as DNA 
extraction, genotyping and 3D image analysis.  
AIM 4: To genotype the DNA samples, using a MPS platform and analyse the data for 
potential association between the craniofacial measurements and additional phenotypic 
traits, such as pigmentation and ancestry, using statistical software. Following the 
association study results, to evaluate the statistically significant markers for their 
prediction power of specific traits.   
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Chapter 2  
Materials and Methods 
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2.1. Ethics approval 
The ethics approval for this project was granted by Bond University Human Ethics 
committee (RO 510). Most of the volunteers who participated in this study were Bond 
University students. All volunteers completed a questionnaire and gave informed 
consent (supplement documents S3 and S4).  
 
2.2. Samples 
In total, 587 DNA samples were used for genotyping purposes. This sample set 
included 534 volunteers who donated both DNA samples and 3D facial images and 14 
DNA samples without 3D images. Each participant donated four (4) buccal swabs. The 
samples without 3D images were accompanied with pigmentation and ancestry 
information. The mean age of the volunteers was 27.4 year old. The phenotype-related 
information in questionaries and all the craniofacial measurements were taken by the 
author. The ethnicity information of the volunteers’ grandparents was recorded. 
Samples of volunteers who had experienced severe facial injury and/or undergone facial 
surgery (e.g. nose or chin plastics) were not used in the craniofacial traits association 
study, although some were used for analysing association of markers with pigmentation 
traits and ancestry. 
An additional 39 DNA samples were obtained from an in-house laboratory database, 
which has pigmentation and ancestry as well as partial cranial measurements 
information (mostly eu-eu, g-op and cephalic indexes) recorded over a period of 10 
years (2000-2009). 
All extracted DNA samples were stored at -80
0 
C. The 3D facial image database and 
recorded personal information were stored in a single user access database on a 
dedicated computer.  
An additional set of samples was used for genotyping as a part of a validation study 
using the GoldenGate assay on the BeadExpress instrument (Illumina). The samples for 
this study originated from three sources: 
 552 DNA samples from the in-house (Bond University) database collected over 
a period of 10 years (2000-2009), with pigmentation (eye, hair and skin colour) 
and ancestry information recorded. 
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 365 DNA samples from the Health Science Center DNA database (University of 
North Texas, Fort Worth, USA). The samples were from the three major US 
population groups: Caucasian, African American and Hispanic. The samples of 
the African American ancestry were assigned with dark skin and black hair 
phenotype. 
 35 DNA samples were sourced from sub-optimal buccal swabs and 
environmentally challenged fieldwork samples. 
A more detailed information on these samples is available in Chapters 3.5.1 and 3.5.2 
 
2.3. DNA extraction  
DNA from the samples collected for this study was purified from saliva using one of 
the following extraction methods. The majority of the samples were extracted manually, 
using the Isohelix DDK isolation kit (Cell Projects, Kent, UK) as per manufacturer 
recommendations [320]. Alternatively, samples (n=120) were purified on the EZ1 
extraction robot using a semi-automated EZ1 Buccal swabs card (Qiagen, Hilden, 
Germany). Twenty four additional DNA samples were extracted in duplicate using a 
DNA IQ purification kit (Promega, US) or a Miniprep kit (Qiagen), according to 
manufacturer recommendations [321, 322]. Each two (2) of four (4) collected buccal 
swabs were used for a single DNA extraction. 
 
2.4. DNA quantification  
DNA samples were quantified using one of two methods. The majority of the 
samples were quantified using a Real Time quantitative PCR (q-PCR) method. This 
assay amplified a 63bp region of the OCA locus. The primer sequences were 5’-  
GCTGCAGGAGTCAGAAGGTT-3’ (forward primer) and 5’- 
CATTTGGCGAGCAGAATCC-3’ (reverse primer) at a final concentration of 200mM. 
The assay was performed on either Rotor-Gene 6000 (Qiagen), Bio-Rad CFX96 (Bio-
Rad, Gladesville, Australia) or 7500 Real-Time (Life Technology) thermal cyclers in a 
25µL reaction volume using SensiMix HRM Master Mix (Bioline).    
The three-step qPCR protocol consisted of an initial 15 minute 95°C Taq DNA 
polymerase activation step, followed by 40 cycles of 15 seconds of denaturation (95°C), 
10 seconds of annealing (60°C) and 10 seconds extension (72°C). High Molecular 
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Weight (HMW) human genomic male DNA of known concentration (Promega, 
Madison, WI) was used as a qPCR quantification standard (0.0254 - 25.4ng/µL). 
Standard curves with good linearity (R
2
 values above 0.99) were accepted for analysis. 
No template controls (NTCs) were included to monitor contamination during qPCR.  
All DNA samples were additionally quantified using the Qubit fluorometer (Life 
Technologies, Mulgrave, VIC, Australia) prior to library construction as per 
manufacturer recommendations.  
 
 
2.5. Candidate genes and SNPs search using bioinformatics resources 
The following web resources were used for identification of candidate genes, which 
may play a role in the embryonic craniofacial development in model organisms and be 
responsible for normal facial variation. Some web resources were used for several 
aspects of the candidate marker selection process and are repeated in different 
categories. 
 
 Search for candidate genes in human and in model organisms 
o Mouse Genome Informatics (The Jackson Laboratory): 
http://www.informatics.jax.org/ 
o dbSNP database: http://www.ncbi.nlm.nih.gov/projects/SNP/ 
o GeneCards server [323]: www.genecards.org 
o Human Osteogenesis PCR Array: 
http://www.sabiosciences.com/rt_pcr_product/HTML/PAHS-
026A.html 
o Ensemble genome browser: 
http://www.ensembl.org/Homo_sapiens/Info/Index 
o HGDP selection browser: http://hgdp.uchicago.edu/cgi-
bin/gbrowse/HGDP/ 
o AmiGo – the gene ontology database [324]: 
http://amigo.geneontology.org/cgi-bin/amigo/go.cgi  
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The following list summarises web resources, used for screening of high population 
differentiation markers in candidate genes: 
 High Fst SNPs and AIMs selection 
o ENGINES: http://spsmart.cesga.es/engines.php?dataSet=engines 
[325]  
o FstSNP-HapMap3 database of 115,213 SNPs based on HapMap data 
http://FstSNP-hapmap3.googlecode.com/[326]  
o A map of human genome variation from population-scale sequencing 
[246] 
o A High-Density SNP Map for Signatures of Natural Selection [261] 
o A list of 582 genes containing at least one genic mutation showing 
signs of positive selection [327] 
o Database of 5,000 AIMs http://www.cs.rpi.edu/~drinep/HGDPAIMS/ 
[265]:  
o UCSC genome browser: http://genome.ucsc.edu/cgi-
bin/hgTracks?org=human 
o Haplotter: http://haplotter.uchicago.edu/ 
o SNP evolution genome browser http://124.16.129.22/cgi-
bin/gbrowse/evolution_B36/ [328]:  
o SPSMart database [329]: http://spsmart.cesga.es/ 
 
The candidate genes and SNPs list was further screened for additional markers 
according to the following categories: 
 nsSNPs in coding regions 
o International HapMap project [277] 
http://hapmap.ncbi.nlm.nih.gov/index.html.en 
o 1000 genomes project http://browser.1000genomes.org/ [246]  
o PolyPhen server for prediction of functional effect of human nsSNPs 
www.bork.embl-heidelberg.de/Poly Phen [330]  
o GeneCards server [323] www.genecards.org 
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 SNPs in transcription regulation sites selection 
o GeneCards server www.genecards.org  [323]  
o F-SNP database: http://compbio.cs.queensu.ca/F-SNP/ 
o GRAIL software for examination of relationships between genes: 
http://www.broadinstitute.org/mpg/grail 
o Multi-genome database of positions and patterns of elements of 
regulation: http://genome.ufl.edu/mapper/run 
o GWAS catalogue http://www.genome.gov/gwastudies/ [71]:  
o is-rSNP software [331]: 
http://bioinformatics.research.nicta.com.au/software/is-rsnp/ 
o SNPNexus http://www.snp-nexus.org/ [332]:  
o Japanese SNP database: http://snp.ims.u-tokyo.ac.jp/ 
o TFSearch: http://www.cbrc.jp/research/db/TFSEARCH.html 
 
 Potentially functional SNPs selection 
o SNP function prediction portal: 
http://snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm 
o Potentially functional SNP search engine [333] 
http://pfs.nus.edu.sg/%28S%28e5qybiumwhvbajcdnpyup32q%29%2
9/QueryInterface_V5_2.aspx 
o Genomic Regions Enrichment of Annotations Tool (GREAT) web-
based platform (http://bejerano.stanford.edu/great/public/html) 
 
 Tag SNPs selection 
o Haploview software for haplotype analysis 
http://www.broadinstitute.org/scientific-
community/science/programs/medical-and-population-
genetics/haploview/haploview  [334]:  
o Snagger http://snagger.sourceforge.net/ [334-337]  
o Tagger : http://www.broadinstitute.org/mpg/tagger/ 
o SNPPicker http://www.mybiosoftware.com/population-
genetics/4430[338]:  
o LD Tag SNP selection server: 
http://snpinfo.niehs.nih.gov/snpinfo/snptag.htm 
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2.6. Target selection and primer design process 
Approximately 1,200 markers in the craniofacial candidate genes were selected 
using various web resources were selected as a list of SNPs with their respective rs 
numbers and chromosomal location. Approximately 700 additional markers, previously 
shown to be associated with pigmentation traits, ancestry and identity informative 
markers were selected from the relevant literature and added to the final markers list. 
The final candidate markers list was submitted online at: 
https://www.ampliseq.com/browse.action for the custom Ampliseq primer design 
pipeline. Based on the design output (failure of some markers), the marker list was 
resubmitted with alternative markers, showing high linkage with the markers that failed 
initial primer design. The final custom Ampliseq primer multiplex set was designed as 
two separate pools of approximately 850 primer pairs each. 
 
 
2.7. 3D facial scanning procedure 
Craniofacial scans were taken with a Konica Minolta Vivid 910 3-D digitiser. A 
Minolta medium range lens with focal length of 14.5 mm was used for surface 
registration. This camera emits an eye safe class I laser (FDA) λ=690 nm at 30 mW 
with an object to scanner distance of 600-2500 mm and scan time of approximately 2.5 
seconds in fine mode. Vivid V910 uses a one-half-frame transfer charged couple device 
(CCD) and can acquire 307,000 data points. The scanner output data are 640 x 480 
pixels for 3D and RGB data. The output data were recorded on a laptop computer with 
Intel Core2 Duo, 3GHz processor, equipped with Polygone® software. Two daylight 
fluorescent sources (3400K/5400K colour temperature) were mounted in the room. 
These lights were placed approximately 1.5 meters from the subject’s head, with the 
main halogen light dimmed, (resulting in a more ambient light coverage and a better 
image quality).  
The scanner was mounted at a distance of approximately 1 meter from the volunteer’s 
head. Each volunteer remained in an upright natural position during the scan. Subjects 
with long hair pulled their hair behind the ears. Glasses and earrings were removed. 
Each volunteer was scanned three times from different angles (front and two sides). 
Three cranial measurements (Eu-Eu, G-Op, V-Gn) were taken, using a digital spreading 
calliper (Paleo-Tech Concepts, USA).  
75 | P a g e  
 
The scanned images were registered and aligned using overlapping coordinates (Figures 
26 and 27). The final merged 3D image was produced by semi-automatically aligning 
all scans and deleting non-overlapping or unnecessary data (e.g. neck area, hair and 
jewellery). The complete coordinates of each merged 3D image were saved in a vivid 
file format (.vvd).  
 
 
Figure 26. An illustration of alligning of two facial scans with the Polygon software. 
 
 
 
Figure 27. An illustration of the final 3D image, produced by merging three facial scans.  
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The image file (see an example on Figures 28) was transferred to Geomagic® software 
for initial image manipulation as below: 
 Three .vvd merged objects (representing three facial scans) from Polygone® 
software were imported and saved in .wrp format as one merged object. 
 Compensation for the noise error made by the scanner was performed by 
automatically moving points to statistically correct locations with fixed 
deviation limit of 0.03mm.  
 A “Mesh doctor” function was applied on low quality images. This procedure 
automatically repaired imperfections in the polygon mesh of the scanned object. 
 Some selected holes, not covered by the scanning process and required for 
analysis (such as eyes or nostrils area) were filled in the polygon object. 
 The resulted 3D merged image was saved for further location of the craniofacial 
landmarks. 
 
Figure 28a  
 
 
Figure 28b 
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Figure 28c 
 
Figure 28. An illustration of a merged image output after initial image processing in the Geomagic software. a) 
side view, b) front view, c) top view. 
 
 
 
 
2.8. Cranial measurements 
 
Three cranial measurements were performed using a sliding digital calliper (Paleo-
Tech Concepts, USA). The measurements were as follows: 
 V-Gn (Craniofacial height)  
 Eu-Eu (Head Width)  
 G-Op (Head Length) 
Based on craniofacial and body height measurements, three craniofacial ratios were 
calculated using a Microsoft Excel software: 
 Cephalic index – (eu-eu)*100/(g-op) 
 Head width – Craniofacial height index (eu-eu)*100/(v-gn) 
 Head – Body height index (v-gn)*100/(body height) 
 
 
2.9. Facial measurements 
 
Facial measurements were recorded upon location of specific anthropometrical 
landmarks and included linear and angular distances as well as ratios between these 
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distances. The following section describes the landmarking protocol used and provides 
details regarding the craniofacial measurements obtained.  
2.9.1. Landmarking protocol 
Each 3D image was analysed to allocate 32 facial landmarks using Geomagic 
software. Each landmark was represented by ‘x’, ‘y’ and ‘z’ coordinates as part of the 
Cartesian coordinate system (Figure 29). The coordinates were exported to an Excel 
spread sheet for subsequent analysis. 
 
 
 
 
Figure 29. Illustration of 32 facial landmarks allocated on face with their corresponding coordinates. 
 
 
 
The following landmarking protocol provides a list of 32 facial landmarks that were 
used in this study, and describes their anthropological location, according to Farkas et.al 
[17, 18] and Swennen et. al. [339]. The left (l) and right (r) sides of the relevant 
landmarks identified according to corresponding anatomical sides of the face. The 
names in parentheses are commonly used alternative anthropometric names of the 
corresponding landmark.  
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Table 4. Facial landmarks used in the project. 
Landmark Number Abbreviation Left (l) or 
Right (r) 
Description Notes 
Gnathion 
(Menthon) 
1 gn  The lowest anterior 
midpoint of the chin, 
located on the skin 
surface in front of the 
identical landmark of the 
mandible 
Identical to the 
bony gnathion. 
The lowest 
point used in 
measuring facial 
height 
Pogonion 2 pg  The most anterior 
midpoint of the chin, 
located on the surface in 
front of the identical 
bony landmark on the 
mandible 
 
Sublabiale 3 sl  Determines the lower 
border of the lower lip or 
the upper border of the 
chin 
 
Labiale 
inferius 
4 li  The midpoint of the 
lower vermillion line 
 
Stomion 5 sto  The imaginary point at 
the crossing of  the 
vertical  facial midline 
and the horizontal labial 
fissure between gently 
closed lips, with teeth 
shut in the natural 
position 
 
Labiale 
superius 
6 ls  The midpoint of the 
upper vermillion line 
 
Cheilion 7 ch(l) Left The point located at each 
labial commissure 
Located on very 
comers of the 
mouth, not the 
lips 
Cheilion 8 ch(r) Right The point located at each 
labial commissure 
Located on very 
comers of the 
mouth, not the 
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lips 
Gonion 9 go(l) Left The most lateral point on 
the mandibular angle 
close to the bony gonion 
If the angle is 
flat or if there is 
a rich soft-tissue 
cover, 
determination of 
this point is very 
difficult 
Gonion 10 go(r) Right The most lateral point on 
the mandibular angle 
close to the bony gonion 
If the angle is 
flat or if there is 
a rich soft-tissue 
cover, 
determination of 
this point is very 
difficult 
Subnasale 11 sn  The midpoint of the 
angle at the columnella 
base where the lower 
border of the nasal 
septum and the surface 
of the upper lip meet. 
The location is 
different to the 
bony subnasion. 
The landmark is 
identified in 
base view of the 
nose or from the 
side. 
Pronasale 12 prn  The most  protruded 
point  of  the apex nasi. 
This point is 
difficult to 
determine if the 
nasal tip is flat.  
In the case of 
the bifid nose, 
the more 
protruding tip is 
chosen for prn 
Alare 13 al(l) Left The most protruded point 
of each alar contour 
 
Alare 14 al(r) Right The most protruded point 
of each alar contour 
 
Nasion (soft 
tissue) 
15 n  The deepest point on the 
nasal bridge 
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Glabella 16 g  The most prominent 
midline point between
 the eyebrows 
 
Trichion 17 tr  The point of the hairline 
in the midline of the 
forehead 
Cannot be 
determined on a 
balding head 
Endocanthion 18 en(l) Left The point at the inner 
commissure of the eye 
fissure 
 
Exocanthion 19 ex(l) Left The point at the outer 
commissure of the eye 
fissure 
 
Palpebrale 
superius 
20 ps(l) Left The highest point in the 
midportion of the free 
margin of each upper 
eyelid 
 
Palpebrale 
inferius 
21 pi(l) Left The lowest point in the 
midportion of the free 
margin of each lower 
eyelid 
 
Endocanthion 22 en(r) Right The point at the inner 
commissure of the eye 
fissure 
 
Exocanthion 23 ex(r) Right The point at the outer 
commissure of the eye 
fissure 
 
Palpebrale 
superius 
24 ps(r) Right The highest point in the 
midportion of the free 
margin of each upper 
eyelid 
 
Palpebrale 
inferius 
25 pi(r) Right The lowest point in the 
midportion of the free 
margin of each lower 
eyelid 
 
Zygion 26 zy(r) Right The most lateral point of 
each zygomatic arch 
Identical to the 
bony zygion of 
the malar bones. 
If the angle is 
flat or if there is 
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a rich soft-tissue 
cover, 
determination of 
this point is 
difficult 
Zygion 27 zy(l) Left The most lateral point of 
each zygomatic arch 
Identical to the 
bony zygion of 
the malar bones. 
If the angle is 
flat or if there is 
a rich soft-tissue 
cover, 
determination of 
this point is 
difficult 
Superaurale 28 sa(l) Left The highest point on the 
free margin  of the ear 
lobe 
 
Subalare 29 sba(l) Left The lowest point on the 
free margin  of the ear 
lobe 
 
Postaurale 30 pa(l) Left The most posterior point 
on the free margin of the 
ear 
 
Tragion 31 t(l) Left The notch on the upper 
margin of the tragus 
 
Tragion 32 t(r) Right The notch on the upper 
margin of the tragus 
 
 
 
All the facial landmarks were allocated manually, using 3D images generated by the 
Geomagic software. 
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2.9.2. Linear measurements 
The data for 32 facial landmarks were processed in Excel to calculate each of the 
54 linear measurements. The general formula for calculating a distance between two 
landmarks in the Euclidean space is:  √(     )  (     )  (     )  where ‘x, 
y and z’ are the coordinates of each landmark in the Cartesian space. The formula was 
used in the Excel spreadsheet for automatic calculation of the linear distances. 
For images of a good quality (full set of 32 facial landmarks available), a full set of 
measurements was generated. For images of a poor quality, a partial set of 
measurements was recorded. 
The data for the following facial measurements were generated for each 3D image: 
 Total face height: tr-gn  
 Face width: zy-zy  
 Morphological face height: n-gn  
 Physiognomical face height: n-sto  
 Lower profile height: prn-gn  
 Lower face height: sn-gn  
 Lower third face depth: t(l)-gn  
 Middle face depth: t(l)-prn  
 Middle face height (right): go(r)-zy(r)  
 Middle face height (left): go(l)-zy(l)  
 Middle face width 1: t(r)-t(l)  
 Middle face width 2 (left): zy(l)-al(l)  
 Middle face width 2 (right): zy(r)-al(r)  
 Upper face depth: (left): t(l)-tr  
 Upper face depth: (right): t(r)-tr  
 Upper third face depth: t(l)-n  
 Forehead height: g-tr  
 Extended forehead height: tr-n  
 Glabella –Gnathion distance: g-gn  
 Supraorbital depth: t(l)-g  
 Trichion – Zygion distance (left): tr-zy(l)  
 Trichion – Zygion distance (right): tr-zy(r)  
 Nasion - Zygion distance (left): n-zy(l)  
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 Nasion - Zygion distance (right): n-zy(r)  
 Zygion – Gnathion distance (left): zy(l)-gn  
 Zygion – Gnathion distance (right): zy(r)-gn  
 Intercanthal width: en-en  
 Biocular width: ex-ex  
 Eye fissure width (left): en(l)-ex(l)  
 Eye fissure width (right): en(r)-ex(r)  
 Eye fissure height (left): ps(l)-pi(l)  
 Eye fissure height (right): ps(r)-pi(r)  
 Ear height (left): sa(l)-sba(l)  
 Ear width (left): t(l)-pa(l)  
 Nasal bridge width: n-prn  
 Nose height: n-sn  
 Nose width: al-al  
 Nasal tip protrusion: sn-prn  
 Ala length (left): prn-al(l)  
 Ala length (right): prn-al(r)  
 Gonion - Trichion distance (left): go(l)-tr  
 Gonion - Trichion distance (right): go(r)-tr  
 Gonion – Glabella distance: g-pg  
 Pronasale - Gonion distance (left): prn-go(l) 
 Pronasale - Gonion distance (right): prn-go(r) 
 Chin height: sl-gn  
 Mandibular region depth (right): t(r)-gn  
 Mandible width: go-go  
 Mandible height: sto-gn  
 Lower jaw depth (left): gn-go(l)  
 Lower jaw depth (right): gn-go(r)  
 Mouth width: ch-ch  
 Upper vermilion height: ls-sto  
 Lower vermilion height: li-sto 
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2.9.3. Angular measurements 
Ten angular measurements were calculated based on previously allocated 
Euclidean coordinates for facial landmarks. Angular measurements were calculated 
between two 3D vectors of the three corresponding landmarks. As shown at the 
following scheme, each three landmarks for any angular measurement form two vectors 
(“ac” and “bc”), and the angle is measured between vectors: 
 
 
 
 
The general formula for calculating an angle between two vectors in the Cartesian 
coordinates system is:  Cos θ = (a.b)/(|a||b|) 
Figure 30 demonstrates all the angular distances, formed by corresponding vectors on a 
facial image with (a) and without (b) removing the facial background. 
 
a) 
 
a b 
c 
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b) 
 
Figure 30. An example of angular distances on a 3D image a) with and b) without facial surface texture.  
 
 
 
 
The following list summarizes ten angular measurements, obtained from 3D facial 
images. 
 Nasal tip angle (n-prn-sn) 
 Nasal vertical prominence angle (tr-prn-gn)  
 Transverse nasal prominence 1 angle (zy(l)-prn-zy(r)) 
 Transverse nasal prominence 2 angle (t(l)-prn-t(r)) 
 Nasolabial angle (prn-sn-ls) 
 Nasofrontal angle (g-n-prn) 
 Nasion depth angle (zy(l)-n-zy(r))  
 Nasomental angle (n-prn-pg) 
 Forehead nasal angle (tr-n-prn)  
 Chin prominence angle (go(l)-gn-go(r))  
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2.9.4. Ratios 
The data acquired from linear measurements were used to calculate 21 facial indices 
(ratios), according to the following list: 
 Forehead height ratio (tr-n)x100/(go(r)-go(l))  
 Upper face height ratio (n-sn)x100/(go(r)-go(l))  
 Lower face height ratio: (sn-gnx100/(go-go)  
 Anterior face height 1 ratio: (n-gn)x100/(go-go)  
 Anterior face height 2 ratio: (n-gn)x100/(zy-zy) 
 Face height index: (n-gn)x100/(tr-gn)   
 Upper – Lower face ratio: (tr-g)x100/(sn-gn)  
 Upper face height ratio: (n-sn)x100/(sn-gn)  
 Upper face width ratio: (n-sn)x100/(zy-zy)  
 Total anterior face height ratio: (tr-gn)x100/(zy-zy)  
 Mouth width ratio: (ch-ch)x100/(en-en)  
 Mandible – Face width ratio: (go-go)x100/(zy-zy) 
 Mandible index: (sto-gn)x100/(go-go) 
 Mandible – Interexocanthion distance ratio (go-go)x100/(ex-ex) 
 Interendocanthion distance ratio: (en-en)x100/(al-al) 
 Intercanthal index: (en(R)-en(L))x100/(ex(R)-ex(L))  
 Intercanthal – Intracanthal index: (ex(R)-en(R))x100/(en(L)-ex(L))  
 Nasal index: (al-al)x100/(n-sn)  
 Nose-face height index: (n-sn)x100/(n-gn)  
 Nose-face width index: (al-al)x100/(zy-zy)  
 Nasal tip protrusion – nose width index: (sn-prn)/(al-al) 
 Nasal tip protrusion –Nose height index: (sn-prn)x100/(n-sn) 
 
2.9.5. Principal components 
All the craniofacial measurements and indexes (n=85) generated in this study were 
used for calculation of 20 principal components, as discussed in details in Section 4.6. 
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2.10. Genotyping methods 
A set of 587 DNA samples was genotyped by sequencing. DNA samples were 
processed according to the following procedures: 
 
2.10.1. Custom Ampliseq protocol for library preparation 
A custom Ampliseq library was prepared from 10 ng of genomic DNA which 
was amplified using an IonAmpliseq library kit in conjunction with a custom Ampliseq 
primer pool, according to manufacturer recommendations [340]. The original 
amplification reaction was split into two 10µl reactions for each of the multiplex pools, 
as per manufacturer’s recommendations. The master mix included 2µl of 5x Ion 
AmpliSeq™ HiFi Master Mix and 5µl of each 2x Ion AmpliSeq™ Primer Pool. Each 
primer pool consisted of approximately 840 primer pairs. Each library was prepared for 
up to 32 DNA samples in a 96 well plate format. The amplification conditions included 
an initial ‘hold’ step of 990C for 2 minutes, 15 cycles of 990C for 15 seconds followed 
by 60
0
C for 8 minutes and a final hold step of 10
0
C for up to 1 hour. 
Following PCR, two pools of amplicons for each sample were mixed in a final volume 
of 20 µl. The resulting amplicons were treated with 2µl FuPa reagent to partially digest 
the primers and phosphorylate the amplicons. The sample plate was placed in a thermal 
cycler and incubated at 50
0
C for 10 minutes, followed by 10 minutes incubation at 55
0
C 
and then by 60
0
C incubation for 20 minutes. 
Subsequent to primer digestion, the amplicons were ligated to Ion Adapters with up to 
32 unique barcodes (according to the number of samples). The master mix consisted of 
4µl Switch solution, 2µl of Ion AmpliSeq barcodes and 2µl of DNA ligase for each well. 
The ligation reaction was performed at 22
0
C for 30 minutes and then at 72
0
C for 10 
minutes. The ligated library products were purified using the Agencourt AMPure
TM
 XP 
reagent according to manufacturer recommendations [341].  
The final libraries were quantified using an Ion Library Quantitation Kit as per 
manufacturer recommendations. The quantitative Real Time PCR mix was prepared in a 
96-well format, either manually or using an epMotion 5075 robot (Eppendorf South 
Pacific, North Ryde, NSW). The amplification reaction was performed in 10µl (half of 
the recommended reaction volume). The master mix consisted of 5µl of 2x Ion TaqMan 
master mix and 0.5µl 20x Ion TaqMan Assay. The volume of DNA sample was 4.5µl 
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per reaction. An E.coli DH10B Ion Control Library was used as a standard. The 
amplification step included 50
0
C for 2 minutes, 95
0
C for 20 seconds, followed by 40 
cycles of 95
0
C for 3 seconds and 60
0
C for 30 seconds each. The quantitative PCR was 
performed using a CFX96 Real-Time system (BioRad), as per manufacturer 
recommendations. The quality of the amplified libraries (e.g. amplicon sizes) was not 
confirmed as recommended due to unavailability of the Bioanalyzer instrument 
(Agilent). 
The pre – PCR and post – PCR steps of the library preparation were performed in two 
separate dedicated hoods. Each step of the protocol was followed by a decontamination 
step, using 10% hypochloride solution and UV irradiation. Figure 31 summarises the 
Ampliseq library preparation step: 
 
 
Figure 31. Ampliseq Library preparation summary. 
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2.10.2. Template preparation 
Each library was diluted to approximately 10 pM to 20 pM and mixed in 
equimolar ratios. Template-positive Ion PGM™ Template 200 Ion Sphere™ Particles 
(ISPs) with 200 base-pair average insert libraries were automatically prepared using 
either OneTouch™, OneTouch™ DL or OneTouch™ 2 instruments. The ISPs were 
subsequently enriched using a semi-automated protocol on the Ion OneTouch™ ES 
instrument. All steps were performed according to manufacturer’s recommendations 
[342]. 
 
2.10.3. Sequencing 
The sequencing step was performed on the Personal Genome Machine (PGM) 
according to manufacturer recommendations [343]. Following the cleaning and 
initialization steps, the 316 chip was loaded with enriched ISPs (following template 
preparation step) and sequenced on the PGM. The sequencing round lasted 
approximately 8 hours and included sequencing of two 316 chips (up to 32 libraries per 
chip).  
 
2.10.4. Data analysis  
During the sequencing process, the initial unaligned sequence data were 
automatically transferred to the Torrent Suite Server (TSS). The TSS automatically 
performed sequence alignment according to the reference sequence, quality control and 
data analysis, such as basic variant calling. The initial data analysis process is 
summarised in Figure 32. 
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Figure 32. Illustration of the data analysis workflow. 
At the end of each sequencing run, the TSS software generated a summary, with the 
following quality control parameters of the sequencing run performance: 
 ISP loading density. This parameter represents the percentage of chip’s wells 
loaded with ISPs. The red-coloured areas in Figure 33 represent fully loaded 
wells, while the yellow colour represents less loaded and blue and green areas 
shows very poorly loaded wells. The blue areas usually represent air bubbles, 
which can be “trapped” inside the chip, during the loading process. Alternatively, 
these areas may be caused by a technical failure in the chip manufacturing 
process. 
 
Figure 33. Loaded chip image, illustrating loading density. In this image, red indicates good loading, yellow is 
passable, and green and blue (air bubbles) show very poor loading. 
 
 Usable reads, representing various parameters of the ISP beads performance 
(Figure 34), such as: 
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o The percentage of loaded vs. empty chip wells. This value depends on 
various parameters, such as the number of beads available and a physical 
distribution of ISPs during the loading process. 
o The percentage of enriched ISP. This value depends on the initial 
concentration of the libraries, used for enrichment and efficiency of the 
template preparation on OneTouch™ instrument. 
o The percentage of live ISPs. This value represents a number of wells, 
which contained an ISP with a signal of sufficient strength to be 
associated with the library fragment of test fragment key. 
o The test fragment key. This parameter represents a number of live ISPs 
that were identical to the test fragment key signal. 
o The percentage of polyclonal beads. This value represents the number of 
beads that have more than a single targeted clone and as a result, cannot 
be used for sequencing and alignment. Based on manufacturer 
recommendations, a sequencing run with polyclonality values of less 
than 40% is considered of a good quality. 
o The percentage of adapter-dimer. This value refers to the formation of a 
sequencing adaptor-dimer, with no targeted insert or a very short insert. 
The fraction of such reads is typically less than 1%.  
o The percentage of low quality reads. Any inserts of less than 8 base pairs 
or low-quality base calls at the 3’ ends are automatically trimmed and 
removed from the final output.  
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Figure 34. An example of sequencing run statistics. 
 
 
 
 
 
 
 Read length represents the distribution of sequenced fragments in the run. The 
ideal distribution of fragments in the custom Ampliseq assay used in this study 
was aimed to be shifted towards the 150-200bp region (Figure 35).  
 
 
 
 
Figure 35. An illustration of amplicon length distribution in a single sequencing run. 
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 Run quality following alignment (AQ17/ AQ20). This value represents the 
greatest position in the read at which the accuracy in the bases meets the 
accuracy threshold (see an example in Figure 36). The AQ17 length of a read is 
the greatest length at which the read error rate is 2% or less and the AQ20 length 
is the greatest length at which the error rate is 1% or less. 
 
 
 
 
Figure 36. An illustration of run quality metrics. 
 
 
 
 
The Ion Torrent data analysis process includes several continuous steps and is 
summarised in Figure 37. 
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Figure 37. A summary of the Ion Torrent data analysis workflow. 
 
 
 
2.10.5. Variants annotation using the Ion Reporter software 
The aligned sequences in BAM format were uploaded to the Ion Reporter (IR) 
cloud-based software for further analysis. Ion Reporter software provided the 
opportunity to annotate and export all the variants, including the reference calls, which 
was not possible with the build-in Variant Caller in the Ion Torrent Suite software. The 
IR output was exported in the VCF format, which included allele calls and various 
sequencing statistics (such as sequencing depth and quality, allele frequency and 
markers type and chromosomal location) for each sample. 
2.11. Statistical analysis 
 
. 
• Data is generated by PGM and saved on Ion Torrent server. 
. 
• Primary data analysis, generation of the summary report. 
• Generation of .BAM and .VCF files. The latest include only unique alleles – 
different from the reference sequence. 
. 
• Uploading the data to the cloud based Ion Reporter (IR) server. 
• Data analysis in the IR. 
. 
• Generation of the .VCF files for each sample, which include reference alleles. 
• Export of the IR output to a local computer for further analysis. 
. 
• Editing and statistical analysis of the data in the GoldenHelix software. 
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2.11.1. Data dimensionality reduction 
In order to more efficiently manage the relatively large number of craniofacial 
measurements (n=92), a Principal Component Analysis (PCA) was conducted on the 
craniofacial measurements dataset, using the PASW Statistics 18 release version (SPSS, 
Inc., Chicago, IL.). A more detailed explanation of this method is provided in Section 
4.6. 
 
 
2.11.2. Markers association analysis 
Ancestry association analyses were performed using SNP & Variation Suite v7 
(Golden Helix, Inc., Bozeman, MT, www.goldenhelix.com) and replicated using 
PLINK v1.07 software [344]. A stepwise linear regression analysis with cofactors such 
as sex and ancestry were implemented to find potential associations of specific 
phenotypic traits with genetic markers. A more detailed explanation of this method is 
provided in Chapters 3 and 5. 
 
 
 
2.11.3. Prediction analysis of phenotypic traits and ancestry 
Numerous craniofacial and pigmentation phenotypic traits and ancestry were 
predicted using stepwise logistic regression models. Multiple determination coefficients 
(R
2
) of these models were used to estimate the predictive power of the model. A more 
detailed explanation of this method is provided in Chapter 5. 
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Chapter 3  
Assessment of samples collection, DNA 
extraction and genotyping equipment 
optimisation 
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3.1.  General Introduction 
 
This chapter refers to aims 1-3 of this project, which were: 
AIM 1:  To review the literature and relevant web resources in order to create a list of 
candidate genes and SNPs, potentially involved in normal craniofacial appearance. To 
generate a shortlist of SNPs, targeted for subsequent genotyping by sequencing. 
AIM 2: To collect a database of 300-500 DNA samples, along with 3D facial images 
and relevant phenotypic information. To analyse the 3D images for a set of craniofacial 
landmarks and various facial measurements.  
AIM 3: To validate and optimize the various methods used in this project, such as DNA 
extraction, genotyping and 3D image analysis.  
 
Specifically, this chapter focuses on the results of following studies: 
 
 DNA sample collection. 
 Validation and optimisation of the DNA extraction methods. 
 Candidate genes and SNP selection. 
 Evaluation of SNP genotyping platforms. 
Prior to performing genotyping all relevant methods and use of equipment were 
optimised, when needed. This was necessary for the subsequent association and 
prediction studies, which were the main aims of this project. 
 
 
3.2.  Sample collection 
 
3.2.1. Introduction  
The sample collection process occurred over a period of three and a half years. 
In order to make the sample collection procedure more convenient and efficient, an 
online booking web site, which provided a user-friendly interface and the opportunity 
for volunteers to book an appointment for the 3D scanning and DNA collection was 
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created. The use of the online schedule helped with the logistics of the sample collection 
process. The booking web site is accessible through the following link:  
http://www.supersaas.com/schedule/DNA_Database/Craniofacial_project  
In order to recruit volunteers, the research project was advertised using flyers and media 
releases, as well as via personal communication. 
 
 
3.2.2. Methods 
DNA samples and 3D images were collected as detailed in the Chapter 2.  
 
 
3.2.3. Results and Discussion 
The sample collection procedure resulted in recruiting 641 samples, with 107 
individuals providing a DNA sample only, without the 3D image. However, of these 
107, fourteen (14) DNA samples were used for pigmentation and ancestry association 
studies only (not for the craniofacial traits association study). As a result, there were 
534 volunteers who donated both a DNA sample and a 3D facial image. In addition, 39 
individuals were sourced from the existing database, collected between 2000 to 2009. 
These samples were accompanied with pigmentation and ancestry information. Overall, 
587 DNA samples were used for genotyping purposes. The mean age of the 587 
volunteers was 27.4 year old with standard deviation of 10 years.  
The volunteers were of various ancestries, with the majority (70%) being Caucasian. A 
sample set comprised of different ancestries can potentially introduce a bias in statistical 
analysis, due to the difference in allele distribution in various populations. However, 
this issue was addressed by performing a statistical correction to address the population 
stratification issue in the association analysis (as detailed in Chapter 5). Table 5 
summarises the volunteer statistics on sex and ancestry. 
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Table 5. Samples collected in the current study as categorised by sex and ancestry. 
 Trait No. samples Percentage 
Sex Male 231 39.5 
Female 354 60.5 
Total 585 100 
      
  
  
 Ancestry 
  
  
  
  
  
Aboriginal 3 0.5 
African 23 3.9 
Admixture 45 7.7 
Asian 55 9.4 
Caucasian 409 69.9 
Indian 46 7.9 
Other 4 0.7 
Total 585 100 
 
 
Generally, the bigger the sample size, the greater the statistical significance of the 
results and the lower the false positive rate. However, collecting and genotyping of 
larger sample numbers is not always feasible, since it is more time-consuming and 
costly. Furthermore, very large sample sets often involve collaborative efforts of several 
researchers, which is also not always possible. The final number of samples used in this 
study may still be considered small for an association study, while the use of a targeted 
gene/SNP approach mitigates this.  
An effective sample size is defined as the minimum number of samples that achieves 
adequate statistical power. A statistical power of 80% is considered sufficient for large-
scale association studies [345, 346]. However, testing a large number of SNP markers 
leads to a large number of multiple comparisons and thus increases false positive rates. 
In order to correct the false positive errors (type I error), either the Bonferroni or the 
false discovery rate correction is generally applied [347]. Given that the more often used 
(and more stringent) Bonferroni correction involves dividing the p-value significance 
threshold by the number of markers tested, a large number of samples is generally 
needed to compensate for this correction. As a result, most GWAS which analyse 
association of millions of markers with a specific trait, require thousands of samples to 
be collected. It has been shown that testing a single SNP in a disease association study 
would require 248 cases, while testing 500,000 markers would require at least 1,206 
cases [348]. Taking into account the relatively small number of markers tested in this 
project (approximately 3,000 SNPs) due to the candidate markers targeted approach, the 
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sample size used in this study (n=587) can be considered sufficient. In fact, results of 
the association analysis demonstrated that the sample size used was statistically 
effective (Chapter 5). However, as in most association studies, an additional set of 
samples might be required in order to replicate these results. 
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3.3. DNA extraction methods evaluation 
 
3.3.1. Introduction 
Different DNA extraction methods were evaluated in order to find a fast, easy, 
robust and cheap method as an alternative to the automated, but costly DNA extraction 
procedure (EZ1 extraction). Given the high number of buccal swabs processed (four per 
individual), a cheap yet effective DNA extraction method was required to meet the 
budget frame of this project.   
 
3.3.2. Methods 
Four DNA extraction methods were evaluated: 
 Qiagen EZ1 purification kit (n=68) 
This protocol utilises a semi-automated DNA purification by a BioRobot EZ1 
workstation purifying up to 6 samples per one extraction. Cost per sample: 
approximately AU $11. 
 Promega DNA IQ extraction kit (n=24) 
This is a manual protocol that uses magnetic particles, specially designed for 
forensic purposes, which are able to capture and purify DNA molecules. There is no 
sample number limitation per extraction, although usually up to 24 samples are 
processed for easier handling. Cost per sample: approximately AU $6.5. 
 Qiagen miniprep kit (n=24) 
This method uses various lysis and precipitation buffers to manually purify up to 20 
µg of DNA per sample from a variety of tissues. There is no sample number 
limitation per extraction, although usually up to 24 samples are processed for easier 
handling. Cost per sample: approximately AU $3.5. 
 Isohelix purification kit (n=70) 
This is a manual protocol. It is specifically formulated to produce high DNA yield 
and purity from buccal samples. There is no specific sample number limitation per 
extraction, although usually up to 24 samples are processed for easier handling. Cost 
per sample, including buccal swab: approximately AU $3
*
. 
* The price for all purification kits, except Isohelix, did not include swabs cost. 
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One set of DNA samples (n=24) was used for the comparison between Qiagen miniprep 
and Promega DNA IQ kits, while another set of samples (n=68) was used for 
comparison between Qiagen EZ1purification procedure and Isohelix kit. Two different 
sets of duplicates were used due to the limited number of buccal swabs collected per 
person (n=4), while each two (2) were used for a single extraction. The DNA 
extractions using four (4) kits were performed over a period of three (3) months. 
 
 
 
3.3.3. Results and Discussion 
The results show that both the DNA IQ and Miniprep kits generated 
significantly lower DNA yields, compared to the EZ1 and Isohelix extractions. The 
Isohelix method resulted in the highest yield, although there was greater variability 
between the samples (Table 6). However, the Isohelix method was cheaper, simpler and 
provided higher throughput. On the other hand, the purity of the DNA extracted with 
Isohelix kit was lower, due to presence of the cellular debris (data not shown). 
Nevertheless, this fact did not compromise the subsequent MPS output.  
Based on these results and extraction cost, Isohelix swabs and extraction kits were 
chosen for sample collection and DNA extraction in this project.  
 
 
Table 6. Real Time PCR quantification results of DNA extraction from buccal swabs, using 4 different extraction 
protocols. The DNA concentration is shown in µg/µl and normalised to 100 µl final volume. Note that samples 
used in EZ1 vs. Isohelix and DNA IQ vs. Mini prep extraction procedures respectively, are non-identical. 
 
Concentration (ng/µl) 
  
EZ1 extraction 
Isohelix 
extraction 
DNA IQ Mini prep 
  
Median 30.86 41.83 4.41 13.44 
SD 11.61 21.01 6.3 18.6 
 
  
104 | P a g e  
 
3.4. Candidate genes and markers selection 
 
3.4.1. Introduction 
The main aim of this research was to find SNPs which affect normal craniofacial 
variation. A candidate gene approach was chosen as the most appropriate and feasible 
method for this project (as discussed in Chapter 1). The process of candidate gene and 
SNP selection involved literature review and screening various bioinformatical web 
resources. This approach provided information on genes and respective polymorphisms, 
potentially influencing craniofacial morphology (discussed in details in Chapters 1 and 
2).  
The number of markers planned to be genotyped initially was 96 SNPs, due to 
limitation of the Golden Gate assay, as detailed in Section 3.5. However, with the 
subsequent opportunity of the greater multiplexing capability of the Ion Torrent 
platform, the original craniofacial SNPs number was increased and also extended to 
markers, which have been shown to be associated with pigmentation traits, ancestry as 
well as identity informative SNPs, INDELs and STRs markers. This assay is expected 
to provide a maximum information from the DNA sample, using a single workflow that 
consumes less amount of a limited template.  
This section provides a summary of the candidate genes and markers selection process 
and details of their annotation analysis. 
 
3.4.2. Methods 
Two main complementary strategies were used to generate a list of candidate 
markers. The first focused on searching the literature for candidate genes, involved 
either in normal craniofacial variation or in craniofacial malformations in both humans 
and model organisms. The resulting set of SNPs and genes was further screened for 
high Fst SNPs (greater than 0.25) as well as potentially functional polymorphisms, such 
as non-synonymous SNPs, markers in transcription factors binding sites and splicing 
sites, using web resources listed in Section 2.5. The second approach focused on 
searching for genes with high Fst SNPs and dedicated databases of ancestry informative 
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markers (AIMs). The resulting set of SNPs was then screened for genes potentially 
involved in the craniofacial embryogenesis.  
The web resources used for searching candidate genes and markers are listed in Section 
2.5. 
 
3.4.3. Results and Discussion 
Both searching methodological approaches were performed simultaneously and 
pinpointed 1,088 candidate genes and intergenic regions. However, 592 of these genes 
showed no clear link with craniofacial development and were therefore not included. 
Most of these 592 genes were originally selected based on high Fst values of respective 
markers. This process resulted in 496 genes and intergenic regions potentially involved 
in regulating normal craniofacial morphology. These 496 genes/regions were screened 
for non-synonymous and potentially functional SNPs, which resulted in 269 genes and 
intergenic regions after removing genes that do not possess such markers, as well as 
SNPs with no evidence of high population differentiation (Fst≤0.25). Subsequent 
analysis of these 269 genes/regions using various resources for functional annotation, 
resulted in 137 candidate genes/regions, possessing 10,746 markers. Notably, the 
majority of these SNPs are located in introns and intergenic regions (as discussed in 
Chapter 5). This list was further analysed for tag SNPs, in order to reduce the number of 
markers for genotyping and subsequent analysis, based on the genotyping platform that 
was available (detailed in section 3.5). Following the availability of a MPS platform to 
this project, forty (40) additional genes were selected from recently published articles, 
all focusing on normal variation in craniofacial morphology, as discussed in Sections 
1.4.1 and 1.4.3. 
The final list comprised 177 candidate genes and intergenic regions, which were further 
screened for high Fst markers, non-synonymous SNPs, SNPs in transcription binding 
sites and SNPs in splicing sites, as summarized in Figure 38. The final screen revealed 
approximately 1,200 SNPs in the candidate genetic regions, potentially involved in 
determining craniofacial morphology and was used for initial primer design. 
The final SNP panel was extended by adding 331 markers, shown to be associated with 
normal pigmentation, such as eye, skin and hair colour, 208 ancestry informative 
markers, 91 identity informative SNPs, 46 INDELs, 17 autosomal STRs, 15 Y-
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chromosome STRs, 37 Y-chromosome SNPs, and 57 Mitochondrial SNPs and resulted 
in 1,985 targets, submitted to Life Technologies
TM
 for initial primer design 
(summarized in Figure 39).  
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Figure 38. A summary of candidate genes and SNPs selection process. 
 
A final set of 1,985 markers selected for sequencing.  
Adding 785 markers previously shown to be associated with pigmentation, ancestry and forensic indetification markers 
Eye, skin and hair colour associated markers  Ancestry Identity Markers Identity Informative SNPs, INDELs and STRs 
Lineage Informative Markers: Y-chr SNPs, Y-chr 
STRs and Mitochondrial DNA SNPs 
Final selection for only potentially functional SNPs  
177 genes and intergenic regions with 1,200 candidate SNPs  
Positive selection for high Fst SNP, ns SNPs, SNPs in transcriptional regulatory sites and tag SNPs 
269 genes and intergenic regions 
Reviewing previous step output and selecting only genes with high Fst SNPs and potentially functional (pf) SNPs 
496 unique genes and intergenic regions 
Additional selection for genes which may have an active role in craniofacial development and genes with unknown function, but carrying high Fst SNPs 
1088 unique genes 
Initial selection step 
Literature review on genes involved in normal craniofacial variation as 
well as in craniofacial disorders in human and model organisms 
Markers linked to visual apperance traits found in GWAS studies SNPs showing high degree of differentiation between populations (Fst) 
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All Y-chromosome STRs, all mitochondrial SNPs, 10 autosomal STRs and 522 
craniofacial candidate SNPs failed the initial primer design process (approximately 20% 
of all markers). Although Life Technologies
TM
 does not provide details for the technical 
issues with primer design failure, the most reasonable explanation is that these markers 
are located in highly polymorphic or repetitive regions of the genome (e.g. 
homopolymer repeats, Alu, LINE etc.). These genomic regions are known to be more 
unfavourable for the primer design process. 
Additional markers that had been found to be in high linkage disequilibrium (LD) with 
the primary targeted SNPs that previously failed the primer design pipeline, were 
identified and used as substitutes. There were five iterations of SNP selection and 
primer design process, before the final set of SNP primers were made. The final list 
covered 1,933 primary targeted markers (Figure 39). 
 
 
 
Figure 39. Initial SNP panel submitted to Life Technologies for primer design. *) These markers were removed 
from the final panel, due to primer design failure. 
 
 
This list was transformed into a hotspot file in .BED format for the subsequent 
sequencing process. Given that each amplicon covers between 125 bp to 225 bp, each 
• 91 SNPs 
• 46 Indels 
• 9 STRs 
• 37 Y-SNPs 
• 57 Mt-SNPs* 
• 15 Y-STRs* 
• 208 AIMs • 1220 Craniofacial 
candidate SNPs 
• 331 Pigmentation 
SNPs 
Phenotype 
Informative 
markers 
Ancestry 
Informative 
markers 
Identity 
Informative 
markers 
Lineage 
Informative 
markers 
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amplicon could potentially cover more than one polymorphism. As a result, the initial 
amplicon list was screened for additional SNPs with 1% or less Minor Allele Frequency 
(MAF), using the UCSC genome browser.  
The final Ampliseq panel size was 15.78 kb and covered 99.3% of the originally 
submitted targets, following the last design step. The final hotspot file of all the markers 
included approximately 6,500 known markers in 985 genes/regions and was used as a 
reference hotspot file for variant caller in the Ion Torrent Suite and Ion Reporter 
software. However, it should be noted that more than 50% of these markers are not 
common (less than 2% frequency) and as a result were filtered from the association 
analysis (Chapter 5).  
The craniofacial candidate marker list (1,220 SNPs) was analysed using the Genomic 
Regions Enrichment of Annotations Tool (GREAT) web-based platform to visualize the 
genomic context of the amplicons covering targeted SNPs. This tool helps annotate non-
coding genomic regions, which typically lack genetic annotation. The analysis revealed 
that almost 99% of the total number of genomic regions (which may cover multiple 
markers) are associated with one or two genes (Figure 40), with approximately 62% of 
genomic regions located between 0-500 kb downstream of a transcription start site 
(Figure 41). 
The same marker list analysed for potential biological processes using the AmiGO Gene 
Onthology component of GREAT, confirmed that all the markers are involved in 
various stages of embryonic development, including: embryonic morphogenesis, 
sensory organ development, tissue development, pattern specification process, tissue 
morphogenesis, ear development, tube morphogenesis, epithelium development, 
chordate embryonic development and morphogenesis of an epithelium (each term has a 
clickable hyperlink to the relevant webpage in the digital version of this document). 
Analysis of potential mouse phenotype associations confirmed that orthologous 
candidate markers were previously detected in mice models displaying abnormal 
morphology of the skeleton, head, viscerocranium and facial area, as well as specific 
malformations of the eye, ear, jaw, palate, limbs, digits and tail. 
In terms of the molecular function, AmiGO revealed that candidate markers might be 
involved in a range of regulatory activities, including: protein dimerization activity, 
chromatin binding, regulatory region DNA binding, sequence-specific DNA binding 
RNA polymerase II transcription factor activity, sequence-specific distal enhancer 
binding activity, heparin binding, RNA polymerase II core promoter proximal region 
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sequence-specific DNA binding transcription factor activity involved in positive 
regulation of transcription, BMP receptor binding and transmembrane receptor protein 
serine/threonine kinase binding (each term has a clickable hyperlink to the relevant 
webpage). In summary, this study provides additional insight into the genetic context of 
targeted markers, confirming the craniofacial link of these SNPs. 
 
 
Figure 40. An illustration of candidate craniofacial markers, associated with genes. The majority of amplicons 
covered multiple markers and were associated with more than one gene.  
 
 
Figure 41. An illustration of genomic location of candidate markers in respect to the transcription start site. 
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3.5. Evaluation of the genotyping methods using GoldenGateTM assay on 
BeadExpress platform 
As a part of a pilot study, the Illumina Golden Gate
TM
 technology was evaluated 
with a set of 96 pigmentation SNPs for prediction of skin, eyes and hair colour, as well 
as ancestry in pristine and suboptimal DNA samples on a BeadExpress platform. 
Specifically, the first study (Section 3.5.1) evaluated the performance of SNPs typing 
from a variety of intact and environmentally challenged DNA samples amplified with 
and without whole genome amplification (WGA) method [349]. The second study 
(Section 3.5.2), investigated the genomic association and subsequent prediction 
efficiency of a custom 96-SNP set. While the SNPs were originally chosen according to 
their association with pigmentation traits, they were also evaluated for potential 
prediction of ancestry in three US population groups. The results of these experiments 
were published or submitted for publication and provided as Sections 3.5.1 and 3.5.2 of 
this document. The results of both studies were included in the thesis of Dr Sheree 
Hughes-Stumm, submitted to the Bond University [350]. 
The association and prediction study provided an important opportunity for evaluation 
of both the genotyping and statistical analysis methods and established an initial 
foundation for subsequent study of externally visible traits and ancestry with more 
advanced genotyping technology (Chapter 5). 
In addition, a subset of DNA samples and genotyped SNPs were overlapping between 
the GoldenGate assay and the Ion Torrent panel. This aspect made possible performing 
a validation study between two genotyping methods, as detailed in Section 3.6.3.  
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3.5.1. Initial evaluation of a 96-plex SNP panel for forensic analysis. 
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3.5.2. Evaluation of a 96-plex phenotypic SNP panel for the prediction of 
ancestry, eye, skin and hair colour in the three major US population 
groups.  
Order of Authors: Sheree Robyn Hughes-Stamm, Ph.D. 
Mark Barash, MSc., BSc. 
Philipp E Bayer, BSc. (Hons) 
Grisedale Kelly, MSc. BSc. 
Wenjie Lui, Ph.D., BSc. (Hons) 
Angela van Daal, Ph.D., BSc. (Hons) 
Abstract: This study evaluated the power of an interacting subset of 96 SNPs, to predict the 
ancestry and various pigmentation traits of the source of a DNA sample using a custom 
GoldenGate® assay. Statistical models were built for the prediction of hair, eye and 
skin colour.  In addition, statistical models were built to test the prediction of the three 
main US population groups (African American, Caucasian and Hispanic). A blind test of 
each model using 100 samples showed the following accuracies for each of the traits 
investigated: 92% - 96% for ancestry, 73% - 94% for hair colours, 78% - 97% for skin 
colours and 83% - 87% for eye colours. This study forms an initial evaluation of this 
custom SNP assay for forensic identification purposes. 
Author Comments: Evaluation of a 96-plex phenotypic SNP panel for the prediction of ancestry, eye, skin 
and hair colour in the three major US population groups. 
 
Sheree Hughes-Stamm1,2,*, Mark Barash1,*, Philipp E. Bayer3,4, Kelly 
Grisedale1, Wenjie Lui1, Angela van Daal1 
 
* Hughes-Stamm and Barash are joint first authors 
 
1 Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, 4223, 
AUSTRALIA 
2 Department of Forensic Science, College of Criminal Justice, Sam Houston State 
University, Huntsville, TX, 77381, USA 
3 Applied Bioinformatics Group, School of Agriculture and Food Sciences, Faculty of 
Science, University of Queensland, Brisbane, AUSTRALIA 
4 Australian Center for Plant Functional Genomics, School of Agriculture and Food 
Sciences, University of Queensland, Brisbane, AUSTRALIA 
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3.6. Ion Torrent platform evaluation and optimization  
 
3.6.1. Introduction 
The massively parallel sequencing (MPS) on the Ion Torrent platform provides 
unprecedented coverage of thousands of markers using only 10 ng of template (or less 
with additional amplification cycles). At the same time, it is relatively novel and is not 
yet a routine method (as discussed in section 1.10). It is prone to fluctuations in 
genomic DNA input, library and template preparation efficiency (e.g. frequent 
instruments malfunction or DNA amplification and/or enrichment efficiency); chip 
loading (e.g. the angle of pipet’s tip while loading the sample and the way of 
centrifuging the chip) and data analysis algorithms, which are frequently updated. As a 
result, the replicates of the same sample on different chips cannot be compared 
accurately by their output (total number of SNPs) or sequencing depth, but only by the 
accuracy of genotyping (concordance between replicates). 
The overarching goal of this study was to undertake a pilot study, evaluating the Ion 
Torrent platform for subsequent genotyping of hundreds of DNA samples and pinpoint 
the steps that could be optimised for improved method performance. 
The main aims of this study were: 
a) To determine the effect of half (10µl) versus full (20µl) volume of the library 
amplification reaction.  
The manufacturer’s protocol recommends using a full 20µl volume per library 
amplification reaction. However, given that custom primers were designed in 
two multiplex pools, this required using double the amount of sequencing 
consumables, significantly increasing the cost and processing time. A half 
reaction volume is mentioned as an option in the protocol, although not 
officially supported by the manufacturer [340]. 
b) To optimize the library concentration input per OneTouch amplification and 
enrichment (10pM vs. 20pM). 
An accurate estimation of library concentration used for template amplification 
and enrichment is important, as it highly correlates with sequencing output, 
although it varies significantly among PGM instruments and sequencing kits. 
The manufacturer recommends using between 10pM and 20pM input, while 
even a slight difference (e.g. 2pM) can make a difference. However, some 
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laboratories use between 8pM to 25pM DNA concentration, based on internal 
validation (personal communication with other laboratories and web forums).  
c) To validate and optimise sequencing throughput (maximum number of DNA 
samples) that can be genotyped on a 316 chip at a minimum depth of x20. 
The manufacturer supported output of the 316 chip is 6.2 million reads and 
between 30 Mb to 200 Mb per run. However, it has been shown that this output 
can be significantly increased, mostly by using in-house chip-loading methods 
(as discussed on the Ion Torrent community web server –  
http://ioncommunity.lifetechnologies.com/welcome). 
 
d) To confirm genotype concordance between sample duplicates. 
The genotyping accuracy is the most important criterion of the sequencing, 
especially in the forensic DNA context. Comparing the sequencing output of the 
DNA sample duplicates or preferably triplicates is an important part of the 
concordance check.   
It should be noted that due to the high cost of the sequencing consumables, only a 
limited number of biological duplicates were assessed in this study.  
 
3.6.2. Materials and Methods  
The following items in this section (items a to d) correspond to the aims listed in the 
Introduction section 3.6.1. 
a) Three DNA samples at an initial concentration of 10ng per reaction were used to 
validate the full (20µl) versus half (10µl) Ampliseq library amplification reaction. 
The samples with half reaction volume were merged after the first amplification step, 
as per manufacturer recommendations (Chapter 2.9.1). Specific Ion Xpress barcode 
X (X= the number of the specific barcode) adapters (Life Technologies) were 
ligated onto the 5′ and 3′ ends of each fragment and linked by nick translation (as 
per manufacturer recommendations) to allow for sequencing multiple samples 
simultaneously (Chapter 2.9.2).  
 
b) Ampliseq libraries were prepared for 32 DNA samples in half reaction volume (10µl) 
in duplicates. Library quantities were determined using the Ion Library Quantitation 
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kit (Life Technologies). An input of 10pM and 20pM (per each set of 32 samples) 
was used for amplification by emulsion PCR using the OneTouch instrument (Life 
Technologies). The libraries were subsequently enriched using the OneTouch ES 
instrument (Life Technologies). 
 
 
c) DNA samples (n=6, 16 or 32) were sequenced on three 316 chips. The sequencing 
was performed on the PGM (Life Technologies) according to the manufacturer 
recommendations (Chapter 2.9.4). The sequencing output was assessed using the 
overall chip output (aligned reads), mean sequencing depths and number of targeted 
markers per samples. 
 
d) Biological duplicates (n=38) and triplicates (n=8) were genotyped by sequencing 
and analysed using the Ion Torrent suite software with the built-in Variant Caller 
(VC) plugin (version 3.2) as well as a cloud-based Ion Reporter software (versions 
1.2, 1.4 and 1.6). The VC parameters were as follows: library type, Ampliseq; 
targeted region, custom designed targets list; hotspot list, all SNPs in the dbSNP132 
database. Variants were detected using the low stringency germ line parameters. The 
rest of the parameters were as per default. The VC output was present in tabular 
format (.vcf file), as a list of differences between the samples and a reference 
sequence (hg19). The “.vcf” files for all the relevant samples were uploaded into the 
SVS software package (GoldenHelix) and analysed for concordance in duplicates or 
triplicates. 
 
 
3.6.3. Results and Discussion 
Of the 587 DNA samples genotyped, the majority were sequenced at high 
coverage (at least x20) and only three samples produced no results.  
A validation of the full versus half amplification reaction volume showed that sample 
outputs of the half reactions performed as well as the full volume reactions (Table 7). 
The overall chip output (for both volumes) was significantly better, compared to the 
value officially supported by the manufacturer – 410 Mb versus 200 Mb. The overall 
chip output is a function of various parameters, although the chip loading is the most 
important. 
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In spite of the limited number of samples tested (only three duplicates sequenced on one 
chip), the results demonstrated that the use of a half volume reaction produced the same 
quality output as the full volume reaction. These conclusions were supported by the 
output of subsequent chips (n=35) that were processed. 
 
Table 7. A summary of the chip output for half versus full reaction volume experiment. 
Barcode # 
Sample 
name Bases 
>=Q20 
bases Reads 
Mean 
read 
length 
Read 
Depth 
Variants 
detected 
IonXpress_001 
10-001 
full 
volume 103,192,101 87,793,917 716,854 143 bp 322.05 1,070 
IonXpress_002 
10-005 
full 
volume 39,448,588 33,845,004 269,476 146 bp 131.51 1,084 
IonXpress_003 
10-007 
full 
volume 64,274,573 55,419,322 431,752 148 bp 226.59 1,019 
IonXpress_004 
10-001 
half 
volume 74,266,749 63,486,418 515,672 144 bp 230.98 1,070 
IonXpress_005 
10-005 
half 
volume 63,038,639 53,912,744 432,493 145 bp 210.47 1,067 
IonXpress_006 
10-007 
half 
volume 66,704,358 57,550,238 449,074 148 bp 235.11 1,010 
 
 
The validation of the library concentration input per OneTouch reaction showed that 
samples at 10pM concentration performed better than at 20pM (Tables 8 and 9). The 
number of polymorphisms detected in the samples at 10pM were slightly higher than in 
the same samples at 20pM (5% difference). Polyclonality was the most significantly 
affected parameter of the run (16% at the 10pM versus 27.4% at the 20pM). 
Polyclonality is the number of ISPs that have more than a single targeted clone and as a 
result, cannot be used for sequencing and alignment. Generally, the higher the 
concentration of enriched beads, the higher the polyclonality was, which may affect the 
sequencing output. The sequencing depth of the 10pM chip was between 73.82 
(maximum) and 4.12 (minimum) compared to 58.67 (maximum) and 6.29 (minimum) 
of the 20pM chip. Following these results, the 10pM library concentration was found 
optimal for all the subsequent samples. 
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Table 8. A summary of 10pM input concentration per chip experiment. 
  AQ17 AQ20 Perfect     
Total Number of Bases 
[Mbp] 
419.47 363.39 282.68 
 
  
Mean Length [bp] 141 127 101 
 
  
Longest Alignment [bp] 313 303 296 
 
  
Total reads 3,117,857     
 
  
Usable reads 77%     
 
  
        
 
  
Addressable Wells 6,348,217   Library ISPs 4,058,401   
With ISPs 4,156,532 65.50% 
Filtered: 
Polyclonal 
647,820 16.00% 
Live 4,147,423 99.80% 
Filtered: Low 
Quality 
283,122 7.00% 
Test Fragment 89,022 2.10% 
Filtered: 
Primer Dimer 
9,602 0.20% 
Library 4,058,401 97.90% 
Final Library 
ISPs 
3,117,857 76.80% 
  
    
  
Average value of 10pM input   
Mapped Reads  On Target  
Mean 
Depth  
Uniformity  
Variants 
detected   
96,386 90.20% 46.6 89.80% 972   
 
 
Table 9. A summary of the 20pM input concentration per chip experiment. 
  AQ17 AQ20 Perfect     
Total Number of Bases 
[Mbp] 
332.44 271.35 214.72 
 
  
Mean Length [bp] 118 102 83 
 
  
Longest Alignment [bp] 297 283 275 
 
  
Total Reads 3,151,433     
 
  
Usable reads 67%     
 
  
        
 
  
Addressable Wells 6,348,217   Library ISPs 4,689,035   
With ISPs 4,856,455 76.50% 
Filtered: 
Polyclonal 
1,285,637 27.40% 
Live 4,738,662 97.60% 
Filtered: Low 
Quality 
244,263 5.20% 
Test Fragment 49,627 1.00% 
Filtered: 
Primer Dimer 
7,702 0.20% 
Library 4,689,035 99.00% 
Final Library 
ISPs 
3,151,433 67.20% 
  
    
  
Average value of 20pM input   
Mapped Reads  On Target  
Mean 
Depth  
Uniformity  
Variants 
detected   
89,031 91.38% 37.91125 89.57% 927.90625   
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Sequencing of 6, 16 and 32 samples per 316 chip demonstrated that chip output (total 
bases) can be significantly increased above the manufacturer supported 200 Mb to more 
than 600 Mb. The increased output was also a function of ISP performance, which was 
optimal at approximately 10pM concentration. The mean sequencing depth was lower 
when a higher number of samples per chip was used (n=32), albeit sufficient for 
comprehensive coverage of targeted markers.  
Alteration to the original chip loading protocol were assessed as recommended on the 
Ion Torrent community forum (http://ioncommunity.lifetechnologies.com/) and also 
following in-house changes (performed by the author), had the greatest influence on 
increased chip output. Various changes included increasing the number of isopropanol 
and annealing buffer washes (three versus one in the protocol); an additional 
centrifugation step and vortex mixing of the loaded chip; blowing the chip with argon 
gas after the washing step and careful loading of the ISPs to prevent potential air 
bubbles from appearing. Based on the results of this study, up to 32 barcoded samples 
were processed on each 316 chip. 
The concordance study of 38 DNA duplicates and eight (8) triplicates, showed various 
discrepancies in allele calls. The discrepancies between duplicates usually included only 
one nucleotide (one DNA strand) difference in SNP (e.g. AC vs. AA or TT vs. GT) and 
a lack/addition of one repeat in INDEL (-/GG vs. GG_GG or TCTAG_TCTAG vs. -
/TCTAG). A missing call in one of the replicates was not considered a discrepancy. The 
two markers that most frequently showed inconsistency in allele calls were the 
chromosome 4:81975674 and chromosome 6:137345858, both INDELs, which are 
more prone to sequencing errors. 
The overall discrepancy among samples analysed at low stringency variant detection 
settings, varied between 2 to 19 markers per sample pair corresponding to 0.29% to 1.9% 
of the total number of polymorphisms. In general, samples sequenced at a higher depth 
showed less discrepancy (three to four markers per sample pair or approximately 0.3%), 
as per Table 10. However, the percentage of inconsistent calls might not be an accurate 
representation, since the total number of markers can be counted in various ways, such 
as the total number of genotyped markers or successfully genotyped markers only.  
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Table 10. Example of three samples duplicates, sequenced on the same chip and analysed under low stringency 
algorithm. The discrepancy in allele calls and its percentage from the total number of calls is shown. 
 sequencing depth  
 
Sample ID 
Chromosome 
location 322.05 230.98 
percentage from the 
total number of 
markers 
10-001 
2:223056368-SNV A_C C_C 0.37 
6:137345858-Ins AA_AA AA_TAA 
 7:130713701-Del -_C A_C 
 11:2192316-Ins TGAA_TGAA -_TGAA 
     sequencing depth  
     131.51 210.47 
 
10-005 
1:242342504-SNV C_T T_T 0.37 
2:152813963-Del -_GG GG_GG 
 4:179555381-SNV A_T T_T 
 10:131092508-Ins -_GGAA GGAA_GGAA 
     sequencing depth 
     226.59 235.11 
 
10-007 
4:42003383-SNV C_T C_C 0.29 
6:137345858-Ins AA_TAA AA_AA 
 
13:31803958-Del G_T -_- 
  
The output for the same samples, compared in triplicates with various sequencing depth 
is summarized in Table 11.  
 
 
Table 11. Comparison between triplicates of three samples, sequenced on two chips and analysed using  low 
stringency parameters. 
  
sequencing depth  
percentage of 
total markers Sample Chr. location 322.05 230.98 40.38 
10-001 
2:223056368-SNV A_C C_C ?_? 
1.13 
4:42003671-Mix G_G G_G A_G 
4:155508898-Del -_AGAAAGAA -_- ?_? 
5:112568212-SNV T_T T_T C_T 
6:21911616-SNV G_G G_G G_T 
6:137345858-Ins AA_AA AA_TAA ?_? 
7:132192020-SNV G_G G_G A_G 
8:61606762-Del C_C C_C -_C 
8:61726879-SNV A_G A_G A_A 
8:139816051-Del G_T G_T -_G 
10:17025666-SNV C_C C_C C_T 
11:2192316-Ins TGAA_TGAA -_TGAA ?_? 
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14:55585558-Sub C_T C_T C_CAT 
15:33023670-SNV T_T T_T C_T 
16:7587676-SNV T_T T_T G_T 
22:19759437-SNV C_G C_G C_C 
X:13779124-SNV A_T A_T A_A 
 
 
sequencing depth  
percentage of 
total markers 
Sample Chr. location 131.51 210.47 11.18  
10-005 
1:103412000-SNV C_C C_C C_T 
1.38 
1:242342504-SNV C_T T_T ?_? 
1:242806860-Mix T_T T_T A_T 
2:16767106-SNV G_G G_G A_G 
2:42577804-Ins AAATACACAC_AAATACACAC AAATACACAC_AAATACACAC -_AAATACACAC 
2:152813963-Del -_GG GG_GG ?_? 
2:224794578-Ins AG_AG AG_AG -_AG 
4:81975674-SNV A_G ?_? G_G 
4:179555381-SNV A_T T_T ?_? 
5:89818764-SNV G_G G_G A_G 
5:123111246-SNV A_A A_A A_C 
5:174157972-SNV C_C C_C C_G 
7:132192020-Del A_G A_G -_A 
8:61595671-SNV C_C C_C C_T 
8:61652144-SNV A_A A_A A_G 
10:115316725-SNV A_C A_C A_A 
11:18317458-SNV A_A A_A A_T 
14:90077221-SNV C_C C_C C_T 
18:19651889-Mix C_C C_C A_C 
22:26862212-Del C_T C_T -_T 
  
 
sequencing depth  
 
percentage of 
total markers 
Sample Chr. location 226.59 235.11 20.81 
 
10-007 
1:103568727-SNV A_T A_T T_T 
1.06 
2:109401292-Ins TCTAG_TCTAG TCTAG_TCTAG -_TCTAG 
2:223055226-SNV ?_? A_C C_C 
4:42003383-SNV C_T C_C C_T 
4:81975674-SNV ?_? A_G G_G 
6:137345858-Ins AA_TAA AA_AA AA_AA 
13:31803958-Del G_T -_- ?_? 
20:25278465-Ins GTGGG_GTGGG GTGGG_GTGGG -_GTGGG 
20:55765485-SNV A_A A_A A_G 
21:17710424-SNV A_A A_A A_G 
22:46808261-SNV G_G G_G C_G 
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The inconsistency in allele calls observed in replicates is most likely related to the 
parameters of sequence alignment algorithms (e.g. low/high stringency) and coverage. 
Three duplicates (see Table 10) sequenced at significantly higher depth, showed less 
discrepancy between each other, compared to the same samples, sequenced at 
approximately ten fold less depth. In addition, the same duplicates while analysed 
according to the high stringency parameters, showed significantly higher concordance 
(from zero to only three markers difference) per duplicate (Table 12). On the other hand, 
applying the higher stringency settings, resulted in less markers detected (down by 
approximately 30%).  
 
 
Table 12. The same samples as in Table 10, analysed using Variant Caller, according to high stringency parameters. 
Sample ID Chromosomal location Variant % of the total number of markers 
10-001 7:130713701 A_C -_C 0.096 
          
10-005 
4:42003360 A_G G_G 0.287 
4:42003383 C_T C_C   
4:179555381 A_T T_T   
          
10-007 no discrepancies       
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The main differences between the low stringency and the high stringency analysis 
settings are summarized in Table 13. 
 
 
Table 13. Comparison between the low and high stringency settings in the Variant Caller plugin. 
  Germ line - Low stringency Germ line - High stringency 
General parameters SNP  INDEL  Hotspot SNP  INDEL  Hotspot 
min cov each strand  0 5 3 3 3 3 
min variant score  10 10 10 10 10 10 
min allele freq  0.1 0.1 0.1 0.15 0.15 0.15 
min coverage  6 15 6 20 20 20 
strand bias  0.95 0.85 0.95 0.95 0.85 0.95 
Torrent Variant Caller parameters Germ line - Low stringency Germ line - High stringency 
data_quality_stringency 6.5   8.5 
 
  
hp_max_length 8   8 
 
  
filter_unusual_predictions 0.3   0.25 
 
  
filter_insertion_predictions 0.2   0.2 
 
  
filter_deletion_predictions 0.2   0.2 
 
  
snp_beta_bias 30   8 
 
  
indel_beta_bias 8   8 
 
  
hotspot_beta_bias 30   8 
 
  
downsample_to_coverage 400   400 
 
  
outlier_probability 0.01   0.01 
 
  
do_snp_realignment 0   0 
 
  
prediction_precision 1   1 
 
  
heavy_tailed 3   3 
 
  
suppress_recalibration 1   1 
 
  
Long Indel Assembly Settings    
  
  
kmer_len 19   19 
 
  
min_var_count 5   5 
 
  
short_suffix_match 5   5 
 
  
min_indel_size 4   4 
 
  
max_hp_length 8   8 
 
  
min_var_freq 0.15   0.15 
 
  
relative_strand_bias 0.8   0.8 
 
  
FreeBayes    
  
  
allow_indels 1   1 
 
  
allow_snps 1   1 
 
  
allow_mnps 0   0 
 
  
min_mapping_qv 4   4 
 
  
min_base_qv 4   4 
 
  
read_mismatch_limit 10   10 
 
  
read_max_mismatch_fraction 1   1 
 
  
gen_min_alt_allele_freq 0.15   0.15 
 
  
gen_min_indel_alt_allele_freq 0.15   0.15 
 
  
gen_min_coverage 6   6 
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For the purpose of the association test, sequences were analysed using the Ion Reporter 
software with at least x6 depth threshold per SNP. However, prior to statistical analysis 
(Chapter 4) the data were filtered by a minimum coverage of x10 and genotype quality 
of 10 (per marker), thus reducing the potential error rate.  
The demonstrated lack of concordance of up to 1.9% (at low stringency parameters) 
may be adequate for research purposes, although it is unacceptable for forensic DNA 
analysis. It should be noted, that approximately 20% of sequencing errors observed in 
this study were within INDEL variations, which are more prone to sequencing errors 
due to homopolymer repeats. Remarkably, an application of the high stringency analysis 
parameters resulted in less than 0.3% discrepancy in allele calls between samples. 
Therefore, for any forensic use, a high coverage (x100 or higher) followed by high 
stringency variant analysis parameters should be considered. This approach would allow 
significantly more accurate sequencing (as the first priority in forensic DNA analysis), 
although significantly increasing cost and decreasing throughput on the other hand. 
Most of the currently available MPS platforms demonstrate high variability in 
sequencing accuracy and are not yet optimal in terms of hardware and software updates. 
For example, the Ion Torrent hardware, software, reagents and laboratory manuals in 
this project were updated through series of optimization as follows: 
 
 The OneTouch instrument (an essential component for template preparation) 
was physically replaced five times in one year and its software was therefore 
also updated five times. 
 Template preparation and sequencing kits were updated and changed three times. 
 The PGM software and the Ion Torrent suite software were updated ten times in 
one year from version 2.1 to 3.6.  
 The manuals for library preparation, template preparation and sequencing were 
updated four times during the project. 
 The Ion Reporter software used for data analysis was updated four times (from 
version 1.2 to 4).  
 
The update of one platform’s component (either software, hardware or reagents) led to a 
subsequent adaptation of all other parts of the Ion Torrent platform, which usually were 
irreversible and non-compatible with previous versions. A more standardized procedure 
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is required in order to increase the robustness of the Ion Torrent platform, prior to its 
potential use for forensic DNA typing. However, given the dynamic nature of the MPS 
technologies, these problems are likely to be addressed in the near future.  
 
A limited validation performed in this study tested the concordance and genotyping 
accuracy within the same platform. Given the relatively novel nature of the Ion Torrent 
platform, it was decided to perform a limited comparison between at least two 
independent genotyping methods. Due to the fact that a subset of DNA samples (n=71) 
were genotyped for 78 SNPs that overlapped between the Golden Gate assay and the 
Ion Torrent platform, this comparison was possible. However, due to the different focus 
and time limits of this project, this validation was not meant to be extensive, and 
included only a subset of samples and SNPs. A limited comparison of five (5) SNPs in 
all samples genotyped using both platforms, was performed. The SNPs that were 
analysed included rs12913832, rs1129038, rs611349, rs739289 and rs12203592. The 
analysis demonstrated only one inconsistency between genotypes of the respective 
samples (‘TC’ versus ‘CC’ in the rs12203592). Given that these two platforms use 
completely different methods for genotyping, this outcome can be considered a 
successful quality control step.  
In order to properly test the concordance and genotyping accuracy within and between 
platforms, a larger set of DNA samples and markers should be genotyped by both 
platforms. However, the results of this preliminary study provided important 
verification of the genotyping output obtained within the Ion Torrent platform, as 
detailed in this section. It should be noted that additional verification of the Ion Torrent 
genotyping output was obtained by performing association analyses of the pigmentation 
traits and ancestry (as discussed in Chapter 5). The results obtained in this study were in 
full concordance with previously published results.    
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 Chapter 4   
Optimization of scanning equipment and 3D 
image processing  
  
151 | P a g e  
4.1.  Introduction 
The main goal of this study was to assess the craniofacial measurements 
reproducibility and normal distribution, as per Aims 2 and 3 of the current project 
(Section 1.10).  
Prior to investing in the 3D technology, the validity of the anthropometric 
measurements using 2D images was tested. This study was required because the 3D 
scanner was not available at the beginning of this project and since it is generally easier 
to generate 2D photographs, which can be taken at various locations without the need to 
attend a scanning session in a dedicated room, as required for the 3D scanning approach. 
Locating anatomical landmarks on the face and obtaining anthropometrical 
measurements from photographs is known as photogrammetry [17]. This method has 
been tested in numerous anthropometrical studies [29, 36, 351-353]. This process is 
easier and less time consuming than the direct measurements and 3D digital image 
processing. On the other hand, it possesses significant disadvantages, such as the quality 
of photographs and thus resulting in a partial coverage of facial landmarks. Although 
most importantly, it is unable to reflect the actual surface distances, but can only 
appreciate the lateral facial distances. The lateral measurement is the linear distance 
between two landmarks, which does not necessarily represent the actual physical 
(Euclidean) distance over the skin surface. As a result, facial measurements obtained 
from 2D images are less accurate than direct or 3D–acquired measurements, hence 
providing only partial and potentially misleading information on facial morphology. 
Conversely, 3D scanning platforms provide a more comprehensive representation of the 
facial morphology. The 3D scanning systems have been extensively used in 
anthropometric studies as well as in medical research, which usually demands a high 
accuracy and precision [354-357]. The Minolta Vivid V910 3D scanner that was 
acquired for this study, has a reported manufacturing precision of ± 0.008mm and 
accuracy of ±0.3 mm. A validation study showed that it is accurate to a level of 
1.1±0.3mm [358], while another study demonstrated a level of accuracy of 0.56± 
0.25mm and the error in computerized registration of left and right scans as 0.13± 0.18 
mm [359]. These observations demonstrate that this platform is more appropriate for the 
present study and would be expected to provide a more accurate representation of the 
facial morphology as compared to less accurate 2D photographs. 
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This study also included a comparison of lateral and surface measurements generated 
from 3D images. The rationale behind this comparison was that it is easier and faster to 
generate the lateral, rather than the surface measurements in the Geomagic software. 
 
 
4.2.  Materials and Methods 
Facial measurements of ten individuals, obtained from lateral dimensions on 2D 
images and lateral and surface measurements generated from 3D images were compared. 
The 2D photographs (n=10) were taken using a Cyber-shot DSC-T100 digital camera 
(Sony) with an approximate resolution of 10 megapixels. The 2D photographs were 
taken under ambient lighting, similar to the 3D scanning settings. The volunteers sat 
holding a ruler near their faces. The photographs were printed on A4 paper and analysed 
for a set of 13 facial measurements. Several measurements were not performed due to 
image quality (as discussed in Section 4.3).  
The scanner used in this study was sensitive to changes in light conditions and was 
calibrated every three months (according to manufactorer’s recommendations) to 
produce high quality standardised 3D images. The 3D facial scans (n=10) and image 
processing were performed as described in the Materials and Methods Chapter 2. 
The quality of the 3D alignment was measured automatically by Polygon software and 
displayed as an ”error average” and “sigma” with values between 0 and 1 (illustrated in 
Figure 27). The final image was considered of good quality if both values were below 
0.4 (as per manufacturer recommendations). If the values were above 0.5 the volunteer 
was re-scanned. The measurements obtained from 2D and 3D images of ten (10) 
individuals were recorded in an Excel spreadsheet and compared manually.  
 
 
4.3.  Results and Discussion 
The 2D photogrammetry provided easier image processing and used inexpensive 
equipment, compared to 3D scanning. The 3D scanning not surprisingly, was found to 
be significantly more accurate and comprehensive. However, the Geomagic software 
(used for 3D image processing), was not designed for craniofacial measurements and 
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elicited significant difficulties. The need for measuring the Euclidian distance between 
landmarks, rather than the lateral distance required a special assistance from the 
manufacturer, although this support was only partial and time consuming. In addition, 
each of the 32 measurements were performed and recorded individually, which made 
the landmarking procedure tedious and time-consuming, requiring approximately 20 
minutes per image. Attempts to generate a ‘macro’ function, which would automatically 
copy a set of specific facial landmarks to a new image using Geomagic program, failed, 
as each face was significantly different from the previous and the software could not 
perform this procedure in an efficient manner.  
Comparison of the measurements showed that lateral and surface measurements 
performed on the 3D digital images were noticeably different. The 3D surface distances 
were longer than the lateral, with the latter more similar to the 2D measurements. The 
results of the comparison between 2D and 3D measurements are summarised in Tables 
14, 15 and Figures 42, 43. 
Since it was obvious that there was a pronounce difference and given that 3D surface 
measurements represent the most adequate information on facial features, it was 
concluded that all the measurements should be calculated using Euclidean coordinates 
of the craniofacial landmarks (representing the actual surface distance), which was 
performed using Microsoft Excel automatic spreadsheet. The 3D surface measurements 
were subsequently used as phenotypes for genetic association study, as detailed in 
Chapter 5.  
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Table 14. Results of the comparison between craniofacial measurements in 2D and 3D images, including lateral and surface distance. The values shown are in millimetres. 
  Volunteers 
  1 2 3 4 5 
  
3D  
Lateral 
3D  
Surface 
2D  
photo 
3D  
Lateral 
3D  
Surface 
2D  
photo 
3D  
Lateral 
3D 
 Surface 
2D  
photo 
3D 
 Lateral 
3D  
Surface 
2D  
photo 
3D  
Lateral 
3D  
Surface 
2D  
photo 
n-gn 123.41 142.88 124.00 114.75 138.88 117.00 113.48 134.20 115.00 137.74 171.33 135.00 114.46 141.02 113.00 
zy-zy 135.53 174.02 135.00 124.73 171.11 121.00 123.47 168.02 128.00 135.72 189.97 127.00 137.69 189.30 127.00 
go-go 111.55 137.12 116.00 114.35 156.48 107.00 103.15 132.28 114.00 108.41 141.94 103.00 123.36 161.33 113.00 
en-en 46.15 65.65 38.00 34.55 57.49 31.00 33.52 52.94 33.00 34.96 54.75 32.00 36.20 56.62 30.00 
ec-ec 114.25 135.51 106.00 94.15 126.84 90.00 97.14 124.71 97.00 95.61 119.15 93.00 95.30 119.72 91.00 
n-sn 50.19 61.66 51.00 49.86 57.73 55.00 46.08 59.49 48.00 55.74 66.31 52.00 53.00 65.04 54.00 
al-al 38.40 48.26 39.00 38.42 50.23 38.00 37.86 51.26 38.00 35.43 51.64 39.00 36.49 52.67 43.00 
ls-li 19.77 23.55 18.00 15.36 19.71 13.00 18.23 19.61 18.00 23.54 26.08 25.00 17.59 19.77 17.00 
ch-ch 50.00 56.34 50.00 47.26 55.47 48.00 48.04 51.16 55.00 49.75 59.20 55.00 52.42 62.20 53.00 
sn-sto 27.67 29.37 26.00 24.57 28.32 21.00 20.77 22.83 20.00 28.17 30.20 26.00 16.53 20.56 15.00 
sn-gn 76.06 84.23 73.00 66.82 79.16 63.00 69.09 79.74 66.00 88.62 102.36 83.00 64.14 80.21 59.00 
sto-lm 21.87 25.38 21.00 15.97 18.56 13.00 20.26 23.30 18.00 19.55 22.53 26.00 19.81 24.16 16.00 
left ear sa-sba 61.85 72.97 66.00 NA NA 62.00 58.70 70.54 58.00 62.17 70.57 62.00 NA NA 71.00 
right ear sa-sba 65.29 72.96 72.00 NA NA 63.00 55.36 76.51 53.00 61.26 79.53 63.00 NA NA 72.00 
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Figure 42. Graphical representation of the comparison between 2D and 3D measurements in individuals 1-5, based on Table 14. 
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Table 15. Results of the comparison between the craniofacial measurements in 2D and 3D images, including later and surface distance. Values shown are in millimetres. 
 
  Volunteers 
  6 7 8 9 10 
Measurements 
3D 
Lateral 
3D  
Surface 
2D 
photo 
3D 
Lateral 
3D 
Surface 
2D 
photo 
3D 
Lateral 
3D 
Surface 
2D 
photo 
3D 
Lateral 
3D 
Surface 
2D 
photo 
3D 
Lateral 
3D 
Surface 
2D 
photo 
n-gn 117.30 139.57 118.00 113.14 128.95 101.00 122.51 145.34 122.00 113.68 127.13 116.00 113.53 135.74 112.00 
zy-zy 138.60 175.13 129.00 130.33 175.87 119.00 124.08 170.40 114.00 129.36 159.22 130.00 136.68 180.11 126.00 
go-go 119.42 149.25 114.00 113.52 138.95 106.00 97.15 144.69 91.00 108.15 133.49 107.00 110.22 144.26 104.00 
en-en 30.59 43.47 28.00 33.49 51.15 28.00 31.39 43.43 27.50 32.24 47.09 28.00 35.37 49.58 30.00 
ec-ec 90.29 103.72 86.00 85.31 106.22 80.00 87.49 106.62 82.00 95.48 117.82 95.00 94.15 113.99 90.00 
n-sn 46.56 59.11 51.00 44.30 56.62 42.00 56.76 72.11 58.00 51.34 59.69 57.00 50.35 60.57 50.00 
al-al 35.35 44.28 37.00 26.42 38.15 29.00 29.54 41.67 34.00 31.57 39.27 27.50 31.89 43.42 33.00 
ls-li 20.70 26.27 19.00 16.69 17.67 15.00 23.49 32.40 23.00 23.01 29.02 20.00 20.92 23.61 20.00 
ch-ch 49.63 58.17 48.00 44.29 51.84 45.00 44.80 51.11 45.00 50.94 56.38 48.00 50.59 59.33 50.00 
sn-sto 24.23 30.67 20.00 19.88 20.93 15.00 21.41 27.10 19.00 20.84 23.96 19.00 24.52 27.10 21.00 
sn-gn 76.17 88.25 66.00 66.47 73.89 59.00 65.57 80.72 64.00 62.89 73.35 59.00 67.12 76.39 62.00 
sto-lm 19.25 22.08 18.00 18.17 21.59 15.00 21.59 29.41 18.00 19.19 23.10 16.00 17.46 21.59 18.00 
left ear sa-sba 66.16 74.37 61.00 53.76 67.09 54.00 63.15 75.07 52.00 58.42 75.40 56.00 54.32 64.92 54.00 
right ear sa-sba 66.33 78.21 60.00 54.74 64.36 55.00 60.76 69.61 53.00 57.75 67.33 59.00 60.07 70.49 54.00 
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Figure 43. Graphical representation of the comparison between 2D and 3D measurements in individuals 6-10, based on Table 15.
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4.4.  Reproducibility of craniofacial measurements  
 
4.4.1. Introduction 
Reproducibility of the craniofacial measurements can be defined as the ability to 
obtain the same result, with the same (or different) examiner over a period of time 
(usually days to months). This concept represents one of the most fundamental 
principles of the anthropometry and must be investigated thoroughly, prior to 
conducting a final study. 
The accurate location of the soft-tissue facial anthropometrical landmarks and 
subsequent measurements are not trivial tasks to perform on a living individual. An 
even higher level of complexity exists when this procedure is performed on a digital 3D 
image. The landmarks are usually palpated for accurate allocation, which is not possible 
with digital images. Palpation is especially required for measurement of the landmarks 
located on or around bony prominences, which are more reproducible, such as left and 
right zygion (zy) and gonion (go). However, this is not possible with 3D images. The 
inability to reach accurate location of specific landmarks, may introduce an error in 
subsequent measurements. Some landmarks may be less reliable because the 3D 
scanning process does not efficiently capture eyes (pupils), hair and sometimes lip area, 
due to technical limitations of the laser capturing method. The landmarks that may 
introduce an error in measurements include the following: trichion (tr), left and right 
exocanthion (ex) and endocanthion (en), labiale inferius (li), labiale superius (ls), left 
and right cheilion (ch) and stomion (sto). In contrast, landmarks that were easier to find, 
included the following: pronasale (prn), left and right alare (al) and nasion (n) all 
located at the nose area; gnation (gn), pogonion (pg) that are located at the chin area;  
sublabiale (sl) that is located at the lips area; glabella (g)) that is located at the forehead; 
left and right endocanthion (en) that are located at the eyes area and all the landmarks 
located on the ear: left and right superaurale (sa), subaurale (sba), postaurale (pa) and 
tragion (t).  
This present study tested the reproducibility of the craniofacial landmarks allocation on 
a small subset of individuals by calculating derived distances. The results of this study 
were used as a proof of concept and provided a basis for collection of a larger dataset.  
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4.4.2. Materials and Methods 
In order to validate the reproducibility of the facial measurements, thirteen 3D 
images were analysed for a full set of 32 facial landmarks twice, as detailed in the 
Chapter 2. The period between the analyses varied from one to six months. All facial 
landmarks were allocated manually, following the same strict methodology. The 
Euclidean coordinates for 32 landmarks were exported into Microsoft Excel and 86 
distances and ratios were calculated automatically using the formulae for linear and 
angular distances, as detailed in Chapter 2. 
The mean difference (MD) was calculated as the discrepancy between the first and the 
second measurements √(            ) . The measurement error (ME) was 
calculated as the standard deviation of the MD divided by square root of 2 
(ME=SD(MD/√ ). 
 
4.4.3. Results and Discussion 
The aim of this study was to evaluate the reproducibility and reliability of 86 
facial measurements, obtained from 3D facial images. In digital images, the bony 
structures lying under the soft tissue are neither visible nor available for palpating. As a 
result, measurements requiring location of bone-related landmarks (such as gonion, 
zygion and glabella) may be less reproducible on 3D laser-captured images. An a priori 
assumption was that measurements generated using landmarks located on the lip and 
eye areas would generate more variation than measurements involving the nose and ear 
landmarks (specifically the nasion, pronasale, subnasale and tragion), because these 
areas were captured with relatively low efficiency by the scanner. In general, the data on 
landmarks in the eye and lips areas were limited as they were captured with low 
efficiency. The nasal area landmarks and tragion were the easiest to find because of 
their defined anatomical location. Due to the location of the trichion (the hairline in the 
middle of the forehead) and given the issues with scan capture of the hair, that landmark 
was also expected to show more variation than others. 
Figure 44 shows an example of the variation between two observations that generated 
the minimum difference between most of the first and the second measurements. In 
contrast, Figure 45 shows an image, which generated the maximum difference between 
these measurements.  
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Figure 44. A 3D image, tested twice for location of 32 facial landmarks and generated minimum variance between 
most of the “old” and the “new” anthropometric measurements. Red circles indicate pairs of landmarks, showing 
significant difference between two observations. 
 
 
 
 
Figure 45. A 3D image, tested twice for location of 32 facial landmarks and generated maximum variance 
between most of the “old” and the “new” anthropometric measurements. Red circles indicate pairs of landmarks, 
showing significant difference between two observations. Note the poor coverage of the eye area. 
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Tables 16, 17 and 18 demonstrate the summary of 54 linear distances, 22 ratios between 
linear distances and 10 angular distances respectively in 13 facial images. For linear 
distances, the highest variance was observed between measurements involving paired 
landmarks, such as gonion and zygion, with two samples generating most of the 
variability observed. A possible explanation for this variability is poor image quality 
and general difficulty in finding these landmarks. The analysis of the average values 
showed that go(r)-zy(r), zy(r)-gn and tr-zy(r) measurements (5.6%) resulted in more 
than 6 mm MD between the two observations; go(l)-zy(l), and zy(l)-gn (3.7%) resulted 
in more than 5 mm MD; seven measurements (13%) resulted in more than 4 mm MD; 
eight measurements resulted in more than 3 mm MD (14.8%); eleven measurements 
(20.4%) resulted in more than 2 mm MD and 23 measurements (42.6%) resulted in less 
than 2 mm MD between two observations. The relatively high variation in linear 
distances involving gonion, zygion and trichion can be explained by the difficulty in 
accurate location of these landmarks. On the other hand, more than 62% of the 
measurements resulted in approximately 2 mm (or less) difference between the two 
observations.  
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Table 16. A summary of 54 linear measurements for thirteen 3D images with detailed average, minimum and maximum values. 
 
 
 
 
 
 
tr-gn zy-zy go-go prn-gn t(L)-gn t(L)-prn t(L)-n t(L)-g t(L)-tr t(R)-tr t(R)-gn t(r)-t(l) tr-zy(l) 
 Average 2.46 2.30 2.68 3.40 1.39 0.91 1.07 1.55 1.41 1.37 1.31 0.81 4.62 
 Minimum 0.10 0.55 0.25 0.01 0.25 0.02 0.04 0.12 0.07 0.40 0.02 0.01 0.07 
 Maximum 7.10 6.55 9.24 6.36 4.41 3.60 5.34 5.47 6.33 3.21 3.24 3.71 10.69 
 
 
tr-zy(r) n-zy(l) n-zy(r) zy(l)-gn zy(r)-gn tr-n g-tr g-gn n-gn n-sto sto-gn n-prn n-sn 
 Average 6.33 3.48 3.06 5.53 6.25 2.06 4.20 4.86 2.67 1.38 2.71 1.13 1.90 
 Minimum 0.76 0.37 0.59 1.02 0.40 0.04 0.92 0.03 0.12 0.24 0.20 0.01 0.43 
 Maximum 14.44 12.32 6.67 14.00 15.13 5.59 10.08 13.60 6.32 3.78 7.42 2.44 3.25 
 
 
sn-prn sn-gn sl-gn gn-go(l) gn-go(r) prn-go(l) prn-go(r) go(l)-tr go(r)-tr go(r)-zy(r) go(l)-zy(l) zy(l)-al(l) zy(r)-al(r) al-al 
Average 1.10 3.13 2.98 3.36 4.42 2.80 4.52 3.51 3.86 6.72 5.66 4.34 3.86 0.77 
Minimum 0.12 0.40 0.50 0.10 0.05 0.16 0.77 1.10 0.93 0.22 0.54 0.31 1.09 0.11 
Maximum 4.42 7.74 7.34 13.84 15.36 6.23 13.35 7.03 12.31 13.27 13.67 14.22 8.62 1.94 
 
prn-al(l) prn-al(r) g-pg en-en ex-ex en(l)-ex(l) 
en(r)-
ex(r) ps(l)-pi(l) ps(r)-pi(r) sa(l)-sba(l) t(l)-pa(l) ch-ch ls-sto li-sto 
Average 1.21 1.26 4.47 1.59 1.79 1.40 2.51 1.17 1.60 2.37 1.33 2.30 0.76 1.17 
Minimum 0.06 0.12 0.31 0.04 0.14 0.06 0.58 0.08 0.07 0.32 0.04 0.18 0.05 0.05 
Maximum 3.02 3.37 9.66 5.37 7.40 7.32 6.93 3.13 3.55 6.94 3.17 7.31 2.67 3.32 
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  Forehead height ratio (tr-n*100/go(r)-go(l)) Upper face height ratio(n-sn*100/go(r)-go(l)) Lower face height ratio (sn-gn*100/go-go) Mandible index: (sto-gn)*100 /(go-go) 
Average 2.16 1.78 2.65 2.13 
Mimimum 0.08 0.14 0.19 0.44 
Maximum 6.09 4.94 6.29 5.08 
  
Interendocanthion distance ratio 
(en-en*100/al-al) 
Upper face height ratio 
(n-sn*100/sn-gn) 
Total anterior face height ratio 
(tr-gn*100/zy-zy) Mandible – Face width ratio (go-go*100/(zy-zy) 
Average 3.86 5.35 3.40 2.85 
Mimimum 0.10 0.48 1.17 0.11 
Maximum 9.48 16.11 5.49 6.53 
  go-go*100/ex-ex 
Exocanthal index 
ex(R)-en(R)*100/en(L)-ex(L) 
Intercanthal index 
en(R)-en(L)*100/ex(R)-ex(L) Face height index: (n-gn)*100/(tr-gn) 
Average 4.65 6.77 2.44 0.88 
Mimimum 0.25 0.42 0.28 0.02 
Maximum 12.95 16.26 10.09 2.84 
  Nose-face height index n-sn/n-gn Nose-face width index al-al/zy-zy 
Nasal tip prostrusion - width index 
sn-prn/al-al 
Nasal Tip Protrusion –Nose height index: 
(sn-prn)x100/(n-sn) 
Average 1.65 0.46 2.98 1.35 
Mimimum 0.11 0.00 0.01 0.08 
Maximum 4.94 1.25 11.45 6.94 
  Anterior face height 1 (n-gn*100/go-go) 
Anterior face height 2 ratio 
(n-gn*100/zy-zy) Upper face height ratio (n-sn*100/zy-zy)   
Average 2.57 2.97 1.25   
Mimimum 0.19 0.09 0.03   
Maximum 8.73 6.25 3.08   
  Mouth width ratio (ch-ch*100/en-en) 
Forehead/lower face height index  
(Tr-g*100/sn-gn) Nasal Index al-al/n-sn   
Average 4.46 8.02 2.12   
Mimimum 0.20 2.37 0.14   
Maximum 11.31 17.40 6.75   
Table 17. A summary of 22 ratios between linear distances for thirteen 3D images with detailed average, minimum and maximum values. 
164 | P a g e  
Table 18. A summary of 10 angular distances for thirteen 3D images with detailed average, minimum and maximum values. 
 
Nasal tip angle (n-prn-sn) Nasal vertical prominence (tr-prn-gn) Transverse nasal prominence (zy(l)-prn-zy(r)) 
Average 2.79 1.12 2.41 
Mimimum 0.19 0.04 0.09 
Maximum 6.84 3.59 6.15 
 
Nasolabial angle (prn-sn-ls) Nasofrontal angle (g-n-prn) Forehead nasal angle (tr-n-prn) 
Average 3.75 2.32 1.14 
Mimimum 0.08 0.45 0.17 
Maximum 9.28 4.20 4.06 
 
Chin prominence (go(l)-gn-go(r)) Transverse nasal prominence 2 (t(l)-prn-t(r)) Nasion depth angle (zy(l)-n-zy(r)) 
Average 2.25 0.38 2.52 
Mimimum 0.24 0.01 0.21 
Maximum 6.89 1.91 7.43 
 
Nasomental angle (n-prn-pg) 
  Average 0.80 
  Mimimum 0.13 
  Maximum 1.63 
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The graphical representation of the results is shown in Figure 46. The highest 
measurement error (ME) was observed in measurements involving paired landmarks 
(gonion and zygion), while the lowest was in measurements involving the nasal area 
landmarks and tragion (ear), as summarised in Figure 47. The analyses of the results 
involved only basic descriptive statistics, as a more comprehensive analysis was beyond 
the scope of this project.  
The comparison between the craniofacial ratios revealed that forehead/lower face height 
index (Tr-g*100/sn-gn) demonstrated the highest variance (8.02 mm), which can be 
accounted for three (3) samples that demonstrated significantly higher values than the 
rest of the dataset. This is most likely due to variation in location of the trichion, which 
can be covered by hair. The exocanthal index also showed relatively high variance (6.77 
mm) due to poor capture of the eye area, confirming the original assumption of poor 
laser capture. However, the majority of the ratios (68.2%) showed MD of less than 3 
mm and ME of less than 1.5 mm (Figures 46 and 47). 
Evaluation of the reproducibility of the angular distances revealed that the nasolabial 
angle (prn-sn-ls) showed the highest variability of 3.75 degrees among the 
measurements. One sample showed significantly higher variance due to poor digital 
capture of the lip area, which affected the accurate location of the labiale superius (ls). 
The rest of the angular measurements showed MD of 0.38 to 2.79 degrees. The ME 
range was also low, with values between 0.39 mm to 1.56 mm.  
The overall low variance in angular distances can be explained by the nature of these 
measurements. In 3D space, the angular distance is mostly affected by the z-axis (the 
depth), which is usually unaffected during the landmark location process. However, the 
variance in landmarks location at x and y-axes can also affect the angular distance. 
Table 19 shows an example of artificial manipulation with x, y and z coordinates of the 
prn landmark. The initial coordinate was either appended or subtracted by 5 mm or 10 
mm and MD from the original value was calculated. Notably, the subtraction in both y 
and z coordinates had a more pronounced effect than addition, while for the x 
coordinate it was the opposite. This phenomenon can potentially be explained by the 
facial anatomy (e.g. skin folds).  
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Figure 46. Three plots showing distribution of the mean difference (MD) values as an average of thirteen samples 
for linear distances (left plot), ratios between linear distances (middle plot) and angular distances (right plot). 
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Figure 47. Three plots showing distribution of the measurement error (ME) values as an average of thirteen 
samples for linear distances (left plot), ratios between linear distances (middle plot) and angular distances (right 
plot). 
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Table 19. An artificial manipulation with original coordinates of the ‘prn’ landmark, showing mean difference 
(MD) comparing to the initial angular distance. The values are shown in degrees. The landmarks that were mostly 
affected by manipulation with coordinates location are highlighted in yellow. 
 
 
 
 
4.4.4. Conclusion 
It is important to demonstrate reproducibility of facial measurements taken by 
different analysts or the same examiner at different times. While this topic has been 
extensively investigated in the traditional direct anthropometry, the number of 
publications exploring this issue in 3D imaging systems is relatively limited [360-362]. 
There are two current studies of the reproducibility of facial soft-tissue landmarks with 
3D laser scans [41, 363]. In addition, all the current articles deal with the reproducibility 
of landmark locations, rather than actual facial measurements (specifically the inter or 
intra-observer variance in location of the x, y and z coordinates). The results of an inter-
observer study with a 3D laser scanning system showed MD values between 0.39 mm to 
1.49 mm for each landmark, while approximately 50% of the landmarks were 
reproducible to 1 mm or less and approximately 11% to more than 1 mm [41]. Another 
study resulted in variance of 0.19 mm to 3.49 mm with a ME range of 0.55 mm to 3.34 
mm [41, 363]. These results are somewhat surprising, as the direct anthropometrical 
measurements error between two observations has been shown to be up to 2 mm in 
morphologically normal subjects, while being considered the most accurate method to 
(n-prn-sn) tr-prn-gn) (zy(l)-prn-zy(r)) (prn-sn-ls) (g-n-prn) (tr-n-prn)  (t(l)-prn-t(r)) (n-prn-pg)
Initial angular distance 101.03 139.66 80.87 124.78 151.08 162.12 65.38 128.33
prn z axis plus 5mm 16.31 6.21 3.30 10.20 6.17 5.95 2.31 10.36
prn z axis minus 5mm 28.80 12.15 6.43 17.09 11.80 11.49 4.48 19.90
prn x axis plus 5mm 11.89 6.05 3.28 5.08 5.62 5.79 2.26 9.63
prn x axis minus 5mm 2.66 1.21 0.56 1.38 1.31 2.65 0.32 2.32
prn y axis plus 5mm 7.10 0.07 0.92 12.45 3.86 4.94 0.00 2.61
prn y axis minus 5mm 16.96 2.08 2.50 22.60 5.70 5.69 0.36 1.64
prn z axis plus 10mm 38.00 12.64 6.79 25.44 12.78 11.70 4.76 21.39
prn z axis minus 10mm 60.36 24.26 12.86 37.18 23.45 22.24 8.98 39.60
prn x axis plus 10mm 17.62 10.82 6.14 6.47 9.34 8.81 4.26 16.24
prn x axis minus 10mm 4.48 2.30 1.11 2.65 2.32 4.39 0.63 4.21
prn y axis plus 10mm 15.02 0.46 1.74 26.22 8.31 10.76 0.03 6.15
prn y axis minus 10mm 34.10 4.21 4.94 45.72 11.75 11.72 0.72 3.52
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date  [17]. In addition, most of the craniofacial landmarks are not defined by a fixed 
precise location on the face and can vary slightly between measurements, even when 
performed by an experienced examiner. Location of the craniofacial landmarks on 3D 
images is significantly more complicated than direct measurement and is expected to 
produce a higher variance between two independent observations. It should also be 
emphasized that linear distances involve location of two landmarks, while angular 
distances require three landmarks. This means that the demonstrated upper variance 
limit of 3.34 mm should be increased two or three fold (6.68-10.02 mm) for actual 
measurements previously demonstrated. In summary, it can be concluded that the mean 
distance difference in the present study successfully produced lower variance and, as a 
result, higher reproducibility, compared to previous published studies. 
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4.5.  Assessment of normal distribution of the craniofacial measurements, 
including sex and ethnic differences. 
 
4.5.1. Introduction 
The variation in craniofacial morphology between genders and ethnic groups has 
been systematically explored since the end of 19
th
 century [19]. Despite the visual 
differences in the craniofacial morphology among races, most research has focused on 
the Caucasian population and particularly on European populations [17, 35]. In the last 
few years several studies of anthropometric measurements in other populations have 
been published. The most comprehensive study compared a set of 14 facial distances 
among a group of 30 males and females from each of 25 countries [28]. Interest in 
finding the differences in craniofacial morphology between various ethnicities has 
practical application in plastic surgery, specifically in craniomaxillofacial and 
rhinoplastical intervention for restoring dysmorphology or improving aesthetics, where 
the knowledge of normal proportions of the head and face is important. Due to the 
limited information currently available, more extensive research involving a greater 
number of individuals from various ethnicities is required to establish a reliable 
database of normal variation in craniofacial morphology.    
Any conclusions regarding the significance of variance between population groups rely 
primarily on statistical analyses of the data. Most of the parametric statistical tests, such 
as correlation, regression and analysis of variance are based on the assumption that the 
data follow a Gaussian (normal) distribution [364, 365]. As a result, prior to performing 
statistical analyses, the dataset should be checked for normality. Numerous publications 
however, argue that in a real dataset there is no such thing as true normality [366, 367]. 
In addition, with a large sample size (hundreds of observations) non-normal distribution 
can be ignored [368, 369]. Nevertheless, the test for normal distribution of data is 
essential to find any extreme values (potential errors), helping to make the outcome of 
statistical tests more accurate and reliable.  
The main aim of this study was to test the craniofacial distances for outliers or extreme 
values from the normal distribution (for each sex), which may represent potential errors 
in measurements. Following the normality test, several measurements were analysed in 
order to find craniofacial regions that contribute most of the differences between the 
five main population groups, according to sex. This evaluation represents an important 
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quality control step in data analysis and adds valuable information of the normal 
craniofacial measurement range to the published data. 
The analysis of distribution of all 92 measurements in several population groups was 
considered unnecessary and beyond the scope of this project. As a result, the data were 
analysed for a few measurements that contribute most significantly to the overall 
variance. These values were represented by principal components (PC).  
Principal component analysis (PCA) is a mathematical algorithm that reduces the 
dimensionality of the data while retaining most of the variation in the data set. This 
reduction is accomplished by identifying directions, visualised as eigenvectors, along 
which the variation in the data is expected to be maximal. By using a few components, 
each sample, genotype or trait can be represented by significantly less numbers instead 
of possibly thousands of variables. Samples, genotypes or traits can then be plotted to 
assess similarities and differences between them and determine whether they can be 
grouped. Several principal components obtained in this study were subsequently used 
for analysing their association with genetic markers, thus significantly reducing the time 
for statistical analysis. Furthermore, performing PCA on the craniofacial measurements 
allowed to produce “morphological vectors” represented by similar anthropometrical 
distances, which represent the facial appearance in a comprehensive fashion (as 
discussed in Section 4.6). As a result, the association analysis of craniofacial principal 
components may reveal more significantly associated genetic markers, hence better 
prediction of the facial appearance. 
 
 
4.5.2. Materials and Methods 
All the statistical analyses were performed using PASW Statistics (SPSS version 19, 
IBM Corp.). The normal distribution of the data was checked by analysing skewness 
and kurtosis of the dataset, as well as by Shapiro-Wilk (S-W) test. The tests were 
performed for each measurement, sex separated. The distribution was considered 
normal if z-scores of skewness and kurtosis were between -2.58 and 2.58 and p-value 
for S-W test greater than 0.01. The Kolmogorov-Smirnov test was not relevant for this 
study, as it is less powerful and more sensitive to extreme values than the S-W test. The 
outliers were defined as either ≥3x interquartile range (IQR) above the third quartile or 
≥3×IQR below the first quartile.  
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Principal component analyses were performed on all the linear and angular 
measurements, including the ratios between these measurements, using PASW Statistics 
(version 19, IBM Corp.). The plots were prepared in PASW Statistics and edited in 
Microsoft Excel. 
 
 
4.5.3. Results and Discussion 
Performing the test for normality on the measurements allowed testing a 
hypothesis of normal distribution of the data, which is an initial step prior to statistical 
analysis. It also helped to identify outliers, represented by extreme values. These values 
were caused either by wrong location of facial landmarks, which led to errors in 
calculations and were identified and corrected in the final dataset.  
The z-scores for skewness and kurtosis values for symmetrical Gaussian distribution, 
were expected to lie between -1.96 and 1.96 at p-value > 0.05. However, in a large 
dataset (≥200 observations) this range can be changed to ±2.58 at p-value >0.01 [368, 
369]. Given the current sample size, these values were applied for analysis of the dataset. 
The normality test performed on direct cranial measurements and respective ratios in the 
whole dataset (all ethnicities together), revealed that two direct measurement (G-Op and 
Eu-Eu) showed normal distribution in both genders, according to the S-W test p-values 
(Tables 20 and 21). The v-gn/height ratio was distributed normally in females only. The 
Eu-Eu distance in females displayed positive skewness and less significant p-value than 
G-Op. The V-Gn distance was negatively skewed, while the eu-eu/v-gn ratio was 
positively skewed in both sexes, failing the normality test. In all the tests of direct 
measurements, no significant outliers from normal distribution were detected. 
 
 
 
 
 
 
173 | P a g e  
Table 20. Normality tests for direct craniofacial measurements and ratios in females. a. Lilliefors Significance 
Correction, *. This is a lower bound of the true significance. Values, within the limits of normal distribution 
highlighted in red. 
Tests of Normality - females 
 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk z-score 
 
 Statistic df Sig. Statistic df Sig. Skewness Kurtosis 
V-Gn (Craniofacial height) mm 
.055 314 .021 .979 314 .000 -3.746 4.283 
Eu-Eu (Head Width) mm .047 314 .087 .990 314 .039 2.590 0.375 
G-Op (Head Length) mm .034 314 .200
*
 .997 314 .805 -0.258 -0.625 
Cephalic Index .063 314 .004 .983 314 .001 3.642 0.838 
Head width – Craniofacial 
height ratio (eu-eu*100/v-gn) .055 314 .022 .973 314 .000 4.840 5.925 
v-gn*100/height .032 314 .200
*
 .995 314 .449 0.656 1.477 
 
 
 
 
 
 
Table 21. Normality tests for direct craniofacial measurements and ratios in males. a. Lilliefors Significance 
Correction, *. This is a lower bound of the true significance. Values, within the limits of normal distribution 
highlighted in red. 
Tests of Normality - males 
 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk z-score 
 
 Statistic df Sig. Statistic df Sig. Skewness Kurtosis 
V-Gn (Craniofacial height) 
mm .053 209 .200
*
 .979 209 .004 -3.144 1.620 
Eu-Eu (Head Width) mm 
.045 209 .200
*
 .993 209 .401 0.554 1.679 
G-Op (Head Length) mm 
.066 209 .026 .989 209 .101 -1.511 -1.178 
Cephalic Index 
.095 209 .000 .972 209 .000 2.901 -0.453 
Head width – Craniofacial 
height ratio (eu-eu*100/v-gn) .057 209 .098 .979 209 .003 2.823 3.703 
v-gn*100/height 
.051 209 .200
*
 .982 209 .009 1.089 3.718 
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Normality tests for linear measurements revealed that majority of the facial distances 
obtained from 3D images were distributed normally after removing several extreme 
outliers. Specifically, three distances displayed deviations from normal distribution in 
females: prn-al(l) prn-al(r) and ps(r)-pi(r) as did one in males: tr-gn (Tables 22 and 23). 
This may be explained by either poor laser capture of the eye and nose areas and 
difficulty in finding an accurate location of the tragion (hindered by hairline) or by 
existence of true outliers, representing actual data points. 
 
 
Table 22. Normality tests for linear facial measurements in females without ethnic separation. a. Lilliefors 
Significance Correction, *This is a lower bound of the true significance. Values, within the limits of normal 
distribution highlighted in red. 
Tests of Normality - female 
 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk z-score 
 
 Statistic df Sig. Statistic df Sig. Skewness Kurtosis 
tr-gn .036 241 .200
*
 .994 241 .511 -0.522 -0.760 
zy-zy .056 241 .063 .994 241 .400 0.446 -0.513 
go-go .044 241 .200
*
 .995 241 .686 1.057 -0.747 
prn-gn .028 241 .200
*
 .994 241 .509 0.433 -1.010 
t(l)-gn .041 241 .200
*
 .995 241 .665 0.561 -0.426 
t(l)-prn .049 241 .200
*
 .987 241 .027 -0.815 -2.157 
t(l)-n .056 241 .061 .991 241 .134 -0.108 -1.978 
t(l)-g .027 241 .200
*
 .997 241 .912 0.363 -0.862 
t(l)-tr .031 241 .200
*
 .991 241 .159 -1.191 -1.218 
t(r)-tr .035 241 .200
*
 .996 241 .747 0.548 -0.737 
t(r)-gn .026 241 .200
*
 .998 241 .997 -0.115 -0.067 
t(r)-t(l) .033 241 .200
*
 .994 241 .450 1.146 0.833 
tr-zy(l) .042 241 .200
*
 .994 241 .510 -0.599 1.298 
tr-zy(r) .041 241 .200
*
 .993 241 .325 -0.573 1.304 
n-zy(l) .027 241 .200
*
 .998 241 .980 0.306 0.029 
n-zy(r) .030 241 .200
*
 .995 241 .681 0.860 -0.551 
zy(l)-gn .031 241 .200
*
 .996 241 .790 -0.357 -0.093 
zy(r)-gn .042 241 .200
*
 .995 241 .557 -0.618 -1.054 
tr-n .039 241 .200
*
 .993 241 .370 -0.828 0.420 
g-tr .048 241 .200
*
 .994 241 .459 -0.070 -1.221 
g-gn .040 241 .200
*
 .993 241 .360 -1.318 0.192 
n-gn .044 241 .200
*
 .995 241 .590 0.299 -0.958 
n-sto .038 241 .200
*
 .997 241 .894 0.452 -0.490 
sto-gn .042 241 .200
*
 .996 241 .751 1.013 -0.353 
n-prn .038 241 .200
*
 .995 241 .639 1.096 0.692 
n-sn .049 241 .200
*
 .991 241 .119 2.019 2.160 
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sn-prn .029 241 .200
*
 .991 241 .167 1.115 1.657 
sn-gn .030 241 .200
*
 .997 241 .923 -0.115 -0.904 
sl-gn .040 241 .200
*
 .993 241 .364 1.344 1.234 
gn-go(l) .033 241 .200
*
 .992 241 .185 -1.089 0.446 
gn-go(r) .034 241 .200
*
 .995 241 .687 -1.459 0.321 
prn-go(l) .058 241 .050 .993 241 .307 0.758 -1.138 
prn-go(r) .045 241 .200
*
 .994 241 .414 0.287 -0.667 
go(l)-tr .048 241 .200
*
 .994 241 .415 -0.796 -0.647 
go(r)-tr .033 241 .200
*
 .998 241 .981 0.000 -0.263 
go(r)-zy(r) .048 241 .200
*
 .993 241 .277 0.892 -0.103 
go(l)-zy(l) .046 241 .200
*
 .994 241 .465 -0.796 -1.016 
zy(l)-al(l) .042 241 .200
*
 .987 241 .026 1.083 2.782 
zy(r)-al(r) .031 241 .200
*
 .990 241 .112 0.924 3.304 
al-al .048 241 .200
*
 .990 241 .082 2.510 0.740 
prn-al(l) .047 241 .200
*
 .981 241 .003 2.892 0.234 
prn-al(r) .061 241 .028 .983 241 .005 2.643 -0.615 
g-pg .046 241 .200
*
 .990 241 .099 -1.408 -0.131 
en-en .052 241 .200
*
 .993 241 .320 0.847 -0.827 
ex-ex .034 241 .200
*
 .994 241 .482 1.013 -1.176 
en(l)-ex(l) .051 241 .200
*
 .995 241 .664 -0.490 -0.756 
en(r)-ex(r) .040 241 .200
*
 .993 241 .273 1.490 1.058 
ps(l)-pi(l) .036 241 .200
*
 .992 241 .180 2.127 1.913 
ps(r)-pi(r) .050 241 .200
*
 .984 241 .009 3.121 2.628 
sa(l)-sba(l) .048 241 .200
*
 .993 241 .308 1.650 0.987 
t(l)-pa(l) .051 241 .200
*
 .993 241 .297 0.268 1.340 
ch-ch .042 241 .200
*
 .995 241 .610 -0.357 -1.026 
ls-sto .047 241 .200
*
 .989 241 .064 1.752 -0.587 
li-sto .038 241 .200
*
 .996 241 .724 0.567 0.872 
 
 
Table 23. Normality tests for linear facial measurements in males without ethnic separation. a. Lilliefors 
Significance Correction, *This is a lower bound of the true significance. Values, within the limits of normal 
distribution highlighted in red. 
Tests of Normality - male 
 
 Kolmogorov-Smirnov
a
 Shapiro-Wilk z-score 
 
 Statistic df Sig. Statistic df Sig. Skewness Kurtosis 
tr-gn .094 129 .008 .969 129 .005 -1.197 0.502 
zy-zy .061 129 .200
*
 .989 129 .425 -2.100 -1.177 
go-go .042 129 .200
*
 .994 129 .851 0.182 -0.993 
prn-gn .057 129 .200
*
 .992 129 .671 -0.244 0.063 
t(l)-gn .053 129 .200
*
 .983 129 .100 -1.770 2.013 
t(l)-prn .062 129 .200
*
 .978 129 .031 -1.856 2.888 
t(l)-n .061 129 .200
*
 .978 129 .036 -2.337 3.236 
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t(l)-g .065 129 .200
*
 .991 129 .582 -0.544 0.079 
t(l)-tr .044 129 .200
*
 .992 129 .684 0.673 -0.808 
t(r)-tr .038 129 .200
*
 .993 129 .820 -0.633 -0.951 
t(r)-gn .051 129 .200
*
 .992 129 .691 -0.611 0.223 
t(r)-t(l) .041 129 .200
*
 .991 129 .587 -1.001 -0.282 
tr-zy(l) .071 129 .186 .986 129 .200 0.483 0.486 
tr-zy(r) .066 129 .200
*
 .988 129 .347 0.788 1.073 
n-zy(l) .049 129 .200
*
 .993 129 .762 0.409 -0.405 
n-zy(r) .054 129 .200
*
 .988 129 .317 1.182 -1.020 
zy(l)-gn .034 129 .200
*
 .994 129 .857 0.332 0.362 
zy(r)-gn .052 129 .200
*
 .983 129 .114 -0.982 -0.005 
tr-n .043 129 .200
*
 .991 129 .575 0.302 -1.131 
g-tr .062 129 .200
*
 .977 129 .030 1.381 -0.870 
g-gn .060 129 .200
*
 .984 129 .124 -1.018 -1.550 
n-gn .056 129 .200
*
 .991 129 .567 0.198 -0.153 
n-sto .057 129 .200
*
 .989 129 .426 0.526 -0.484 
sto-gn .052 129 .200
*
 .988 129 .332 1.767 1.019 
n-prn .054 129 .200
*
 .987 129 .241 1.565 0.270 
n-sn .059 129 .200
*
 .991 129 .541 0.719 -0.729 
sn-prn .039 129 .200
*
 .992 129 .664 -0.418 0.207 
sn-gn .033 129 .200
*
 .995 129 .921 0.875 -0.117 
sl-gn .049 129 .200
*
 .985 129 .184 1.855 1.471 
gn-go(l) .044 129 .200
*
 .996 129 .967 -0.363 0.764 
gn-go(r) .073 129 .088 .974 129 .014 -2.352 2.321 
prn-go(l) .055 129 .200
*
 .990 129 .502 -1.094 -0.048 
prn-go(r) .061 129 .200
*
 .985 129 .169 0.236 2.047 
go(l)-tr .048 129 .200
*
 .988 129 .311 0.227 -1.215 
go(r)-tr .049 129 .200
*
 .993 129 .814 -0.206 0.186 
go(r)-zy(r) .063 129 .200
*
 .986 129 .229 -0.558 -0.628 
go(l)-zy(l) .101 129 .003 .977 129 .030 -0.895 -0.265 
zy(l)-al(l) .055 129 .200
*
 .990 129 .477 0.500 -0.987 
zy(r)-al(r) .054 129 .200
*
 .988 129 .333 0.202 -1.087 
al-al .094 129 .007 .976 129 .021 2.205 -0.509 
prn-al(l) .040 129 .200
*
 .994 129 .899 -0.019 0.133 
prn-al(r) .062 129 .200
*
 .989 129 .388 0.891 -0.987 
g-pg .067 129 .200
*
 .987 129 .236 -0.862 -1.219 
en-en .063 129 .200
*
 .988 129 .343 0.848 1.068 
ex-ex .055 129 .200
*
 .991 129 .564 -0.803 -0.216 
en(l)-ex(l) .049 129 .200
*
 .992 129 .678 0.411 -0.717 
en(r)-ex(r) .065 129 .200
*
 .992 129 .635 0.852 -0.540 
ps(l)-pi(l) .073 129 .085 .981 129 .067 2.146 -0.234 
ps(r)-pi(r) .046 129 .200
*
 .993 129 .776 0.709 -0.301 
sa(l)-sba(l) .040 129 .200
*
 .992 129 .652 0.215 -0.681 
t(l)-pa(l) .050 129 .200
*
 .987 129 .289 0.410 -0.699 
ch-ch .044 129 .200
*
 .993 129 .749 -0.956 0.649 
ls-sto .057 129 .200
*
 .984 129 .126 1.670 -0.393 
li-sto .080 129 .042 .989 129 .427 -0.351 -0.388 
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Most ratios between linear facial distances showed normal distribution except for upper 
face height ratio, intercanthal index and nose-face width index in females and “tr-
g*100/sn-gn” ratio in males (Tables 24 and 25). These ratios were calculated using 
several landmarks, which showed more variability in the reproducibility study, due to 
poor image quality and complexity in allocating these landmarks, as discussed in 
Section 4.4.  
 
 
Table 24. Normality tests for facial ratios in females, without ethnic separation. Values, within the limits of 
normal distribution highlighted in red. 
Tests of Normality for ratios - females 
 
 Shapiro-Wilk z-score 
 
 Statistic df Sig. Skewness Kurtosis 
Forehead height ratio (tr-n*100/go(r)-go(l)) .995 283 .474 1.302 -0.533 
Upper face height ratio (n-sn*100/go(r)-go(l)) .993 283 .188 2.016 1.219 
Lower faceheight ratio (sn-gn*100/go-go) .993 283 .244 1.408 -0.245 
Anterior face height 1 (n-gn*100/go-go) .992 283 .125 1.988 -0.418 
Anterior face height 2 ratio (n-gn*100/zy-zy) .988 283 .020 2.930 0.745 
Interendocanthion distance ratio (en-en*100/al-al) .994 283 .375 1.389 -0.513 
Upper face height ratio (n-sn*100/sn-gn) .995 283 .516 0.722 0.725 
Total anterior face height ratio (tr-gn*100/zy-zy) .991 283 .068 1.396 -0.905 
Upper face height ratio (n-sn*100/zy-zy) .980 283 .001 3.607 3.913 
Mouth width ratio (ch-ch*100/en-en) .994 283 .280 1.144 1.203 
go-go*100/ex-ex .995 283 .511 0.822 -0.407 
ex(R)-en(R)*100/en(L)-ex(L) .989 283 .030 2.295 0.252 
Intercanthal index en(R)-en(L)*100/ex(R)-ex(L) .996 283 .684 0.367 -0.714 
tr-g*100/sn-gn .990 283 .056 2.116 0.333 
Nasal Index al-al/n-sn .984 283 .003 2.987 2.636 
Nose-face height index n-sn/n-gn .994 283 .393 -0.841 1.007 
Nose-face width index al-al/zy-zy .985 283 .004 2.411 4.493 
Nasal tip prostrusion - width index sn-prn/al-al .998 283 .964 0.411 0.645 
Mandible – Face width ratio (go-go*100/(zy-zy) .993 283 .207 -1.608 1.172 
Mandible index: (sto-gn)*100 /(go-go) .992 283 .128 2.137 0.342 
Face height index: (n-gn)*100/(tr-gn) .995 283 .408 0.933 0.368 
Nasal Tip Protrusion –Nose height index: (sn-prn)x100/(n-sn) .992 283 .147 1.894 1.614 
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Table 25. Normality tests for facial ratios in males, without ethnic separation. Values, within the limits of normal 
distribution are highlighted in red. 
Tests of Normality for ratios- males 
 
 Shapiro-Wilk z-score 
 
 Statistic df Sig. Skewness Kurtosis 
Forehead height ratio (tr-n*100/go(r)-go(l)) 0.987 174 0.113 0.831 -0.177 
Upper face height ratio (n-sn*100/go(r)-go(l)) 0.993 174 0.593 -0.086 1.399 
Lower faceheight ratio (sn-gn*100/go-go) 0.991 174 0.356 1.379 0.412 
Anterior face height 1 (n-gn*100/go-go) 0.991 174 0.327 0.62 0.272 
Anterior face height 2 ratio (n-gn*100/zy-zy) 0.995 174 0.873 0.778 -0.313 
Interendocanthion distance ratio (en-en*100/al-al) 0.985 174 0.061 2.397 1.522 
Upper face height ratio (n-sn*100/sn-gn) 0.996 174 0.886 0.394 0.768 
Total anterior face height ratio (tr-gn*100/zy-zy) 0.987 174 0.094 -0.622 -0.318 
Upper face height ratio (n-sn*100/zy-zy) 0.989 174 0.179 -0.913 1.468 
Mouth width ratio (ch-ch*100/en-en) 0.989 174 0.216 1.203 -0.432 
go-go*100/ex-ex 0.991 174 0.302 0.747 1.116 
ex(R)-en(R)*100/en(L)-ex(L) 0.994 174 0.759 0.455 -0.387 
Intercanthal index en(R)-en(L)*100/ex(R)-ex(L) 0.997 174 0.978 0.096 0.813 
tr-g*100/sn-gn 0.969 174 0.001 2.757 -0.751 
Nasal Index al-al/n-sn 0.982 174 0.026 2.814 1.632 
Nose-face height index n-sn/n-gn 0.993 174 0.529 -1.483 1.049 
Nose-face width index al-al/zy-zy 0.983 174 0.03 2.654 1.698 
Nasal tip prostrusion - width index sn-prn/al-al 0.995 174 0.844 0.399 1.001 
Mandible – Face width ratio (go-go*100/(zy-zy) 0.986 174 0.075 -0.606 -0.501 
Mandible index: (sto-gn)*100 /(go-go) 0.979 174 0.011 2.93 1.503 
Face height index: (n-gn)*100/(tr-gn) 0.994 174 0.73 0.283 -1.111 
Nasal Tip Protrusion –Nose height index: (sn-prn)x100/(n-sn) 0.992 174 0.4 1.362 0.02 
 
 
The normality test for angular distances revealed that all the measurements distributed 
normally in both genders, after removing six outliers (Tables 26 and 27). The outliers 
were caused by wrong location of the landmarks (as discussed in paragraph below) and 
were subsequently corrected. These results were expected, because angular distances 
demonstrated better reproducibility between measurements, as discussed in Section 4.4. 
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Table 26. Normality tests for angular distances in females, without ethnic separation. Values, within the limits of 
normal distribution are highlighted in red. 
Tests of Normality for angular distances - female 
 
 Kolmogorov-Smirnov Shapiro-Wilk z-score 
 
 Statistic df Sig. Statistic df Sig. Skewness Kurtosis 
Nasal tip angle (n-prn-sn) 0.046 276 .200
*
 0.993 276 0.189 1.645 0.67 
Nasal vertical prominence (tr-prn-gn) 0.044 276 .200
*
 0.992 276 0.165 1.075 0.076 
Transverse nasal prominence (zy(l)-prn-zy(r)) 0.056 276 0.036 0.992 276 0.144 2.003 -0.112 
Nasolabial angle (prn-sn-ls) 0.036 276 .200
*
 0.995 276 0.565 -1.428 0.741 
Nasofrontal angle (g-n-prn) 0.032 276 .200
*
 0.992 276 0.139 1.834 0.059 
Forehead nasal angle (tr-n-prn) 0.051 276 0.076 0.994 276 0.324 0.884 0.799 
Chin prominence (go(l)-gn-go(r)) 0.042 276 .200
*
 0.987 276 0.011 2.052 -1.211 
Transverse nasal prominence 2 (t(l)-prn-t(r)) 0.048 276 .200
*
 0.994 276 0.374 1.369 0.255 
Nasion depth angle (zy(l)-n-zy(r)) 0.044 276 .200
*
 0.987 276 0.016 2.172 1.46 
Nasomental angle (n-prn-pg) 0.032 276 .200
*
 0.995 276 0.605 -0.006 -0.616 
 
 
 
Table 27. Normality tests for angular distances in males, without ethnic separation. Values, within the limits of 
normal distribution are highlighted in red. 
Tests of Normality for angular distances - male 
 
 Kolmogorov-Smirnov Shapiro-Wilk z-score 
 
 Statistic df Sig. Statistic df Sig. Skewness Kurtosis 
Nasal tip angle (n-prn-sn) 0.042 179 .200* 0.994 179 0.624 0.822 0.222 
Nasal vertical prominence (tr-prn-gn) 0.033 179 .200* 0.995 179 0.861 0.373 -1.026 
Transverse nasal prominence (zy(l)-prn-
zy(r)) 
0.046 179 .200* 0.987 179 0.084 1.747 -0.668 
Nasolabial angle (prn-sn-ls) 0.056 179 .200* 0.988 179 0.125 -2.026 -0.049 
Nasofrontal angle (g-n-prn) 0.048 179 .200* 0.991 179 0.33 -1.079 0.846 
Forehead nasal angle (tr-n-prn) 0.053 179 .200* 0.989 179 0.203 -1.195 1.121 
Chin prominence (go(l)-gn-go(r)) 0.071 179 0.029 0.984 179 0.038 2.389 0.754 
Transverse nasal prominence 2 (t(l)-
prn-t(r)) 
0.06 179 .200* 0.984 179 0.036 2.384 -0.339 
Nasion depth angle (zy(l)-n-zy(r)) 0.053 179 .200* 0.992 179 0.408 0.213 1.515 
Nasomental angle (n-prn-pg) 0.044 179 .200* 0.997 179 0.969 -0.19 -0.482 
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This study identified potential outliers, represented by extreme values in the dataset and 
caused by either wrong assignment of facial landmarks and subsequent wrong 
calculations of the distances using an Excel spreadsheet. The errors in assigning the 
landmarks in a few images were found in two main landmark pairs: the left and right 
zygion and gonion. The location of all landmarks was always performed in the same 
order: from number 1 to number 32. For example, the left gonion being manually 
appointed number 9, the right gonion number 10, the right zygion – number 26 and the 
left zygion – number 27 (Table 4 and Figure 29). In a few images this order was 
disrupted because of human error. For example, the right gonion was allocated first and 
incorrectly assigned as number 9 and then the left gonion as number 10, whereas instead, 
it should be in the opposite order. In addition, when some of the landmarks had to be 
edited or deleted as a part of the annotation process, the Geomagic software arranged 
these updated landmarks in a new order, causing errors in the Excel formulas that were 
based on the specific order of these values. Conducting the test for normality of the 
measurements, assessed the normal distribution of the data and found the extreme 
outliers (potentially representing errors in the measurements), which were corrected. 
The final dataset was subsequently processed for statistical analysis of potential 
associations with genetic markers (as detailed in Chapter  5). 
 
 
 
4.5.4. Variation in craniofacial measurements between ethnic groups 
The purpose of this study was to test several craniofacial distances for normal 
distribution in six populations as well as for sex and ethnic variation and to compare 
these data with published resources.  
Despite the abnormal distribution of several direct craniofacial measurements in the 
original (complete) dataset, these same measurements showed normal distribution 
following splitting data by ethnic origin (Table 28).  
The distances were analysed for the distribution of mean values between four main 
populations: Asian, African, Caucasian and Indian (other populations were not analysed 
due to insufficient sample size). The resulting box plots (data not shown) demonstrated 
a very wide distribution of data in the Caucasian population, with high standard 
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deviation and numerous outliers, where outliers were defined as either ≥3x interquartile 
range (IQR) above the third quartile or ≥3×IQR below the first quartile.  
As a result, the Caucasian group was split into three relatively homogeneous sub-
populations as East Europeans (EE), West Europeans (WE) and Middle Eastern (ME). 
The results that compared these six population groups for direct craniofacial 
measurements and Cephalic index in both sexes are shown in Table 28 and Figure 48. 
For the head height and length, the results were consistent with published data [17, 28]. 
Males in general, demonstrated longer mean distances than females for all direct 
measurements. Head height was found to be the highest in the African population and 
the shortest in the Indian population in both sexes. Head width was the widest in the 
African population in females and in the Asian population in males, while being the 
narrowest in the ME population in females and in the African population in males. Head 
length was found to be the longest in the African population and the shortest in the 
Asian population in both genders, which is similar to published data [17, 18]. The 
Cephalic index showed a distribution from 77.4 to 84.5 in females and between 74.7 
and 85.6 in males, with higher values in the Asian population in both genders, 
demonstrating a brachycephalic or even a hyperbrachycephalic head. 
Among the population groups tested, Asians were found to have the widest, but the 
shortest head. Africans had the longest head as Asians, especially in females; while 
Indians and three Caucasian sub-populations demonstrated various, but generally 
medial mean values for all manual measurements (Figure 48). These results were in 
general consensus with previous published data. 
All linear and angular distances demonstrated normal distribution in all ethnic groups 
tested (only partial data is shown due to space limits). Ten linear and six angular 
distances were summarized for the purpose of this study (Tables 29-31 and Figures 49-
51). All five horizontal linear distances tested were longer in males, except for en-en 
distance in Asians, which was slightly longer in females (Table 29 and Figure 50). Two 
vertical distances (n-prn and tr-gn) were longer in males, except for the tr-gn distance in 
the African population, which was longer in females (Table 29 and Figure 49). The 
other three vertical distances demonstrated no clear pattern. Two angular distances 
(transverse nasal prominence and nasal tip prominence) showed higher angles for 
females, while four angles were represented by a mixed pattern (Table 31 and Figure 
51).  
To summarize, males in general, had longer and wider faces, with more prominent 
larger noses and more widely set eyes in most populations tested. Population wise, the 
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Asians demonstrated the widest face and cranium, the Africans the widest nose, lips and 
binocular width, while the Middle Eastern males and Indian females were found to have 
the longest noses. These results are in general consensus with published data and may 
form foundation for extended follow up study with a larger sample set. 
 
 
 
Table 28. Average distances, standard errors and Shapiro-Wilk test generated p-values of three direct craniofacial 
measurements and cephalic index in various population groups tested. 
Descriptives - females   Descriptives - males 
  Population Mean 
distance 
Std. 
Error 
Shapiro-Wilk  
p-value   
  Population Mean 
distance 
Std. 
Error 
Shapiro-Wilk  
p-value 
V
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n
 (
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ad
  h
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gh
t)
 m
m
 
African  247.939 1.582 0.663   
V
-G
n
 (
H
e
ad
  h
ei
gh
t)
 m
m
 
African  262.244 3.033 0.631 
Asian  240.581 1.206 0.115   Asian  254.019 2.214 0.587 
EE  239.511 1.314 0.034   EE  252.824 2.432 0.993 
Indian  237.237 1.191 0.010   Indian  246.901 1.965 0.857 
ME  240.393 2.560 0.724   ME  253.584 1.568 0.925 
WE  240.102 0.604 0.027 
  
WE 
 
256.623 0.787 0.089 
Eu
-E
u
 (
H
ea
d
 w
id
th
) 
m
m
 
African  157.279 3.035 0.498   
Eu
-E
u
 (
H
ea
d
 w
id
th
) 
m
m
 
African  152.448 5.977 0.936 
Asian  153.623 1.145 0.619   Asian  161.995 1.686 0.759 
EE  149.576 1.531 0.310   EE  155.201 1.816 0.520 
Indian  148.482 1.115 0.215   Indian  154.586 1.106 0.425 
ME  146.677 1.839 0.996   ME  155.575 1.350 0.918 
WE  148.334 0.362 0.631   WE 
 155.321 0.446 0.442 
G
-O
p
 (
H
ea
d
 le
n
gt
h
) 
m
m
 
African  199.627 3.010 0.435   
G
-O
p
 (
H
ea
d
 le
n
gt
h
) 
m
m
 
African  203.734 1.974 0.761 
Asian  182.059 1.195 0.783   Asian  189.251 1.708 0.590 
EE  188.538 1.195 0.946   EE  197.233 4.014 0.710 
Indian  183.821 1.069 0.530   Indian  194.788 1.901 0.639 
ME  187.599 1.941 0.990   ME  193.742 1.225 0.211 
WE  191.804 0.456 0.304   WE 
 202.854 0.504 0.682 
C
ep
h
al
ic
 In
d
ex
 
African  78.896 1.937 0.857   
C
ep
h
al
ic
 In
d
ex
 
African  74.741 2.224 0.956 
Asian  84.491 0.869 0.427   Asian  85.596 0.407 0.514 
EE  79.400 1.046 0.392   EE  78.913 2.016 0.289 
Indian  80.829 0.735 0.079   Indian  79.513 0.994 0.724 
ME  78.218 0.877 0.174   ME  80.348 0.753 0.294 
WE  77.417 0.257 0.170   WE  76.597 0.238 0.904 
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Figure 48. Comparison of ethnic and sex –related variation in direct craniofacial measurements in various population groups.
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Table 29. Average distances, standard errors and Shapiro-Wilk test generated p-values of five linear vertical facial 
distances in various population groups tested. 
Descriptives - females 
 
Descriptives - males 
Population 
Mean 
value - 
females 
Std. 
Error 
Shapiro-Wilk 
p-value 
  
Population 
Mean 
value - 
males 
Std. 
Error 
Shapiro-Wilk 
p-value 
tr-gn 
African  187.164 1.901 0.399   African  181.824 8.041 0.876 
Asian    179.393 2.217 0.129   Asian    188.439 2.855 0.170 
EE       176.365 1.619 0.874   EE       182.078 4.082 0.579 
Indian   174.327 1.954 0.593   Indian   175.984 1.723 0.995 
ME       174.551 3.385 0.063   ME       183.000 1.881 0.451 
WE       178.670 0.667 0.752   WE       186.651 1.018 0.312 
tr-n 
African  83.093 3.910 0.551   African  69.762 4.203 0.178 
Asian    73.729 1.820 0.750   Asian    75.132 2.131 0.066 
EE       72.425 1.407 0.287   EE       68.385 5.264 0.127 
Indian   70.714 1.494 0.745   Indian   64.345 1.709 0.831 
ME       69.316 2.080 0.459   ME       66.393 1.419 0.853 
WE       73.168 0.555 0.075   WE       71.748 0.927 0.129 
n-prn 
African  37.374 2.450 0.411   African  43.377 2.457 0.420 
Asian    42.361 0.655 0.064   Asian    45.455 0.883 0.330 
EE       42.893 0.751 0.387   EE       46.445 1.033 0.987 
Indian   44.083 0.940 0.553   Indian   45.474 0.827 0.484 
ME       41.788 1.051 0.311   ME       49.864 0.917 0.897 
WE       42.924 0.335 0.555   WE       46.401 0.393 0.072 
ps(l)-
pi(l) 
African  8.442 0.220 0.653   African  8.722 0.993 0.155 
Asian    8.769 0.334 0.959   Asian    8.622 0.582 0.492 
EE       8.819 0.325 0.885   EE       9.337 0.897 0.302 
Indian   11.105 0.435 0.665   Indian   9.524 0.310 0.317 
ME       9.580 0.427 0.288   ME       9.008 0.319 0.174 
WE       9.389 0.131 0.337   WE       8.669 0.159 0.063 
li-sto 
African  12.640 1.106 0.160   African  12.231 0.375 0.131 
Asian    9.861 0.356 0.453   Asian    10.070 0.923 0.214 
EE       8.597 0.349 0.977   EE       8.205 0.327 0.180 
Indian   10.433 0.436 0.427   Indian   10.184 0.381 0.707 
ME       10.168 0.937 0.684   ME       10.523 0.475 0.792 
WE       9.081 0.147 0.865   WE       8.823 0.219 0.069 
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Table 30. Average distances, standard errors and Shapiro-Wilk test generated p-values of five linear horizonthal 
facial distances in various population groups tested. 
Descriptives - females 
 
Descriptives - males 
Population 
Mean 
value - 
females 
Std. 
Error 
Shapiro-Wilk 
p-value 
  
Population 
Mean 
value - 
males 
Std. 
Error 
Shapiro-Wilk 
p-value 
zy-zy 
African  137.973 1.879 0.379 
 
African  142.194 7.082 0.812 
Asian    142.130 1.543 0.020 
 
Asian    147.781 1.650 0.613 
EE       137.686 1.479 0.332 
 
EE       142.049 2.056 0.297 
Indian   134.855 1.551 0.188 
 
Indian   141.938 1.856 0.026 
ME       131.970 1.261 0.858 
 
ME       141.752 1.823 0.065 
WE       135.586 0.476 0.652 
 
WE       141.406 0.723 0.029 
go-go 
African  119.734 2.233 0.488 
 
African  128.499 4.374 0.083 
Asian    125.931 1.850 0.476 
 
Asian    131.214 1.572 0.036 
EE       120.549 1.517 0.394 
 
EE       128.158 1.869 0.727 
Indian   117.599 1.983 0.866 
 
Indian   129.309 1.762 0.020 
ME       115.133 2.041 0.435 
 
ME       127.098 1.942 0.182 
WE       118.734 0.558 0.638 
 
WE       127.673 0.790 0.161 
al-al 
African  39.647 2.171 0.634 
 
African  46.524 1.101 0.654 
Asian    36.987 0.583 0.887 
 
Asian    39.559 0.666 0.804 
EE       34.477 0.501 0.121 
 
EE       36.990 0.810 0.761 
Indian   35.052 0.655 0.993 
 
Indian   38.578 0.858 0.003 
ME       32.598 1.144 0.729 
 
ME       37.454 0.515 0.903 
WE       32.807 0.201 0.860 
 
WE       36.332 0.297 0.021 
en-en 
African  38.927 1.349 0.304 
 
African  41.139 3.222 0.526 
Asian    39.248 0.551 0.166 
 
Asian    38.181 0.625 0.343 
EE       37.391 0.823 0.985 
 
EE       39.489   0.652 
Indian   33.925 0.752 0.492 
 
Indian   35.956 0.731 0.836 
ME       34.200 1.324 0.063 
 
ME       36.737 0.585 0.561 
WE       35.521 0.232 0.182 
 
WE       37.534 0.363 0.735 
ex-ex 
African  89.580 1.260 0.095 
 
African  92.875 3.728 0.376 
Asian    86.192 1.055 0.858 
 
Asian    89.247 0.872 0.754 
EE       85.014 0.875 0.245 
 
EE       88.207 1.460 0.434 
Indian   87.548 0.968 0.209 
 
Indian   89.057 0.853 0.971 
ME       81.894 2.098 0.853 
 
ME       87.758 1.177 0.930 
  WE       84.213 0.322 0.592   WE       86.876 0.423 0.290 
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Figure 49. Comparison of ethnic and sex –related variation in linear vertical facial measurements in various population groups. 
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Figure 50. Comparison of ethnic and sex –related variation in linear horizontal facial measurements in various population groups.
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Table 31. Average distances, standard errors and Shapiro-Wilk test generated p-values of six angular facial 
distances in various population groups tested. 
Descriptives - females 
 
Descriptives - males 
 
 Population Statistic 
Std. 
Error 
Shapiro-
Wilk p-
value   
Population Statistic 
Std. 
Error 
Shapiro-
Wilk p-
value 
N
as
al
 t
ip
 a
n
gl
e 
 (
n
-p
rn
-s
n
) 
African  102.368 2.115 .768   African  100.189 2.550 .679 
Asian    101.299 1.370 .790   Asian    99.061 1.506 .340 
EU       94.284 1.297 .471   EU       93.646 1.779 .435 
Indian   92.517 1.213 .791   Indian   95.431 1.139 .804 
ME       97.490 2.464 .589   ME       92.984 1.037 .217 
WE       94.889 0.391 .667   WE       93.527 0.522 .512 
Tr
an
sv
er
se
 n
as
al
 
p
ro
m
in
en
ce
  
(z
y(
l)
-p
rn
-z
y(
r)
) 
African  87.876 1.704 .369   African  85.975 2.219 .381 
Asian    89.773 0.881 .129   Asian    89.135 0.696 .258 
EU       81.958 1.088 .588   EU       79.706 1.422 .628 
Indian   82.253 0.787 .259   Indian   80.732 0.674 .136 
ME       82.542 1.211 .167   ME       80.531 0.880 .043 
WE       82.241 0.285 .879   WE       80.395 0.398 .956 
N
as
o
la
b
ia
l a
n
gl
e 
 
(p
rn
-s
n
-l
s)
 
African  105.143 3.603 .442   African  99.244 2.345 .352 
Asian    112.619 1.776 .472   Asian    115.747 2.654 .426 
EU       118.786 2.174 .489   EU       125.511 2.147 .509 
Indian   115.557 2.383 .906   Indian   120.307 2.026 .212 
ME       121.135 3.947 .389   ME       120.591 2.291 .415 
WE       121.572 0.614 .721   WE       121.989 0.929 .169 
N
as
o
fr
o
n
ta
l a
n
gl
e 
 
(g
-n
-p
rn
) 
African  146.359 0.759 .931   African  142.569 1.711 .979 
Asian    149.527 0.999 .639   Asian    149.320 1.148 .794 
EU       150.500 1.341 .339   EU       148.387 2.533 .314 
Indian   150.387 1.035 .881   Indian   151.681 1.196 .397 
ME       151.540 1.469 .578   ME       154.441 1.209 .714 
WE       149.276 0.370 .712   WE       150.112 0.550 .421 
N
as
io
n
 d
ep
th
 a
n
gl
e 
(z
y(
l)
-n
-z
y(
r)
) 
African  105.844 1.302 .562   African  99.238 1.923 .196 
Asian    108.047 1.112 .047   Asian    109.622 0.982 .200 
EU       99.683 1.405 .184   EU       97.334 2.410 .340 
Indian   102.531 0.647 .603   Indian   97.680 1.007 .597 
ME       99.646 1.763 .615   ME       96.979 1.054 .600 
WE       99.831 0.296 .848   WE       97.028 0.494 .408 
N
as
o
m
en
ta
l a
n
gl
e 
 
(n
-p
rn
-p
g)
 
African  132.433 2.209 .045   African  134.588 2.386 .156 
Asian    135.088 0.777 .108   Asian    132.399 1.006 .882 
EU       129.236 1.136 .072   EU       127.386 1.287 .086 
Indian   128.280 1.241 .220   Indian   129.334 1.170 .271 
ME       129.329 1.452 .500   ME       130.147 1.174 .959 
WE       129.765 0.353 .381   WE       130.731 0.485 .663 
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Figure 51. Comparison of ethnic and sex –related variation in the angular facial distances in various population groups. 
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4.6.  Principal component analysis 
The main goal of principal component analysis (PCA) was to reduce the number 
of traits for subsequent association study. Principal component analysis of all 92 
measurements (detailed in Sections 2.9.2, 2.9.3 and 2.9.4) as one set, produced 20 
principal components, which accounted for almost 90% of the variance (Table 32 and 
Figure 52). The efficiency of PCA can be demonstrated by the fact that the first three 
components and another seven components explained 1/3 and 2/3 of the total variance 
respectively. These results demonstrated that subsequent analysis of genotype 
association may be performed with 20 (or less) principal components (instead of 92 
individual measurements), which can potentially provide information on approximately 
90% of the craniofacial traits used.  
However, given that direct measurements were tested together with respective ratios, 
this analysis did not produce a clear anthropometric pattern of linear distances (Table 
33). As a result, the linear and angular measurements were split from ratios and 
analysed separately (Tables 34 and 35). 
Table 32. Rotated component matrix results for linear and angular measurements, including ratios between these 
measurements. 
All the measurements - Total Variance Explained 
Component 
Rotation Sums of Squared Loadings 
Total % of Variance Cumulative % 
1 13.379 14.542 14.542 
2 9.238 10.041 24.584 
3 7.584 8.244 32.828 
4 6.266 6.811 39.638 
5 5.480 5.957 45.595 
6 5.118 5.563 51.159 
7 3.844 4.179 55.337 
8 3.752 4.078 59.416 
9 3.621 3.936 63.352 
10 3.444 3.744 67.096 
11 3.258 3.541 70.637 
12 2.862 3.111 73.748 
13 2.644 2.874 76.622 
14 2.094 2.276 78.898 
15 1.829 1.988 80.886 
16 1.826 1.985 82.872 
17 1.729 1.880 84.751 
18 1.668 1.813 86.564 
19 1.579 1.716 88.280 
20 1.378 1.498 89.778 
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Figure 52. The scree plot of linear and angular measurements, including ratios between these measurements. 
 
 
 
Table 33. Total variance in linear and angular measurements, including ratios explained by principal components. 
An eigenvalue threshold of 0.6 was applied in order to produce a clearer pattern of principal components. 
All the measurements - Rotated Component Matrix 
 
 
Component 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
t(l)-g .905                                       
t(l)-n .870                                       
t(r)-tr .843                                       
t(l)-prn .840                                       
t(l)-tr .833                                       
t(l)-gn .786                                       
t(r)-t(l) .773                                       
t(r)-gn .751                                       
Eu-Eu (Head 
Width) mm 
.654                                       
G-Op (Head 
Length) mm 
.640                                       
V-Gn 
(Craniofacial 
height) mm 
.606                                       
zy-zy                                         
sn-gn   .901                                     
Mandible index: 
(sto-gn)*100 /(go-
go) 
  .875                                     
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sto-gn   .867                                     
Lower face height 
ratio (sn-
gn*100/go-go) 
  .867                                     
prn-gn   .843                                     
n-gn   .727                                     
Upper face height 
ratio (n-
sn*100/sn-gn) 
  -.700 .676                                   
Anterior face 
height 2 ratio (n-
gn*100/zy-zy) 
  .686                                     
sl-gn   .676                                     
Anterior face 
height 1 (n-
gn*100/go-go) 
  .646                                     
g-gn                                         
g-pg                                         
Upper face height 
ratio (n-
sn*100/zy-zy) 
    .918                                   
n-sn     .889                                   
Upper face height 
ratio (n-
sn*100/go(r)-
go(l)) 
    .837                                   
n-prn     .829                                   
Nose-face height 
index n-sn/n-gn 
  -.674 .696                                   
n-sto     .676                                   
tr-n       .933                                 
g-tr       .931                                 
Tr-g*100/sn-gn       .833                                 
Forehead height 
ratio (tr-
n*100/go(r)-go(l)) 
      .831                                 
Face height 
index: (n-
gn)*100/(tr-gn) 
      -.727                                 
tr-gn       .683                                 
Total anterior 
face height ratio 
(tr-gn*100/zy-zy) 
      .622                                 
go(r)-tr       .612                                 
go(l)-tr                                         
Forehead nasal 
angle (tr-n-prn) 
                                        
n-zy(l)         .802                               
zy(r)-al(r)         .780                               
zy(l)-al(l)         .772                               
n-zy(r)         .759                               
Nasion depth 
angle (zy(l)-n-
zy(r)) 
        -.601                               
Transverse nasal 
prominence 
(zy(l)-prn-zy(r)) 
                                        
Mandible – Face 
width ratio (go-
go*100/(zy-zy) 
          .895                             
go-go           .746                             
go-go*100/ex-ex           .731                             
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gn-go(l)           .710                             
gn-go(r)           .707                             
prn-go(r)                                         
prn-go(l)                                         
Nose-face width 
index al-al/zy-zy 
            .923                           
al-al             .846                           
Nasal Index al-
al/n-sn 
    -.650       .700                           
Interendocanthion 
distance ratio (en-
en*100/al-al) 
            -.683       .641                   
prn-al(l)                                         
prn-al(r)                                         
go(l)-zy(l)               .910                         
go(r)-zy(r)               .893                         
tr-zy(r)                                         
zy(l)-gn                                         
tr-zy(l)                                         
zy(r)-gn                                         
Cephalic Index                 .861                       
Head width – 
Craniofacial 
height ratio (eu-
eu*100/v-gn) 
                .661                       
Transverse nasal 
prominence 2 
(t(l)-prn-t(r)) 
                                        
ps(l)-pi(l)                   .798                     
ps(r)-pi(r)                   .786                     
en(l)-ex(l)                   .735                     
en(r)-ex(r)                   .648                     
ex-ex                   .629                     
Mouth width ratio 
(ch-ch*100/en-en) 
                    -.918                   
en-en                     .801                   
Intercanthal index 
en(R)-
en(L)*100/ex(R)-
ex(L) 
                    .744                   
sn-prn                       .895                 
Nasal Tip 
Protrusion –Nose 
height index: (sn-
prn)x100/(n-sn) 
                      .893                 
Nasal tip 
prostrusion - 
width index sn-
prn/al-al 
                      .765                 
Nasomental 
angle (n-prn-pg) 
                        .869               
Nasal vertical 
prominence (tr-
prn-gn) 
                        .733               
ls-sto                           .826             
li-sto                           .768             
Chin prominence 
(go(l)-gn-go(r)) 
                            .692           
ch-ch                                         
v-gn*100/height                               .727         
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Nasofrontal angle 
(g-n-prn) 
                                .634       
Nasolabial angle 
(prn-sn-ls) 
                                  .738     
Nasal tip angle 
(n-prn-sn) 
                                  .732     
t(l)-pa(l)                                     .663   
sa(l)-sba(l)                                         
ex(R)-
en(R)*100/en(L)-
ex(L) 
                                      .958 
 
 
 
Tables 34, 35 and Figure 53 demonstrate the results of the PCA on the linear and 
angular distances, not including the ratios. 
 
 
Table 34. Total variance in linear and angular measurements explained by principal components. 
Total Variance Explained – Linear and angular distances 
Component 
Rotation Sums of Squared Loadings 
Total % of Variance Cumulative % 
1 6.762 12.523 12.523 
2 5.947 11.014 23.536 
3 4.738 8.773 32.310 
4 4.440 8.222 40.531 
5 4.046 7.492 48.023 
6 3.684 6.822 54.845 
7 3.422 6.336 61.181 
8 2.779 5.147 66.328 
9 2.550 4.722 71.049 
10 2.227 4.124 75.174 
11 1.889 3.498 78.672 
12 1.685 3.120 81.792 
13 1.612 2.985 84.776 
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Figure 53. The scree plot of PCA performed on the linear and angular measurements, excluding ratios. 
 
 
The results of PCA on linear and angular measurements are summarised in Table 34 
and Figure 53. Thirteen principal components for all 54 distances were obtained, while 
three and eight principal components explained 1/3 and 2/3 of the total variance 
respectively (Table 33).  
Separating direct craniofacial measurements (linear and angular) from ratios, and 
performing PCA on each group provided a more explanatory picture (in biological 
sense) of principal components. Most of the distances in each principal component were 
automatically grouped according to their similarity in Euclidean space orientation and 
corresponding landmarks. For easier presentation of the data and due to space limits, 
only the linear distances are shown (Table 35). For example, the first principal 
component was formed by horizontal distances, which all include the tragion (located 
on the ear). The second principal component represented vertical distances, which all 
include the gnation or pogonion (chin area). The third principal component was 
represented by horizontal measurements that all included the zygion. The fourth 
principal component incorporated horizontal measurements, which all included the 
gonion as one of the paired landmarks. The same rational is applicable for the rest of the 
principal components. Two distances ex-ex and ch-ch were not included in any 
principal component. This exclusion was most likely due to inaccurate measurements of 
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both eye and lip areas, as a result of poor laser coverage, as previously discussed in 
Section 4.4.  
Figure 54 illustrates an example of the linear craniofacial distances, coloured according 
to the principal components they represent (as detailed in Table 35).  
 
 
Table 35. Rotated Component Matrix results for linear craniofacial measurements. 
 
Rotated Component Matrix - Linear and angular distances 
 
 
 Component 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
P
C
 I
 
t(l)-g .852                         
t(l)-n .802                         
t(l)-tr .762                         
t(r)-tr .744                         
t(l)-prn .714                         
t(r)-t(l) .629                         
t(l)-gn .619                         
t(r)-gn .541                         
P
C
 I
I 
sn-gn   .904                       
sto-gn   .900                       
prn-gn   .866                       
sl-gn   .765                       
P
C
 I
I 
+
 V
I n-gn   .740       .542               
P
C
 I
I g-gn   .621                       
g-pg   .530                       
P
C
 I
II
 
zy(l)-al(l)     .846                     
zy(r)-al(r)     .836                     
n-zy(l)     .796                     
n-zy(r)     .761                     
zy-zy     .620                     
P
C
 I
V
 
gn-go(l)       .851                   
gn-go(r)       .844                   
go-go       .698                   
prn-go(r)       .681                   
prn-go(l)       .664                   
P
C
 V
 g-tr         .901                 
tr-n         .875                 
tr-gn         .729                 
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go(r)-tr         .713                 
go(l)-tr         .687                 
P
C
 V
 +
 V
II
 
tr-zy(l)         .532   -.505             
P
C
 V
I n-prn           .902               
n-sn           .882               
n-sto           .767               
P
C
 V
II
 
go(l)-zy(l)             .924             
go(r)-zy(r)             .916             
P
C
 I
V
 +
V
II
 
tr-zy(r)         .526   -.567             
P
C
 I
II
 +
 V
II
 
zy(l)-gn     .514       .523             
zy(r)-gn     .500       .503             
P
C
 V
II
I 
ps(r)-pi(r)               .871           
ps(l)-pi(l)               .869           
en(l)-ex(l)               .688           
en(r)-ex(r)               .628           
P
C
 I
X
 
al-al                 .734         
P
C
 X
 sn-prn                   .825       
prn-al(l)                   .655       
prn-al(r)                   .641       
P
C
 X
I li-sto                     .813     
ls-sto                     .778     
P
C
 X
II
 
t(l)-pa(l)                       .855   
sa(l)-sba(l)                       .688   
P
C
 X
II
I en-en                         .545 
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Figure 54. An illustration of the linear craniofacial distances according to respective colouring of the major 
principal components. A few distances are not shown due to image resolution.  
 
These results supply further confirmation of the validity of the 3D craniofacial 
measurements and provide a solid foundation for the subsequent genetic association 
analysis described in Chapter 5. 
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 Chapter 5   
Association and prediction study of the 
externally visible traits and ancestry 
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5.1. Introduction 
The overall goal of this project was to contribute to prediction of Externally Visible 
Traits (EVTs), such as facial appearance, eye, skin and hair pigmentation and also 
ancestry. The main aim of this study was to find potential associations between 
candidate genetic markers and craniofacial traits. A secondary aim was to analyse 
associations of observed pigmentation traits (eye, skin and hair colour) with previously 
published or novel markers as well as with main ancestry groups. A further aim was to 
assess the potential of a set of significantly associated SNPs in establishing prediction 
models of EVT and ancestry.  
The association and prediction analyses of pigmentation traits and ancestry origin were 
important to investigate for two reasons. Firstly, conducting an association study with 
previously associated markers allowed confirmation of the validity of the statistical 
modelling, thus ensuring results for novel (craniofacial) traits are robust. Secondly, 
performing prediction modelling provides an opportunity to test the predictive power of 
the pigmentation and ancestry SNPs set used in this study, potentially improving the 
current forensic assays. 
The following section summarizes results of the genetic association analyses for 
ancestry, pigmentation and craniofacial phenotypes as well as evaluation of statistical 
models for these phenotypes prediction. 
 
5.1.1. Ancestry informative markers (AIMs) 
Ancestry Informative markers (AIMs) are generally defined as genetic markers 
that display low heterozygosity and high Fst values [247]. In the genetic context, these 
markers can be found in various genes that have been subject to positive selection under 
the adaptation process, such as pigmentation–related or immunity–regulating genes 
[370]. As a result, AIMs may provide indirect information on phenotype. For example, 
in North Europeans, skin pigmentation is lighter compared to most other populations, 
however this correlation cannot be used as a precise predictor of the phenotype and 
must be treated accordingly [371].  
In general, ancestry prediction focuses on three main categories or “dimensions” [372, 
373]. The first is the continental ancestry, which assumes the existence of 
approximately five major populations that originally gave rise to existing major 
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population groups at approximately 100,000 years ago. The second is the biogeographic 
ancestry, which relates to the geographic location of a specific population living in this 
area and usually refers to unlinked autosomal ancestry informative markers (AIMs). The 
third category is the lineage ancestry, which refers to the paternal or maternal family 
history. This history can be revealed through genotyping of the uniparental markers (mt-
DNA or Y-chromosome haplotypes). In the forensic context, prediction of the 
biogeographic and lineage ancestries can be used as intelligence information to solve 
crimes with no suspect available and assist in missing person and DVI cases. In general, 
the more geographically localized the information that can be predicted is, the more 
useful it is for the investigative purpose. However, estimation of genetic ancestry can be 
challenging, given that human demographic history and specifically population 
admixture as a result of recent migration dynamics. This project explored only the 
biogeographical ancestry associations and prediction queries. 
Estimating an individual’s ancestry from DNA markers is not a novel concept [249]. 
Research on ancestry prediction using genetic markers has rapidly progressed from a 
continental resolution down to a more focused geographical location, forming the basis 
for forensically–relevant assays [374, 375]. Some of these assays are able to predict 
additional traits by incorporating pigmentation-informative markers, such as skin, hair 
or eye colour from DNA samples of various amount and quality [9, 16, 267, 291, 376-
378]. A few ancestry-predictive assays have been recently validated as successful 
investigative tools in several forensic cases [16, 379]. For example, in the Louisiana 
serial killer case, the police were searching for a Caucasian suspect (based on 
eyewitnesses testimony), when in fact he was predicted to be 85% sub-Saharan African 
and 15% Native American, as revealed from ancestry DNA testing and subsequently 
matching the ancestry origin of the offender [16]. In addition, the use of genetic 
approaches for predicting ancestry of human remains is highly preferable over forensic 
anthropology, with the latter considered unreliable and prone to errors [380]. 
Nevertheless, it should be emphasized that ancestry prediction using a genetic approach 
should be treated as an investigative lead and not as an identity-confirmatory test. 
The potential correlation between AIMs and SNPs involved in the craniofacial traits 
variation has not yet been explored. Given that ancestry is correlative to external 
appearance and that the markers for this project were chosen with high Fst values, an 
overlap between ancestry, pigmentation and craniofacial markers is expected. Therefore, 
the incorporation of such markers in an assay may simultaneously provide investigative 
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information on the facial appearance, pigmentation and bio-geographical ancestry of an 
individual.  
 
 
5.1.2. Pigmentation traits in humans 
Eye, skin and hair colour are among the most visible external features. Knowledge 
of the genetics of human pigmentation has been enriched by studies of mice and zebra 
fish mutants [381-383], as well as by an extended use of GWAS on human populations 
[250-252, 264, 384-389].  
The level of pigmentation in the iris, hair and dermis is determined by the amount, type 
and distribution of melanin in specialized cells, the melanocytes. Melanin is a bio-
polymer, produced by melanocytes from tyrosine and catalysed by tyrosinase (TYR). 
There are two main types of melanin: eumelanin, which is responsible for darker 
colours, such as black and brown hair, brown eyes and darker skin; and pheomelanin, 
which determines lighter colours, such as blond and red hair, blue eyes and fair skin [72, 
390]. 
Pigmentation is a polygenic trait regulated by many genes. However, a relatively 
limited number of genes have a major effect on these traits. Some of these genes, 
including TYR, TYRP1, DCT, OCA2, MC1R, ASIP and KITLG, are known to be 
directly involved in the regulation of melanogenesis, while others, such as HERC2, 
SLC24A5, SLC45A2, SLC24A4, IRF4 and TPCN2 have been associated with 
pigmentation variation, although their exact interaction and function remain unclear.  
Table 36 summarizes both the genes and SNPs most significantly associated with 
human pigmentation traits [14, 72, 384, 387, 390]. 
 
Table 36. SNPs and genes significantly associated with human pigmentation traits, listed in the order of 
prediction significance. 
Gene SNP Trait associated 
HERC2 rs12913832 eye, hair and skin colour 
HERC2 rs1129038, rs1667394, rs7183877 eye colour 
OCA2 rs1800407 eye and hair colour 
OCA2 rs1545397 skin colour 
SLC24A4 rs12896399 eye colour 
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SLC24A4 rs2402130 eye and hair colour 
SLC24A5 rs1426654 skin colour 
SCL45A2 rs16891982 eye and skin colour 
SCL45A3 rs28777 hair colour 
SCL45A4 rs16891982 hair and eye colour 
TYR rs1393350 eye colour 
TYR rs1042602 hair colour 
TYRP1 rs683 hair colour 
IRF4 rs12203592 eye, hair and skin colour 
IRF4 rs4959270 hair colour 
MC1R rs885479, rs11547464, rs1805007, rs1805008, rs1805009 skin and hair colour 
KITLG rs12821256 hair colour 
ASIP rs2378249 hair colour 
ASIP rs6119471 skin colour 
 
 
A number of genetic assays able to predict pigmentation traits have recently been 
developed [10, 252, 296, 297]. Most of these however, were focused on the European 
population, providing only a partial spectrum of loci affecting pigmentation away from 
other population groups. Several recent studies have screened additional populations, 
confirming known SNPs as well as identifying additional novel markers associated with 
pigmentation traits [391, 392]. Despite the identification of a significant number of 
genes and loci affecting the eye, skin and hair colour, the exact interaction between 
these genes remains unclear [393, 394]. Particularly for the eye and skin colour, it is 
more likely that a small number of genes with relatively moderate effect such as OCA2, 
HERC2, SLC24A5 and TYR act together with many genes of a small effect (only partly 
identified yet), cumulatively explaining the major percentage of heritability [393]. This 
hypothesis supports the idea that pigmentation prediction should be based on a dense 
genotype rather than on a small panel of SNPs. 
Nevertheless, recent studies demonstrated that a panel of only six SNPs in six 
pigmentation genes can predict iris colour with particular specificity of the brown and 
blue shades [292, 293, 297]. In addition, Walsh et. al. demonstrated that 24 SNPs could 
efficiently predict hair colour [296]. However, some studies argue that the actual 
prediction accuracy of these assays is significantly lower than claimed due to the high 
percentage of inconclusive results [394, 395]. The inconclusive results originated 
mainly in uncertainty of the intermediate eye colour prediction, such as green and hazel. 
Natural variation in human skin colour is believed to be a result of positive natural 
selection as an adaptation to various levels of solar radiation in different habitats [250, 
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251, 390, 396]. A recent study illustrated that a lighter skin colour in Europeans 
appeared approximately 11,000 to 19,000 years ago as a mutation from a darker 
(ancestral) skin colour [397]. Interestingly, two studies in 2014 suggest that a lighter 
skin colour and hair texture of the evolutionary modern H. sapiens (specifically a 
number of polymorphisms in BNC2 and POU2F3 genes) may have been inherited from 
Neanderthals through interbreeding and were maintained through evolution, as an 
adaptation to non-African environments, following exodus from Africa [398, 399]. 
Notably, a number of polymorphisms in the POU2F3 gene were significantly associated 
with pigmentation levels as well as with European and Asian ancestries in the current 
study (detailed in Sections 5.3.4 and 5.3.5). 
Despite the fact that pigmentation traits were shown to be under positive evolutionary 
selection and may strongly correlate to ancestry, estimating ancestry based solely on 
skin colour is not accurate [15, 250, 251, 400]. There is a strong existing correlation 
between geographical latitude and skin pigmentation, but the degree of correlation 
between skin colour and ancestry can vary greatly [371]. Dark skin pigmentation, for 
example, does not automatically mean that the person is of African ancestry, as many 
native non-African populations may have dark skin. Conversely, some Asians may have 
skin as light as many Europeans. Similar skin pigmentation may thus be regulated by 
different population-specific markers. In order to obtain a complex picture, it is 
therefore important to screen different populations for pigmentation–associated markers, 
which was an important aspect of this project. 
 
 
5.1.3. Craniofacial traits  
The human face is the most noticeable of all visible physical traits, and has an 
extraordinary role in social interactions, medical diagnostics and forensic investigation. 
The genetic basis of craniofacial morphology has been explored in numerous animal 
studies with multiple genes shown to be involved as reviewed in Chapter 1 of this 
document and elsewhere [62, 63, 65, 89, 98, 165, 169-171, 185, 191, 195, 196, 200, 210, 
401-409]. Most studies however, have focused on the genetics of craniofacial 
malformations, rather than providing information on the normal phenotype. The most 
common disorder associated with various craniofacial abnormalities is craniosynostosis, 
which symptoms are observed in more than 250 hereditary syndromes [80, 81]. Given 
that craniosynostosis affects the cranial sutures, genes mutated in this syndrome may 
205 | P a g e  
also be involved in influencing normal craniofacial variation and specifically the cranial 
width and length (reviewed in Section 1.4.2). 
A few studies have explored this link and identified several markers significantly 
associated with cephalic index within the FGFR1 gene [74, 410, 411]. Other studies 
have focused on cleft lip/palate disorder, affecting the normal facial morphology [144, 
412, 413]. A recent study investigated the hypothesis that the same genes that affect 
non-syndromic clefts may also be responsible for normal phenotype (specifically the 
bizygomatic distance) and found two SNPs being significantly associated with normal 
facial variation [160]. Additional studies which focused on the GWAS approach, 
detected a number of specific polymorphisms in genes that may contribute to normal 
variation of the nasal area morphology [76, 77]. The limited number of studies focusing 
on the genetics of normal human craniofacial appearance, illustrates the demand for 
additional efforts in disclosing the genes and specific markers influencing normal facial 
variation. This study represents a candidate genes approach, which has not been 
attempted previously (as reviewed in Chapter 1).  
Collecting a large set of craniofacial measurements is essential for performing an 
association study with candidate genomic markers. This task is tedious, as the 
anthropometric craniofacial measurements are significantly complex and diverse. 
Although traditional direct craniofacial measurement methods are considered the 
anthropometrical “gold standard”, they are time consuming, hence less appropriate for a 
large sample set. Conversely, 3D high resolution technologies, such as laser scanners 
provide fast and accurate methods for capturing facial landmarks and subsequently 
calculating a variety of relevant distances using a specialized computer software [41, 
76]. 
Finding specific genetic polymorphisms, affecting facial morphology variation will 
extend the current limited knowledge on the craniofacial embryogenetics and will 
enable incorporation of this novel information into a future comprehensive phenotyping 
assay for forensic intelligence purposes. 
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5.2.  Materials and Methods 
 
5.2.1. AIMs selection 
Various online databases and literature sources were screened for potential 
ancestry informative markers (AIMs) [12, 249, 265, 267, 268, 291, 374, 376, 378, 414-
417]. The initial output of these searches represented more than 5,000 AIMs in 1,088 
unique genes. These genes were further screened for candidate genes that might be 
involved in craniofacial development, using web-based bioinformatics tools, as detailed 
in Material and Methods Chapter 2. The final list included 263 candidate ancestry-
informative markers, although due to overlap between AIMs, pigmentation and 
craniofacial markers, this number is in fact greater, as discussed in Section 5.1.1. Donor 
ethnicities were recorded based on the self-reported information provided by 
participants. 
 
 
5.2.2. Pigmentation markers selection and traits assessment 
Genetic polymorphisms, affecting eye, skin and hair colour were selected from 
previously published sources, as detailed in Chapters 1 and 2.  
The pigmentation traits were assigned by a single examiner (the author) according to 
previously published colour charts. Specifically, eye colour was assessed according to 
Martin–Schultz scale, hair colour according to Fischer-Saller Scale and finally skin 
colour according to Fitzpatrick Scale [418-420].  
 
 
5.2.3. Craniofacial markers and traits selection 
Approximately 1,900 genetic polymorphisms were selected as primary 
genotyping targets within approximately 170 candidate genes and genomic regions, as 
detailed in Chapter 1. The final amplicon list however, included additional markers 
found in linkage disequilibrium (LD) with the original SNPs.  
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A total of ninety two (92) anthropometric measurements, characterizing various facial 
features and represented by linear and angular distances between craniofacial landmarks, 
as well as ratios between them, were generated using several computer programs, as 
discussed in Chapter 2. Additional information about visible traits, including eye lid 
(single or double); ear lobe (attached or detached); hair texture (straight, wavy, curly or 
very curly); freckling (none, light, medium or extensive); moles (none, few or many); 
height, weight and BMI was collected. 
 
 
5.2.4. Genotyping 
Five hundred and eighty seven (587) DNA samples were genotyped for 
approximately 6,500 genomic markers, using the Ion Torrent sequencing platform, as 
discussed in Chapter 3. Three samples failed the genotyping step, due to poor sample 
quantity and/or quality. The sequences were aligned automatically by the Ion Torrent 
suite software and analysed using the Ion Torrent Reporter software, as discussed in 
Sections 2.10.4 and 2.10.5.  
 
 
5.2.5. Statistical analysis 
Ancestry inferences were performed using the Structure v2.3.4 software with default 
parameters as per software developer recommendations [421]. Ancestry estimation 
analyses were initially performed assuming between two to ten presumed output 
population clusters (without predefined clusters) or between five to eight pre-defined 
population clusters. The final analyses were performed assuming four predefined 
clusters: Europeans, East Asians, Africans and Indians. Analyses were conducted on a 
reduced set of 523 samples and 1,757 loci following the removal of samples with more 
than 85% missing alleles. The final ancestry origin was assigned according to “Structure” 
output. The ancestry origin was estimated as a single (unmixed) source where the main 
ancestry group could be affiliated with at least 80% of the total mixed ancestry. 
Association analyses were performed using SNP & Variation Suite v7 (Golden Helix, 
Inc., Bozeman, MT) and replicated using PLINK v1.07 software [344]. Statistical 
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analyses in both software programs implicated linear regression under the assumption of 
an additive genetic model, while each genotype was binary encoded as 0, 1 or 2. 
Population stratification correction, incorporated by the EIGENSTRAT function was 
implemented in SNP & Variation Suite analyses [422, 423]. The PLINK analysis 
involved usage of a Cochran-Mantel-Haenszel test for the same purpose [424]. In order 
to reduce any potential confounding effects, all external trait association analyses were 
performed using sex and BMI compensation algorithm, although for the pigmentation 
traits, only sex was used as a covariate. 
 
 
5.2.6. Genes and SNPs annotation analysis 
The GeneCards, ENTREZ and UniProtKB/Swiss-Prot web portals were used for 
annotation analysis of significantly associated genes. The MalaCards web site was used 
to find potential association between the genes and hereditary syndromes. The 
GeneMania web site was used to identify a functional network among the genes and 
encoded proteins. The AmiGo web site was used to find orthologes of unknown Human 
genes in other organisms. Mouse genome database (MGI) was used to search for genes 
phenotype in relevant craniofacial mouse mutants SNPnexus and Alfred websites were 
used to annotate SNPs. 
The SNP Annotation and Proxy Search (SNAP) web portal was used to find SNPs in 
linkage disequilibrium (LD) and generate LD plots, based on the CEU population panel 
from the 1000 genomes data set, within a distance of up to 500kb and r
2
 threshold of 0.8 
[425].  
The Regulome database and potentially functional database (PFS) searches were 
implemented to annotate SNPs with known and predicted regulatory elements in the 
intergenic regions of the H. sapiens genome [333, 426]. 
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5.3.  Results and Discussion 
The following section aims to summarise the genetic association studies of ancestry, 
pigmentation and craniofacial traits. Following these association results, predictive 
statistical analyses undertaken for each of the specific traits are presented (Section 5.4). 
 
 
5.3.1. Sample descriptive statistics 
The following section briefly outlines the numbers and their percentage 
proportions of samples used for each trait in the present study. 
 
 
5.3.1.1. Ancestry origin descriptive statistics 
The majority of the sample set was composed of 363 self-declared Caucasians. 
These samples were merged with additional 29 samples from the Middle Eastern 
population to satisfy analysis purposes, as there was a relatively limited sample number 
of the latter. Additional population samples included 56 East Asians, 45 South Asians 
(Indians), 23 Africans, 3 Aboriginals and 4 samples of other population groups. Sixty 
one (61) samples were defined as “Admixture”, based on ancestry information provided 
by volunteers (Table 37).  
 
Table 37. Sample numbers as categorised by self-reported ancestry. 
Ancestry Number of samples Percentage 
Caucasian 363 62.16 
E. Asian 56 9.59 
African 23 3.94 
Aboriginal 3 0.51 
Indian 45 7.71 
Admixture 61 10.45 
Other 4 0.68 
Middle Eastern 29 4.97 
Total 584 100 
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The majority of genetic association studies are usually performed on relatively 
homogenic (population-wise) sample sets [427]. The reason for this is that association 
analysis performed on a diverse sample set may introduce substantial bias due to 
etiological population stratification and may produce spurious (false positive) 
associations. Population stratification results from the fact that allele frequencies in 
different populations may vary significantly due to their respective biological adaptation. 
These are driven by positive selection throughout the evolution process, increasing 
population differentiation at specific genomic regions [251, 253, 254, 257, 262, 428]. 
As a result, risk alleles or quantitative trait loci (QTL) in this specific case, may differ in 
their occurrence across populations or even be absent in certain ethnic groups. This 
plays a critical role in assessing risk factors of certain medical conditions in a 
developing personalized medicine field as well as in accurate prediction of EVTs in the 
forensic context. 
The relative diversity of samples used in this study permitted the discovery of genetic 
associations and subsequent prediction of phenotypic traits in various population groups. 
Therefore, performing both accurate ancestry estimation and statistical correction for 
population stratification was an important step in this study (as detailed in Sections 
5.2.5 and 5.3.2) 
 
 
5.3.1.2. Pigmentation traits descriptive statistics 
Eye pigmentation was grouped into four main colour categories that included 
brown, blue, green and hazel (Table 38). Not surprisingly, brown eyed individuals 
accounted for half of the dataset, since brown is dominant and the most common iris 
colour in the world [429]. The next major group was represented by individuals with 
blue eyes (28.5%) and the rest by intermediate colours such as green and hazel.  
Approximately half of the participants had brown hair (Table 38), almost 28% had 
black hair, 17.5% had blond hair, while red haired individuals (including various shades 
of red such as auburn, carrot, orange and strawberry) contributed only almost 4% of the 
sample set. 
The fair and average skin colours, which are often hard to distinguish, represented 
together approximately 67% of the samples. The dark skin colours (black and brown) 
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contributed almost 20%, and the intermediate “olive” colour approximately 13% of the 
total sample numbers. 
Three additional shades of each colour (light, medium and dark) were used to describe 
the pigmentation pattern. However, these sub-categories were not used for the purpose 
of the association and prediction studies, as this study has focused only on the main 
pigmentation shades. 
 
 
Table 38. Eye, skin and hair colour distribution among genotyped samples. 
Eyes colour Number of samples Percentage 
Brown 291 50.0 
Blue 166 28.5 
Green 65 11.2 
Hazel 60 10.3 
Total 582   
  
 
  
Hair colour Number of samples Percentage 
Black 163 27.9 
Brown 296 50.7 
Blonde 102 17.5 
Red 23 3.9 
Total 584   
  
 
  
Skin colour Number of samples Percentage 
Fair 173 29.7 
Average 216 37.1 
Olive 78 13.4 
Black 14 2.4 
Brown 101 17.4 
Total 582   
 
 
Contrary to many published studies where skin, hair and eye colours were self-reported 
or assessed by multiple examiners, pigmentation phenotype assessment in this project 
was performed by a single examiner (the author). This approach should decrease any 
bias introduced by subjective phenotype assessment of participants. Nonetheless, a 
“single examiner” approach lacks objective standardization as it is based on the 
examiner’s ability to clearly distinguish pigmentation patterns. This problem can 
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potentially be solved by using digital methods (such as spectrophotometry) for colour 
quantification. A Chroma Meters CR-400 by Konica Minolta was tested in this study 
for this purpose, but due to possible eye damage, it was not eventually pursued in this 
current project.  
 
 
5.3.1.3. Craniofacial traits descriptive statistics 
A comprehensive summary of the craniofacial trait – related statistics is detailed 
in Section 4.4.  
 
5.3.2. Ancestry estimation using STRUCTURE 
A significant difference in allele frequencies among populations (Fst) 
emphasizes an importance of accurate ancestry estimation, prior to undertaking any trait 
association analyses, as discussed in Section 5.3.1.1 and reviewed in other studies [430]. 
Self-reported ancestry however, cannot be considered a fully reliable source due to 
either lack of accurate information or misleading information on individual’s report on 
family history [431, 432]. Additionally, some of the population clusters commonly used 
in genetic association studies (e.g. Caucasians or Africans) are not always represented 
by genetically homogeneous groups and may display significant inter-population 
diversity. For example, a recent study in 2009 investigated 121 African populations and 
60 non-African populations and found a higher genetic diversity between African 
populations compared to non-African populations, among other differences [433]. Self-
declared ancestry should therefore be confirmed by analysis of the ancestry-informative 
genetic markers, which would aim on providing a more reliable and less biased ancestry 
estimation. The most widely used software for this purpose is the Structure [421]. 
Population analysis using the Structure package enables to visualize the ancestry 
composition of samples, indicating potential admixture, and categorize them more 
accurately into specific clusters, allowing reliable analysis of potential genomic 
associations. This software was widely used in numerous studies, including forensically 
– focused publications [246, 265, 434, 435]. The Structure clustering model assumes 
"k" populations, each of which is characterized by a set of allele frequencies at each 
locus. Analysed samples are assigned (probability-wise) to specific population clusters, 
213 | P a g e  
or jointly to two or more populations if there is an indication of admixture. Structure 
algorithms can be applied to most of the commonly used genetic markers, if they are not 
closely linked. 
Ancestry estimation was performed using all 3,477 genetic markers (not only initial 
AIMs), following sequencing quality control filtering (DP and GQ >10) and MAF≥2%, 
as discussed in Section 5.3.3. The initial Structure analysis was performed with various 
numbers of predefined population clusters (up to nine), incorporating admixture model 
and prior population information. This clustering made it possible to test how well the 
software can estimate (predict) the ancestry origin. This test revealed that four and five 
clusters (k=4 or k=5) produced the most informative data output. The five output 
clusters grouped samples as follows with (1) Caucasian, (2) East Asian, (3) African, (4) 
South Asian (Indian) and (5) Aboriginal. The program assigned resulting samples to 
either the original (identical to self-reported) ancestry clusters (based on up to 20% 
admixture threshold), or to the Admixture group, if major ancestry contribution was 
below 20 percent. Ancestry estimation based on the five pre-defined clusters resulted in 
the following number of samples: Caucasian (n=365), Asian (n=50), African (n=16), 
Indian (n=40), Aboriginal (n=7) and the rest estimated as an admixture of these 
population groups (Figure 55).  
Notably, a significant proportion of Caucasian samples showed various levels of 
admixture with Aboriginal and Indian population groups. This finding may reflect 
recent Australian history, although a more stringent analysis with a larger sample size, 
especially of the Indigenous samples, is needed to test this hypothesis.    
 
 
Figure 55. Structure output visualized as a color-coded Q plot, based on five pre-defined population clusters. X 
axis – overall percentage, Y axis – clusters (k). The colours represent: red – Caucasian, green – Asian, Blue –
African, Yellow –Aboriginal and Purple – Indian ancestry clusters. 
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Due to a limited number of Aboriginal samples, the final Structure analysis was 
performed assuming only four population groups, excluding the Aboriginal cluster. 
After removing Aboriginal ancestry samples and samples that were missing more than 
80% of genotyped markers, a total number of 516 samples remained. The majority of 
the remaining samples were distinctly categorized in clear clusters, in general 
concordance with their original (self-defined) ancestry. However, several samples were 
assigned to a new (different to the self-reported) ancestry cluster (Figures 56 and 57). In 
summary: 459 samples (89%) tested with Structure were assigned the same ancestry 
cluster (sole or mixed origin) as initially collected self-reported ancestry information. Of 
the remaining 57 individuals, a total number of 39 individuals were estimated as an 
‘Admixture’ (based on up to 20% admixture threshold) and 18 samples were assigned a 
different single ancestry, when compared to the original self-reported ancestry (Table 
39). Of the 39 newly estimated ‘Admixture’ samples, 16 samples were originally self-
reported as Middle Eastern, 12 samples as Caucasian, seven (7) samples as Indian and 
four (4) as African. This is not surprising for the Middle Eastern and Indian ancestry 
individuals, as the geographic regions such as Indian peninsula and especially Levant 
are known for extensive demographic movement and admixture [436]. Interestingly, 
two samples of Russian descent who were self-declared as Caucasian, were estimated as 
Admixture by the Structure. This outcome can be explained by the population 
admixture, that possibly historically resulted from Mongol invasion that lasted from 
1237 AD to 1480 AD. 
 
 
Figure 56. Triangle plot of the sample subset tested with STRUCTURE. The colours represent: red – Caucasian, 
green – Asian, Blue –African and Yellow – Indian ancestry clusters. Some samples show same clustering within 
their self-reported ancestry clusters, while others demonstrate different clustering pattern. 
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Figure 57. STRUCTURE output visualized as a color-coded Q plot, based on four pre-defined population clusters. X 
axis – overall percentage, Y axis – clusters (k). The colours represent: red – Caucasian, green – Asian, Blue –
African and Yellow – Indian ancestry clusters. Note that the yellow colour in this figure represents a different 
cluster comparing to Figure 55. 
 
Following Structure data output, of the 18 samples predicted differently (non-admixed 
ancestry), ten (10) were from the original (self-reported) Middle Eastern sub-population. 
These samples were re-clustered as European, based on Structure prediction. The 
majority of these individuals were either of Lebanese or Greek background. 
Interestingly, all the Lebanese individuals who were estimated as Europeans by 
Structure were self-declared Arab Christians. This result may illustrate the evidence of 
an European population admixture with the local populations during the Crusader 
period in this region [437].  
In summary, the self-reported Admixture cluster was mostly affected by Structure 
algorithm prediction. This group has grown from 61 samples (based on the self-reported 
ancestry) to 107 samples (based on the Structure prediction). Following the removal of 
a mixed ancestry samples from the Caucasian cluster, it was renamed ‘European’, based 
on its homologous population content. 
New ancestry clusters estimated by Structure were incorporated into the SVS 
GoldenHelix and PLINK softwares and used for association analyses, as detailed in 
Sections 5.3.3 and 5.3.4. It should be noted however, that Structure prediction is mainly 
based on the differences in allele frequencies between populations (Fst) and its 
“resolution” is largely dependent on the differentiation ability of the specific markers 
used for ancestry estimation. As a result, this approach is not error-free and must be 
treated with caution. Nevertheless, ancestry prediction by Structure is considered as less 
biased and more accurate than self-reported ancestry [430, 434].  In this study, ancestry 
prediction for the majority of samples was concordant with the self-reported source. 
Given that many people are not fully aware of their family history, re-clustering of their 
ancestry by Structure to the Admixture cluster was considered beneficial for this study. 
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Only 18 samples that were clustered into a different (single) ancestry group were in a 
conflict with their self-declared ancestry. In these cases, Structure prediction was 
considered more reliable. Table 39 provides a summary of sample numbers based on 
Structure-estimated ancestries and on the original self-reported ancestries. 
 
Table 39. Final ancestry statistics, estimated by Structure software and used for the association analysis. 
Self-reported ancestry 
Number of 
samples 
Percentage 
  
Structure- estimated ancestry 
Number of 
samples 
Percentage 
Caucasian 363 62.16   European 367 62.84 
E. Asian 56 9.59   E. Asian 51 8.73 
African 23 3.94   African 16 2.74 
Aboriginal 3 0.51   Indian 43 7.36 
Indian 45 7.71   Admixture 107 18.32 
Admixture 61 10.45   Total 584 100 
Other 4 0.68   
  
Middle Eastern 29 4.97   
Total 584 100   
 
 
 
 
5.3.3. Genotyping statistics and initial filtering of the data 
Five hundred and eighty seven (587) DNA samples were genotyped by sequencing 
using the Ion Torrent platform, as detailed in Chapter 2. Three (3) samples did not 
produce results due to either poor DNA quality or unsuccessful library and template 
preparation. Targeted genotyping of 584 samples resulted in 9,051 unique markers, 
although the majority of markers (>5,000) were represented by rare polymorphisms of 1% 
MAF or less (Figure 58).  
An essential step of data quality control was performed by removing markers of low 
genotype quality (GQ>10) and sequencing depth (DP>10), which ultimately resulted in 
8,229 markers. The majority of the filtered markers were represented by relatively rare 
minor frequency alleles (MAF<5%). Figure 58 shows the distribution of minor allele 
frequency and call rates among samples prior to MAF pruning. 
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Figure 58. Allele frequencies and call rate distribution among genotyped samples, prior to filtering (n=9,051). 
 
Filtering of markers by various levels of MAF (1%, 2% and 3%), produced 3,653, 3,477 
and 3,367 markers respectively, while a 2% MAF cut-off was considered the most 
appropriate, based on the literature [438, 439]. Additional filtering based on the Hardy-
Weinberg equilibrium (HWE) threshold of 1E-07, resulted in 2,858 markers.  
An important criterion for assessing the association results is the accuracy of 
genotyping, which can be measured by the sequencing depth. The average sequencing 
depth for the significantly associated markers in this study was approximately x57. This 
is a high sequencing depth, particularly compared to only x4, which was orriginally 
used for the first published stages of the Hapmap and the 1000 genomes genotyping 
projects, or x30 depth, used for their subsequent stages [245, 440]. 
 
 
5.3.4. AIMs association analysis 
Association analyses performed on four (4) main population groups (European, East 
Asian, African and Indian) produced similar results in both SVS and PLINK software. 
However, the relative ranking of several statistically significant SNPs and their relative 
SNP number 
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p-values was the only slight difference that could be noted. The results presented in 
Tables 40-43 are based on the SVS analyses. Given the very large number of significant 
markers that were detected, only the top twenty SNPs are listed. 
 
 
Table 40. Twenty top SNPs and respective genes found to be associated with European ancestry. Chromosomal 
location, average sequencing depth per SNP, rs number of each marker and original and Bonferroni –corrected p-
values are included. SNPs found in linkage disequilibrium are highlighted in yellow. 
Marker Average Depth  rsID Gene  Full-Model P-Value Bonferroni P 
5:33951693 51.9114 rs16891982 SLC45A2 1.01E-66 2.07E-63 
15:28365618 63.5959 rs12913832 HERC2 2.34E-27 4.79E-24 
17:19175317 65.7768 rs28591622 EPN2 1.83E-26 3.76E-23 
17:19239432 42.9114 rs1043809 EPN2 3.22E-24 6.60E-21 
17:19204863 56.3708 rs4924980 EPN2 1.80E-23 3.69E-20 
2:152829657 91.5424 rs6721518 CACNB4 2.48E-23 5.09E-20 
17:19172505 37.4594 rs28760541 EPN2 2.23E-21 4.58E-18 
15:48426484 47.4004 rs1426654 SLC24A5 1.35E-20 2.77E-17 
17:19211073 40.4834 rs8072587 EPN2 4.25E-20 8.72E-17 
11:120133494 98.3911 rs2715883 POU2F3 1.79E-19 3.67E-16 
12:66168151 69.1679 rs7134682 near RPSAP52 1.81E-19 3.72E-16 
5:33969628 48.3911 rs35414 SLC45A2 2.56E-19 5.25E-16 
17:19224397 62.5221 rs6587216 EPN2 3.78E-19 7.75E-16 
13:102816760 59.7048 rs2607642 FGF14 5.31E-19 1.09E-15 
11:120130512 46.8339 rs1941411 POU2F3 5.04E-18 1.03E-14 
17:19247075 43.8229 rs4924987 B9D1 1.02E-17 2.09E-14 
5:33958910 65.0609 rs1010872 SLC45A2 1.60E-17 3.28E-14 
13:102821327 44.81 rs4771420 FGF14 1.70E-17 3.48E-14 
2:152829626 92.0793 rs16830527 CACNB4 1.76E-17 3.62E-14 
5:33954511 80.2694 rs2287949 SLC45A2 2.09E-17 4.29E-14 
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Table 41. Twenty top SNPs and respective genes found to be associated with Asian ancestry. Chromosomal 
location, average sequencing depth per SNP, rs number of each marker and original and Bonferroni –corrected p-
values are included. SNPs found in linkage disequilibrium are highlighted in yellow. 
Marker Average Depth  rsID Gene  Full-Model P-Value Bonferroni P 
22:46835000 99.9133 rs4823810 CELSR1 5.98E-79 1.23E-75 
1:36437991 73.6494 rs12096413 EIF2C3 8.36E-70 1.71E-66 
1:36426398 28.9502 rs7521611 EIF2C3 2.71E-60 5.56E-57 
1:36099200 80.6328 rs6668101 PSMB2 1.31E-53 2.69E-50 
11:120129533 55.4446 rs11217777 POU2F3 9.65E-52 1.98E-48 
11:120169962 41.0203 rs11217806 POU2F3 1.23E-51 2.52E-48 
11:120121323 45.8118 rs11217775 POU2F3 5.38E-51 1.10E-47 
2:109556761 63.1882 rs260710 EDAR 2.60E-50 5.34E-47 
12:112843363 49.4852 rs2301723 RPL6 7.25E-50 1.49E-46 
11:120170030 43.5 rs11217807 POU2F3 1.66E-49 3.40E-46 
15:48426484 47.4004 rs1426654 SLC24A5 1.77E-49 3.62E-46 
1:36424338 43.6421 rs716924 EIF2C3 1.92E-48 3.93E-45 
8:73848139 63.9317 rs3735829 KCNB2 9.89E-46 2.03E-42 
1:234330571 58.7768 rs7531988 SLC35F3 9.00E-45 1.84E-41 
2:109556667 66.5683 rs260709 EDAR 1.65E-44 3.37E-41 
11:120122394 39.4336 rs11827471 POU2F3 3.47E-43 7.12E-40 
2:109579738 62.7011 rs260690 EDAR 6.86E-43 1.41E-39 
13:34864240 64.5738 rs2065982 
between RFC3 
and GAMTP2 8.55E-43 1.75E-39 
2:109616376 35.0627 rs17034770 near EDAR 1.52E-42 3.11E-39 
2:109586371 63.5959 rs11123719 EDAR 3.45E-41 7.06E-38 
 
 
 
Table 42. Twenty top SNPs and respective genes found to be associated with Indian ancestry. Chromosomal 
location, average sequencing depth per SNP, rs number of each marker and original and Bonferroni –corrected p-
values are included.  
Marker Average Depth  rsID Gene  Full-Model P-Value Bonferroni P 
5:33951693 51.9114 rs16891982 SLC45A2 3.17E-17 6.49E-14 
5:33958910 65.0609 rs1010872 SLC45A2 4.99E-16 1.02E-12 
5:33954511 80.2694 rs2287949 SLC45A2 3.57E-14 7.31E-11 
17:19157989 88.0554 rs4924960 EPN2 5.48E-10 1.12E-06 
17:19163690 35.8007 rs4924778 EPN2 3.38E-09 6.93E-06 
11:113291752 80.5683 rs117431082 DRD2 5.98E-09 1.23E-05 
2:152814028 45.7177 rs16830498 CACNB4 1.05E-08 2.16E-05 
2:152829626 92.0793 rs16830527 CACNB4 1.57E-08 3.22E-05 
15:28365618 63.5959 rs12913832 HERC2 1.82E-08 3.74E-05 
12:66256395 58.5129 rs11175944 HMGA2 5.41E-08 1.11E-04 
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9:12672320 36.5609 rs1408801 near TYRP1 5.56E-08 1.14E-04 
5:33969628 48.3911 rs35414 SLC45A2 1.20E-07 2.45E-04 
13:111827167 87.3155 rs9522149 ARHGEF7 1.94E-07 3.97E-04 
5:61013725 87.0923 rs16894149 - 2.14E-07 4.39E-04 
1:27931698 49 rs4908343 AHDC1 2.24E-07 4.59E-04 
9:12672396 36.6937 rs9919017 - 2.67E-07 5.47E-04 
12:66260924 62.131 rs343087 HMGA2 3.89E-07 7.98E-04 
12:66236735 27.1974 rs2272047 HMGA2 5.12E-07 1.05E-03 
17:19172505 37.4594 rs28760541 EPN2 1.05E-06 2.15E-03 
12:66256395 58.5129 rs11175944 HMGA2 5.41E-08 1.11E-04 
 
 
 
 
Table 43. Twenty top SNPs and respective genes found to be associated with African ancestry. Chromosomal 
location, average sequencing depth per SNP, rs number of each marker and original and Bonferroni –corrected p-
values are included.  
Marker 
Average 
Depth  
rsID Gene  Full-Model P-Value Bonferroni P 
7:83030169 26.3506 rs2709927 SEMA3E 3.53E-118 7.23E-115 
18:67672106 58.8616 rs56293475 RTTN 1.14E-116 2.34E-113 
10:34755348 32.3266 rs1978806 PARD3 7.91E-109 1.62E-105 
2:232198375 73.4834 rs6747710 ARMC9 2.71E-104 5.56E-101 
7:41986689 82.1162 rs7789366 near GLI3 1.32E-98 2.71E-95 
8:72131359 68.3893 rs73684719 EYA1 1.09E-88 2.24E-85 
7:107704688 66.2269 rs10257477 LAMB4 3.06E-87 6.26E-84 
7:83033303 34.321 rs2722980 SEMA3E 8.38E-83 1.72E-79 
7:83041344 60.8137 rs2709963 SEMA3E 1.41E-80 2.88E-77 
7:107696289 64.7565 rs17154865 LAMB4 7.21E-78 1.48E-74 
8:72127562 34.5258 rs79867447 EYA1 1.42E-77 2.91E-74 
8:116700847 40.9004 rs7842702 TRPS1 3.56E-77 7.30E-74 
8:116776330 42.4465 rs10505268 TRPS1 5.44E-76 1.11E-72 
20:45801340 61.5517 rs6090632 EYA2 3.36E-70 6.88E-67 
18:19765739 45.5203 rs16964572 GATA6 5.15E-70 1.06E-66 
7:83041372 59.6753 rs2709964 SEMA3E 2.11E-69 4.32E-66 
10:24195798 26.6513 rs73604433 KIAA1217 2.99E-69 6.12E-66 
2:177992107 52.7546 rs6433650 near RPL29P8 1.31E-68 2.69E-65 
6:137345768 34.5203 rs276488 IL20RA 4.16E-67 8.54E-64 
2:232198327 74.1716 rs6719593 ARMC9 6.48E-67 1.33E-63 
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Based on the Bonferroni corrected p-value threshold of <0.05, 215 markers were 
significantly associated with the European ancestry, 495 with the Asian ancestry, 627 
with the African ancestry and 41 with the Indian ancestry. The relatively small number 
of SNPs associated with Indian population could be explained by the fact that AIMs 
used in this study were selected from a number of publications that focused primarily on 
the Caucasian, Asian and African populations (as detailed in Section 5.1.1).  
Given that most GWAS studies use a more stringent threshold of between 1E-05 to   
1E-08 of the non-corrected p-value, a higher threshold of unadjusted p-value was 
considered. An application of a threshold of 1E-07 resulted in reduction of statistically 
significant markers from 215 to 142 for the European, from 495 to 364 for the Asian, 
from 627 to 528 for the African and from 41 to 19 for the Indian.  
Based on the top 20 significant markers for each ancestry, 72 non-tagged significant 
SNPs in 35 genes and genetic regions were detected (Tables 40-43). The strongest 
(Bonferroni-corrected) significance of association was demonstrated for the African 
ancestry cluster (down to 7.23E-115 p-value for the top SNP) and the lowest for the 
Indian population (down to 6.49E-49
 
p-value for the top SNP). Given the stringent 
Bonferroni correction, these results demonstrate strong association between each of the 
four ancestry groups and specific genetic markers, tested in this study. The most 
significant similarities in both SNPs and genes were observed between the European 
and the Indian populations (4 genes and 7 SNPs). In contrary, the markers and genes in 
the Asian and African populations showed no overlap. The existence of a common 
Indo-European proto-language and relevant genetic studies suggests that European and 
Indian populations are indeed genetically more similar, compared to Africans and East 
Asians [441, 442]. Notably, the major similarity in the craniofacial measurements in this 
dataset was observed between the Indian and the West European population groups, as 
discussed in Section 4.5. On the other hand, this observation may be due to population 
heterozygosity (Fst) of the specific markers used in this study, which were unable to 
distinguish between these population groups.  
The two SNPs most significantly associated with European and three markers most 
significantly associated with Indian population groups were found in genes previously 
associated with eye or skin pigmentation as SLC45A2 and HERC2 genes. This is likely 
the result of an overlap between ancestry and pigmentation-informative markers (as 
discussed in Section 5.1). For example, rs16891982 in SLC45A2 gene was the top SNP 
found to be associated with European ancestry (Leu374Phe amino acid change). This 
allele was previously associated with light-skin European ancestry [443]. Another 
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polymorphism in this gene was documented to be in association with light skin and with 
protection from malignant melanoma within European population (F374L amino acid 
change) as well as with black hair phenotype [386, 444, 445]. The rs12913832 in the 
HERC2 gene was found as the second mostly significant marker associated with the 
European ancestry and it was also identified as the most important SNP for eye 
pigmentation variation (brown versus blue eyes) [446, 447]. While the pigmentation 
genetics is the primary association of these markers, they are clearly informative for 
ancestry prediction, although indirectly.  
Other phenotypic traits may also provide complementary information on ancestry. For 
example, Asian ancestry associated gene EDAR, was previously shown to be associated 
with hair morphology (thick hair) and this trait is especially common in the Asian 
population [448, 449]. Polymorphisms in several genes such as TRPS1, ARMC9, GLI3, 
LAMB4 and EYA1 were found significantly associated with the African ancestry in this 
study, as well as with very curly hair (see Table 45). Interestingly, mutations in the 
TRPS1 gene were previously identified in the Hypertrichosis (also called Ambras 
syndrome), a condition that is associated with abnormal amount of hair growth over the 
body [450]. The association of this gene with very curly hair is a novel finding and has 
not been described previously. It should be emphasized however, that the observed 
association could be a result of relatively small African sample set and should be 
subsequently checked in replication study with larger sample set .   
Additional significantly associated genes, such as LAMB4, RTTN, SEMA3E and 
CELSR1 were previously shown to have a function (known or unknown) in embryonic 
development regulation, including craniofacial embryogenesis in human or model 
organisms [323]. Notably, these genes also demonstrated association with craniofacial 
traits in the current study (as discussed in Section 5.3.6). 
The SVS genomic browser analysis showed that almost all of the significantly 
associated markers are located in introns or in intergenic regions, in concordance with 
candidate markers selection process and as discussed elsewhere [261]. The Regulome 
database analysis which predicts regulatory elements in intergenic SNPs, revealed that 
43 of 73 top SNPs in all tested ancestries have a potential role in either regulating 
DNAase hypersensitivity, affecting binding sites of transcription factors and altering 
promoter regions. A search using potentially functional database (PFS), which predicts 
regulatory elements in the intragenic and intergenic regions resulted in 68 SNPs that 
may have potential function in regulation of various cellular processes.  
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Based on SNAP analysis, numerous markers located in the RTTN, POU2F3 and EDAR 
genes were found to be in linkage disequilibrium, (highlighted in Tables 39 and 41 and 
Figure 59) and potentially representing a haploblock.  Tag SNP analysis of 215 markers 
that were significantly associated with the European ancestry resulted in 48 tag SNPs. 
The use of these tag SNPs provided an almost five-fold reduction of markers, offering 
greater flexibility for the use of different genotyping platforms with limited capabilities, 
without decreasing prediction accuracy.   
 
 
 
Figure 59. An example of LD plot, visualizing the top 20 SNPs associated with Caucasian ancestry, generated by 
SNAP. 
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5.3.5. Pigmentation traits association study 
This section summarises the association analysis of the pigmentation traits. The 
results are organized in three sub-sections, according to eye, skin and hair colour with a 
separate discussion for each section.  
In general, eye, skin and hair association results demonstrated an overlap in markers 
between these traits, as well as with the ancestry informative markers, as discussed in 
Section 5.3.4. The “key” pigmentation genes that have a major impact on the 
pigmentation, such as HERC2, OCA2, SLC45A2, SLC24A5 produced the most 
significant associations with all pigmentation traits, consistent with published sources.  
The average SNP sequencing depth was approximately x57. This high sequencing depth 
provides additional confidence in the association results of this study.  
 
 
5.3.5.1. Eye colour 
The genetics of the eye pigmentation is better understood relatively to skin and 
hair. Several genes such as HERC2, OCA2, SLC24A4 and SLC24A5 are known to play 
a central role in iris pigmentation patterning, while a single SNP rs12913832 in the 
HERC2-OCA2 intergenic region has the highest prediction ability of blue/brown eye 
colour [296]. 
Eye colour in this study was grouped into four main categories that included brown, 
blue, green and hazel, and analysed for potential association with a set of candidate 
SNPs. The summary of the eye colour association results are presented in Table 44. 
 
Table 44. A summary of eye colour association study. 
Trait Marker 
Average 
Depth 
rsID Gene Name 
FvR Model 
P-Value 
Bonferroni P-
Value 
B
ro
w
n
 e
ye
s 
15:28365618 63.5959 rs12913832 HERC2 6.41E-71 1.30E-67 
5:33951693 51.9114 rs16891982 SLC45A2 2.45E-28 4.98E-25 
15:28356859 69.3697 rs1129038 HERC2 1.83E-26 3.72E-23 
15:28516084 53.155 rs8039195 HERC2 2.50E-23 5.08E-20 
15:28344238 64.7122 rs7495174 OCA2 8.34E-19 1.69E-15 
15:28513364 50.3991 rs916977 HERC2 3.04E-15 6.17E-12 
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15:48426484 47.4004 rs1426654 SLC24A5 1.25E-14 2.55E-11 
15:28268990 43.7915 rs749846 OCA2 3.46E-10 7.02E-07 
15:28200408 43.5111 rs7170989 OCA2 5.35E-10 1.09E-06 
15:52611451 61.0443 rs2290332 MYO5A 3.45E-09 7.00E-06 
15:28231279 45.5018 rs4778221 OCA2 6.38E-09 1.30E-05 
5:33958910 65.0609 rs1010872 SLC45A2 2.17E-08 4.41E-05 
9:87772807 55.7546 rs526454 
between NTRK2 and 
STK33P1 
2.20E-08 4.47E-05 
5:33954511 80.2694 rs2287949 SLC45A2 1.21E-07 2.45E-04 
10:55949899 34.7048 rs16905691 PCDH15 1.37E-07 2.78E-04 
17:19174874 76.6417 rs1467028 EPN2 1.69E-07 3.42E-04 
3:58112440 56.6937 rs2362903 FLNB 2.03E-07 4.13E-04 
2:240282208 86.7675 rs12471054 HDAC4 2.10E-07 4.27E-04 
1:36424338 43.6421 rs716924 EIF2C3 2.52E-07 5.11E-04 
12:112843363 49.4852 rs2301723 RPL6 4.07E-07 8.26E-04 
2:109556761 63.1882 rs260710 EDAR 4.97E-07 1.01E-03 
13:111827167 87.3155 rs9522149 ARHGEF7 5.87E-07 1.19E-03 
11:120133494 98.3911 rs2715883 POU2F3 6.54E-07 1.33E-03 
12:66115201 52.0996 rs12300373 
between PCNPP3 and 
RPSAP52 
7.01E-07 1.42E-03 
2:152814028 45.7177 rs16830498 CACNB4 7.02E-07 1.42E-03 
11:120170030 43.5 rs11217807 POU2F3 7.03E-07 1.43E-03 
2:109557099 54.6218 rs260711 EDAR 8.80E-07 1.79E-03 
1:36437991 73.6494 rs12096413 EIF2C3 9.35E-07 1.90E-03 
10:55968685 64.7048 rs10825273 PCDH15 9.88E-07 2.01E-03 
       
B
lu
e
 e
ye
s 
15:28365618 63.5959 rs12913832 HERC2 2.38E-39 4.82E-36 
15:28356859 69.3697 rs1129038 HERC2 8.55E-27 1.74E-23 
15:28513364 50.3991 rs916977 HERC2 1.35E-16 2.75E-13 
15:28516084 53.155 rs8039195 HERC2 2.66E-16 5.39E-13 
15:28365733 108.0498 rs7183877 HERC2 6.41E-09 1.30E-05 
5:33951693 51.9114 rs16891982 SLC45A2 1.10E-08 2.23E-05 
15:28344238 64.7122 rs7495174 OCA2 7.06E-08 1.43E-04 
15:28268990 43.7915 rs749846 OCA2 7.21E-07 1.46E-03 
14:92781001 44.607 rs4904868 
between CPSF2 and 
SLC24A4 
1.95E-06 3.96E-03 
14:92773903 39.8911 rs12896471 - 7.32E-06 1.49E-02 
Y:15026424 13.885 rs2032624 DDX3Y 8.76E-06 1.78E-02 
15:28200408 43.5111 rs7170989 OCA2 1.10E-05 2.24E-02 
       
G
re
en
 e
ye
s 
15:28365618 63.5959 rs12913832 HERC2 6.87E-11 1.41E-07 
5:33951693 51.9114 rs16891982 SLC45A2 4.25E-07 8.71E-04 
5:33969628 48.3911 rs35414 SLC45A2 6.04E-06 1.24E-02 
       
H
az
el
 e
ye
s 
15:28356859 69.3697 rs1129038 HERC2 2.27E-06 4.65E-03 
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The most significantly associated markers with eye colour were in general consensus 
with the published sources. Following the application of 1E-07 Bonferroni un-adjusted 
p-value threshold (due to high number of associated markers), brown eye colour 
association analysis produced the majority of significant results, revealing 29 significant 
markers in 17 genes and genomic regions. It was followed by the blue eye colour, 
showing association with 12 markers in five genes. Green eye colour was found 
associated with three markers in two genes, while the hazel eye colour was associated 
with only one marker. Not surprisingly, both intermediate colours revealed less 
significant p-values of associated markers compared to the brown and blue colours [394, 
395]. The outcome of this genetic association analysis can be clustered into three main 
groups, according to the functional role of the identified gene (as summarized in Table 
45).   
The most significant markers were found in genes which have a major impact on 
pigmentation such as HERC2, OCA2, SLC45A2, SLC24A5 and MYO5A. Among these 
markers, the lowest p-value was associated with rs12913832 in the HERC2-OCA2 
genomic region, followed by rs16891982 in the SLC45A2 and rs1129038 in the HERC2 
gene (as illustrated in Figure 60). These markers are known to be the key players in eye 
pigmentation regulation and most significant predictors of the blue and brown eye 
colours, as discussed in Section 5.1.2. 
Additional markers were found in several genes that were not previously shown to be 
associated directly with the eye colour. However, these genes were shown to be 
involved in melanogenesis or be expressed in melanoma, hence potentially affecting 
pigmentation regulation. Another group of genes can be considered ‘novel’ 
pigmentation genes, as no potential association of these genes with pigmentation (either 
eye, skin or hair) has been demonstrated to date. A summary of the mostly significant 
associated genes is shown in Table 45. The electronic version of this table includes web 
links to the relevant references. 
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Figure 60. A Manhattan plot illustrating associations of genetic markers with brown eyes. Note the top associated 
SNPs: rs12913832 in HERC2 gene (chr. 15) and rs16891982 in SLC45A2 (chr. 5). 
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Table 45.  A summary of genes significantly associated with eye colour, segregated into three groups according to 
their role in the pigmentation process. The genes are categorized according to their role in the pigmentation 
regulation. The relative protein role (or absence of such) in the pigmentation regulation has been inferred from 
the GeneCards web site: http://www.genecards.org/ and published references. 
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PCDH15 Expressed in the eye epithelium 
 
 
RPL6 Involved in retinal pigmentation and melanoma 
ARHGEF7 Possible involvement in melanoma 
POU2F3 
 
Transcription factor in melanocytes and in 
keratinocyte differentiation [451] 
DDX3Y Expressed in melanoma   
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NTRK2, STK33P1, EPN2, 
HDAC4, EIF2C3, PCNPP3, 
RPSAP52, CACNB4 
No significant role in pigmentation found yet  
 
 
 
 
Hair morphology [448, 449] EDAR 
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5.3.5.2. Hair colour 
Human hair colour varies from the light blond and red, all the way through light 
brown to dark black shade. Hair pigmentation has been associated with at least 15 genes, 
with many genes playing a central role in this process, such as MC1R, ASIP, SLC45A2, 
OCA2, HERC2, SLC24A4, KITLG, TYR, TPCN2, TYRP1 and IRF4 [384, 389].  
In the current study, various shades of hair pigmentation as well as hair morphology 
were tested for potential association with candidate genetic markers. Hair colour and 
hair morphology (very curly hair) association results are summarized in Table 46. Only 
the most significant results for the black hair are shown, as a very large number of 
significant markers (more than 250 SNPs in 78 genes) was identified. 
After applying a 1.0E-5 p-value threshold, 48 SNPs in 19 genes were associated with 
different shades of hair colour (the black shade is represented by the top 30 markers) 
and 20 SNPs in 11 genes were found to be associated with curly hair (Table 46). Black 
hair association analysis demonstrated the highest number of significant SNPs (>250 
markers), followed by brown (17 markers). Blond and red colours revealed a genetic 
association with five and two markers respectively. Notably, the p-value threshold 
applied in the hair colour association study was lower, compared to 1.0E-07 threshold, 
applied in the eye colour study, due to the higher number of significant markers 
associated with the latter phenotype.   
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Table 46. A summary of the hair colour and hair curliness association study. 
Trait Marker 
Average 
Depth 
rsID Gene Name 
FvR Model 
P-Value 
Bonferroni P-Value 
B
la
ck
 h
ai
r 
5:33951693 51.9114 rs16891982 SLC45A2 2.42E-67 4.96E-64 
15:28365618 63.5959 rs12913832 HERC2 8.38E-39 1.72E-35 
15:48426484 47.4004 rs1426654 SLC24A5 3.37E-31 6.91E-28 
17:19175317 65.7768 rs28591622 EPN2 6.88E-24 1.41E-20 
17:19204863 56.3708 rs4924980 EPN2 2.74E-22 5.62E-19 
11:120133494 98.3911 rs2715883 POU2F3 2.90E-22 5.95E-19 
17:19239432 42.9114 rs1043809 EPN2 6.72E-22 1.38E-18 
17:19172505 37.4594 rs28760541 EPN2 8.01E-21 1.64E-17 
13:102821327 44.81 rs4771420 FGF14 6.94E-20 1.42E-16 
14:101142890 43.2491 rs730570 C14orf70 1.35E-19 2.76E-16 
12:66115201 52.0996 rs12300373 near RPSAP52 2.09E-19 4.29E-16 
2:152829657 91.5424 rs6721518 CACNB4 2.20E-19 4.50E-16 
13:102816760 59.7048 rs2607642 FGF14 2.32E-19 4.75E-16 
11:120130512 46.8339 rs1941411 POU2F3 6.02E-19 1.23E-15 
17:19224397 62.5221 rs6587216 EPN2 7.22E-19 1.48E-15 
11:120118498 74.0258 rs2847502 POU2F3 2.73E-18 5.59E-15 
5:33958910 65.0609 rs1010872 SLC45A2 1.73E-17 3.54E-14 
13:102824147 43.845 rs9557826 FGF14 2.50E-17 5.13E-14 
17:19211073 40.4834 rs8072587 EPN2 3.71E-17 7.60E-14 
13:111827167 87.3155 rs9522149 ARHGEF7 1.14E-16 2.34E-13 
6:145055331 52.5387 rs4463276 UTRN 1.60E-16 3.29E-13 
11:120107411 46.9889 rs882856 POU2F3 2.02E-16 4.15E-13 
15:28268990 43.7915 rs749846 OCA2 2.06E-16 4.22E-13 
17:19247075 43.8229 rs4924987 B9D1 2.18E-16 4.46E-13 
5:33954511 80.2694 rs2287949 SLC45A2 2.19E-16 4.48E-13 
15:28516084 53.155 rs8039195 HERC2 2.53E-16 5.19E-13 
12:66168151 69.1679 rs7134682 - 2.92E-16 5.98E-13 
2:152829626 92.0793 rs16830527 CACNB4 3.67E-16 7.52E-13 
2:240282208 86.7675 rs12471054 HDAC4 4.41E-16 9.04E-13 
1:36367780 89.7804 rs595961 EIF2C1 5.49E-16 1.12E-12 
 
  
            
B
ro
w
n
 h
ai
r 
5:33951693 51.9114 rs16891982 SLC45A2 1.30E-08 2.65E-05 
17:19204863 56.3708 rs4924980 EPN2 1.11E-07 2.27E-04 
17:19175317 65.7768 rs28591622 EPN2 1.80E-07 3.66E-04 
17:19239432 42.9114 rs1043809 EPN2 7.05E-07 1.44E-03 
17:19172505 37.4594 rs28760541 EPN2 1.16E-06 2.36E-03 
17:19224397 62.5221 rs6587216 EPN2 3.87E-06 7.89E-03 
15:48426484 47.4004 rs1426654 SLC24A5 9.08E-06 1.85E-02 
17:19211073 40.4834 rs8072587 EPN2 9.65E-06 1.97E-02 
15:28356859 69.3697 rs1129038 HERC2 1.75E-05 3.57E-02 
17:48168877 69.6587 rs11657072 
 
1.78E-05 3.63E-02 
13:102821327 44.81 rs4771420 FGF14 2.07E-05 4.21E-02 
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Trait Marker 
Average 
Depth 
rsID Gene Name 
FvR Model 
P-Value 
Bonferroni P-Value 
B
lo
n
d
 h
ai
r 
15:28365618 63.5959 rs12913832 HERC2 2.62E-11 5.34E-08 
15:28356859 69.3697 rs1129038 HERC2 1.46E-06 
2.98E-03 
15:28513364 50.3991 rs916977 HERC2 9.19E-06 
1.87E-02 
14:92781001 44.607 rs4904868 near SLC24A4 1.29E-05 
2.62E-02 
6:396321 41.821 rs12203592 IRF4 1.70E-05 
3.47E-02 
       
R
e
d
 h
ai
r 
8:4190796 64.2804 rs117368188 CSMD1 3.07E-06 6.25E-03 
5:79085726 95.0018 rs12657828 CMYA5 1.41E-05 2.88E-02 
       
V
e
ry
 c
u
rl
y 
h
ai
r 
8:116670666 58.3266 rs10505261 TRPS1 1.47E-23 3.00E-20 
8:116700847 40.9004 rs7842702 TRPS1 2.12E-21 4.33E-18 
2:232198327 74.1716 rs6719593 ARMC9 4.04E-21 8.23E-18 
7:41986689 82.1162 rs7789366 near GLI3 6.54E-21 1.33E-17 
8:72131359 68.3893 rs73684719 EYA1 2.80E-20 5.71E-17 
4:5638652 69.3266 rs4353849 EVC2 2.95E-20 6.01E-17 
8:116776330 42.4465 rs10505268 TRPS1 3.92E-20 7.98E-17 
7:107696289 64.7565 rs17154865 LAMB4 1.32E-19 2.69E-16 
2:232198375 73.4834 rs6747710 ARMC9 4.98E-19 1.01E-15 
20:45801340 61.5517 rs6090632 EYA2 1.13E-17 2.29E-14 
8:116673229 40.3579 rs10955754 TRPS1 1.24E-17 2.52E-14 
7:107693455 46.6052 rs11487091 LAMB4 2.16E-17 4.41E-14 
8:116823046 51.3579 rs6981915 near EIF3H 1.33E-16 2.71E-13 
7:107704688 66.2269 rs10257477 LAMB4 3.10E-16 6.33E-13 
4:5638799 24.6458 rs10001971 EVC2 1.44E-15 2.93E-12 
5:138439801 69.655 rs1368374 SIL1 3.86E-15 7.87E-12 
7:83033303 34.321 rs2722980 SEMA3E 8.90E-15 1.81E-11 
7:83030169 26.3506 rs2709927 SEMA3E 1.17E-14 2.39E-11 
7:83041344 60.8137 rs2709963 SEMA3E 1.30E-14 2.65E-11 
22:46764108 59.5018 rs73448947 CELSR1 4.79E-14 9.77E-11 
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Table 47 summarizes the hair colour and morphology association results segregated 
according to each gene’s role in pigmentation regulation. The electronic version of this 
table includes web links to the relevant references. 
 
Table 47. A summary of genes, associated with hair colour and curly hair according to their role in the 
pigmentation regulation. The genes are categorized according to their role in the pigmentation regulation. The 
relative protein role (or absence of such) in the pigmentation regulation has been inferred from the GeneCards 
web site: http://www.genecards.org/ and published references. 
  
Gene name Role in pigmentation 
H
ai
r 
p
ig
m
e
n
ta
ti
o
n
 
G
en
es
 d
ir
ec
tl
y 
as
so
ci
at
e
d
 w
it
h
  
h
ai
r 
co
lo
u
r  
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FGF14 Expressed in developing retina  
ARHGEF7 Risk factor in melanoma  
HDAC4 Involved in the melanin synthesis  
POU2F3 Transcription factor in melanocytes  
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EPN2, C14orf70, RPSAP52, 
CACNB4, UTRN, B9D1, 
EIF2C1, CSMD1, CMYA5, 
GLI3, EYA1, EVC2, EIF3H, 
SIL1, SEMA3E, CELSR1 No significant role in pigmentation found yet  
 
V
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rl
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ai
r 
TRPS1 Hair morphogenesis  
ARMC9 Melanoma biomarker  
GLI3 Essential for hair follicle development  
EYA2 Promotes hair cell fate  
LAMB4 Downregulated in melanoma  
TRPS1, EIF3H 
Associated with Langer-Giedion syndrome - symptoms 
include sparse scalp hair, thin upper lip and rounded nose 
[453] 
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A number of significantly associated genes such as SLC45A2, HERC2, SLC24A5, 
OCA2, SLC24A4, IRF4 were previously shown as important pigmentation regulators, 
while three (3) SNPs (rs16891982, rs12913832 and rs1426654) were described as the 
main predictors of hair colour (see Figure 61), as discussed in Section 5.1.2 and 
reviewed elsewhere [14, 72].  
 
 
 
Figure 61. Manhattan plot illustrating associations of genetic markers with black hair. The most highly associated 
SNPs are highlighted in red (rs16891982 on chromosome 5) and purple (rs12913832 and rs1426654 on 
chromosome 15). 
 
 
Several additional significant genes, such as FGF14, ARHGEF7, HDAC4 and POU2F3  
were previously shown to be involved in various cellular processes, including hair 
morphogenesis, melanin synthesis and melanoma expression, albeit not associated 
directly with prediction of hair colour. Sixteen additional genes however, were not 
identified as pigmentation regulators both directly or indirectly and may represent novel 
candidates, affecting skin pigmentation.  
Red hair did not produce any associations with markers in the MC1R genes, which is 
known as the major predictor of red hair [294, 454]. This was expected, as the number 
of available markers in this gene was greatly reduced due to manufacturer primer design 
failure (as discussed in Section 3.4.3). Nevertheless, red hair was associated with two 
markers in the CSMD1 and CMYA5 genes. Interestingly, the expression of CSMD1 is 
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localized at the top of sensory hair cells in the inner ear, although with no link to the 
body hair pigmentation [455]. The CMYA5 gene was hypothesized as a skeletal muscle 
regeneration regulator, with no known connection to pigmentation regulation as yet 
[323].   
Markers in six genes, TRPS1, ARMC9, GLI3, EYA2, LAMB4 and EIF3H, showed 
significant association with very curly hair. All these genes are involved in either hair 
growth and morphology or are differentially expressed in melanoma. Notably, five of 
the six genes (not EIF3H), were significantly associated with African ancestry (as 
detailed in Section 5.3.4). This overlap is not surprising, given the hair morphology in 
the African population, although the association with curly hair is probably the primary 
one, providing indirect information on ancestry. Interestingly, the TRPS1 gene was 
previously associated with Hypertrichosis (also called Ambras syndrome). The major 
symptom of this disorder is an abnormal amount of hair growth over the body [450]. 
Additionally, the TRPS1 and another significantly associated gene EIF3H, were 
previously found to be involved in the Langer-Giedion syndrome. The symptoms of this 
disorder include sparse, slowly growing scalp hair and craniofacial dysmorphisms, such 
as bulbous-shaped nose, thin upper lip and large prominent ears [453]. The association 
of these six genes with very curly hair is novel and has not been described previously. 
Interestingly, the association of polymorphisms in the TRPS1 gene with nose 
morphology (specifically with nose width) was also demonstrated in the current study, 
as discussed in Section 5.3.6. 
 
 
 
 
 
 
 
 
 
235 | P a g e  
5.3.5.3. Skin colour 
Normal human skin pigmentation ranges from very pale (fair) to very dark 
(black) shade, increasing in pigmentation towards the equator and providing better UV 
protection [72, 371]. With increased UV exposure, melanocytes produce more melanin, 
which is used by keratinocytes to protect DNA in the nuclei from UV damage. This 
complex process is regulated through signalling cascades of various factors and not 
fully understood yet.   
This study analysed four shades of skin colour (fair, average, olive and dark) as well as 
freckling for potential association with genetic markers (see Table 48). The black skin 
genetic association analysis demonstrated the highest number of significantly associated 
markers with 367 markers when applying a 1.0E-7 threshold in approximately 100 
genes and intergenic regions. The olive skin genetic association analysis revealed 33 
significant markers in 13 genes and intergenic regions. The fair skin was associated 
with seven SNPs in six different genes, while the average shade did not produce any 
significant associations with genetic markers.  
 
 
Table 48. A summary of the association study for skin colour and freckling. 
Trait Marker 
Average 
Depth 
rsID Gene Name 
FvR 
Model P-
Value 
Bonferroni 
P-Value 
Fa
ir
 s
ki
n
 
3:58112440 56.6937 rs2362903 FLNB 9.44E-08 1.92E-04 
5:33951693 51.9114 rs16891982 SLC45A2 1.67E-07 3.40E-04 
6:396321 41.821 rs12203592 IRF4 3.08E-06 6.27E-03 
6:542416 84.7417 rs3799296 EXOC2 3.56E-06 7.26E-03 
15:28365618 63.5959 rs12913832 HERC2 5.42E-06 1.10E-02 
5:33969628 48.3911 rs35414 SLC45A2 1.25E-05 2.54E-02 
15:28344238 64.7122 rs7495174 OCA2 2.04E-05 4.15E-02 
 
O
liv
e 
sk
in
 
22:46835000 99.9133 rs4823810 CELSR1 2.59E-14 5.28E-11 
11:120170030 43.5 rs11217807 POU2F3 2.81E-14 5.72E-11 
13:34864240 64.5738 rs2065982 
between RFC3  
and NBEA 
1.05E-13 2.14E-10 
11:120169962 41.0203 rs11217806 POU2F3 1.25E-13 2.56E-10 
11:120129533 55.4446 rs11217777 POU2F3 2.36E-12 4.82E-09 
12:66114478 77.5812 rs10784490 near RPSAP52 8.93E-12 1.82E-08 
12:112843363 49.4852 rs2301723 RPL6 1.63E-11 3.33E-08 
1:36099200 80.6328 rs6668101 PSMB2 2.73E-10 5.56E-07 
6:21911616 61.7712 rs7745461 - 7.38E-09 1.50E-05 
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2:240282208 86.7675 rs12471054 HDAC4 8.76E-09 1.78E-05 
6:21911578 59.6015 rs6456456 - 1.27E-08 2.58E-05 
2:240295613 59.3506 rs2176046 HDAC4 1.72E-08 3.50E-05 
2:223089431 32.214 rs2289266 PAX3 2.98E-08 6.08E-05 
1:36437991 73.6494 rs12096413 EIF2C3 3.43E-08 7.00E-05 
2:109556418 48.8413 rs7598206 EDAR 5.43E-08 1.11E-04 
15:28344238 64.7122 rs7495174 OCA2 7.68E-08 1.56E-04 
2:109556365 49.2528 rs6542787 EDAR 9.21E-08 1.88E-04 
2:109616376 35.0627 rs17034770 near EDAR 1.11E-07 2.26E-04 
2:223086976 80.0074 rs6741337 PAX3 1.53E-07 3.12E-04 
2:109556761 63.1882 rs260710 EDAR 1.66E-07 3.38E-04 
11:120121323 45.8118 rs11217775 POU2F3 2.51E-07 5.12E-04 
2:16795905 67.9041 rs6724022 FAM49A 2.93E-07 5.97E-04 
2:109556667 66.5683 rs260709 EDAR 3.10E-07 6.32E-04 
5:174135737 46.5166 rs17063871                   - 3.22E-07 6.55E-04 
2:109550092 54.8284 rs6761501 EDAR 3.29E-07 6.70E-04 
15:28268990 43.7915 rs749846 OCA2 3.62E-07 7.38E-04 
15:26905021 56.0904 rs17738087 GABRB3 4.04E-07 8.24E-04 
2:109557099 54.6218 rs260711 EDAR 4.26E-07 8.69E-04 
2:109599256 45.5572 rs260674 EDAR 5.31E-07 1.08E-03 
2:109586371 63.5959 rs11123719 EDAR 5.91E-07 1.20E-03 
       
D
ar
k 
sk
in
 
8:116700847 40.9004 rs7842702 TRPS1 7.15E-67 1.46E-63 
2:232198375 73.4834 rs6747710 ARMC9 5.44E-62 1.11E-58 
7:41986689 82.1162 rs7789366 near GLI3 6.67E-62 1.36E-58 
2:177992107 52.7546 rs6433650 near RPL29P8  5.24E-59 1.07E-55 
8:116776330 42.4465 rs10505268 TRPS1 1.75E-53 3.57E-50 
10:34755348 32.3266 rs1978806 PARD3 1.76E-53 3.58E-50 
8:116670666 58.3266 rs10505261 TRPS1 1.75E-52 3.57E-49 
7:83030169 26.3506 rs2709927 SEMA3E 5.67E-51 1.15E-47 
20:62164263 51.3413 rs6010957 PTK6 8.10E-50 1.65E-46 
6:137345768 34.5203 rs276488 IL20RA 1.06E-49 2.16E-46 
7:83033303 34.321 rs2722980 SEMA3E 8.28E-48 1.69E-44 
2:232198327 74.1716 rs6719593 ARMC9 8.09E-47 1.65E-43 
18:67672106 58.8616 rs56293475 RTTN 5.98E-46 1.22E-42 
7:107704688 66.2269 rs10257477 LAMB4 7.31E-46 1.49E-42 
7:107696289 64.7565 rs17154865 LAMB4 4.02E-45 8.19E-42 
8:116673229 40.3579 rs10955754 TRPS1 1.17E-43 2.39E-40 
8:72127562 34.5258 rs79867447 EYA1 7.12E-41 1.45E-37 
20:45801340 61.5517 rs6090632 EYA2 2.61E-40 5.32E-37 
8:72131359 68.3893 rs73684719 EYA1 6.05E-39 1.23E-35 
18:19765739 45.5203 rs16964572 GATA6 8.02E-38 1.63E-34 
7:83041344 60.8137 rs2709963 SEMA3E 8.83E-37 1.80E-33 
10:24195798 26.6513 rs73604433 KIAA1217 1.59E-36 3.23E-33 
4:5638652 69.3266 rs4353849 EVC2 3.96E-35 8.07E-32 
7:83041372 59.6753 rs2709964 SEMA3E 4.10E-35 8.36E-32 
7:107689844 57.6531 rs10260756 LAMB4 1.49E-34 3.03E-31 
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5:78190471 60.5009 rs16876062 ARSB 1.34E-33 2.73E-30 
20:62164242 51.0535 rs6011878 PTK6 5.17E-33 1.05E-29 
12:56603834 42.6176 rs773658 RNF41 2.41E-32 4.92E-29 
7:107693455 46.6052 rs11487091 LAMB4 2.00E-31 4.07E-28 
17:72434959 48.6771 rs7222873 GPRC5C 3.16E-31 6.45E-28 
       
Fr
e
ck
lin
g 
6:396321 41.821 rs12203592 IRF4 2.40E-10 4.89E-07 
 
 
 
Fair skin genetic association with the HERC2, OCA2, SLC45A2, IRF4 and FLNB 
genes confirmed previously published results, as discussed in Section 5.1.2. Although 
the EXOC2 gene was known previously to be associated with hair colour, its 
association with skin pigmentation was novel in this current study [386]. The absence of 
significant markers associated with the average colour may be a result of an “ambiguous” 
definition of this category, as discussed in Section 5.3.1.2. 
The olive and black skin shades produced numerous associations with eight (8) and 
eighteen (18) genes and intergenic regions respectively. While the TRPS1 and OCA2 
genes are known to have a major impact on pigmentation and specifically melanin 
synthesis, both were not associated specifically with dark or olive skin. According to the 
literature, the main predictor of dark skin is rs6119471 in the agouti signalling protein 
(ASIP) gene [10, 456]. However, this SNP was not included in the current study due to 
technical difficulties with primer design. The most significantly associated genes with 
olive skin were the CELSR1 and POU2F3, while the TRPS1 and ARMC9 demonstrated 
association with dark skin. Both the TRPS1 and POU2F3 genes were previously 
associated with pigmentation, however both the CELSR1, ARMC9 and other 
significantly associated genes were not documented to be linked with pigmentation 
genetics. In the contrary, these two genes were found associated with craniofacial 
embryogenetics, including several associations with craniofacial measurements in this 
project (Section 5.3.6). On the one hand, these results may reveal a new functional role 
for these genes and their encoded proteins. On the other hand, this may be a somehow 
spurious result, because of the small sample size used for this specific trait analysis 
(olive and dark skin) and therefore, must be checked for replication in the future study. 
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In summary, eleven (11) genes associated with skin colour in this study were not 
previously described as pigmentation predictors, although they were linked to 
melanogenesis regulation in several studies (summarized in Table 49). Interestingly, 
one of these genes, LAMB4, was found to be downregulated in skin exposed to UV 
radiation and together with several other genes was included in an assay used for the 
detection of UV exposure [457]. 
SNP rs12203592, located in the enhancer region of the IRF4 gene, was found associated 
with freckling and fair skin. Notably, the association of rs12203592 in the IRF4 gene 
with freckling has replicated previously reported evidence of this gene’s involvement in 
melanin synthesis [384, 458]. A recent study has found an association of this marker 
with high sensitivity to UV exposure, blue eyes and brown hair. It was demonstrated to 
regulate transcription of the TYR gene through interaction with TFAP2A and MITF 
transcriptional factors [459].  
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The summary of genes association with the three skin shades and freckling is 
summarised in Table 49. The electronic version of this table includes web links to the 
relevant references. 
 
Table 49. A summary of genes, significantly associated with skin colour and freckling. The genes are categorized 
according to their role in the pigmentation regulation. The relative protein role (or absence of such) in the 
pigmentation regulation has been inferred from the GeneCards web site: http://www.genecards.org/ and 
published references. 
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SLC45A2, HERC2, 
OCA2, TRPS1, IRF4 Major genes effecting pigmentation pattern [390, 394, 452] 
 
FLNB A gene recently associated with skin pigmentation [385] 
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POU2F3 Transcription factor in melanocytes and keranocytes 
RPL6 Differentially expressed in melanoma  
HDAC4 Expressed in melanocytes 
PAX3 Involved in melanogenesis 
ARMC9 Up-regulation in melanoma  
GLI3 Required for retinal pigment development 
PARD3 Increased expression in melanoma 
SEMA3E Potentially involved in retinal pigment epithelial cell activity    
PTK6 Potentially involved in melanoma  
IL20RA Deregulated in melanoma  
LAMB4 Differentially regulated in exposure to UV radiation  
N
o
ve
l g
en
es
 p
re
vi
o
u
sl
y 
n
o
t 
sh
o
w
n
 t
o
 b
e 
in
vo
lv
ed
  
in
 t
h
e 
p
ig
m
e
n
ta
ti
o
n
 p
ro
ce
ss
 
CELSR1, RFC3, 
PCNPP3, PSMB2, 
EIF2C3, EDAR, 
FAM49A, GABRB3, 
RPL29P8, RTTN, 
EYA1, EYA2, GATA6, 
KIAA1217, EVC2, 
ARSB, RNF41, 
GPRC5C, NBEA, 
RPSAP52 
No significant role in skin pigmentation identified yet  
 
 
The association analysis of eye, skin and hair colour produced a large number of 
strongly associated markers. The most significantly associated SNPs were in full 
concordance with previously published studies, confirming statistical methods used in 
this project and providing a solid basis for subsequent craniofacial traits analysis. In 
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addition, a significant number of novel genes either not associated with pigmentation or 
not associated with a specific trait previously, were identified. This information will 
extend the current knowledge of the pigmentation genetics and assist in developing 
more accurate forensic assays for eye, skin and hair colour prediction. 
 
 
5.3.6. Craniofacial traits association study  
This section summarises the results of the craniofacial traits genetic association 
study. Over 100 craniofacial traits were analysed for potential association with genetic 
markers. The association analysis was performed using a stringent linear regression 
model, incorporating a correction factor for population stratification and covariates such 
as sex and BMI. The population stratification issue was discussed in Sections 5.2.5 and 
5.3.2. The use of covariates in the statistical analysis aimed to reduce the risk of 
introducing confounding effects, which can result in false positive associations. While 
sexual dimorphism in the craniofacial morphology is a well-known aspect [460-462], 
BMI may also affect craniofacial traits, since the soft facial tissue may change 
significantly with weight gain or loss. Despite that, this potential confounding factor has 
been disregarded in association studies of normal craniofacial morphology performed to 
date. Age was not considered a significant covariate, given that almost all the volunteers 
participated in this study were young students whose average age was approximately 27 
years old. 
The results of the association analyses of the craniofacial traits are summarized in 
Tables 50-53. In general, thirteen linear distances, four angular distances and one ratio 
revealed significant associations with 58 genetic markers in 33 different genes and 
intergenic regions (Tables 50 and 51). The nasal area measurements, including either 
“n”, “prn”, “sn” or “al” landmarks, produced the majority of the total number of 
significant associations. The superior reproducibility of the nasal area landmarks 
compared to other landmarks (as discussed in Section 4.4) is likely a factor in these 
findings. Additional measurements such as maximum facial width, upper lip width and 
ear height also produced significant associations with various genetic markers.  
An association analysis of a non-anthropometrical phenotypic trait - single vs double 
eye lid, demonstrated significant association with nine markers in six genes and 
intergenic regions (Table 52).  
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The most significant associations with genetic markers (based on p-values) were 
produced by the principal components (Table 53). This result is not surprising, as the 
principal components represented vectors of different craniofacial measurements and as 
a result were expected to produce more significant associations with SNPs (both p-value 
and number–wise). The 3D craniofacial measurements association results (Section 
5.3.6.1) are followed by the principal components association results and discussion 
(Section 5.3.6.2). Overall, the statistical analysis revealed 161 unique markers in 63 
genes and intergenic regions associated with either craniofacial measurements or 
principal components. 
 
 
Table 50. A summary of the association analyses of the linear craniofacial distances. 
Trait Marker 
Average 
Depth 
rsID Gene Name 
FvR Model 
P-Value 
Bonferroni  
P-Value 
Eu
-E
u
 
1:103420759 47.8524 rs4908280 COL11A1 4.60E-07 9.26E-04 
1:103483514 41.4649 rs945748 COL11A1 8.13E-07 1.64E-03 
1:103444679 61.4668 rs11164649 COL11A1 5.08E-06 1.02E-02 
2:121708589 76.0554 rs60613333 GLI2 1.64E-05 3.31E-02 
  
     
  
C
e
p
h
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ic
 in
d
e
x 
2:121708589 76.0554 rs60613333 GLI2 1.16E-07 2.35E-04 
2:121708596 77.393 rs60640022 GLI2 1.57E-07 3.17E-04 
2:121708140 47.8524 rs11899735 GLI2 1.88E-06 3.80E-03 
1:36099200 80.6328 rs6668101 PSMB2 1.27E-05 2.56E-02 
4:5638652 69.3266 rs4353849 EVC2 1.67E-05 3.38E-02 
6:44405327 37.19 rs559035 CDC5L 2.09E-05 4.21E-02 
1:103444679 61.4668 rs11164649 COL11A1 2.24E-05 4.51E-02 
       
zy-zy 16:71186860 133.7119 rs3114614 HYDIN 6.76E-06 1.36E-02 
      
  
al
-a
l 
1:156098620 66.3467 rs528636 LMNA 3.31E-08 6.66E-05 
1:156106185 80.0779 rs505058 LMNA 1.81E-07 3.65E-04 
14:23598760 44.9446 rs7151708 SLC7A8 1.32E-06 2.65E-03 
1:156100739 63.1081 rs61726477 LMNA 5.70E-06 1.15E-02 
10:34755348 32.3266 rs1978806 PARD3 1.49E-05 3.00E-02 
2:232198375 73.4834 rs6747710 ARMC9 1.78E-05 3.59E-02 
8:116776330 42.4465 rs10505268 TRPS1 2.04E-05 4.12E-02 
  
     
  
g-
gn
 6:137345768 34.5203 rs276488 IL20RA 4.13E-06 8.30E-03 
7:19129767 51.8376 rs11981706 TWIST1 2.54E-05 5.10E-02 
7:19104204 102.6494 rs2717340 TWIST1 6.25E-05 1.26E-01 
  
     
  
n
-s
to
 
1:36367780 89.7804 rs595961 EIF2C1 7.90E-07 1.59E-03 
15:26905021 56.0904 rs17738087 GABRB3 1.02E-06 2.04E-03 
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14:101142890 43.2491 rs730570 C14orf70 3.84E-06 7.71E-03 
22:35466515 56.9472 rs362038 ISX 9.36E-05 1.88E-01 
  
     
  
n
-s
n
 
15:26905021 56.0904 rs17738087 GABRB3 2.55E-08 5.12E-05 
1:79225423 84.8023 rs1937025 - 7.73E-06 1.55E-02 
1:36367780 89.7804 rs595961 EIF2C1 1.11E-05 2.23E-02 
6:145055331 52.5387 rs4463276 UTRN 1.62E-05 3.26E-02 
22:35470453 138.2841 rs1883384 ISX 1.74E-05 3.50E-02 
  
     
  
sl
-g
n
 
7:55131686 38.6402 rs17335912 EGFR 9.20E-06 1.85E-02 
5:112572574 58.1162 rs2416309 MCC 1.94E-05 3.90E-02 
       
  
p
rn
-g
o
 1:197109042 39.2657 rs1332663 ASPM 9.50E-08 1.91E-04 
1:197070815 45.7786 rs1412640 ASPM 2.22E-07 4.46E-04 
1:197059892 24.9428 rs10754214 ASPM 5.80E-07 1.17E-03 
1:197086669 48.786 rs10754215 ASPM 7.67E-07 1.54E-03 
         
g-pg 6:137345768 34.5203 rs276488 IL20RA 3.24E-05 6.53E-02 
       
  
sa-
sba 
2:152814028 45.7177 rs16830498 CACNB4 1.89E-05 3.80E-02 
20:62164263 51.3413 rs6010957 PTK6 4.72E-05 9.49E-02 
       
  
ls
-s
to
 
2:109579738 62.7011 rs260690 EDAR 8.41E-08 1.69E-04 
2:109562495 67.6753 rs260714 EDAR 5.43E-07 1.09E-03 
13:111827167 87.3155 rs9522149 ARHGEF7 1.31E-06 2.64E-03 
2:109567925 64.8321 rs260700 EDAR 1.39E-06 2.79E-03 
12:66168151 69.1679 rs7134682 
 
1.74E-06 3.51E-03 
1:36367780 89.7804 rs595961 EIF2C1 1.90E-06 3.82E-03 
13:102816760 59.7048 rs2607642 FGF14 1.91E-06 3.84E-03 
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Table 51. A summary of the association analyses of the angular craniofacial distances and ratios between the 
linear distances. 
  Marker 
Average 
Depth 
rsID Gene Name 
FvR Model 
P-Value 
Bonferroni  
P-Value 
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17:19204863 56.3708 rs4924980 EPN2 8.25E-07 1.66E-03 
6:145055331 52.5387 rs4463276 UTRN 1.51E-06 3.04E-03 
17:19175317 65.7768 rs28591622 EPN2 2.11E-06 4.24E-03 
17:19239432 42.9114 rs1043809 EPN2 3.50E-06 7.03E-03 
17:69512099 65.2251 rs10512572 - 5.88E-06 1.18E-02 
17:19211073 40.4834 rs8072587 EPN2 1.35E-05 2.72E-02 
9:12704725 54.3616 rs2733832 TYRP1 1.36E-05 2.73E-02 
17:19224397 62.5221 rs6587216 EPN2 1.62E-05 3.25E-02 
17:19172505 37.4594 rs28760541 EPN2 2.33E-05 4.69E-02 
          
n
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al
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gl
e 
(n
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) 7:107696289 64.7565 rs17154865 LAMB4 7.98E-06 1.60E-02 
16:86386367 37.7712 rs11642858  - 1.70E-05 3.42E-02 
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15:26905021 56.0904 rs17738087 GABRB3 2.51E-06 5.04E-03 
2:109579738 62.7011 rs260690 EDAR 5.98E-06 1.20E-02 
2:109567925 64.8321 rs260700 EDAR 6.98E-06 1.40E-02 
2:109556761 63.1882 rs260710 EDAR 1.35E-05 2.71E-02 
1:234330571 58.7768 rs7531988 SLC35F3 1.66E-05 3.33E-02 
8:72264982 3.369 rs6988283 EYA1 1.79E-05 3.59E-02 
11:120126277 40.2825 rs2715881 POU2F3 2.34E-05 4.70E-02 
              
n
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4:146418167 34.762 rs17020235 SMAD1 1.91E-06 3.85E-03 
          
n
as
o
fr
o
n
ta
l 
an
gl
e
 
 (
g-
n
-p
rn
) 12:83421757 56.9631 rs10862564 TMTC2 3.73E-06 7.49E-03 
12:83421860 54.1384 rs10506886 TMTC2 3.85E-06 7.74E-03 
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Table 52. An association analysis of the eye lid (single/double). 
Trait Marker 
Average 
Depth 
rsID Gene Name 
FvR 
Model P-
Value 
Bonferroni  
P-Value 
ey
e 
lid
 
16:71186834 135.1328 rs3094869 HYDIN 1.15E-15 2.35E-12 
22:46835000 99.9133 rs4823810 CELSR1 1.55E-09 3.17E-06 
16:71186740 134.2694 rs3094868 HYDIN 2.04E-08 4.16E-05 
2:224794572 53.0295 rs4674831 WDFY1 3.09E-07 6.31E-04 
11:120170030 43.5 rs11217807 POU2F3 4.92E-07 1.01E-03 
16:71186860 133.7119 rs3114614 HYDIN 1.40E-06 2.86E-03 
20:55762947 60.5941 rs6123674 BMP7 1.42E-06 2.90E-03 
2:177418275 49.8133 rs725395 near MTX2 7.58E-06 1.55E-02 
11:120169962 41.0203 rs11217806 POU2F3 7.93E-06 1.62E-02 
 
 
The analysis of direct cranial measurements revealed a significant association between 
genetic markers and both the Cephalic index (CI) and the maximum cranial width (eu-
eu), which is used for the calculation of CI. There was also an overlap between the 
markers and genes in both traits. No significant associations of the maximum cranial 
length (g-op), also used for calculation of the CI, were found. This outcome may be a 
result of the insufficient representation of the candidate markers influencing this and 
possibly other traits.  
The annotations of gene function in this section are based on the RefSeq database 
(http://www.ncbi.nlm.nih.gov/refseq/), GeneCards web portal 
(http://www.genecards.org) and AmiGO database (http://amigo.geneontology.org/cgi-
bin/amigo/go.cgi), while the information on the related disorders was sourced from the 
MalaCard database (http://www.malacards.org/) and OMIM database (http://omim.org/). 
SNPs annotation was performed using a Regulome database 
(http://www.regulomedb.org/) and Polyphen database 
(http://genetics.bwh.harvard.edu/pph2/)  search, as detailed in the Material and Methods 
section. 
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5.3.6.1. Direct craniofacial measurements association results 
The most significant gene found to be associated with the eu-eu distance as well 
as with the CI (although less significant), was collagen (COL11A1). Based on the 
RefSeq database information, this gene encodes one of the two alpha chains of type XI 
fibrillar collagen and is known to have multiple transcripts, as a result of an alternative 
splicing. The secreted protein is hypothesised to play an important role in fibrillogenesis 
by controlling lateral growth of collagen II fibrils. Interestingly, this gene was found 
mutated in Stickler Syndrome (OMIM: 604841) and Marshall Syndrome (OMIM: 
154780) [99]. These two inherited disorders have very similar phenotypes and are 
characterized by distinctive facial appearance, such as flat midface, very small jaw, cleft 
lip/palate, large eyes, short upturned nose, eye abnormalities, round face and short 
stature. However, the facial features of Stickler syndrome are less severe and include a 
flat face with depressed nasal bridge and cheekbones, caused by underdeveloped bones 
in the middle of the face. Notably, another member of the collagen family, COL17A1 
was recently associated with the distance between the eyeballs and the nasion [77]. This 
finding can be considered as a confirmation for this study result. 
Another gene, GLI2, which was found in association with both eu-eu distance and CI, 
encodes a transcriptional factor that binds to DNA via zinc finger motifs. This gene is 
an activator of the Sonic Hedgehog (SHH) signalling pathway, which plays a central 
role in embryogenesis. The encoded protein is associated with cleft lip and palate as 
well as with other genetic disorders, such as Greig cephalopolysyndactyly syndrome, 
Pallister-Hall syndrome and preaxial and postaxial polydactyly.  
Three additional genes that were found strongly associated with CI were PSMB2, EVC2 
and CDC5L. The PSMB2 gene encodes a proteasome beta type subunit with a trypsin-
like activity, although without any known involvement in embryonic craniofacial 
development. The EVC2 gene encodes a positive regulator of the hedgehog signalling 
pathway and plays a critical role in bone formation and skeletal development. The 
EVC2 gene was named after the Ellis Van Creveld Syndrome 2, which is associated 
with this gene [463]. This disorder is characterised by various skeletal abnormalities and 
especially by a very short stature. The ENTREZ database suggests that the cell division 
cycle 5-like (CDC5L) is a DNA-binding protein involved in the cell cycle control and 
forms an essential component of a non-snRNA spliceosome. The UniProtKB/Swiss-
Prot web portal proposes that it may act as a transcription activator required for 
activating pre-mRNA splicing. However, GeneCards and MalaCards web site searches, 
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did not find any association of the PSMB2 and CDC5L genes with either craniofacial 
development or related inherited disorders. 
Functional prediction of COL11A1 and GLI2 genes using the GeneMania web site, 
revealed a strong interaction between these factors (as well as with the COL17A1 gene, 
discussed above) through a network of genetic and physical interactions, as shown in 
Figure 62. A search with all five genes that were associated with the Cephalic index 
(including COL11A1 and GLI2 genes) also found a complex network of interactions 
between all these factors (Figure 63).  
The results of this study provide important piece of evidence explaining, although partly, 
the complexity of processes affecting craniofacial embryonic development and expand 
the current knowledge in this field. 
 
 
 
Figure 62. COL11A1 and GLI2 protein interactions based on the GeneMania database output 
(http://www.genemania.org/). 
 
 
247 | P a g e  
 
 
 
Figure 63. Interactions between factors found in significant association with the Cephalic index, based on the 
GeneMania web site output (http://www.genemania.org/). 
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Bizygomatic distance (maximum facial breadth) association results 
Maximum facial breadth distance (zy-zy) produced a significant association with 
rs3114614, which is located in the intron of the Hydrocephalus inducing gene (HYDIN). 
This gene encodes a protein that is hypothesized to be involved in sperm cell cilia 
motility. However, it may have additional functions, given that mutations in HYDIN are 
associated with Primary Ciliary Dyskinesia 5 and Hydrocephalus (OMIM: 236600) 
disorders in both human and mouse models. The Hydrocephalus condition is 
characterized by a very large head size due to excessive accumulation of fluid in the 
brain, although the pathophysiology and biochemistry of this process is not clear.  
While HYDIN has not previously been linked to normal craniofacial morphology, the 
bizygomatic distance was recently associated with SNP rs987525 near the CCDC26 
gene, although with a relatively weak p-value of 0.017 [160]. Although not 
contradictory to the published results (as the CCDC26 gene was not covered in the 
current research due to manufacturer primer design failure), this study demonstrated a 
stronger evidence of association, based on the p-value of 6.76E-06. 
 
Nasal area association results 
Five linear morphological distances, four angular distances and one ratio, all from the 
nasal area demonstrated significant associations with twenty genes, including LMNA, 
EIF2C1, GABRB3, ASPM, PARD3, EPN2 and TRPS1. The following section provides 
a brief annotation of these genes function and description of their potential involvement 
in craniofacial disorders.   
Lamin A (LMNA) together with other Lamin proteins, is a component of a fibrous layer 
on the nucleoplasmic side of the inner nuclear membrane, which provides a framework 
for the nuclear envelope and also interacts with chromatin. LMNA encoded protein acts 
to disrupt mitosis and induces DNA damage in vascular smooth muscle cells, leading to 
mitotic failure, genomic instability, and premature senescence of the cell. This gene has 
been found mutated in Mandibuloacral Dysplasia which is characterized by various 
skeletal and craniofacial abnormalities, including delayed closure of the cranial sutures 
and undersized jaw [464]. 
Argonaute RISC Catalytic Component (EIF2C1) is a member of a gene family, which 
plays a role in RNA interference. It is required specifically for the RNA-mediated gene 
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silencing and repression of translation by microRNAs. To date, this gene has not been 
linked to normal craniofacial development or to craniofacial malformations as to date. 
The GABA-Alpha Receptor Beta-2 Subunit (GABRB3) gene encodes a subunit of a 
chloride channel that serves as the receptor for gamma-aminobutyric acid, a major 
inhibitory neurotransmitter of the nervous system. This gene was associated with the 
pathogenesis of several disorders including nonsyndromic orofacial clefts and Prader-
Willi syndrome (OMIM:176270), which is characterised by specific facial appearance 
such as elongated face, thin upper lip and a prominent nose. 
Abnormal Spindle-Like Microcephaly-Associated Protein (ASPM) is the human 
ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is 
essential for normal mitotic spindle function in embryonic neuroblasts. Mutations in this 
gene are associated with microcephaly primary type 5. 
Par-3 Family Cell Polarity Regulator protein (PARD3) is known to have multiple 
alternatively spliced transcript variants and was described to affect asymmetrical cell 
division and direct polarized cell growth. This gene may be involved in signalling 
pathways, directing cells through proliferation and migration in the developing face, 
which regulate facial symmetry. 
Alternate splicing of the Epsin 2 (EPN2) gene results in multiple transcripts, encoding 
different isoforms, which play a role in the formation of clathrin-coated invaginations 
and endocytosis. A duplication/deletion of the 17p11.2 chromosomal region (including 
EPN2 gene) is associated with Smith–Magenis syndrome [465]. Interestingly, this 
syndrome is characterized by specific craniofacial features, including cleft lip/palate, 
microcephaly, triangular face and a broad nasal bridge.  
Trichorhinophalangeal Syndrome I (TRPS1) encodes a transcription factor that binds 
specifically to GATA sequences and represses expression of GATA-regulated genes at 
selected  stages of vertebrate development. Known to regulate chondrocyte proliferation 
and differentiation. Mutations in this gene were previously associated with Ambras 
syndrome (discussed in Sections 5.3.4 and 5.3.5.2) and with Langer-Giedion syndrome 
(OMIM: 190350). The symptoms of the latter syndrome include sparse, slowly growing 
scalp hair and craniofacial dysmorphisms, such as rounded nose, thin upper lip and 
large prominent ears [453] 
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A functional analysis of the 20 significant genes associated with nasal area 
measurements revealed that 19 of these factors (all but ASPM) interconnect with each 
other, forming a complex cluster of interactions on various molecular levels (Figure 64). 
The Regulome annotation of the SNPs significantly associated with the linear and 
angular measurements, revealed that 36 of the 61 markers may be involved in various 
types of regulatory activity including affecting promoter regions and transcriptional 
binding sites.  
 
 
 
 
Figure 64. A network chart of genes, found in association with the nasal area measurements. Based on the 
GeneMania web site search (http://www.genemania.org/). 
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Eyelid genetic association results 
Eyelid is a non-anthropometric, although a highly visible facial trait. The formation of 
eyelids in foetus starts at approximately 8 weeks, while the folds of surface ectoderm 
overgrow the eyes to form the eyelids, which remain closed until the seventh month of 
development. The eyelid can be largely segregated into double or single (according to 
presence or absence of a skin fold), while the former is more dominant in the East Asian 
population and the latter in the rest. The association analysis of this trait revealed a 
strong association with three SNPs located in the HYDIN gene. This gene was also 
associated with the bizygomatic distance in the current study. It might be hypothesized 
that the same gene is responsible for regulating cell migration and differentiation in 
different parts of the developing head, perhaps even in the forehead area specifically. 
Considering the high p-value of this association (1.15E-15), this marker might be a 
good predictor of this trait and provide indirect information on the East Asian ancestry. 
Several other genes were also associated with the eyelid, such as CELSR1, POU2F3, 
WDFY1 and BMP7. The following section provides a brief overview of these genes and 
encoded protein function as well as their potential involvement in the craniofacial 
embryogenetics. 
CELSR1 gene represents a part of the cadherin superfamily, involved in cell adhesion 
and receptor-ligand interactions. In general, cadherins participate in signal transduction 
in the WNT signalling pathway, which in central to embryonic development. This 
specific protein is a developmentally regulated neural-specific factor, which plays an 
unspecified role in early embryogenesis. AmiGO ontology database search found 
however, that this gene may play a role in the establishment of planar cell polarity. 
Specifically, it may be one of the several factors that coordinate organization of groups 
of cells in the plane of an epithelium, such that they all orient in the similar direction. 
Similarly to the PARD3 gene, discussed above, it may also play a role in regulating 
facial symmetry. Interestingly, the CELSR1 deficiency in mice results in various 
craniofacial defects, such as craniorachischisis (neural tube defects) and failure of the 
eyelid closure [466, 467]. Notably, CELSR1 was also found in significant association 
with the Asian ancestry in this project (Table 41) and can be used as an AIM . 
POU2F3 gene encodes a transcriptional factor, which regulates cell type-specific 
differentiation pathways. The encoded protein is primarily expressed in the epidermis 
and plays a critical role in keratinocyte proliferation and differentiation, while also 
being a candidate tumour suppressor protein. In the current study, this gene was also 
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associated with European and Asian ancestry, brown eyes, black hair and olive skin as 
well as with nasal vertical prominence angle. The association of POU2F3 with the 
eyelid or any other craniofacial feature has not been reported before. 
WD Repeat and FYVE Domain Containing 1 (WDFY1) encoded protein mediates the 
recruitment of proteins involved in membrane trafficking and cell signalling with 
localization in endosomes. To date, it has not been described as a craniofacial 
development factor. 
Conversely, bone morphogenetic protein 7 (BMP7) encodes a growth factor. It plays a 
role in early development, specifically in bone inductive activity through calcium 
regulation and bone homeostasis. Deletion of this factor in mice leads to severe 
abnormalities of the orofacial complex [204]. 
Another significantly associated SNP rs725395 is an intergenic marker, which is located 
between MTX2 gene and MIR1246 gene. While both genes have not been associated 
with craniofacial morphology regulation, this marker is located in the transcriptional 
factor binding site (based on the Regulome search). Hypothetically, it may be a part of 
an enhancer element, which can be located far away from the regulated gene, while 
fine-tuning the craniofacial morphology variation indirectly, as has been proposed 
previously [213]. 
 
 
5.3.6.2. Principal components association results 
Twenty principal components, representing all craniofacial measurements 
collected in this study (n=92), were generated using SVS software and analysed for 
potential association with candidate genetic markers. Of the twenty principal 
components that were generated, fourteen PCs were associated with 130 significantly 
associated markers in 57 different genes, with approximately half of genes common to 
3D measurements and principal components (Table 53). 
It should be noted however, that eigenvectors (hence principal components) analysed in 
this study, are not identical (although similar) to eigenvectors shown in Table 53 and 
Figure 54 as they were generated using all craniofacial measurements (and not only 
linear and angular distances). In addition, due to technical reasons, they were generated 
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using the SVS software, rather than PASW Statistics (as in Section 4.6), which 
theoretically may use slightly different algorithms for principal component analysis.  
 
 
 
Table 53.  An association analyses of principal components. 
Trait Marker 
Average 
Depth 
rsID Gene Name 
FvR 
Model  
P-Value 
Bonferroni  
P-Value 
P
C
1
 
16:71186860 133.7119 rs3114614 HYDIN 1.75E-15 3.54E-12 
16:71186834 135.1328 rs3094869 HYDIN 6.18E-12 1.25E-08 
16:71186888 112.1089 rs3094870 HYDIN 1.82E-10 3.68E-07 
16:71186740 134.2694 rs3094868 HYDIN 5.03E-09 1.02E-05 
         
P
C
2
 
16:71186860 133.7119 rs3114614 HYDIN 3.02E-16 6.09E-13 
16:71186834 135.1328 rs3094869 HYDIN 9.45E-16 1.91E-12 
16:71186740 134.2694 rs3094868 HYDIN 3.46E-13 7.00E-10 
16:71186888 112.1089 rs3094870 HYDIN 2.67E-12 5.39E-09 
13:111827167 87.3155 rs9522149 ARHGEF7 4.77E-08 9.64E-05 
3:58006600 58.8173 rs839241 FLNB 6.89E-08 1.39E-04 
10:55949899 34.7048 rs16905691 PCDH15 5.83E-07 1.18E-03 
14:101142890 43.2491 rs730570 C14orf70 8.32E-07 1.68E-03 
8:73848139 63.9317 rs3735829 KCNB2 1.36E-06 2.75E-03 
10:55602540 51.786 rs12263108 PCDH15 1.97E-06 3.98E-03 
10:55884789 62.7399 rs10825242 PCDH15 2.66E-06 5.37E-03 
22:47836412 55.4207 rs2040411 
between 
LOC339685 and 
FLJ46257 
2.93E-06 5.92E-03 
13:76024169 65.6974 rs9593078 TBC1D4 5.34E-06 1.08E-02 
10:55968685 64.7048 rs10825273 PCDH15 7.18E-06 1.45E-02 
8:73845337 32.2472 rs16919329 KCNB2 7.29E-06 1.47E-02 
11:120121323 45.8118 rs11217775 POU2F3 8.56E-06 1.73E-02 
8:72174978 66.5609 rs1445407 EYA1 8.99E-06 1.82E-02 
  
     
  
P
C
 3
 
16:71186740 134.2694 rs3094868 HYDIN 1.21E-10 2.45E-07 
1:18956404 62.4871 rs766324 - 2.66E-07 5.37E-04 
16:71186834 135.1328 rs3094869 HYDIN 5.10E-07 1.03E-03 
16:71186860 133.7119 rs3114614 HYDIN 1.70E-06 3.43E-03 
4:42065293 64.8672 rs3804191 SLC30A9 2.10E-06 4.24E-03 
1:18956458 62.5129 rs766325 PAX7 3.23E-06 6.52E-03 
4:42089177 87.0812 rs11051 SLC30A9 4.87E-06 9.83E-03 
4:42065269 65.0554 rs3804190 SLC30A9 4.87E-06 9.84E-03 
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16:71186888 112.1089 rs3094870 HYDIN 5.04E-06 1.02E-02 
10:34755348 32.3266 rs1978806 PARD3 5.20E-06 1.05E-02 
2:177992107 52.7546 rs6433650 
between RPL29P8 
and LOC391465 
1.02E-05 2.06E-02 
9:939738 39.7288 rs10977650 DMRT1 1.12E-05 2.25E-02 
4:42050768 42.5554 rs10433709 SLC30A9 1.19E-05 2.39E-02 
4:42003671 39.6328 rs1047626 SLC30A9 1.41E-05 2.84E-02 
9:95325631 72.4649 rs7865019 CENPP 1.64E-05 3.30E-02 
  
 
     
  
P
C
 4
 
15:26905021 56.0904 rs17738087 GABRB3 5.14E-10 1.04E-06 
2:216299550 44.1605 rs2577290 FN1 3.20E-09 6.47E-06 
2:216299551 44.4758 rs202099802 FN1 7.68E-08 1.55E-04 
2:216277672 53.8801 rs7588830 FN1 2.02E-07 4.08E-04 
8:73848139 63.9317 rs3735829 KCNB2 3.12E-07 6.31E-04 
2:216276856 53.5923 rs17457252 FN1 4.04E-07 8.16E-04 
11:120121323 45.8118 rs11217775 POU2F3 1.25E-06 2.53E-03 
15:37247246 62.524 rs2122497 MEIS2 1.39E-06 2.80E-03 
4:5570221 50.1162 rs12511039 EVC2 1.70E-06 3.43E-03 
22:46835000 99.9133 rs4823810 CELSR1 1.99E-06 4.02E-03 
13:95096013 76.6697 rs1407995 DCT 2.77E-06 5.59E-03 
1:234330571 58.7768 rs7531988 SLC35F3 3.59E-06 7.24E-03 
12:66114478 77.5812 rs10784490 
between PCNPP3 
and RPSAP52 
3.87E-06 7.82E-03 
10:55884789 62.7399 rs10825242 PCDH15 4.05E-06 8.19E-03 
10:55873113 53.5738 rs4281403 PCDH15 4.37E-06 8.82E-03 
11:120169962 41.0203 rs11217806 POU2F3 4.76E-06 9.61E-03 
10:55935850 65.0369 rs4935501 PCDH15 5.78E-06 1.17E-02 
3:71626262 78.7159 rs830599 FOXP1 6.13E-06 1.24E-02 
8:73845337 32.2472 rs16919329 KCNB2 6.31E-06 1.27E-02 
7:55154688 69.5996 rs2302535 EGFR 6.46E-06 1.31E-02 
14:101142890 43.2491 rs730570 C14orf70 6.74E-06 1.36E-02 
10:55996761 44.9871 rs721825 PCDH15 7.71E-06 1.56E-02 
18:67672106 58.8616 rs56293475 RTTN 7.77E-06 1.57E-02 
18:67741309 38.3198 rs1369293 RTTN 1.06E-05 2.14E-02 
   
     
  
P
C
 8
 
15:48426484 47.4004 rs1426654 SLC24A5 2.62E-12 5.30E-09 
15:26905021 56.0904 rs17738087 GABRB3 1.34E-10 2.71E-07 
13:34864240 64.5738 rs2065982 
between RFC3 
and GAMTP2 
2.50E-10 5.05E-07 
2:152814028 45.7177 rs16830498 CACNB4 3.09E-09 6.24E-06 
22:46835000 99.9133 rs4823810 CELSR1 4.76E-09 9.61E-06 
12:66114478 77.5812 rs10784490 
between PCNPP3 
and RPSAP52 
7.53E-09 1.52E-05 
2:240282208 86.7675 rs12471054 HDAC4 1.55E-08 3.14E-05 
8:73848139 63.9317 rs3735829 KCNB2 2.81E-08 5.67E-05 
1:234330571 58.7768 rs7531988 SLC35F3 2.85E-08 5.76E-05 
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2:216299550 44.1605 rs2577290 FN1 3.44E-08 6.94E-05 
1:36437991 73.6494 rs12096413 EIF2C3 5.89E-08 1.19E-04 
2:216299551 44.4758 rs202099802 FN1 8.57E-08 1.73E-04 
11:120169962 41.0203 rs11217806 POU2F3 1.77E-07 3.57E-04 
14:52607967 47.6033 rs2357442 
between 
COX5AP2 and 
PTGDR 
1.80E-07 3.64E-04 
13:102824147 43.845 rs9557826 FGF14 2.26E-07 4.56E-04 
11:120170030 43.5 rs11217807 POU2F3 2.50E-07 5.06E-04 
2:16815844 42.0387 rs16982612 FAM49A 4.46E-07 9.01E-04 
1:75609049 37.4354 rs12041465 LHX8 4.76E-07 9.61E-04 
2:216276856 53.5923 rs17457252 FN1 4.93E-07 9.96E-04 
13:102816760 59.7048 rs2607642 FGF14 6.37E-07 1.29E-03 
2:149234861 80.7509 rs7569399 MBD5 6.50E-07 1.31E-03 
1:79225423 84.8023 rs1937025 - 7.57E-07 1.53E-03 
2:240295613 59.3506 rs2176046 HDAC4 8.00E-07 1.62E-03 
6:7137363 41.5904 rs1285879 RREB1 9.08E-07 1.84E-03 
X:39934488 75.9539 rs6610384 BCOR 1.04E-06 2.11E-03 
13:95096013 76.6697 rs1407995 DCT 1.09E-06 2.20E-03 
  
     
  
P
C
 9
 
2:109556761 63.1882 rs260710 EDAR 9.24E-23 1.87E-19 
2:109579738 62.7011 rs260690 EDAR 1.57E-21 3.18E-18 
2:109557099 54.6218 rs260711 EDAR 2.77E-19 5.60E-16 
2:109556667 66.5683 rs260709 EDAR 5.77E-19 1.17E-15 
1:36426398 28.9502 rs7521611 EIF2C3 3.37E-18 6.80E-15 
1:36424338 43.6421 rs716924 EIF2C3 1.18E-17 2.38E-14 
15:48426484 47.4004 rs1426654 SLC24A5 2.15E-17 4.33E-14 
2:109556365 49.2528 rs6542787 EDAR 5.53E-17 1.12E-13 
2:109556418 48.8413 rs7598206 EDAR 7.36E-17 1.49E-13 
2:109567925 64.8321 rs260700 EDAR 1.54E-16 3.10E-13 
2:109562495 67.6753 rs260714 EDAR 3.12E-16 6.30E-13 
17:19175317 65.7768 rs28591622 EPN2 5.42E-16 1.09E-12 
1:36099200 80.6328 rs6668101 PSMB2 2.63E-15 5.30E-12 
1:36437991 73.6494 rs12096413 EIF2C3 3.28E-15 6.62E-12 
17:19239432 42.9114 rs1043809 EPN2 1.71E-14 3.45E-11 
13:102778223 39.8653 rs66578550 FGF14 2.35E-14 4.74E-11 
17:19204863 56.3708 rs4924980 EPN2 3.08E-14 6.23E-11 
3:58091098 50.4041 rs7638552 FLNB 6.43E-14 1.30E-10 
13:102778196 39.5387 rs16959781 FGF14 6.80E-14 1.37E-10 
17:19224397 62.5221 rs6587216 EPN2 7.57E-14 1.53E-10 
10:55949899 34.7048 rs16905691 PCDH15 7.82E-14 1.58E-10 
12:66115201 52.0996 rs12300373 
between PCNPP3 
and RPSAP52 
8.29E-14 1.67E-10 
3:58112556 54.9797 rs2362905 FLNB 1.08E-13 2.18E-10 
17:19247075 43.8229 rs4924987 B9D1 1.09E-13 2.20E-10 
11:120169962 41.0203 rs11217806 POU2F3 1.19E-13 2.41E-10 
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10:55971427 55.2399 rs11004141 PCDH15 1.47E-13 2.96E-10 
17:19172505 37.4594 rs28760541 EPN2 1.94E-13 3.92E-10 
17:19211073 40.4834 rs8072587 EPN2 1.94E-13 3.93E-10 
1:234330571 58.7768 rs7531988 SLC35F3 2.46E-13 4.96E-10 
2:109616376 35.0627 rs17034770 near EDAR    5.74E-10 
         
P
C
 1
1
 
22:46835000 99.9133 rs4823810 CELSR1 3.96E-29 8.00E-26 
1:234330571 58.7768 rs7531988 SLC35F3 1.67E-28 3.37E-25 
2:109556761 63.1882 rs260710 EDAR 3.52E-26 7.11E-23 
1:36437991 73.6494 rs12096413 EIF2C3 5.84E-26 1.18E-22 
2:109556667 66.5683 rs260709 EDAR 5.32E-25 1.07E-21 
11:120169962 41.0203 rs11217806 POU2F3 1.11E-23 2.25E-20 
11:120170030 43.5 rs11217807 POU2F3 5.14E-23 1.04E-19 
1:36426398 28.9502 rs7521611 EIF2C3 8.34E-23 1.68E-19 
15:48426484 47.4004 rs1426654 SLC24A5 1.85E-22 3.74E-19 
2:109579738 62.7011 rs260690 EDAR 8.37E-22 1.69E-18 
12:66114478 77.5812 rs10784490 - 1.37E-21 2.76E-18 
2:109557099 54.6218 rs260711 EDAR 1.53E-21 3.10E-18 
13:102824147 43.845 rs9557826 FGF14 1.69E-21 3.41E-18 
15:26905021 56.0904 rs17738087 GABRB3 4.53E-21 9.16E-18 
2:109567925 64.8321 rs260700 EDAR 4.94E-21 9.99E-18 
2:109616376 35.0627 rs17034770 near EDAR 6.53E-21 1.32E-17 
1:36099200 80.6328 rs6668101 PSMB2 1.27E-20 2.57E-17 
11:120121323 45.8118 rs11217775 POU2F3 1.42E-19 2.87E-16 
8:73848139 63.9317 rs3735829 KCNB2 1.55E-19 3.13E-16 
2:109586371 63.5959 rs11123719 EDAR 2.94E-19 5.94E-16 
11:120129533 55.4446 rs11217777 POU2F3 3.18E-19 6.43E-16 
9:125799927 43.821 rs10985869 RABGAP1 3.96E-19 7.99E-16 
13:34864240 64.5738 rs2065982 
between RFC3 
and GAMTP2 
2.53E-18 5.11E-15 
13:102821327 44.81 rs4771420 FGF14 2.88E-18 5.83E-15 
17:19224397 62.5221 rs6587216 EPN2 2.94E-18 5.95E-15 
10:55949151 88.9483 rs16905686 PCDH15 5.29E-18 1.07E-14 
10:55935850 65.0369 rs4935501 PCDH15 5.94E-18 1.20E-14 
14:97277005 61.9908 rs722869 VRK1 9.44E-18 1.91E-14 
11:120126277 40.2825 rs2715881 POU2F3 1.05E-17 2.11E-14 
1:36424338 43.6421 rs716924 EIF2C3 1.26E-17 2.55E-14 
  
     
  
P
C
 1
2
 
17:19172505 37.4594 rs28760541 EPN2 2.12E-29 4.28E-26 
12:66115201 52.0996 rs12300373 
between PCNPP3 
and RPSAP52 
 
2.67E-28 
  
5.38E-25 
13:102816760 59.7048 rs2607642 FGF14 3.10E-28 6.25E-25 
3:58118555 85.8007 rs12632456 FLNB 2.20E-27 4.45E-24 
17:19175317 65.7768 rs28591622 EPN2 2.98E-27 6.02E-24 
17:19211073 40.4834 rs8072587 EPN2 3.36E-27 6.78E-24 
17:19204863 56.3708 rs4924980 EPN2 3.94E-27 7.96E-24 
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3:58114655 48.4779 rs9311669 FLNB 1.07E-26 2.17E-23 
11:120118498 74.0258 rs2847502 POU2F3 4.05E-26 8.18E-23 
3:58006600 58.8173 rs839241 FLNB 3.30E-25 6.67E-22 
17:19239432 42.9114 rs1043809 EPN2 3.64E-25 7.36E-22 
11:120130512 46.8339 rs1941411 POU2F3 4.10E-25 8.29E-22 
3:58112556 54.9797 rs2362905 FLNB 4.17E-25 8.41E-22 
1:234330571 58.7768 rs7531988 SLC35F3 6.03E-25 1.22E-21 
3:58112488 57.8506 rs2362904 FLNB 6.43E-25 1.30E-21 
11:120133494 98.3911 rs2715883 POU2F3 1.30E-24 2.63E-21 
3:58113930 49.703 rs2362907 FLNB 1.48E-24 2.98E-21 
1:36437991 73.6494 rs12096413 EIF2C3 3.85E-24 7.78E-21 
17:19247075 43.8229 rs4924987 B9D1 4.30E-24 8.68E-21 
12:112843363 49.4852 rs2301723 RPL6 1.11E-23 2.24E-20 
3:58091098 50.4041 rs7638552 FLNB 2.96E-23 5.97E-20 
8:73848139 63.9317 rs3735829 KCNB2 4.25E-23 8.58E-20 
11:120107411 46.9889 rs882856 POU2F3 4.44E-23 8.97E-20 
14:101142890 43.2491 rs730570 C14orf70 1.19E-22 2.40E-19 
2:109557099 54.6218 rs260711 EDAR 1.56E-22 3.14E-19 
15:26905021 56.0904 rs17738087 GABRB3 2.87E-22 5.80E-19 
6:145055331 52.5387 rs4463276 UTRN 3.10E-22 6.26E-19 
2:109562495 67.6753 rs260714 EDAR 3.26E-22 6.59E-19 
13:34864240 64.5738 rs2065982 
between RFC3 
and GAMTP2 
4.73E-22 9.55E-19 
1:36367780 89.7804 rs595961 EIF2C1 5.83E-22 1.18E-18 
  
     
  
P
C
 1
3
 
17:19239432 42.9114 rs1043809 EPN2 7.53E-11 1.52E-07 
17:19211073 40.4834 rs8072587 EPN2 1.25E-10 2.51E-07 
17:19172505 37.4594 rs28760541 EPN2 2.13E-10 4.29E-07 
16:71186860 133.7119 rs3114614 HYDIN 2.49E-10 5.02E-07 
17:19175317 65.7768 rs28591622 EPN2 2.61E-10 5.28E-07 
13:102778223 39.8653 rs66578550 FGF14 3.03E-10 6.11E-07 
17:19204863 56.3708 rs4924980 EPN2 1.89E-09 3.81E-06 
17:19247075 43.8229 rs4924987 B9D1 1.99E-09 4.02E-06 
13:102778196 39.5387 rs16959781 FGF14 3.10E-09 6.27E-06 
17:19224397 62.5221 rs6587216 EPN2 7.38E-09 1.49E-05 
11:120130512 46.8339 rs1941411 POU2F3 1.32E-08 2.67E-05 
2:109579738 62.7011 rs260690 EDAR 1.36E-08 2.75E-05 
11:120133494 98.3911 rs2715883 POU2F3 1.61E-08 3.25E-05 
1:36133918 52.0491 rs677661 
between PSMB2 
and C1orf216 
9.52E-08 1.92E-04 
2:109557099 54.6218 rs260711 EDAR 1.15E-07 2.31E-04 
17:19265797 20.9685 rs10445411 B9D1 1.38E-07 2.78E-04 
1:36426398 28.9502 rs7521611 EIF2C3 1.53E-07 3.08E-04 
2:109562495 67.6753 rs260714 EDAR 1.53E-07 3.10E-04 
3:58112488 57.8506 rs2362904 FLNB 1.64E-07 3.31E-04 
2:109556761 63.1882 rs260710 EDAR 1.64E-07 3.31E-04 
2:109557036 51.8727 rs11123718 EDAR 1.77E-07 3.57E-04 
12:112843363 49.4852 rs2301723 RPL6 1.81E-07 3.65E-04 
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P
C
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2:109579738 62.7011 rs260690 EDAR 1.01E-20 2.03E-17 
2:109556761 63.1882 rs260710 EDAR 2.99E-20 6.03E-17 
2:109557099 54.6218 rs260711 EDAR 7.56E-18 1.53E-14 
1:36424338 43.6421 rs716924 EIF2C3 2.08E-17 4.20E-14 
2:109556667 66.5683 rs260709 EDAR 3.14E-17 6.35E-14 
17:19175317 65.7768 rs28591622 EPN2 3.89E-17 7.86E-14 
1:36426398 28.9502 rs7521611 EIF2C3 1.22E-16 2.47E-13 
2:109567925 64.8321 rs260700 EDAR 3.69E-16 7.46E-13 
2:109562495 67.6753 rs260714 EDAR 5.90E-16 1.19E-12 
12:66115201 52.0996 rs12300373 
between PCNPP3 
and RPSAP52 
 
6.95E-16 
  
1.40E-12 
17:19239432 42.9114 rs1043809 EPN2 3.27E-15 6.60E-12 
2:109556365 49.2528 rs6542787 EDAR 3.50E-15 7.06E-12 
17:19204863 56.3708 rs4924980 EPN2 4.52E-15 9.13E-12 
2:109556418 48.8413 rs7598206 EDAR 7.81E-15 1.58E-11 
1:36099200 80.6328 rs6668101 PSMB2 1.41E-14 2.85E-11 
13:102778223 39.8653 rs66578550 FGF14 1.63E-14 3.28E-11 
3:58091098 50.4041 rs7638552 FLNB 2.02E-14 4.08E-11 
1:36437991 73.6494 rs12096413 EIF2C3 2.02E-14 4.08E-11 
3:58112556 54.9797 rs2362905 FLNB 2.26E-14 4.57E-11 
17:19247075 43.8229 rs4924987 B9D1 3.07E-14 6.20E-11 
13:102778196 39.5387 rs16959781 FGF14 3.36E-14 6.79E-11 
3:58112488 57.8506 rs2362904 FLNB 4.35E-14 8.78E-11 
17:19172505 37.4594 rs28760541 EPN2 6.72E-14 1.36E-10 
11:120169962 41.0203 rs11217806 POU2F3 6.85E-14 1.38E-10 
17:19211073 40.4834 rs8072587 EPN2 7.32E-14 1.48E-10 
3:58114655 48.4779 rs9311669 FLNB 1.13E-13 2.27E-10 
17:19224397 62.5221 rs6587216 EPN2 1.22E-13 2.46E-10 
10:55949899 34.7048 rs16905691 PCDH15 1.24E-13 2.50E-10 
3:58118555 85.8007 rs12632456 FLNB 1.49E-13 3.02E-10 
13:102821327 44.81 rs4771420 FGF14 1.67E-13 3.37E-10 
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1:234330571 58.7768 rs7531988 SLC35F3 8.24E-50 1.66E-46 
22:46835000 99.9133 rs4823810 CELSR1 5.65E-46 1.14E-42 
1:36437991 73.6494 rs12096413 EIF2C3 1.10E-45 2.23E-42 
11:120169962 41.0203 rs11217806 POU2F3 1.02E-44 2.07E-41 
8:73848139 63.9317 rs3735829 KCNB2 1.35E-42 2.72E-39 
15:26905021 56.0904 rs17738087 GABRB3 2.79E-42 5.63E-39 
13:102824147 43.845 rs9557826 FGF14 3.24E-41 6.54E-38 
11:120170030 43.5 rs11217807 POU2F3 7.63E-41 1.54E-37 
1:36426398 28.9502 rs7521611 EIF2C3 3.63E-40 7.33E-37 
1:36099200 80.6328 rs6668101 PSMB2 1.69E-37 3.41E-34 
13:102816760 59.7048 rs2607642 FGF14 2.22E-37 4.49E-34 
2:109579738 62.7011 rs260690 EDAR 5.99E-37 1.21E-33 
12:66114478 77.5812 rs10784490 
between PCNPP3 
and RPSAP52 
1.20E-36 2.43E-33 
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11:120121323 45.8118 rs11217775 POU2F3 2.49E-36 5.03E-33 
2:109556667 66.5683 rs260709 EDAR 4.41E-36 8.90E-33 
10:55935850 65.0369 rs4935501 PCDH15 3.71E-35 7.49E-32 
2:109567925 64.8321 rs260700 EDAR 7.64E-35 1.54E-31 
11:120129533 55.4446 rs11217777 POU2F3 1.82E-34 3.68E-31 
13:102821327 44.81 rs4771420 FGF14 1.85E-34 3.74E-31 
1:36424338 43.6421 rs716924 EIF2C3 3.71E-34 7.49E-31 
8:73845337 32.2472 rs16919329 KCNB2 1.14E-33 2.31E-30 
2:109556761 63.1882 rs260710 EDAR 1.16E-33 2.35E-30 
13:34864240 64.5738 rs2065982 
between RFC3 
and GAMTP2 
1.94E-33 3.91E-30 
10:55949151 88.9483 rs16905686 PCDH15 2.72E-33 5.50E-30 
2:109557099 54.6218 rs260711 EDAR 5.14E-33 1.04E-29 
3:58118555 85.8007 rs12632456 FLNB 1.73E-32 3.49E-29 
2:152829657 91.5424 rs6721518 CACNB4 3.26E-32 6.57E-29 
12:66115201 52.0996 rs12300373 
between PCNPP3 
and RPSAP52 
6.21E-32 1.25E-28 
2:240282208 86.7675 rs12471054 HDAC4 2.02E-31 4.08E-28 
3:58091098 50.4041 rs7638552 FLNB 2.35E-31 4.75E-28 
  
     
  
P
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17:19172505 37.4594 rs28760541 EPN2 3.19E-24 6.45E-21 
17:19175317 65.7768 rs28591622 EPN2 6.40E-24 1.29E-20 
17:19204863 56.3708 rs4924980 EPN2 7.78E-24 1.57E-20 
18:19765739 45.5203 rs16964572 GATA6 1.14E-22 2.30E-19 
11:120133494 98.3911 rs2715883 POU2F3 1.97E-22 3.97E-19 
17:19239432 42.9114 rs1043809 EPN2 7.72E-22 1.56E-18 
17:19211073 40.4834 rs8072587 EPN2 1.86E-21 3.75E-18 
8:116776330 42.4465 rs10505268 TRPS1 1.89E-21 3.83E-18 
12:66168151 69.1679 rs7134682 - 5.90E-21 1.19E-17 
8:116700847 40.9004 rs7842702 TRPS1 6.50E-21 1.31E-17 
11:120130512 46.8339 rs1941411 POU2F3 8.60E-21 1.74E-17 
10:34755348 32.3266 rs1978806 PARD3 1.14E-20 2.30E-17 
12:66115201 52.0996 rs12300373 
between PCNPP3 
and RPSAP52 
2.98E-20 6.02E-17 
6:145055331 52.5387 rs4463276 UTRN 6.70E-20 1.35E-16 
17:19247075 43.8229 rs4924987 B9D1 7.21E-20 1.46E-16 
13:102816760 59.7048 rs2607642 FGF14 8.02E-19 1.62E-15 
8:116673229 40.3579 rs10955754 TRPS1 1.10E-18 2.23E-15 
8:116670666 58.3266 rs10505261 TRPS1 1.86E-18 3.76E-15 
11:66910826 78.0111 rs4375446 KDM2A 2.73E-18 5.50E-15 
1:36367780 89.7804 rs595961 EIF2C1 3.87E-18 7.82E-15 
12:66256395 58.5129 rs11175944 HMGA2 6.78E-18 1.37E-14 
7:107704688 66.2269 rs10257477 LAMB4 1.14E-17 2.31E-14 
11:66889299 44.5055 rs4244819 KDM2A 1.31E-17 2.64E-14 
8:116823046 51.3579 rs6981915 near EIF3H 3.47E-17 7.01E-14 
X:39944072 44.6808 rs5963734 BCOR 3.80E-17 7.67E-14 
11:64532579 68.7435 rs523200 SF1 3.81E-17 7.69E-14 
11:120118498 74.0258 rs2847502 POU2F3 4.44E-17 8.97E-14 
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14:101142890 43.2491 rs730570 C14orf70 7.78E-17 1.57E-13 
X:39934488 75.9539 rs6610384 BCOR 1.22E-16 2.46E-13 
8:72127562 34.5258 rs79867447 EYA1 2.08E-16 4.20E-13 
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13:102824147 43.845 rs9557826 FGF14 1.08E-37 2.19E-34 
1:36099200 80.6328 rs6668101 PSMB2 9.32E-37 1.88E-33 
13:102816760 59.7048 rs2607642 FGF14 3.53E-36 7.12E-33 
1:36437991 73.6494 rs12096413 EIF2C3 4.84E-36 9.78E-33 
1:36426398 28.9502 rs7521611 EIF2C3 5.28E-34 1.07E-30 
11:120169962 41.0203 rs11217806 POU2F3 7.27E-34 1.47E-30 
2:109579738 62.7011 rs260690 EDAR 1.39E-33 2.81E-30 
13:102821327 44.81 rs4771420 FGF14 1.87E-33 3.77E-30 
11:120170030 43.5 rs11217807 POU2F3 2.86E-33 5.78E-30 
17:19224397 62.5221 rs6587216 EPN2 6.78E-33 1.37E-29 
17:19175317 65.7768 rs28591622 EPN2 4.91E-32 9.91E-29 
17:19172505 37.4594 rs28760541 EPN2 5.31E-32 1.07E-28 
17:19204863 56.3708 rs4924980 EPN2 8.39E-32 1.69E-28 
22:46835000 99.9133 rs4823810 CELSR1 3.26E-31 6.59E-28 
8:73848139 63.9317 rs3735829 KCNB2 4.08E-31 8.24E-28 
1:234330571 58.7768 rs7531988 SLC35F3 6.60E-31 1.33E-27 
2:240282208 86.7675 rs12471054 HDAC4 1.03E-30 2.09E-27 
13:102778223 39.8653 rs66578550 FGF14 1.09E-30 2.21E-27 
17:19211073 40.4834 rs8072587 EPN2 1.87E-30 3.77E-27 
13:102778196 39.5387 rs16959781 FGF14 5.24E-30 1.06E-26 
17:19239432 42.9114 rs1043809 EPN2 7.00E-30 1.41E-26 
2:109567925 64.8321 rs260700 EDAR 9.50E-30 1.92E-26 
13:34864240 64.5738 rs2065982 
between RFC3 
and GAMTP2 
1.95E-29 3.95E-26 
12:112843363 49.4852 rs2301723 RPL6 9.99E-29 2.02E-25 
2:109556667 66.5683 rs260709 EDAR 5.24E-28 1.06E-24 
11:120118498 74.0258 rs2847502 POU2F3 1.28E-27 2.58E-24 
3:58118555 85.8007 rs12632456 FLNB 1.47E-27 2.98E-24 
2:109562495 67.6753 rs260714 EDAR 1.50E-27 3.03E-24 
8:73845337 32.2472 rs16919329 KCNB2 2.44E-27 4.92E-24 
1:36424338 43.6421 rs716924 EIF2C3 2.49E-27 5.03E-24 
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2:109556761 63.1882 rs260710 EDAR 5.93E-18 1.20E-14 
2:109579738 62.7011 rs260690 EDAR 5.46E-17 1.10E-13 
2:109557099 54.6218 rs260711 EDAR 7.39E-16 1.49E-12 
10:55971427 55.2399 rs11004141 PCDH15 3.79E-15 7.66E-12 
2:109556667 66.5683 rs260709 EDAR 1.02E-14 2.07E-11 
3:58091098 50.4041 rs7638552 FLNB 1.38E-14 2.78E-11 
2:109567925 64.8321 rs260700 EDAR 3.45E-14 6.97E-11 
3:58112556 54.9797 rs2362905 FLNB 3.92E-14 7.92E-11 
12:66115201 52.0996 rs12300373 
between PCNPP3 
and RPSAP52 
7.29E-14 1.47E-10 
3:58118555 85.8007 rs12632456 FLNB 7.48E-14 1.51E-10 
3:58114655 48.4779 rs9311669 FLNB 7.59E-14 1.53E-10 
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3:58112488 57.8506 rs2362904 FLNB 7.71E-14 1.56E-10 
10:55968685 64.7048 rs10825273 PCDH15 1.34E-13 2.70E-10 
1:36426398 28.9502 rs7521611 EIF2C3 1.72E-13 3.47E-10 
11:120169962 41.0203 rs11217806 POU2F3 1.80E-13 3.63E-10 
2:109562495 67.6753 rs260714 EDAR 2.08E-13 4.20E-10 
1:36437991 73.6494 rs12096413 EIF2C3 2.76E-13 5.58E-10 
1:36424338 43.6421 rs716924 EIF2C3 3.02E-13 6.09E-10 
1:234330571 58.7768 rs7531988 SLC35F3 4.01E-13 8.10E-10 
10:55949151 88.9483 rs16905686 PCDH15 4.09E-13 8.25E-10 
3:58113930 49.703 rs2362907 FLNB 4.92E-13 9.93E-10 
10:55996761 44.9871 rs721825 PCDH15 4.97E-13 1.00E-09 
3:58144340 62.6845 rs6787425 FLNB 8.64E-13 1.74E-09 
3:58109162 64.0148 rs1131356 FLNB 1.44E-12 2.92E-09 
11:120170030 43.5 rs11217807 POU2F3 1.48E-12 2.98E-09 
17:19175317 65.7768 rs28591622 EPN2 2.11E-12 4.26E-09 
10:55935850 65.0369 rs4935501 PCDH15 2.46E-12 4.96E-09 
10:55949899 34.7048 rs16905691 PCDH15 3.68E-12 7.43E-09 
14:97277005 61.9908 rs722869 VRK1 4.85E-12 9.79E-09 
11:120129533 55.4446 rs11217777 POU2F3 1.18E-11 2.38E-08 
 
 
 
In general, all the principal components demonstrated higher association values (lower 
p-values) than the actual craniofacial measurements they were representing. This is not 
surprising, given the fact that each principal component represents numerous 
measurements and as a result may demonstrate association with several markers. A fact 
that is even more important, is that principal components may represent the craniofacial 
“vectors” (or shapes), which in essence indicate the morphological direction (or areas) 
in which a group of cells is migrated during proliferation and formation of specific 
facial structures. This complex process is clearly regulated by hundreds of genes, while 
a few of them were specified in the current project. 
Given a large number of significantly associated markers and genes, the following 
section briefly outlines only a few, which demonstrated the most significant association 
with the principal components.  
Principal component number 15 demonstrated the most significant p-values and was 
associated with 30 markers in 13 genes and 2 intergenic regions, such as SLC35F3, 
CELSR1, EIF2C3, POU2F3, KCNB2, GABRB3, FGF14, PSMB2 genes. The majority 
of these genes previously were not associated with craniofacial morphology or related 
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genetic syndromes. The most significant association was demonstrated with intronic 
SNP rs7531988 (p-value 8.24E-50), located in the Solute Carrier Family 35 Member F3 
(SLC35F3) gene, which encodes solute transporter, although its specific function is 
unknown. The same gene was also associated with the nasal vertical prominence angle 
(Table 51). Notably, an important paralog of this gene is SLC35F4, which was linked to 
bipolar disorder as a part of a GWAS study [468]. Bipolar disorder is a serious mental 
illness, related to schizophrenia. Interestingly, schizophrenia was previously associated 
with distinctive facial features, as discussed in Chapter 1 and elsewhere [109, 110]. 
Another protein of the same Solute Carrier Family 35, SLC35D1 was previously linked 
to the Schneckenbecken Dysplasia condition (OMIM:269250), which is associated with 
several symptoms, such as macrocephaly, depressed midface, superliorly oriented orbits 
and short neck. 
Another important gene, significantly associated with multiple principal components is 
EIF2C3. This gene encodes a protein that has a similar function to EIF2C1, which has 
been previously described in this section. KCNB2 gene encodes a potassium voltage-
gated channel required for epithelial electrolyte transport. CELSR1, POU2F3 and 
GABRB3 genes were found associated with specific craniofacial measurements and 
briefly described previously in this section. On the contrary, the fibroblast growth factor 
(FGF14) was shown to be involved in a variety of biological processes, including 
embryonic development, cell growth and morphogenesis 
SNP annotation analysis using SNPnexus revealed that of the 161 significant markers, 
the majority were found in introns. While only twelve (12) are located in coding regions, 
of which 6 are non-synonymous SNPs. Functional prediction by both SIFT and 
PolyPhen demonstrated however, that these amino acid substitutions would probably 
have no significant effect on the protein function. Ten more SNPs (out of 161 markers) 
are located in either 3’ or 5’ genomic regions, which are known to be involved in gene 
regulation. Five of these SNPs (rs61726477, rs1937025, rs16905686, rs2715881 and 
rs56293475) were predicted to affect transcription binding sites. Regulome analysis of 
all significant markers predicted 126 markers to have a regulatory function. This finding 
can be seen as a confirmation for the 2013 publication (discussed previously in this 
section), which utilized mouse model and found that transcriptional enhancers may 
regulate fine-tuning of the craniofacial shape and contribute to the spectrum of facial 
variation found in human population [213].  
In conclusion, this study has identified numerous genetic markers in a set of candidate 
genes, significantly associated with various visible craniofacial traits. All the 
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associations revealed in this study are novel and have not been previously reported. The 
results of the association analysis also demonstrated a complex level of interactions 
between the genes involved in the craniofacial embryonic development. Despite the 
importance of the association between specific 3D measurements and SNPs, the 
association of principal components provide more composite information. Given that 
embryonic developmental processes such as cells proliferation, polarity orientation and 
migration occur in the 3D environment, principal components that in essence represent 
specific facial shapes (or “vectors”) provide a more accurate representation of these 
processes. It should be emphasized though, that given the nature of the craniofacial 
traits, these complex traits are regulated by many different genes. This aspect highlights 
the demand for additional association studies, incorporating dense SNP panels and even 
more importantly, better coverage of the craniofacial characteristics, perhaps with a 
dense polygon mesh.  
The identification of associated genetic markers in this project forms a foundation for 
designing statistical models and subsequent assays for prediction of facial appearance. 
However, keeping in mind the recent human height studies association result, which 
screened more than 180,000 individuals and found more than 180 significant variants; 
the prediction of the facial appearance would probably be a more complicated task 
[298-300, 469]. 
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5.4.  Assessment of statistical models for prediction of EVTs and ancestry 
 
5.4.1. Introduction 
A comprehensive EVT prediction assay is expected to include both AIMs and 
pigmentation-informative markers, providing extensive information for investigative 
purposes. This approach can be called a “meta-analysis” as it will analyse and predict 
the likelihood of specific external appearance, most likely by classifying an unknown 
individual with a relevant database hit. Although it is not likely that predictive kit in the 
near future will produce an image comparable to a photograph, this tool can provide an 
independent means for validating eyewitness testimony, (given the notorious inaccuracy 
of eyewitness description) or supply valuable information in the absence of such. 
This section summarizes the results of a preliminary statistical analysis for prediction of 
several pigmentation and craniofacial traits and ancestry. Due to a time limit of this 
project, only a small subset of traits was evaluated for prediction purposes, and the 
results presented in this section are currently undergoing further analysis. Regardless, 
these results demonstrate a first attempt to create statistical models for prediction of the 
craniofacial traits, which has not been performed previously.  
 
5.4.2. Methods 
Statistical modelling was performed using the same genotype and phenotype 
data, which were detailed in Section 5.2. Prediction model was based on the forward 
stepwise conditional logistic regression, using PASW Statistics 18 (SPSS, Inc., 2009, 
Chicago, IL). In this model, each marker is added at a time and after each step, the 
model measures a pseudo-R
2
 (Nagelkerke) value of the output to assess its predictive 
power. Following this algorithm, each step of the regression has iterated over all alleles 
and included them in the model when the p-value for prediction of the phenotype was 
improved.  
The PASW Statistics algorithm used for the logistic regression analysis removed 
samples, if even one datum point (genotype or phenotype) used to generate the 
predictive model was missing. Given that algorithm was not tolerant for missing data, 
an imputation approach using BEAGLE software was undertaken. This software 
package applies a localised haplotype-cluster model by alignment of missing genotypes 
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in the analysed sample set to other individuals in the relevant population [470]. The 
imputation resulted in 1,642 fully genotyped markers in 567 individuals. As a result, the 
PASW Statistics was able to predict phenotypes of these samples.  
For prediction purposes, each of the numeric craniofacial distances was artificially 
divided into five bins, by finding the minimum and maximum value of each phenotype 
and calculating their difference. Subsequently, a calculation of 0.2 x ‘difference’ was 
used as a "step size" function, to obtain five bins per each trait. To test the accuracy of 
the model, twenty five “blind” samples were randomly removed from the dataset and 
used for prediction. Based on the prediction analysis, the following statistics were 
calculated: true and false positives, true and false negatives, sensitivity, specificity, 
positive predictive value, negative predictive value, positive likelihood ratio (LR+) and 
negative likelihood ratio (LR-). 
 
 
5.4.3. Results and discussion 
Statistical models were generated for prediction of pigmentation traits, such as 
blue eyes, brown eyes, brown hair, black hair, fair skin, and black skin; European and 
Asian ancestries; craniofacial measurements (divided into five bins each), such as 
cephalic index (CI), zy-zy, n-prn, n-sn and al-al. Each model estimated the phenotype of 
567 individuals by analysing their regression with 1,462 genetic markers. 
The results of the statistical modelling are summarized in Table 54. 
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Table 54. Prediction model results for investigated phenotypes (blue eyes, brown eyes, brown hair, black hair, fair skin, and black skin; European and Asian ancestries; cephalic index (CI), zy-zy, n-prn, n-
sn and al-al) in 567 individuals. The numbers (1-5) near each craniofacial distance represent artificial bins. Legends: (TP and FP) are true and false positives, (TN and FN) are true and false negatives, (LR+) 
is a positive likelihood ratio and (LR-) is a negative likelihood ratio.  
 
TP TN FP FN Correct Incorrect Total % of correct predictions
Nagelkerke R 
Square
Sensitivity Specificity Positive predictive value
Negative predictive 
value
LR+ LR-
Brown hair 262 261 19 25 523 44 567 92.2 .850 91.29% 33.29% 93.24% 91.26% 1.4 0.3
Black hair 134 389 19 25 523 44 567 92.2 .855 84.28% 42.65% 87.58% 93.96% 1.5 0.4
Blue eyes 132 372 35 28 504 63 567 88.9 .733 82.50% 91.40% 79.04% 93.00% 9.6 0.2
Brown eyes 274 279 6 8 553 14 567 97.5 .918 97.16% 97.89% 97.86% 97.21% 46.2 0.0
European 
ancestry
351 194 13 9 545 22 567 96.1 .902 97.50% 93.72% 96.43% 95.57% 15.5 0.0
Asian ancestry 42 511 5 9 553 14 567 97.5 .833 82.35% 99.03% 89.36% 98.27% 85.0 0.2
Fair skin 115 362 37 53 477 90 567 84.1 .598 68.45% 90.73% 75.66% 87.23% 7.4 0.3
Black skin 11 413 142 1 424 143 567 74.8 .657 91.67% 74.41% 7.19% 99.76% 3.6 0.1
CI 1 16 532 2 17 548 19 567 96.6 .525 48.48% 99.63% 88.89% 96.90% 129.5 0.5
CI 2 308 182 42 35 490 77 567 86.4 .760 89.80% 81.25% 88.00% 83.87% 4.8 0.1
CI 3 103 410 20 34 513 54 567 90.5 .774 75.18% 95.35% 83.74% 92.34% 16.2 0.3
CI 4 0 556 0 11 556 11 567 98.1 .450 - 100.00% - 98.06% - -
CI 5 1 565 1 0 566 1 567 99.8 .667 100.00% 99.82% 50.00% 100.00% 566.0 0.0
zy-zy 1 191 290 36 50 481 86 567 84.8 .705 79.25% 88.96% 84.14% 85.29% 7.2 0.2
zy-zy 2 173 344 22 28 517 50 567 91.2 .830 86.07% 93.99% 88.72% 92.47% 14.3 0.1
zy-zy 3 16 526 5 20 542 25 567 95.6 .577 44.44% 99.06% 76.19% 96.34% 47.2 0.6
zy-zy 4 0 565 0 2 565 2 567 99.6 .395 - 100.00% - 99.65% - -
zy-zy 5 3 532 5 27 535 32 567 94.4 .363 10.00% 99.07% 37.50% 95.17% 10.7 0.9
n-prn 1 135 373 23 36 508 59 567 89.6 .745 78.95% 94.19% 85.44% 91.20% 13.6 0.2
n-prn 2 185 314 34 34 499 68 567 88.0 .788 84.47% 90.23% 84.47% 90.23% 8.6 0.2
n-prn 3 52 475 14 26 527 40 567 92.9 .673 66.67% 97.14% 78.79% 94.81% 23.3 0.3
n-prn 4 2 552 0 13 554 13 567 97.7 .765 13.33% 100.00% 100.00% 97.70% 0.9
n-prn 5 7 534 3 23 541 26 567 95.4 .437 23.33% 99.44% 70.00% 95.87% 41.8 0.8
n-sn 1 134 361 32 40 495 72 567 87.3 .758 77.01% 91.86% 80.72% 90.02% 9.5 0.3
n-sn 2 174 315 41 37 489 78 567 86.2 .734 82.46% 88.48% 80.93% 89.49% 7.2 0.2
n-sn 3 53 478 10 26 531 36 567 93.7 .665 67.09% 97.95% 84.13% 94.84% 32.7 0.3
n-sn 4 2 553 1 11 555 12 567 97.9 .486 15.38% 99.82% 66.67% 98.05% 85.2 0.8
n-sn 5 12 526 4 25 538 29 567 94.9 .457 32.43% 99.25% 75.00% 95.46% 43.0 0.7
al-al 1 189 309 34 35 498 69 567 87.8 .737 84.38% 90.09% 84.75% 89.83% 8.5 0.2
al-al 2 169 327 34 37 496 71 567 87.5 .743 82.04% 90.58% 83.25% 89.84% 8.7 0.2
al-al 3 25 508 11 23 533 34 567 94.0 .624 52.08% 97.88% 69.44% 95.67% 24.6 0.5
al-al 4 3 557 3 4 560 7 567 98.8 .556 42.86% 99.46% 50.00% 99.29% 80.0 0.6
al-al 5 5 534 5 23 539 28 567 95.1 .454 17.86% 99.07% 50.00% 95.87% 19.2 0.8
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Blue and brown eyes, as well as European and Asian ancestries demonstrated the 
highest accuracy of prediction (from 88.9% to 97.5%) in the general prediction model. 
The accuracy and efficiency of prediction was also assessed by evaluating the following 
parameters: Nagelkerke R
2
 (between 0.733 to 0.918), sensitivity (between 82.4% and 
97.5%), specificity (between 91.4% and 99.0%), positive predictive value (between 79.0% 
and 97.9%), negative predictive value (between 93% to 98.3%), positive likelihood ratio 
(between 9.6 to 85) and negative likelihood ratio (between 0 to 0.2). A brief 
interpretation of these results is that these models demonstrated high robustness (R
2
 
values) and high ability to accurately include or exclude an individual from these 
phenotypes.  
Prediction models for brown and black hair demonstrated high accuracy (92.2%), 
robustness (R
2 
= 0.850) and sensitivity (between 84.3% and 91.3%), although low 
specificity of exclusion. Prediction of the black and fair skin colour demonstrated a 
moderate accuracy and efficiency of prediction, although the sample size for black skin 
was of a limit number, which could affect the output. 
Prediction of the craniofacial distances demonstrated relatively high accuracy for 
several phenotypes. It should be noted however, that due to non-equal (non-normal) 
distribution of numeric values in each bin, some of them do not represent an adequate 
phenotype for prediction (e.g. CI 1, 4 and 5). As a result, prediction models for only the 
following phenotypes were evaluated: CI 2, CI 3, zy-zy 1, zy-zy 2, n-prn 1, n-prn 2, n-
prn 3, n-sn 1, n-sn 2, n-sn 3, al-al 1 and al-al 2.  
In general, all these phenotypes demonstrated a good prediction accuracy (between 84.8% 
and 93.7%). The goodness-of-fit for these models varied from 0.665 to 0.830 and the 
sensitivity and specificity showed values between 66.7% to 98.8% and between 81.3% 
and 98% respectively. The rest of the statistical values, such as negative and positive 
predictive value and negative and positive likelihood ratio also confirmed the robustness 
of these models.  
 
5.4.4. Accuracy of prediction on blind samples 
To ascertain the validity of the model predictions for each phenotype, binary 
logistic regressions were run on 25 randomly chosen “blind” samples. The results of 
phenotype prediction for these samples are summarized in Table 55. 
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Table 55. Actual prediction results for 25 blind samples. The numbers (1-5) near each craniofacial distance represent artificial bins. Legends: (TP and FP) are true and false positives, (TN and FN) are true 
and false negatives, (LR+) is a positive likelihood ratio and (LR-) is a negative likelihood ratio. 
 
TP TN FP FN Correct Incorrect Total % of correct predictions Sensitivity Specificity Positive predictive value Negative predictive value LR+ LR-
Brown hair 8 6 5 6 14 11 25 56.0 57.1% 30.0% 61.5% 50.0% 0.8 1.4
Black hair 1 16 4 4 17 8 25 68.0 20.0% 48.5% 20.0% 80.0% 0.4 1.7
Blue eyes 8 15 2 0 23 2 25 92.0 100.0% 88.2% 80.0% 100.0% 8.5 0.0
Brown eyes 7 16 1 1 23 2 25 92.0 87.5% 94.1% 87.5% 94.1% 14.9 0.1
European 
ancestry
14 6 1 4 20 5 25 80.0 77.8% 85.7% 93.3% 60.0% 5.4 0.3
Asian ancestry 1 22 0 2 23 2 25 92.0 33.3% 100.0% 100.0% 91.7% - 0.7
Fair skin 5 11 5 4 16 9 25 64.0 55.6% 68.8% 50.0% 73.3% 1.8 0.6
Black skin 0 20 5 0 20 5 25 80.0 - 80.0% - 100.0% - -
CI 1 0 25 0 0 25 0 25 100.0 - 100.0% - 100.0% - -
CI 2 7 5 7 6 12 13 25 48.0 53.8% 41.7% 50.0% 45.5% 0.9 1.1
CI 3 3 10 4 8 13 12 25 52.0 27.3% 71.4% 42.9% 55.6% 1.0 1.0
CI 4 0 25 0 0 25 0 25 100.0 - 100.0% - 100.0% - -
CI 5 0 24 1 0 24 1 25 96.0 - 96.0% - 100.0% - -
zy-zy 1 7 4 4 10 11 14 25 44.0 41.2% 50.0% 63.6% 28.6% 0.8 1.2
zy-zy 2 2 13 6 4 15 10 25 60.0 33.3% 68.4% 25.0% 76.5% 1.1 1.0
zy-zy 3 0 24 1 0 24 1 25 96.0 - 96.0% - 100.0% - -
zy-zy 4 0 25 0 0 25 0 25 100.0 - 100.0% - 100.0% - -
zy-zy 5 0 23 1 1 23 2 25 92.0 0.0% 95.8% - 95.8% 0.0 1.0
n-prn 1 3 10 6 6 13 12 25 52.0 33.3% 62.5% 33.3% 62.5% 0.9 1.1
n-prn 2 1 12 5 7 13 12 25 52.0 12.5% 70.6% 16.7% 63.2% 0.4 1.2
n-prn 3 0 19 3 3 19 6 25 76.0 0.0% 86.4% - 86.4% 0.0 1.2
n-prn 4 0 23 0 2 23 2 25 92.0 0.0% 100.0% - 92.0% - 1.0
n-prn 5 0 23 0 2 23 2 25 92.0 0.0% 100.0% - 92.0% - 1.0
n-sn 1 2 9 5 9 11 14 25 44.0 18.2% 64.3% 28.6% 50.0% 0.5 1.3
n-sn 2 2 10 10 3 12 13 25 48.0 40.0% 50.0% 16.7% 76.9% 0.8 1.2
n-sn 3 1 20 0 4 21 4 25 84.0 20.0% 100.0% 100.0% 83.3% - 0.8
n-sn 4 0 24 0 1 24 1 25 96.0 0.0% 100.0% - 96.0% - 1.0
n-sn 5 0 21 2 2 21 4 25 84.0 0.0% 91.3% - 91.3% 0.0 1.1
al-al 1 4 14 3 4 18 7 25 72.0 50.0% 82.4% 57.1% 77.8% 2.8 0.6
al-al 2 7 9 4 5 16 9 25 64.0 58.3% 69.2% 63.6% 64.3% 1.9 0.6
al-al 3 0 23 2 0 23 2 25 92.0 - 92.0% - 100.0% - -
al-al 4 0 25 0 0 25 0 25 100.0 - 100.0% - 100.0% - -
al-al 5 0 19 2 4 19 6 25 76.0 0.0% 90.5% - 82.6% 0.0 1.1
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Prediction of the blue and brown eyes and the Asian ancestry resulted in 92% accuracy 
and high sensitivity (except for the Asian ancestry), specificity and efficiency. 
Compared to the model, these values were slightly lower for the brown eye and Asian 
ancestry and slightly higher for the blue eye prediction (Table 55). The European 
ancestry and black skin colour prediction resulted in 80% accuracy (compared to 96% 
and 74.8% in the model respectively) and lower specificity and sensitivity. The 
prediction accuracies for black and brown hair as well as for fair skin, were significantly 
lower than predicted by the model (between 56% and 68% compared to between 84% 
and 92% respectively). 
Published data demonstrate over 90% accuracy for blue and brown eye colour, 78.5% 
for brown and 87.5% for black hair colour on average [296]. Another recent study 
demonstrated predictions of eye colour being 85 % correct for brown and 70 % correct 
for blue eyes, predictions of hair colour 72 % accurate for brown and 58 % accurate for 
black hair and 97% accurate for European and Asian ancestries [377]. Considering 
published results, it can be summarized that prediction accuracy of blind samples 
demonstrated in this study, was in consensus with published data. 
Prediction of al-al 1 and al-al 2 bins however, demonstrated low prediction accuracy of 
72% and 64%, compared to 87.8% and 87.5% respectively in the model. While the 
prediction of CI 2, CI 3, zy-zy 1, zy-zy 2, n-prn 1, n-prn 2, n-prn 3, n-sn 1, n-sn 2 and n-
sn 3 bins was completely unsuccessful (equal to flipping a coin). These results however, 
maybe misleading, as only 25 blind samples were used for prediction. In addition, most 
craniofacial phenotypes were underrepresented or represented unequally in their 
respective bins due to “unweighted” bins separation. 
As noted in Section 5.4.1, these results are only preliminary and are currently under 
further analysis. This analysis includes usage to alternative statistical software in order 
to reduce the problem of algorithm intolerance of missing data, calculating adequately 
weighted bins for craniofacial measurements and using a bigger blind sample set for 
prediction. Given the high association linkage demonstrated by these traits as well as 
according to the accuracy demonstrated by prediction model, the final prediction of 
these phenotypes in a larger blind sample set, holds promise to surpass preliminary 
output.  
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 Chapter 6   
Summary, conclusions and future directions 
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6.1.  Introduction 
The overall goal of the current study was to identify SNPs involved in the 
determination of craniofacial morphology. To confirm the statistical methods used, an 
analysis of the association of pigmentation traits and ancestry with known previously 
described genetic markers was also performed. The final aim was to incorporate 
significantly associated SNPs in prediction models for accurate estimation of externally 
visible traits (EVT) and ancestry in a blind sample set. 
Single nucleotide polymorphisms (SNPs) have started to play a progressively important 
role in the forensic DNA analysis over the last ten years. While short tandem repeats 
(STRs) continue to be the main “players” in the forensic identification frontier, other 
fields such as forensic molecular phenotyping (FMP) are predominated by SNP usage. 
The main “non-identity” fields of forensic interest are pigmentation and ancestry 
prediction. Estimation of eye, skin and hair colour as well as ancestry of an unknown 
DNA sample holds great potential as an investigative lead by reducing a pool of 
potential suspects as well as assisting with uncovering the identity of unknown human 
remains and mass disaster victims. However, the genetic factors behind the most 
important part of human visual appearance – the face, remain poorly understood.  
This project attempted to find genetic polymorphisms that influence normal variation in 
specific craniofacial characteristics. Subsequently, these markers can be incorporated 
with pigmentation, ancestry and identity-informative SNPs into a comprehensive 
forensic assay. 
    
6.2.  Candidate genes and SNPs selection process 
In the last two years, a limited number of attempts have been made to identify SNPs 
that may contribute to normal variation in craniofacial appearance. To date, several 
markers, associated with bizygomatic distance and several nasal area features have been 
identified [76, 77]. While both studies have implemented a genome wide association 
study (GWAS) approach by screening hundreds of thousands SNPs, the current project 
strived to achieve the same goal using candidate genes approach. The main advantage of 
the candidate genes study over GWAS is that the former was focused on genes that 
were previously associated with craniofacial embryogenetics or various inherited 
craniofacial syndromes, rather than screening hundreds of thousands of non-specific 
markers. This approach aimed to increase the chances of finding significant associations 
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between SNPs and visible traits and also to reduce the number of samples needed for 
robust association analysis.  
An extensive literature and web database search for candidate genes and markers 
revealed 177 genes and intergenic regions comprising approximately 1,200 SNPs, 
potentially involved in normal craniofacial appearance variation. This list was 
subsequently extended by 331 markers, previously associated with normal pigmentation, 
208 ancestry informative markers, 91 identity informative SNPs, 46 INDELs, 17 
autosomal STRs, 15 Y-chromosome STRs, 37 Y-chromosome SNPs and 57 
Mitochondrial SNPs. The addition of non-craniofacial markers was made in order to 
build a comprehensive forensic “Identikit”, able to provide complete forensic molecular 
portrait of a questionable sample, including identity-informative, ancestry-informative, 
lineage-informative and appearance-informative markers. It should be noted however, 
that some markers such as mitochondrial SNPs, Y chromosome STRs and 
approximately 20% of the other markers were not genotyped due to primer design 
failure. Other markers, such as autosomal STRs and INDELs were not analysed, due to 
time limits of this project. Nevertheless, the relevant data generated in this study are 
available for subsequent analysis in a future project and demonstrate one of the first 
attempts to incorporate different forensic markers in one assay. 
 
6.3.  Assessment of reproducibility and normal distribution of the craniofacial 
measurements 
The reproducibility of facial measurements was assessed in 54 linear distances, 22 
ratios between linear distances and 10 angular distances in 13 facial images tested on 
two occasions, by the same examiner. The assessment of the linear craniofacial 
measurements reproducibility from 3D images, demonstrated between 6 mm and less 
than 2 mm median difference (MD), with the majority of measurements (62%), showing 
the lower variation range (≤ 2mm). The evaluation of facial indexes reproducibility 
resulted in the highest MD of 8.02 mm, although 68.2% of all values demonstrated 
significantly lower MD of 3 mm. The reproducibility of the angular distances 
demonstrated very robust results of between 3.75 and 0.38 degrees between paired 
measurements.    
Poor image quality and general difficulty in finding specific craniofacial landmarks in a 
few 3D images were the main factors responsible for the variability between 
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measurements observed. Nevertheless, the current study demonstrated generally higher 
reproducibility, compared to published studies and provided reliable data for genomic 
association analysis. 
 
Assessment of normal distribution of the collected data is the first essential step in the 
quality control process, prior to performing an association (or any other) study with 
genetic markers. While there is no wide scientific consensus on existence of normality 
in a real dataset, this test helps to identify extreme outliers, which may represent 
potential errors in measurements that need to be evaluated and corrected if required. 
The Shapiro-Wilk test for normality was calculated for the craniofacial dataset that was 
segregated by sex and six main population groups. This analysis helped to identify 
several outliers in measurements, resulting from erroneous assignment of craniofacial 
landmarks and subsequent miscalculation of the relevant distances. Following 
correction of the miscalculated values, the majority of the measurements demonstrated 
normal distribution and allowed a robust and more accurate association study.   
The evaluation of such a big variety of craniofacial measurements (n=92) in different 
population groups provided an opportunity to collect valuable data, considering a very 
limited availability of similar data in published sources. While many recorded 
measurements were consistent with the published data, several facial distances produced 
data, which were unavailable previously in the specific population groups (especially 
from 3D images), providing novel and useful information for anthropological research 
and aesthetics medicine application. It should be noted however, that a larger sample set 
(especially of specific ethnicities) is required to replicate the results of this study and 
make further conclusions. 
 
Principal component analysis (PCA) was applied on the craniofacial measurements in 
order to reduce the dimensionality of the data by identifying eigenvectors, along which 
the variation in the data is expected to be maximal. The PCA identified 20 principal 
components, which accounted for almost 90% of total variance (Table 32 and Figure 
52), while the first three and another seven components explained 1/3 and 2/3 of the 
variance respectively. 
The validity of PCA was confirmed by the fact that the craniofacial distances in each 
principal component were automatically grouped according to their similarity in the 
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Euclidean space orientation and corresponding landmarks (Figure 52). The main reason 
behind PCA was to use only these components for subsequent association analysis, 
rather than all the individual measurements, due to time limits. However, eventually all 
the individual measurements and all the principal components were analysed for 
association with genetic markers.   
An additional advantage of PCA was that these eigenvectors provided a more adequate 
representation of the craniofacial morphological structure than individual distances, 
considering the complexity of facial structures formation during the embryonic 
development. In fact, the associations of principal components with genetic markers 
were stronger than of individual measurements, providing valuable information on 
novel genes involved in the craniofacial morphology and the opportunity to incorporate 
these markers in prediction models. 
 
 
6.4.  A pilot study for evaluation of the GoldenGate platform for SNP 
genotyping of pristine and degraded DNA samples 
Supplementary to phenotype prediction capabilities, SNPs offer a greater success 
rate for genotyping severely degraded DNA samples due to shorter regions of amplified 
genome, often impossible with routine STR typing. This advantage was investigated by 
genotyping pristine (n=57) and environmentally challenged (n=42) DNA samples of 
various quantity (20 – 250 ng), implementing both manufacturer recommended and 
complementary methods of whole genome amplification (WGA).  
The sensitivity study demonstrated that the GoldenGate assay is tolerant to a more than 
fivefold decrease in template input (<50 ng vs 250 ng, as recommended by the 
manufacturer). However, it also demonstrated that the genomic template must be of 
high quality, without DNA degradation.  
When the DNA amount was reduced to 20 ng or less, a significant decrease in 
performance as demonstrated by poor call rate and poor allele clustering was observed. 
The exposure of DNA samples to various environmental insults (heat, fresh water and 
salt water) significantly reduced genotyping performance. 
The GoldenGate assay’s input amount of between 50 ng to 250 ng DNA template has 
no practical forensic application (except reference databasing), as routine forensic DNA 
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typing typically deals with 0.5-1 ng of template. In attempts to assess the performance 
of this method with low DNA quantities, samples with a range of 10 ng and 80 ng of 
high molecular weight template were subjected to WGA protocol with several 
alterations. However, the results of the WGA reactions suggest that even for the high 
quality DNA sample, a decent quantity of approximately 50 ng template was needed for 
robust output. In addition, the WGA method introduced an amplification bias, 
especially in samples of low quantity and quality. 
These results demonstrate that despite its relatively high multiplexing ability (up to 96 
markers per reaction), GoldenGate assay does not hold promise for application in the 
routine forensic DNA casework. This conclusion led to assessment of a Massive 
Parallel Sequencing (MPS) platform, capable of genotyping thousands of target markers 
from 10 ng (recommended amount) and down to 100 pg of DNA (with additional 
amplification). The results of this study were published in Journal of Forensic 
Investigation, 1:1 (8), 2013 [349]. 
 
 
6.5.  A pilot study for evaluation of a 96 SNP panel for prediction of 
pigmentation and ancestry 
The visual traits such as eye, hair and skin colour are important characteristics in 
forensic investigation. These traits are highly heritable and are known to be regulated by 
many genes. Extensive research in this field disclosed many specific polymorphisms 
associated with variation in pigmentation that were subsequently incorporated in a 
number of predictive assays. Among other studies, this project included a pilot study 
that investigated performance of the 96-plex SNP assay for prediction of pigmentation 
and ancestry in 917 DNA samples from three main US population groups (African 
Americans, Hispanics and Caucasians). Given that certain pigmentation-informative 
SNPs overlap with AIMs, a relatively small subset of markers can provide enhanced 
assistance by predicting both pigmentation phenotype and ancestry [12, 471]. This topic 
was explored in the current project and demonstrated relatively high prediction accuracy 
for ancestry (84-94% accuracy), although lower accuracy for eye colour (between 71% 
and 89%) and hair and skin colour (between 47% and 85%). The explanation for 
relatively low performance of this assay lay in the significant variation in DNA quality 
and quantity of samples as well as variability between different assay runs, which 
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resulted in many samples and loci with missing data. Given that the algorithm used for 
prediction analysis was intolerant for missing data, approximately 20% of samples and 
28% of SNPs did not meet the requirements for statistical analysis and were exclided. 
Altogether, this led to decreased sensitivity of the prediction model.   
In conclusion, the 96-plex GoldenGate assay demonstrated a relatively low performance 
considering its high demand for DNA quantity and quality and consequently a lower-
than-expected prediction ability. Nevertheless, this pilot study was an important 
performance test for potential forensic use of a high multiplex SNP assay and an 
opportunity to develop predictive models, which were used for subsequent study. 
The results of this study were submitted for publication in the Journal of Forensic 
Investigation. 
 
 
6.6.  Ion Torrent platform evaluation study 
The use of Ion Torrent is relatively new in the research field and completely novel 
in the forensic DNA area. Compared to the GoldenGate assay, it offers almost unlimited 
multiplex capacity and significantly lower DNA input (recommended as 10 ng, which 
although can be decreased to 100 pg with additional amplification steps). Both 
platforms however, are time consuming and require approximately three to four days to 
complete a multistep laboratory procedure. 
This platform was successfully evaluated for the best sample processing and data 
analysis procedures and demonstrated a threefold increase in the sequencing output per 
chip (over 600 Mb compared to 200 Mb), providing superior barcoding options and 
throughput (up to 32 samples per chip). It should be noted however, that “in-house” 
alterations of the chip loading protocol, rather than manufacturer recommendations, 
were mainly responsible for greater sequencing performance in this study. Coupled with 
frequent updates of the Ion Torrent software, hardware and laboratory protocols, these 
issues emphasize the current vulnerability of this platform.  
The sequencing concordance study results demonstrated a relatively high accuracy of 
genotyping, which was significantly increased when a higher sequencing depth and 
stringency of analysis were applied. This pilot study provided novel and promising 
results for potential forensic use of this platform. However, considering the relatively 
277 | P a g e  
low sample size used for this evaluation (due to high cost), an additional study with a 
larger sample size might be required to further validate these results.    
It can be concluded that Ion Torrent with its unprecedented multiplex capacity of 
genotyping thousands of amplicons and relatively low template input holds promise for 
forensic application, although it must be extensively validated prior to routine use. 
 
 
6.7.  Genomic association analysis of externally visible traits (EVT) and 
ancestry 
 
6.7.1. Ancestry association analysis 
The majority of candidate craniofacial markers used in this project were selected 
according to their high Fst values, reflecting high population differentiation. The 
rationale behind this selection was that different population groups demonstrate distinct 
differences in facial features. In addition, many pigmentation markers naturally overlap 
with ancestry informative markers (AIMs) and can potentially predict both 
characteristics (as demonstrated in this study). This singularity is often used by people 
(including eyewitness) to estimate individual’s ancestry, although being quite an 
unreliable estimator. Predicting the ancestry of an unknown DNA sample is valuable for 
both crime investigation, including unidentified human remains, and for anthropology 
research, including ancient DNA analysis.  
This project investigated genetic association of four main ancestries: European, East 
Asian, African and South Asian (Indian). For European ancestry, the most significantly 
associated markers were rs16891982 in SLC45A2 gene (p-value 1.01E-66) and 
rs12913832 in HERC2 gene (p-value 2.34E-27). For Asian ancestry, the most 
significantly associated markers were rs4823810 in CELSR1 gene (p-value 5.98E-79) 
and rs12096413 in EIF2C3 gene (p-value 8.36E-70). For African ancestry, the most 
significantly associated markers were rs2709927 in SEMA3E gene (p-value 3.53E-118) 
and rs56293475 in RTTN gene (p-value 1.14E-116). For Indian ancestry the most 
significantly associated markers were rs16891982 in SLC45A2 gene (p-value 3.17E-17) 
and rs1010872 in SLC45A2 (p-value 4.99E-16). Notably, the European and Indian 
populations produced associations with similar markers, compared to African and Asian 
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population groups. This observation was supported by comparison of craniofacial 
measurements performed in this project as well as by published studies on the linguistic, 
ethno-geographic and genetic history of the Indo-European population [441, 442].  
As expected, some of the significantly associated genes that were identified have a 
predominant role in the pigmentation process, including HERC2 and SLC45A2, while 
others such as CELSR1, SEMA3E and RTTN were linked to the craniofacial embryonic 
development. 
In summary, the genetic associations demonstrated in this project were confirmed by 
previously published results (specifically for the European ancestry), while others 
provided new associations and potential predictors of ancestry in other population 
groups. 
 
 
6.7.2. Pigmentation traits association analysis 
Despite the major contributors for differences in eye, skin and hair colour having 
been identified over the last decade, the function of many genes involved in this process 
is still not fully understood. Given that known genes only partially explain the normal 
pigmentation phenotype, identification of other genes involved in this process could 
provide complimentary information and better prediction accuracy of these traits.  
This project has contributed to this goal by both confirming the association with already 
known genes such as HERC2, OCA2, SLC45A2, SLC24A5 and IRF4 as well as with 
fifteen novel pigmentation genes, including HDAC4, POU2F3, PCDH15, RPL6, 
ARHGEF7, DDX3Y, SEMA3E, PTK6, IL20RA and LAMB4 which were not 
associated previously with particular pigmentation traits, although linked to 
pigmentation-related cellular process or disease (e.g. melanogenesis or melanoma). In 
addition, numerous polymorphisms in 38 genes were found to be in strong association 
with either eye, skin or hair colour, providing new evidence of their potential role in 
pigmentation. Notably, SNP rs10505261 in the TRPS1 gene was strongly associated 
with hair curliness (p-value 1.47E-23). Interestingly, this gene was previously 
associated with the Hypertrichosis syndrome, which involves abnormal amounts of hair 
growth over the body [450]. However, considering the association of the same gene with 
dark skin in this study (p-value 7.15E-67), this finding may indicate an insufficient 
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African population sample size was used. On the other hand, given the very strong 
association results, these findings may indeed be true positive. 
These results not only expand the current knowledge of pigmentation genetics, but also 
form a basis for incorporating these markers in a pigmentation assay for more robust 
prediction.  
 
 
6.7.3. Craniofacial traits association analysis 
Genetic association analysis of the craniofacial features included 92 measurements 
and ratios, collected and calculated using 3D images as well as by direct anthropometric 
examination using a calliper. All the craniofacial measurements were used to perform a 
principal component analysis (PCA) and identify 20 principal components that 
represent all the measurements. Considering the number of measurements used in this 
project for genetic association analysis, it represents the most comprehensive study 
performed to date. In addition, the measurements in this project were collected by a 
single examiner, potentially reducing variability between observations and producing a 
well-grounded data. Opposite to other published studies, which used a combined dataset 
of measurements collected from 2D and 3D images of individuals with a wide range of 
ages, this study focused only on measurements obtained from 3D images of volunteers 
from a compact age group.  
The association analysis was performed using stringent statistical model, incorporating 
the EIGENSTRAT function for population stratification correction conjointly with 
covariates such as sex and BMI, potentially reducing the possibility of false positive 
results. Association analysis revealed 58 genetic markers in 33 different genes and 
intergenic regions that were significantly associated with thirteen linear distances, four 
angular distances and one ratio. Interestingly, the nasal area demonstrated the strongest 
genetic association within the direct measurements, most likely due to the higher 
reproducibility of the relevant measurements (as discussed in Section 4.4). The most 
significantly associated markers were found in the following genes: COL11A1, GLI2, 
LMNA, EPN2 and BMP7 (as shown in Tables 50 and 51). The majority of these genes 
were previously assigned a role in the craniofacial embryonic development or 
associated with syndromes displaying various craniofacial abnormalities in humans or 
model organisms.  
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An association analysis of a non-anthropometrical phenotypic trait - single vs double 
eye lid, showed significant association with nine markers in six genes and intergenic 
regions (Table 52). Several markers in two genes, HYDIN and CELSR1, demonstrated 
the strongest association with this trait. A single eye lid is especially common in the 
East Asian population and these SNPs therefore, can also provide ancestry estimation.  
The most significant associations were found between principal components and genetic 
markers, such as rs7531988 in SLC35F3 gene (p-value 8.24E-50), rs4823810 in 
CELSR1 gene (p-value 5.65E-46) and rs12096413 in EIF2C3 gene (p-value 1.10E-45) 
(summarized in Table 53). Such a strong association can be explained by the fact that 
each component (essentially the eigenvector) incorporates numerous measurements, 
which collectively produce stronger association. The association of eigenvectors with 
specific genes may illustrate underlying morphological processes during the facial 
tissues development (for example cells proliferation, polarity and migration), which in 
essence are regulated by these genes.    
All the associations revealed in this study are novel and have not been previously 
reported. A recently published GWAS found association between the bizygomatic 
distance (zy-zy) and SNP rs987525 near the CCDC26 gene [160]. While the current 
study has not investigated this linkage (as the specific marker was not included in the 
assay), a strong associations between zy-zy distance and a number of markers in the 
HYDIN gene (lowest p-value 6.76E-06) were identified. Despite that, no functional 
linkage between these two genes has been found yet. These results provide an additional 
piece in the complex puzzle of craniofacial genetics.    
Overall, the statistical analysis revealed 161 unique markers in 63 genes and intergenic 
regions associated with either individual craniofacial measurements or principal 
components, with the majority of markers located in either introns, 5` and 3` of genes or 
in the intergenic regions. The functional annotation of these markers revealed that 126 
of 161 markers may have potentially functional regulatory role, such as affecting 
transcription binding sites. A search for protein network annotation with all significant 
genes demonstrated a complex level of interactions between almost all genes (except 
one). 
The identification of novel genetic associations found in this project, provides valuable 
information for better understanding of the craniofacial embryogenetics and establishes 
the first attempt to predict facial appearance from a DNA sample. 
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6.8.  Assessment of the prediction power of a SNP set for EVTs and ancestry 
Following the genetic association analysis, a pilot study for constructing statistical 
prediction models was performed. Statistical models, generated for prediction of several 
phenotypes, including craniofacial traits, demonstrated reasonably high prediction 
accuracy, specificity and sensitivity. However, an actual prediction of these phenotypes 
on a “blind” sample set of 25 individuals resulted in lower prediction accuracy. It must 
be noted, that these results are preliminary and currently undergoing further analysis 
and refinement. 
 
 
6.9.  Future directions 
Genetic regulation of the craniofacial embryonic development and as a result an 
extraordinary variety in human facial appearance is extremely complex process. This 
project has briefly investigated a set of candidate markers, which may be responsible for 
these variations. Numerous genetic markers were found associated with several 
craniofacial measurements and shapes (represented by principal components), revealing 
novel and important details of the craniofacial embryogenetics. However, due to time, 
cost and labour limitations, this study has not achieved its full potential. There is a clear 
need to continue and extend this study in the near future by implementing several 
potential directions, such as:    
 Developing a robust method to acquire maximum information from the 3D 
images by collecting a polygonal mesh details, rather than individual 
landmarks. 
 Performing a follow up study with increased sample size of 3D images and 
DNA samples, especially of specific population groups, such as Africans and 
Aboriginals. This study is essential to replicate the association results of the 
current project. 
 Performing a full genome sequencing of the same samples to identify 
additional markers, involved in the craniofacial morphology.   
 Performing microRNA and methylation pattern profiling to investigate 
additional factors that may be involved in this process. 
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 Conducting an Ion Torrent sensitivity and mixture study to investigate this 
platform’s performance with low DNA quality and quantity as well as its 
mixture deconvulation potential. 
 
 
6.10. Final Conclusions 
This research project has investigated genetic polymorphisms, potentially 
influencing normal craniofacial morphology. An application of relatively novel 
Massively Parallel Sequencing platform for genotyping approximately 6,500 markers 
enabled to identify numerous markers, significantly associated with specific visible 
traits. A large database of almost 600 DNA samples and 3D images was collected. In 
addition to craniofacial characteristics, this study has also investigated an association 
between known SNPs and pigmentation traits and ancestry. The most significantly 
associated pigmentation and ancestry markers found in this project were confirmed by 
previously published results. In addition, a number of novel genes were linked to 
specific pigmentation traits and population groups. The association of SNPs with 
European and Asian ancestry was in general consensus with published data, while the 
identification of most ancestry-informative markers in African and Indian populations 
were novel. 
The association analysis results enabled construction of statistical models for prediction 
of externally visible traits (EVT) and ancestry. Although preliminary, these results are 
highly encouraging and demonstrate a first attempt to predict facial appearance and 
incorporate this information into the all-inclusive forensic Identikit.  
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Gene Protein name Major defects Primary abnormality Human 
orthologue 
Human disorder 
(if known) 
Acvr2  Activin receptor 
IIA  
Meckel’s cartilage/mandibular 
hypoplasia, cleft palate, defective 
eyelid closure (22%)   
Altered signalling during 
early mandible 
development  
ACVR2  –  
Alx3/4  Aristaless 4  Reduced size of parietal bone  Delay in ossification  ALX4  Parietal foramina  
Apaf1  Apoptotic 
protease-
activating factor 
1  
Midline facial cleft, absence of skull 
vault, vomer, ethmoid,rostral 
exencephaly, cleft palate  
Participates in apoptosis  APAF1  –  
Apob  Apolipoprotein 
B  
Exencephaly  –  APOB  Hypobetalipoprot
einemia  
Bapx1  Bagpipe 
homeobox 1  
Reduced or absent 
supraoccipital,exoccipital, 
basioccipital,basisphenoid bones  
Early marker of 
chondrogenesis  
BAPX1  –  
Bmp1  Bone morpho-
genetic protein 1  
Reduced size of frontal, parietal and 
interparietal bones   
Collagen-processing 
defect  
BMP1  –  
Bmp4  Bone morpho-
genetic protein 4  
Haploinsufficiency: short, bent frontal 
and nasal bones (12%), eye defects 
(35%).  
Required for mesoderm 
formation at gastrulation  
BMP4  –  
Bmp5  Bone morpho-
genetic protein 5  
Small external ears  –  BMP5  –  
Bmp7  Bone morpho-
genetic protein 7  
Anophthalmia   At or after lens induction  BMP7  –  
Cart1  Cartilage 
homeoprotein 1  
Failure of neural-tube closure   Deficit of forebrain 
mesenchyme caused 
byexcessive cell death  
CART1  –  
Chrd  Chordin  Defective inner and outer ear 
development  
–  CHRD  –  
Chuk1  Conserved 
helix– loop–
helix 
ubiquitouskinase 
(IKKα)  
Small, missing, maldevelopedskull 
bones   
Intact IKK activation  CHUK  –  
Chx10  ceh-10 homeo-
domain 
homologue  
Microphthalmia, optic nerve aplasia, 
cataract   
Impaired retinal 
progenitor proliferation 
and bipolar-cell 
differentiation  
CHX10  Microphthalmia, 
cataracts  
Col11a1  Procollagen, 
type XI, α1 
Short mandible, cleft palate  Disorganized 
extracellularmatrix  
COL11A1  Stickler syndrome  
Col2a1  Procollagen, Bulging forehead, short snout, cleft Defective endochondral COL2A1  Stickler 
Table S1. A list of loss-of-function mutations that cause craniofacial defects in mice 
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type II, α1  palate  bone formation  syndrome, Kniest 
dysplasia,achondr
ogenesis type II  
Crkol  v-crk avian 
sarcoma CT10 
oncogenehomolo
gue-like  
Short, broad skull   Post-migratory defect 
ofneural crest  
CRKL  –  
Crtl1  Cartilage 
linkprotein 1  
Short skull base with reduced 
ethmoid, sphenoid body, occipital 
bone, Meckel’scartilage, middle ear 
bones  
Required to form cartilage 
proteoglycan aggregates  
CRTL1  –  
Dhcr7  7-dehydrochol-
esterol reductase  
Cleft palate (8%)) Palatal shelves elevate but 
fail to fuse  
DHCR7  Smith–Lemli–
Opitzsyndrome  
Dlx1 Distal-less 
homeobox 
Abnormal ala temporalis, 
minorabnormalities of some other 
bones, small cleft palate in 10%of 
cases  
- DLX1 –  
Dlx2  Distal-less 
homeobox 2  
Abnormal derivatives of first and 
second arches, 80% cleft palate; more 
severe if Dlx1-/-  
Respecification of fate of 
asubset of neural-crest 
cells  
DLX2 –  
Dlx5  Distal-less 
homeobox 5  
28% exencephaly, hypomineralized – 
parietal/ interparietal bones,abnormal 
nasal and otic capsules,branchial 
arches, 88% cleft palate,malformed 
teeth  
 DLX5  –  
Dnmt3b DNA 
methyltrans-
ferase 3b 
Neural-tube defect Defective methylation DNMT3B ICF syndrome 
Ece1 Endothelin-
converting 
enzyme 
Reduced mandible, 
alisphenoid,squamosal, palatine 
bones,absent tympanic ring, Meckel’s 
cartilage 
Abnormal developmentof 
subsets of cephalicneural-
crest tissue  
ECE1 Hirschsprung 
disease,cardiac 
defects 
dysmorphism 
Edn1 Endothelin 1 Reduced mandible, 
zygomatic,temporal bones, absent 
auditoryossicles and tympanic ring 
Abnormal developmentof 
subsets of cephalicneural-
crest tissue 
EDN1 –  
Ednra Endothelin 
receptor type A 
Reduced mandible, 
alisphenoid,squamosal, palatine 
bones, absent tympanic ring, 
Meckel’s cartilage 
Abnormal developmentof 
subsets of cephalicneural-
crest tissue 
EDNRA –  
Egfr Epidermal 
growth factor 
receptor 
Short mandible, 5% cleft palate Abnormal 
morphogenesisof 
Meckel’s cartilage 
EGFR –  
Eya1 Eyes absent 1 Homozygote: absent/malformed  EYA1 Branchio-oto-
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Arrest of inner ear at otic auricles, 
meatus, malleus, inner ear, vesicle 
stage with mandible, maxilla, reduced 
skull increased apoptosis ossification. 
Heterozygote: hearing loss due to 
abnormal sound conduction in middle 
ear 
renal syndrome 
Folbp1 Folate-
bindingprotein 1 
Neural-tube defect Thin neuroepithelium 
with absent forebrain and 
opticvesicles 
FOLR1 – 
Foxa2  Forkhead box a2 
(HNF3β)  
Loss of structures anterior to 
hindbrain  
Required for node and 
notochord formation  
HNF3B  – 
Foxc2  Forkhead box 
C2 (Mfh1)  
 Defects of several skull 
bones   
FOXC2 Lymphoedema– 
distichiasis 
syndrome  
Foxe1  Forkhead box E1 
(thyroid 
transcription 
factor 2)  
 Defective migration 
ofthyroid precursor cells, 
palatal shelves 
movecorrectly but do not 
fuse  
FOXE1  Thyroid agenesis, 
cleft palate, 
choanal atresia 
Fst  Follistatin  Cleft palate or absent hard palate (16–
55%), delayed/absent lower incisors 
Defective chondrogenesis/ 
bone formation  
FST  –  
Gabrb3  γ-amino 
butyricacid 
receptor,subunit 
β3  
Cleft palate  GABRB3 –  
Gad1  Glutamic acid 
decarboxylase 
1(Gad67)  
Cleft palate  Palatal shelves elevate but 
fail to fuse  
GAD1  –  
Gja1 Gap 
junctionmembra
ne channel 
protein α1 
(Connexin43) 
Delayed membranous 
andendochondral ossification of skull  
Impaired neural-crest 
migration and 
osteoblastdysfunction  
GJA1 –  
Gli2  GLI-Kruppel 
familymember 2  
Deficient medial ossification of 
frontal and parietal bones,absent 
upper/lower incisors,cleft palate 
Skeletal development  GLI2 –  
Gli3  GLI-Kruppel 
familymember 3  
Neural-tube defect, largemaxilla and 
premaxilla  
Defective neural-tube 
closure and skeletogenesis  
GLI3  Greig, Pallister 
Hall syndromes  
Gp330  Glycoprotein 
330 (megalin)  
Holoprosencephaly  Reduced 
telencephalicvesicle; 
mediates endocytosis of 
lipoproteins andother 
LRP2  –  
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macromolecules  
Gsc  Goosecoid  Hypoplastic lower mandible,aplastic 
nasal cavity, capsule, inner ear  
Expression in neural-crest 
derivates 
(mandibulararch) after 
E10.5  
GSC  –  
Hes1  Hairy and 
enhancerof split 
1  
Failure of neural-tube closure  Premature neurogenesis  HRY  –  
Hesx1  Homeobox 
geneexpressed in 
ES cells  
Reduction of telencephalicvesicles, 
eyes, olfactoryplacodes, frontonasal 
mass   
First expressed in anterior 
ventral endoderm; 
defectiveinduction of 
prospective 
prosencephalic neuro-
ectoderm  
HESX1  Septo-optic 
dysplasia  
Hhex  Haematopoietica
llyexpressed 
homeobox  
Variable anterior truncations  Required for specification 
of axial mesendoderm  
HHEX  –  
Hic1  Hypermethylate
din cancer 1  
Variable, 50% with gross defects 
including acrania, exencephaly,cleft 
palate  
–  HIC1  –  
Hoxa1  Homeobox A1  Delayed neural-tube closure, 
abnormal basioccipital, ex-occipital, 
interparietal bones,inner ear  
Abnormal patterning of 
hindbrain rhombomeres 
and associated neural crest  
HOXA1  –  
Hoxa2  Homeobox A2  Duplication of proximal first arch 
elements (malleus, incus, gonial, 
squamosal, pterygoidbones), 80% 
cleft palate  
Homeotic respecification 
of second to first arch 
identity  
HOXA2  –  
Hoxa3  Homeobox A3  Mild shortening of mandible Abnormal developmentof 
pharyngeal 
arches,especially 3 and 4  
HOXA3  –  
Hspg2  Perlecan  40% die at E10.5 with defective head 
development; 6%exencephaly, rest 
short-domed skull, cleft palate, wide 
sutures  
Inhibition of chondrocyte 
proliferation  
HSPG2  Schwartz–
Jampelsyndrome, 
dyssegmented 
dysplasia  
Inhba  Activin βA  Cleft seconary palate (variable 
%),absent lower incisors  
Defective chondrogenesis/ 
bone formation  
INHBA   
Itgav  Integrin αv  Cleft palate in 20% survivors  Delayed growth in head 
structures  
ITGAV   
Jag2  Jagged 2  Cleft secondary palate  Failure of palatal shelves 
to elevate  
JAG2   
Klf2 Kruppel-like 
factor2 (lung) 
Malformed lower jaw Secondary to haemato-
logical defect  
KLF2   
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Lef1  Lymphoid-
enhancerbinding 
factor 1  
Loss of teeth   –  LEF1  –  
Lhx1  LIM homeobox 
protein 1  
Absent node at E7.5, lack ofhead 
structures anterior to otic vesicle  
First expressed in 
anterioventral 
endoderm;failure of brain 
specificationjust anterior 
to rhomomere 3  
LHX1  –  
Lhx8  LIM homeobox 
protein 8  
Isolated cleft secondary palate  Palatal shelves form and 
elevate, but fail to fuse  
–  –  
Lmx1b  LIM homeobox 
transcription 
factor 1β  
Absent fontanelles and supra-occipital 
bone, small interparietalbone, partial 
cranial suture fusion  
–  LMX1B  Nail–patella 
syndrome  
Macs  Myristoylatedala
nine-rich 
proteinkinase C 
substrate  
Exencephaly (25%)  –  MACS  –  
Madh2  MAD 
homologue 2  
Haploinsufficiency: absent or 
hypoplastic mandible, absenteye 
(E6.0, lethal)  
Required for organization 
of primitive germ 
layersbefore gastrulation  
MADH2  –  
Mmp14  Matrix metallo-
proteinase 14 
(membrane-
inserted)  
Domed head, prominent cranial 
sutures (birth)  
Generalized ossification 
defect  
MMP14  –  
Msx1  Msh-like 
homeobox 1  
Short mandible, absent incisors,cleft 
secondary palate, minorabnormality 
of skull vault   
Differentiation of 
pharyngeal arch 
ectomesenchyme into 
bones and teeth,impaired 
development ofpalatal 
shelves  
MSX1  Selective tooth 
agenesis, cleft 
lip/palate  
Msx2  Msh-like 
homeobox 2  
Frontal bone defect, small inter-
parietal and supraoccipitalbones  
Reduced progenitors in 
osteogenic fronts  
MSX2  Craniosynostosis,
Boston type; 
parietalforamina  
Nog  Noggin  Exencephaly  Required for neural-tube 
patterning  
NOG  Proximal 
symphalangism, 
multiple 
synostosessyndro
me 1  
Otx2  Orthodenticle 
homologue 2  
Homozygote: reduced embryonic 
ectoderm at E7.5,absent fore- and 
midbrain regions at E9.5 
(E7.5).Heterozygote: normal 
(16%),through to acrania (3%),most 
First expressed in anterio-
ventral endoderm; 
primaryrole in 
specification of head  
OTX2  –  
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with micro/agnathiaand 
micro/anophthalmia  
Pax2  Paired box 2  Exencephaly, failure to close optic 
fissure, abnormal otic vesicle  
Regulator of pattern in 
eye and ear  
PAX2  Renal coloboma 
syndrome  
Pax3  Paired box 3  Neural-tube defect, deficiencyof 
melanocytes, Schwann cells,dorsal 
root ganglia  
Abnormal neural-crest 
development  
PAX3  Waardenburg 
syndrome type 1  
Pax6  Paired box 6  Homozygote: absent eyes andnasal 
cavities. Heterozygote: small eyes, 
iris hypoplasia  
Aberrant lens and nasal 
placode formation, 
delayedclosure of optic 
fissure  
PAX6  Aniridia  
 
Pax7  
Paired box 7  Short maxilla, hypoplastic 
nasalstructures  
–  PAX7  – 
Pax9  Paired box 9  Cleft secondary palate, absentteeth  –  PAX9  Oligodontia 
Pcsk6  Proprotein 
convertase 
subtilisin/kexin 
type 6  
Cyclopia, anterior truncationswith 
absence of telencephalon, nasal 
capsule, upper and lowerjaw, 
laterality effects   
Impaired processing of 
BMPs  
PACE4  –  
Pdgfra  Platelet-derived 
growth factor 
receptor, α-poly-
peptide  
Cleft face, bleb over neural tube  Failure of subset of non-
neuronal neural-crest cells 
to migrate  
PDGFRA  –  
Pitx1  Paired-like 
homeodomain 
transcriptionfact
or 1  
Very short mandible, normal teeth   Required for bone 
development  
PITX1  –  
Pitx2  Paired-like 
homeodomain 
transcriptionfact
or 2  
Cleft palate, abnormal maxillaand 
mandible with arrested tooth 
development, malformedeyes   
Abnormal Fgf8 andBmp4 
signalling 
duringmorphogenesis  
PITX2  Rieger syndrome  
Prrx1  Paired related 
homeobox 1  
Cleft secondary palate, 
absentsquamosal, zygomatic, 
tympanicring, hypoplastic mandible   
Defective growth of 
mandibular arch 
components; 
normalneural-crest 
migration  
PMX1  –  
Raldh2  Retinaldehydede
hydrogenase 2  
Short frontonasal region, neural-tube 
defect   
Synthetic deficiency 
ofretinoic acid; rescued 
bymaternal RA 
administration  
RALDH2  –  
Rax  Retina and 
anterior neural 
fold homeobox  
Anophthalmia, absent forebrain, 
reduced midbrain   
Failure of optic cup 
formation  
RX  Severe congenital 
microphthalmia  
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Runx2  Runt-related 
transcription 
factor 2  
Homozygote: defectiveossification of 
all bones (E17.5).Heterozygote: 
defectiveossification of skull vault, 
clavicle,hypoplastic hyoid, pubic, 
ischial,wide xiphoid process  
Required for osteoblast 
differentiation  
RUNX2  Cleidocranial 
dysplasia  
Ryk  Receptor-like 
tyrosine kinase  
Cleft secondary palate (88%),short 
snout, small, rounded cranial vault  
Defective 
extrapalatalmorphogenesi
s  
RYK  –  
Shh  Sonic hedgehog  Central optic vesicle, underdeveloped 
mid- and forebrain  
Maintenance of notochord  SHH  Holoprosencephal
y  
Sil  Tal1 interrupting 
locus  
Cyclopia and neural-tube defect; 
lethal by  
Possible block in Shh-
mediated signalling  
SIL  –  
Ski  Sloan–
Ketteringviral 
oncogenehomolo
gue  
Failure of neural-tube closure, absent 
presphenoid, small mandible, 
basioccipital,basisphenoid   
Excessive apoptosis 
incranial mesenchymeand 
neural tube  
SKI  –  
Tbx1  T-box 1  Abnormal mandible, ears; cleft palate  Absent second and third 
TBX1 branchial arches, 
otic vesicles  
 DiGeorge 
syndrome 
Tcfap2a  Transcription 
factor 
Exencephaly, reduced maxilla  and 
mandible 
Neural-crest migration 
normal; excess 
neuroepithelial 
proliferation 
and cell death 
TFAP2A – 
Tcof1 Treacher 
Collins– 
Franceschetti 
syndrome 1, 
homologue 
Exencephaly, anophthalmia, nasal 
agenesis, abnormalmaxilla 
Neural-crest apoptosis  TCOF1  Treacher Collins– 
Franceschetti 
syndrome 
Tgfb2  Transforming 
growth factor β2  
Cleft palate (23%), reduced  size and 
ossification of frontal interparietal, 
parietal, squamosal 
Neural crest and 
skeletogenesis 
TGFB2 – 
Tgfb3  Transforming 
growth factor β3  
Isolated cleft secondary palate  Palatal shelves apposebut 
fail to fuse  
TGFB3  – 
Trp53  Transformation-
related protein 
53(p53)  
8–16% exencephaly  –  TP53  Li–Fraumeni 
syndrome  
Trp63  Transformation-
related protein 
63 (p63)  
Small mandible   Required for epithelial 
development  
TP63  Ectrodactyly, 
ectodermal 
dysplasia,clefting  
Twist  Twist  Failure of neural-tube closure, 
abnormal branchial arches  
Mesenchymal expression 
required for neural-tube 
TWIST  Saethre–Chotzen 
syndrome  
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      GLI2  2q14  –  
 
closure and neural-crest  
Vax1  Ventral anterior 
homeobox 1  
contribution to branchial    –  
Vcl  Vinculin  arches    –  
Wnt5a  Wingless-related 
MMTV 
integrationSite 
5A  
Lobar holoprosencephaly, fused 
maxillary incisors, cleft palate  
Required for optic nerve 
and forebrain 
development; also first 
branchial arch  
VAX1  –  
Zfx1a  Zinc-
fingerhomeobox 
1a (δEF1)  
Neural-tube defect   Failure of closure  VCL  –  
  Short maxilla and mandible   Reduced amount of 
mesoderm leading 
toreduced outgrowth  
WNT5A  –  
  Neural-tube defect (1%), shortdistal 
maxilla and mandible,hyperplastic 
Meckel’s cartilage,cleft palate   
Neural crest and 
skeletogenesis  
TCF8  –  
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Table S2: Common human craniofacial disorders with known single gene mutations. 
Disorder Gene Major craniofacial 
abnormalities 
Parietal foramina 2 ALX4 
 
Parietal foramina, 
cranium bifidum 
Gardner syndrome APC Jaw cysts 
Chondrodysplasia punctata, 
X-linked recessive 
ARSE Nasal hypoplasia 
Marshall syndrome COL11A1 
 
Flat midface, cleft palate, 
hearing loss 
Stickler syndrome, type II Cleft palate, micrognathia, 
Myopia, beaded vitreous 
hearing loss 
Otospondylomega-epiphyseal 
dysplasia syndrome 
COL11A2 
 
Cleft palate, deafness 
Stickler syndrome, type III, 
Weissenbacher–Zweymuller 
syndrome 
Cleft palate, micrognathia, 
hearing loss 
Knobloch syndrome COL18A1 Occipital encephalocele 
Kniest dysplasia COL2A1 Cleft palate 
Spondyloepimetaphyseal 
dysplasia, Strudwick type 
Stickler syndrome, type I 
Cleft palate, micrognathia, 
Myopia, retinal hearing 
lossdetachment 
Pycnodysostosis CTSK 
 
Hypoplastic mandible, 
delayed eruption of teeth, 
wide cranial sutures 
Smith–Lemli–Opitz syndrome DHCR7 
 
Cleft palate, 
holoprosencephaly 
Trichodentoosseous syndrome DLX3 
 
Macrocephaly, skull 
sclerosis, delayed dental 
eruption 
Dentinogenesis imperfecta DSPP Abnormal dentin production 
and mineralization, 
sensorineural hearing loss 
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Atelosteogenesis dysplasia I 
(Neonatal osseus type II) 
DTDST Cleft palate 
Diastrophic dysplasia Malformed external ears, 
cleft palate 
Ectodermal dysplasia, 
anhydrotic 
ED1 Absent or pointed teeth 
Ellis–van Creveld syndrome EVC Lip-tie, hypodontia 
Weyers acrofacial dysostosis Conical teeth, abnormal 
mandible 
Branchio-oto-renal dysplasia EYA1 Branchial fistulas, 
malformed ears, cochlear 
malformation 
Shprintzen–Goldberg 
syndrome 
FBN1 
 
Craniosynostosis 
 
Pfeiffer syndrome FGFR1 Craniosynostosis 
Apert syndrome 
Beare–Stevenson cutis gyrata 
syndrome 
Crouzon syndrome, Jackson–
Weiss syndrome 
FGFR2 Craniosynostosis 
Achondroplasia FGFR3 Macrocephaly 
 
Crouzon syndrome with 
acanthosis nigricans 
Craniosynostosis, 
cementomas of jaw 
 
Muenke syndrome Coronal synostosis 
 
Thanatophoric dysplasia, types 
I and II 
Severe craniosynostosis 
 
Lymphoedema–distichiasis 
syndrome 
FOXC2 Cleft palate 
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Hypothyroidism, athyroidal, 
with spiky hair and cleft palate 
 
FOXE1 
 
Cleft palate 
 
Greig cephalopoly-syndactyly GLI3 
 
Macrocephaly 
Pallister–Hall syndrome Cleft palate, microtia 
Simpson–Golabi–Behmel 
syndrome, type 1 
 
GPC3 
 
Macrocephaly, cleft palate 
Dyssegmental dysplasia, 
Silverman–Handmaker type 
HSPG2 Cleft palate, small jaw, flat 
face, encephalocele 
Hyaluronidase deficiency 
 
HYAL1 
 
Submucous cleft palate 
 
Opitz G syndrome, type I 
 
MID1 
 
Hypertelorism, cleft 
lip/palate 
 
Hypodontia with 
orofacial cleft 
MSX1 
 
Cleft lip/palate, 
hypodontia 
Craniosynostosis, type 2  
(Boston) 
MSX2 Variable craniosynostosis 
Parietal foramina 1 Parietal foramina 
Oral–facial–digital syndome OFD1 Midline clefts, tongue 
hamartomas, dystopia 
canthorum 
Craniofacial–deafness–hand 
syndrome 
PAX3 Hypertelorism, hypoplastic 
nose, hearing loss 
Waardenburg syndrome, types 
I and III 
Dystopia canthorum 
 
Aniridia PAX6 Aniridia, Peters anomaly, 
foveal hypoplasia, keratitis 
anophthalmia 
(homozygous) 
Oligodontia PAX9 Oligodontia 
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Rieger syndrome, type 1 PITX2 Hypodontia 
Basal cell nevus syndrome PTCH Jaw cysts, macrocephaly 
Bannayan–Zonana syndrome PTEN Macrocephaly 
Metaphyseal 
chondrodysplasia, Murk 
Jansen 
PTHR Cranial sclerosis, choanal 
stenosis 
Cleft lip/palate ectodermal 
dysplasia syndrome, 
Zlotogora– Ogur syndrome 
PVRL1 Delayed membraneous skull 
ossification, dental 
abnormalities 
Robinow syndrome, autosomal 
recessive 
ROR2 Macrocephaly, facial cleft 
Cleidocranial dysplasia RUNX2 
 
Cleft lip/palate 
Dental anomalies, isolated Delayed eruption of 
permanent teeth 
Townes–Brocks syndrome SALL1 Dysplastic ears, preauricular 
pits/tags, hearing loss 
Holoprosencephaly-3 SHH Holoprosencephaly, 
cyclopia, proboscis 
Hirschsprung disease with 
microcephaly, mental 
retardation, distinct facial 
features 
SIP1 Hypertelorism, 
microcephaly 
Holoprosencephaly-2 SIX3 Holoprosencephaly, cleft 
lip/palate 
Sclerosteosis SOST Cortical hyperostosis 
Van Buchem disease Osteosclerosis of skull, 
mandible 
Campomelic dysplasia with 
autosomal sex reversal 
SOX9 Cleft palate 
DiGeorge syndrome TBX1 Cleft palate 
Treacher Collins 
mandibulofacial dysostosis 
 
TCOF1 
 
Malar hypoplasia, ear 
anomalies, cleft palate 
Holoprosencephaly-4 TGIF Lobar or semilobar 
holoprosencephaly, midline 
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cleft lip/palate 
Ectrodactyly, ectodermal 
dysplasia, and cleft lip/palate 
syndrome 3 
TP63 Cleft lip/palate 
Saethre–Chotzen syndrome 
 
TWIST 
 
Craniosynostosis 
 
Holoprosencephaly-5 ZIC2 Alobar or semilobar 
holoprosencephaly, mild 
facial anomaly 
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STATEMENT OF CONSENT 
 
I, (Name, please print) _____________________________________________ 
 
agree to participate in this study. 
 
I have read the attached explanatory information.  
 
I understand that this study will be of no direct benefit to me. 
 
I understand that participation in this study is voluntary and that I am free to 
withdraw at any time without penalty or comment. 
 
      I am happy for a blood/saliva sample to be taken.  
       
      I am happy for an image of my face to be taken 
 
      I am happy for my sample to be used for other studies in the future.  
 
      I am happy to complete the questionnaire.  
 
 
Please tick the appropriate boxes. 
 
If you are under 18, a parent/guardian signature is required. 
 
I understand that my anonymity will be strictly preserved and photographs will 
be used only to classify my facial features and colouring. 
 
 
Signature of Participant ______________________________  
 
 
 
Date ___________ 
 
 
 
 
Signature of parent/guardian_____________________________ 
 
 
Date ___________ 
 
Supplemental document S3. Consent form and explanatory statement 
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EXPLANATORY STATEMENT 
 
Project Title: Inheritance of complex physical characteristics such as hair colour 
Chief Investigator: Dr Angela van Daal 
Faculty of Health Sciences and Medicine, Bond University. 
Gold Coast, Queensland 4229 
Ph: 07 5595 4433 
e-mail: avandaal@staff.bond.edu.au 
 
Bond University is committed to research in various forms. In order to conduct some research 
projects biological samples from individuals are required.  
This project aims to investigate the inheritance of complex physical characteristics (eg hair 
colour, height) by analysing genes identified as associated with the particular physical trait. To 
carry out this research biological samples from individuals of families or groups with a high 
incidence of the particular physical characteristic are required (eg families containing many 
individuals with red hair). 
Your involvement will be limited to a buccal swab sample (swab from inner cheek) or blood 
sample. A buccal swab is collected by simply rubbing a cotton bud (or something similar) 
firmly against the inside of your cheek. This is allowed to dry before placing it in the plastic 
sleeve. Alternatively or additionally a blood sample will be collected.  
If you do not wish your sample to be used for these purposes, then you must not volunteer 
for this study.  
Before signing this consent form you should be aware that your participation is voluntary. If 
you decide to take part you may also discontinue your participation at any time without 
comment or penalty.  
 
If you are under 18, a parent/guardian signature is required 
 
The results of this research may be published at a future date. Your anonymity will be 
preserved. 
 
You may contact the Chief Investigator about any matter of concern (see address and contact 
details above) should you wish to raise any concern. If you have any concerns about the ethical 
conduct of this research, please contact the Bond University Human Research Ethics Committee 
located at Level 2, Central Building, Bond University QLD 4229 Phone: 5595 4194 Fax: 5595 
4122 E-mail: buhrec@bond.edu.au  
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Supplemental document S4- Questionnaire 
 
QUESTIONNAIRE 
Name:             __________________________________     
Date of Birth:   ______________       Email/Phone: ______________ 
Please answer the following questions for your appearance as at about 20 
years of age by circling the most appropriate category.  
Ancestry Caucasian 
 
Asian 
 
Indian  Indigenous 
Australian 
African Other 
Ancestry Details  
Face/Head 
measurements 
v-gn (craniofacial height) eu-eu (head width)   g-op (head length) 
HAIR  
Natural Colour & 
Shade: 
RED Auburn Orange Carrot Strawberry 
 BLONDE Light Blonde Dark Blonde 
 BROWN Light Brown Medium 
Brown  
Dark Brown Brown with red  
 BLACK Light Black Dark Black 
Significant hair colour change from child to adult? No Yes 
 got much darker got lighter 
Curliness VERY CURLY CURLY HAS BODY STRAIGHT 
Beard  Red Blonde Brown Black Mixture 
Eyebrows Red Blonde Brown Black Mixture 
EYES Eyelid  single double 
Colour & Shade BLUE Light Blue Medium Blue Dark Blue 
 GREEN Light Green  Medium Green Dark Green 
 GRAY Light Gray Medium Gray Dark Gray 
 HAZEL Light Hazel Medium Hazel Dark Hazel 
 BROWN Light Brown Medium Brown Dark Brown 
Skin Colour & 
Freckling 
FAIR Extensive 
Freckling 
Medium 
Freckling 
Light 
Freckling 
No Freckling 
 AVERAGE Extensive 
Freckling 
Medium 
Freckling 
Light 
Freckling 
No Freckling 
 DARK Olive Light Brown Dark Brown Black 
Ears  attached  non - attached 
Height Your height (cm or feet, inches)  
Weight Your current weight (kg or stones, pounds)  
Weight Your weight at 20-25 years of age (kgs, stones, pounds)  
Have you had any severe facial injuries or undergone facial surgery? If yes, please provide general details 
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